TW575564B - Piperazine derivatives and process for the preparation thereof - Google Patents

Piperazine derivatives and process for the preparation thereof Download PDF

Info

Publication number
TW575564B
TW575564B TW86112235A TW86112235A TW575564B TW 575564 B TW575564 B TW 575564B TW 86112235 A TW86112235 A TW 86112235A TW 86112235 A TW86112235 A TW 86112235A TW 575564 B TW575564 B TW 575564B
Authority
TW
Taiwan
Prior art keywords
ome
yield
nmr
piperazine
melting point
Prior art date
Application number
TW86112235A
Other languages
Chinese (zh)
Inventor
Eui-Hwan Cho
Sun-Gan Chung
Sun-Hwan Lee
Ho-Seok Kwon
Jae-Eung Lee
Original Assignee
Samjin Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019970022984A external-priority patent/KR100204320B1/en
Application filed by Samjin Pharm Co Ltd filed Critical Samjin Pharm Co Ltd
Application granted granted Critical
Publication of TW575564B publication Critical patent/TW575564B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

575564 A7 B7 五、發明説明(575564 A7 B7 V. Description of the invention (

(I) 經濟部中央標準局員工消費合作社印製 式中,心及I分別表氫原子、取代或非取代的 〜cs烷基、C3〜cs之取代或非取代的3〜6環之環烷 基、取代或非取代之c:2〜C8不飽和烷基、酮基、取代 或非取代的芳香基、取代或非取代的^〜匕烷氧基、 取代或非取代的芳香羥基、取代或非取代的胺基、Cl 〜C4低級酯基、低級硫代酯基、硫醇基、取代 或非取代的羧基、環氧基、取代或非取代的Ci〜c4低 級硫代烷氧基;或1及R2同時形成碳化氳3〜4不飽 和或飽和環、而I、Re、r5、心及心分別代表氫原 子、鹵原子、羥基、硝基、Cl〜c4低級酯基、Ci〜c4 低級烧基、C3〜C8之取代或非取代的3〜6環之環烧 基、心〜匕低級烷氧基、6〜(:4低級硫代烷氧基、取 代或非取代的芳香基、取代或非取代的芳香基低級烷 氧基、取代或非取代低級烷胺基、或以低級烷基取代 或非取代之甲酸酯基、或R3、R4、r5、r6及r7其中 二個相鄰接的基團互相結合,而形成伸苯環或伸萘環; -6 _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面、^注意事項再填寫本頁) -裝· 經濟部中央標準局員工消費合作社印製 A7 "1 ----__B7 五、發明説明(2 ) " '---— :系.曰氧原子、硫原子、取代或非取代的胺基; ,氧原子或…基(此處係與上述所述R8相同); Y係指結構式(1)化合物中,結合於γ所結合芳香 族環的3-位置或4_位置處者; 、、z係指氫原子、羥原子、C!〜c4低級烷氧基、取 2 ,非取代的氧化芳香基、Cl〜低級烷基胺基、可 含氮原子1〜5為止進行取代或非取代的環狀胺基; A係指一CH=或氮原子;(I) In the printed format of the Consumer Cooperative Organization of the Central Standards Bureau of the Ministry of Economic Affairs, I and I respectively represent hydrogen atoms, substituted or unsubstituted ~ cs alkyl groups, and substituted or unsubstituted 3 to 6 cyclocycloalkanes of C3 to cs. Group, substituted or unsubstituted c: 2 ~ C8 unsaturated alkyl group, keto group, substituted or unsubstituted aromatic group, substituted or unsubstituted ^ ~ alkoxy group, substituted or unsubstituted aromatic hydroxyl group, substituted or Unsubstituted amine group, Cl ~ C4 lower ester group, lower thioester group, thiol group, substituted or unsubstituted carboxyl group, epoxy group, substituted or unsubstituted Ci ~ c4 lower thioalkoxy group; or 1 and R2 simultaneously form 氲 3 ~ 4 unsaturated or saturated rings of carbonized carbide, and I, Re, r5, heart and heart respectively represent hydrogen atom, halogen atom, hydroxyl group, nitro group, Cl ~ c4 lower ester group, and Ci ~ c4 lower group Alkyl, C3 to C8 substituted or unsubstituted 3 to 6 ring alkynyl, heart to lower alkoxy, 6 to (: 4 lower thioalkoxy, substituted or unsubstituted aromatic, substituted Or unsubstituted aromatic lower alkoxy, substituted or unsubstituted lower alkylamino, or substituted or unsubstituted methyl with lower alkyl Acid ester group, or two adjacent groups of R3, R4, r5, r6 and r7 are combined with each other to form a benzene ring or a naphthalene ring; -6 _ This paper size applies to Chinese National Standard (CNS) A4 Specifications (210X297 mm) (Please read the back, ^ Note before filling in this page)-Equipment · Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 " 1 ----__ B7 V. Invention Description (2) " '----: Department. Said oxygen atom, sulfur atom, substituted or unsubstituted amine group;, oxygen atom or ... group (here is the same as the above-mentioned R8); Y means the structural formula (1) In the compound, those which are bound at the 3-position or the 4-position of the aromatic ring to which γ is bound;,, and z refer to a hydrogen atom, a hydroxyl atom, a C! ~ C4 lower alkoxy group, and 2, a non-substituted oxidized aromatic Group, Cl ~ lower alkylamine group, cyclic amine group which may be substituted or unsubstituted up to 1 ~ 5 nitrogen atoms; A means a CH = or nitrogen atom;

Ci〜Cs烷基係指甲基、乙基、丙基、異丙基、n_ 丁基、異丁基、t-丁基、戊基、異戊基、己基、庚基、 辛基、2-甲基戊基等直鏈或分枝狀的烷基; A低級烧基係指甲基、乙基、丙基、異丙基、 η-丁基、異丁基、卜丁基等; C3〜C8取代或非取代的3〜6環之環烷基係指環 丙基、環丁基、環戊基、環己基、取代環丙基、取代 環戊基、取代環己基等取代或非取代的環烷基; ci〜C4低級酯基係指羧基利用低級烷基進行酯化 的基團; 仏〜匕低級烷氧基係指甲氧基、乙氧基、丙氧基、 異丙氧基、丁氧基、異丁氧基、t-丁氧基等; C!〜C4低級硫代烷氧基係指硫代甲基、硫代乙基、 硫代丙基、硫代異丙基、硫代丁基、t-硫代丁基等; c 1〜c4低級烷基胺基係指甲胺基、乙胺基、丙胺 基、丁胺基等; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁} 裝. 、可 575564 A7 B7 經濟部中央標準局員工消費合作社印製 1、發明説明(3 ) 氧化芳香基係指苯氧基、取代苯氧基、萘氧基、 或取代萘氧基等; 可含氮原子1〜5為止的環狀胺基係指吡咯烷 基、吡咯啉基、脒嗤啉基、吡唑基、吡唑啉基、吡唑 烷基、三唑啉基、四唑啉基、哌嗪烷基等。 本發明乃針對具抗癌活性的相關化合物,經進行 長時間研究而所獲得的結果,由結果顯示,本發明者 赫然發現本發明所揭結構式(1)化合物的酸加成鹽具有 優越的抗癌效果,且所具毒性極少的驚人事實存在, 故造就本發明的出現。 没是,本發明之目的,係提供一種具優越抗癌效 果且毒性極少之結構式(1)所示化合物及其酸加成鹽。 本發明之另一目的,係提供一種結構式(1)化合物 及其酸加成鹽的製造方法。 本發明之化合物,係可與藥學上許可的賦形劑等 共同混合,利用藥學上通常使用的製劑方式,進行荜 學製劑的製造,而可使用於多種類腫瘤的預防與治療。 故,本發明之另-目的,係提供一種包含以結構 式(1)化合物為有效成分的藥學製劑。 在本發明中,能與化合物⑴進行反應而形成酸加 成鹽的酸類,乃為藥學上許可的無機酸或有機酸,毯 如鹽酸、演酸、硫酸、燐酸、氮酸等無機酸,甲酸、 乙酸、丙酸、琥珀酸、瓜胺酸、馬來酸、丙二酸等有 機酸類,絲胺酸、半光胺酸、脫胺酸、天冬酿胺、谷 -8- 本紙張尺度適用中國國豕標準(CNS ) A4規格(210X297:^^1 ~一 -----— _Ci ~ Cs alkyl means methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, t-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, 2- Linear or branched alkyl such as methylpentyl; A lower alkyl refers to methyl, ethyl, propyl, isopropyl, η-butyl, isobutyl, butyl, etc .; C3 ~ C8 substitution Or unsubstituted 3 to 6 ring cycloalkyl refers to substituted or unsubstituted cycloalkyl such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, substituted cyclopropyl, substituted cyclopentyl, substituted cyclohexyl, etc. Ci ~ C4 lower ester group refers to a group in which a carboxyl group is esterified with a lower alkyl group; 仏 ~ lower alkoxy is nailoxy, ethoxy, propoxy, isopropoxy, butoxy, Isobutoxy, t-butoxy, etc .; C! ~ C4 lower thioalkoxy refers to thiomethyl, thioethyl, thiopropyl, thioisopropyl, thiobutyl, t-thiobutyl, etc .; c 1 ~ c4 lower alkylamines are nailamine, ethylamine, propylamine, butylamine, etc .; this paper size is applicable to China National Standard (CNS) A4 specifications (210X297 mm) ) (Please read the first Note: Please fill in this page again} Pack. 575564 A7 B7 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 1. Description of the invention (3) Oxidized aromatic group refers to phenoxy, substituted phenoxy, naphthyloxy, or Substituted naphthyloxy, etc .; Cyclic amine groups that can contain 1 to 5 nitrogen atoms refer to pyrrolidinyl, pyrrolinyl, fluorinyl, pyrazolyl, pyrazolinyl, pyrazolyl, triazole Porphyrinyl, tetrazolinyl, piperazinyl, etc. The present invention is a result obtained through long-term research on related compounds with anticancer activity. The results show that the present inventors have discovered the present invention. The acid addition salt of the compound of formula (1) has superior anti-cancer effects, and the surprising fact that it has very little toxicity exists, which led to the appearance of the present invention. No, the object of the present invention is to provide an excellent anti-cancer agent. The compound represented by structural formula (1) and its acid addition salt with little effect and little toxicity. Another object of the present invention is to provide a method for producing a compound of structural formula (1) and its acid addition salt. Compounds of the present invention Is compatible with pharmacy Excipients and the like are mixed together, and the pharmaceutical preparations are generally used to manufacture medical preparations, which can be used for the prevention and treatment of various types of tumors. Therefore, another object of the present invention is to provide a structure comprising The compound of formula (1) is an active ingredient of a pharmaceutical preparation. In the present invention, the acids capable of reacting with the compound 形成 to form an acid addition salt are pharmaceutically acceptable inorganic or organic acids, such as hydrochloric acid, or acid. , Sulfuric acid, acetic acid, nitric acid and other inorganic acids, formic acid, acetic acid, propionic acid, succinic acid, citric acid, maleic acid, malonic acid and other organic acids, serine, semi-photoamine, deaminate Winter stuffed amine, grain-8- This paper size is applicable to China National Standard (CNS) A4 specification (210X297: ^^ 1 ~ 一 -----— _

A7 A7 五 、發明説明 胺酸、賴胺酸、掉々 甲石^ Z “酸、酪胺酸、脯胺酸等氨基酸類, T石頁酸、乙石黃酸、婪戌成 土又胡 本只酉夂、甲苯石黃酸等石黃酸類。 成分t:Lt:丨ΐ製造含有以結構式⑴化合物為有效 :…子製劑時所採用的賦形劑,可使用鐾如甘味 2結合劑、溶解劑、溶解辅助劑、濕潤劑、柔 劑崩壞劑、氧化防止劑、防腐劑、 :二充劑、芳香劑等,具體而言,則如乳糖、 方疋糖、庶糖、甘露糖醇、山梨糖醇、纖維素、甘氨 s夂、矽酸酐、滑石、硬脂酸、甾醇、黃蓍膠、甲基纖 維素、羧甲基纖維素納鹽、凝穋、對氨苯基肿酸、水、 乙醇、具乙二醇、聚乙烯吡咯烷酮、氯化鈉、氯化鉀、 橘子香精、草莓香精、香草精等。 至於本發明所提供結構式(1)化合物的使用量,乃 依照患者的年齡、性別、病患程度之不同而有互異。 基本上,一天可分一次或數次投與lmg至50〇〇mg左右 的藥劑量。 方 本發明所提供的結構式(1)化合物,可利用下列 私式I進行製造。A7 A7 V. Description of the invention Amino acid, lysine acid, arsenite ^ Z "Amino acids such as acid, tyrosine, proline, etc. Only lutein acids such as osmium, toluene lutein and so on. Ingredient t: Lt: 丨 ΐ Manufactured with excipients containing the compound of formula 为 as effective: ... Sub-formulations can be used, such as sweet taste 2 binding agent, Dissolving agents, dissolving aids, wetting agents, softeners, disintegrating agents, oxidation inhibitors, preservatives, secondary fillers, fragrances, etc., specifically, such as lactose, cube sugar, caramel, mannitol, Sorbitol, cellulose, glycine stilbene, silicic anhydride, talc, stearic acid, sterol, tragacanth, methyl cellulose, sodium carboxymethylcellulose, gelatin, p-aminophenyl tumour acid, Water, ethanol, ethylene glycol, polyvinylpyrrolidone, sodium chloride, potassium chloride, orange flavor, strawberry flavor, vanilla extract, etc. As for the amount of the compound of formula (1) provided by the present invention, it is based on the patient's Different ages, genders, and patient levels vary. Basically, it can be divided once a day or Several doses of about 1 mg to about 50,000 mg are administered. Formula The compound of formula (1) provided by the present invention can be manufactured using the following private formula I.

方裎式ISquare I

-9 (c)-9 (c)

H-N NH-N N

本、’'氏張尺度適用中關家標準(CNS ) A4規格( 210X297公釐) 575564The “Zhang” scale is applicable to the Zhongguanjia Standard (CNS) A4 specification (210X297 mm) 575564

五、發明説明(5 )V. Description of the invention (5)

(I) 經濟部中央標準局員工消費合作社印製 式中,心^2卫3,:^4,尺5术6卫7,,又,弋2係指如同前所 述’而Lie則係指_原子或與磺醯基相同的脫離基。 將結構式(a)化合物,在一 c(=X) —供給試藥存在 下,於通常的有機溶劑中,進行反應,便可有效的製 得結構式(b)化合物。然後在連續的與結構式(c)化合物 進行反應後,便可獲得結構式(1)化合物。 所謂一C(=X)—基供給試藥,係可採用諸如丨,〗-羰 二咪唑基、1,1-羰硫代二咪唑基、磷酸肌酸、硫代石舞 酸肌酸、羰二苯氧基、苯氯化甲酸酯等。 在該反應中,可使用通常所使用的有機溶劑,諸如 四氯甲烷、二氯甲烷、氯仿、乙腈、二曱基甲醯胺等。 此外,該反應係最好在結合試藥存在下,進行反應 者為佳。而在該反應中所可以採用的結合試藥,則為 一般所通用的無機或有機鹼基者。 上述所謂該反應的無機或有機鹼基,係指氫化鈉、 氫化鉀、氫氧化鈉、氫氧化鉀、碳酸鈉、碳酸鉀、碳 酸硒、碳酸氫鈉、碳酸氫鉀、三曱基胺、咄啶、db= 等。使用量則以1當量至5當量間者為佳。 該反應係在由3 °C至溶劑沸點溫度之間,最好係在 (請先閱讀背面之注意事項再填寫本頁) -裝· 訂 10-(I) In the printed format of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, the heart ^ 2 Wei 3, ^ 4, ruler 5 surgery 6 Wei 7, and 弋 2 means as described above, and Lie means _ Atom or the same leaving group as sulfofluorenyl. The compound of structural formula (b) can be effectively prepared by reacting the compound of structural formula (a) in the presence of a c (= X) -provided reagent in a common organic solvent. The compound of formula (1) can be obtained by continuously reacting with the compound of formula (c). The so-called C (= X) -based supply reagent can be used, such as 丨, carbonyldiimidazolyl, 1,1-carbonylthiodiimidazolyl, creatine phosphate, thiocreatine creatine, carbonyl Diphenoxy, phenylchloroformate, etc. In this reaction, commonly used organic solvents such as tetrachloromethane, dichloromethane, chloroform, acetonitrile, dimethylformamide and the like can be used. In addition, the reaction system is preferably performed in the presence of a combined reagent. The binding reagents that can be used in this reaction are those generally used in inorganic or organic bases. The above-mentioned inorganic or organic base of the reaction refers to sodium hydride, potassium hydride, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, selenium carbonate, sodium bicarbonate, potassium bicarbonate, trimethylamine, amidine Pyridine, db =, etc. The amount used is preferably between 1 equivalent and 5 equivalents. The reaction is from 3 ° C to the boiling point of the solvent, preferably at (Please read the precautions on the back before filling this page)-Binding · Order 10-

575564 A7 、發明説明( 5代至10(TC下進行反應5〜48小日夺尤以ι〇~ 者為佳。 j時 -C(=x)-基供給試藥的使用量係在卜15當量間, 別係以1〜11當量者為佳。 将 上述反應物中’當反應進行之際,產生酸性 副反應時,最好添加為將該#物質由反應“中予勺 去除的驗基性物質後,再進行反應。料絲性物質, 係譬如氫氧化鈉、氫氧化卸、氫氧储、氫氧化鎮、、’ 氧化鎂、氧化詞、石炭酸鉀、碳酸鈉、碳酸钾、碳酸鎂 重碳酸鎂、重碳酸鈉、重碳酸鉀等鹼金屬或鹼土金屬、 的氫氧化物、氧化物、碳酸鹽或重碳酸鹽,以及 胺基系統的鹼基存在下,進行反應進行者為佳。 上述結構式(2)所示化合物,係可利用如】575564 A7, description of the invention (5th generation to 10th (5 to 48 hours at TC), especially ι0 ~ is preferred. The amount of j-C (= x) -based supply reagent is used in Bu 15 Between equivalents, it is better to use 1 to 11 equivalents. When the above reactants are reacted with an acidic side reaction, it is best to add a test substance to remove the #substance from the reaction. After the substance is reacted, the material is silky, such as sodium hydroxide, hydroxide discharge, hydrogen storage, hydroxide hydroxide, magnesium oxide, oxidized word, potassium carboxylate, sodium carbonate, potassium carbonate, magnesium carbonate. The reaction is preferably carried out in the presence of alkali or alkaline earth metals such as magnesium bicarbonate, sodium bicarbonate, potassium bicarbonate, hydroxides, oxides, carbonates, or bicarbonates, and bases of the amine-based system. The compound represented by the above structural formula (2) can be used as

Chem.,1992,35,3784,3792等中所記載的方式,或 用其類似方法進行製造。 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) ( 210X297^^T^~~--—---- 575564 A7 B7 五、發明説明( 實施例 依照上述方法,而可製得下列化合物Chem., 1992, 35, 3784, 3792, etc., or a method similar to that described above. Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, the paper size is applicable to Chinese National Standards (CNS) (210X297 ^^ T ^ ~~ ---------- 575564 A7 B7 V. Description of the invention (The embodiment follows the above method, and The following compounds can be prepared

上述式.中,Ri Y、Z均如同上述所定義者 R4、R5、R6、 R7、A、X、 (請先閲讀背面t注意事項再填寫本頁) -裝· 經濟部中央標隼局員工消費合作社印製 實施例· .編號 Ri R2 Rs R4 R5 Re Rt A X V Z Y 1 Me Me SMe H H H H N 〇 NH 〇Me 3-N 2 Me Me 人 H H H H N 〇 NH 〇Me 3-N 3 Me Me Me Me H Me Me N 〇 NH OMe 3-N 4 Me Et SMe H H H H N 〇 NH 〇Me 3-N 5 Me Et 人 H H H H N 〇 NH OMe 3-N 6 Me Et Me Me H Me Me N 〇 NH OMe 3-N 7 Me Et H SH H H H N 〇 NH OMe 3-N 8 Me nPr H 〇Me H 〇Me H N 0 NH OMe 3-N 9 Me nPr H Me H Me H N 〇 NH OMe 3-N 10 Me nPr H F H F H N 〇 NH OMe 3-N 11 Me nPr 〇Me H H H H N 〇 NH OMe 3-N 12 Et Me H 〇Me H 〇Me H N 〇 NH OMe 3-N 13 Et Me H Me H Me H N 〇 NH OMe 3-N 14 Et Me H OH H H H N 〇 NH OMe 3-N 12- 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564In the above formula, Ri Y and Z are the same as defined above. R4, R5, R6, R7, A, X, (please read the precautions on the back before filling this page)-staff of the Central Bureau of Standards, Ministry of Economic Affairs Consumer Cooperative Cooperative Printed Example · .Ri R2 Rs R4 R5 Re Rt AXVZY 1 Me Me SH HHHHN 〇NH 〇Me 3-N 2 Me Me Human HHHHN 〇NH 〇Me 3-N 3 Me Me Me H Me Me N 〇NH OMe 3-N 4 Me Et SMe HHHHN 〇NH 〇Me 3-N 5 Me Et Human HHHHN 〇NH OMe 3-N 6 Me Et Me Me H Me Me N 〇NH OMe 3-N 7 Me Et H SH HHHN 〇NH OMe 3-N 8 Me nPr H 〇Me H 〇Me HN 0 NH OMe 3-N 9 Me nPr H Me H Me HN 〇NH OMe 3-N 10 Me nPr HFHFHN 〇NH OMe 3-N 11 Me nPr 〇 Me HHHHN 〇NH OMe 3-N 12 Et Me H 〇Me H 〇Me HN 〇NH OMe 3-N 13 Et Me H Me H Me HN 〇NH OMe 3-N 14 Et Me H OH HHHN 〇NH OMe 3-N 12- The size of the paper is applicable to the Chinese National Standard (CNS) A4 (210X297 mm) 575564

A 五、發明説明(8 ) 經濟部中央標準局員工消費合作社印製A V. Description of the invention (8) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

.實施例 編號 Ri r2 t Rs R4 Rs ^- Rc I rt ! ! ' A X Y | Z Y | 15 nPr Me H OMe H OMe H N 〇 NH OMe , 3-N 16 nPr Me H Me H Me H N 〇 NH OMe 3-N I 17 nPr Me H OH H H H N 〇 NH OMe 3-N 18 - (CH2)3- H OMe H OMe H N 〇 NH OMe 3-N 19 -(CH2)3- H Me H Me H N 〇 NH OMe 3-N 20 - (CH2)4- H OMe H OMe H N 〇 NH OMe 3-N 21 -(CH2)4- H Me H Me H N 〇 NH OMe 3-N| 22 Me Me H Me H Me H • N s NH OMe 3-N 23 Me Me H F H F H N s NH OMe ~j 3-N| __i 24 Me Me H OH H H H N s NH OMe 3-N 25 Me nPr H OMe H OMe H N s NH OMe 3-N 26 nPr Me H OMe H OMe H N s NH OMe 3-N 27 nPr Me H Me H Me H N s NH OMe 3-n! ! 28 nPr Me H OH H H H N s NH OMe 3-N丨 29 -(ch2)3- H OMe H OMe H N s NH OMe 3-N! | 30 -(ch2)3- H Me H Me H N s NH OMe 3-N 31 -(CH2)4- H OMe H OMe H N s NH OMe 3-N 32 - (CH2)4_ H Me H Me H N s NH OMe 3-N 33 Me Me H OMe H OMe H N 〇 NH NHMe 3-N 34 Me Me H Me H Me H N 〇 NH NHMe 3-N 35 Me Et H Me H Me H N 〇 NH NHMe 3-N 36 -(ch2)3- H OMe H OMe H N 〇 NH NHMe 3-N 37 - (CH2)3- H Me H Me H N 〇 NH MHMe 3-N 38 Me Me H OMe H OMe H N 〇 NH ^\q〇c 3-N 39 Me Me H Me H Me H N 〇 NH \/ \iBoc 3-N -13- (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564Example number Ri r2 t Rs R4 Rs ^-Rc I rt!! 'AXY | ZY | 15 nPr Me H OMe H OMe HN 〇NH OMe, 3-N 16 nPr Me H Me H Me HN 〇NH OMe 3- NI 17 nPr Me H OH HHHN 〇NH OMe 3-N 18-(CH2) 3- H OMe H OMe HN 〇NH OMe 3-N 19-(CH2) 3- H Me H Me HN 〇NH OMe 3-N 20 -(CH2) 4- H OMe H OMe HN 〇NH OMe 3-N 21-(CH2) 4- H Me H Me HN 〇NH OMe 3-N | 22 Me Me H Me H Me H • N s NH OMe 3 -N 23 Me Me HFHFHN s NH OMe ~ j 3-N | __i 24 Me Me H OH HHHN s NH OMe 3-N 25 Me nPr H OMe H OMe HN s NH OMe 3-N 26 nPr Me H OMe H OMe HN s NH OMe 3-N 27 nPr Me H Me H Me HN s NH OMe 3-n!! 28 nPr Me H OH HHHN s NH OMe 3-N 丨 29-(ch2) 3- H OMe H OMe HN s NH OMe 3-N! | 30-(ch2) 3- H Me H Me HN s NH OMe 3-N 31-(CH2) 4- H OMe H OMe HN s NH OMe 3-N 32-(CH2) 4_ H Me H Me HN s NH OMe 3-N 33 Me Me H OMe H OMe HN 〇NH NHMe 3-N 34 Me Me H Me H Me HN 〇NH NHMe 3-N 35 Me Et H Me H Me HN 〇NH NHMe 3-N 36-(ch2) 3- H OMe H OMe HN 〇NH NHMe 3-N 37-(CH2) 3- H Me H Me HN 〇NH MHMe 3-N 38 Me Me H OMe H OMe HN 〇NH ^ \ q〇c 3-N 39 Me Me H Me H Me HN 〇NH \ / \ iBoc 3-N -13- (Please first Read the notes on the reverse side and fill out this page) This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) 575564

A 五、發明説明(9 ) 經濟部中央標準局員工消費合作社印製A V. Description of invention (9) Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

.實施例 編號丨 Ri丨 ( R2 Rs R4 I I Rs ! 1 > R7 A X Y ! z Y 40 Me Et H 〇Me H 〇Me H N 〇 NH H ~\b〇c 3-N 41 Me Et H Me H Me H N 〇 NH H ~\lBoc 3-N 42 Me Me H 〇Me H 〇Me H N 〇 NH N0H 3-N 43 Me Me H Me H · Me H •N 〇 NH /~\h 3-N 44 Me Et H 〇Me H 〇Me H N 〇 NH Ο 3-N 45 Me Et H Me H Me H N 〇 NH 3-N 46 Me Ac H 〇Me H 〇Me H N 〇 NH OMe 3-N 47 Me Ac H Me H Me H N 〇 NH 〇Me 3-N 48 Me Ac H F H F H ' N 〇 NH OMe 3~N ! 1 49 Me Ac H Cl H Cl H N 〇 NH 1 OMe 3-N 1 50 Me Ac Me Me H H H N 〇 NH OMe 3-N 1 51 Me Ac 〇Me H H H IT N 〇 NH OMe 3-N 52 Me Ac H OH H H H N 〇 NH OMe 3-N 53 Me Ac H 〇Me H 〇Me H N S NH :OMe ! _ i 3-N 1 I t 54 Me Ac H Me H Me H N S NH OMe 3-N I 55 Me Ac H OH H H H N s NH OMe 3-N 56 Me OH 人 H 〇Me H 〇Me H N 〇 NH OMe 3-N 57 Me OH 人 H Me H Me. H N 〇 NH OMe 3-N 58 Me OH 人 Me Me H H H N 〇 NH OMe 3-N 59 Me OH 人 H F H F H N 〇 NH OMe 3-N 60 Me OH 人 H Cl H Cl H N 〇 NH OMe 3-N 61 Me OH 人 H 〇Me H H H N 〇 NH OMe 3-N 62 Me OH 人 H OH H H H N 〇 NH OMe 3-N 63 Me OH 人 H 〇Me H 〇Me H N s NH OMe 3-N 64 Me OH 人 H Me H Me H N s NH OMe 3-N -14 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 裝- 訂 575564 A7 B7 五、發明説明(10 ) 經濟部中央標準局員工消費合作社印製Example number 丨 Ri 丨 (R2 Rs R4 II Rs! 1 > R7 AXY! Z Y 40 Me Et H 〇Me H 〇Me HN 〇NH H ~ \ b〇c 3-N 41 Me Et H Me H Me HN 〇NH H ~ \ lBoc 3-N 42 Me Me H 〇Me H 〇Me HN 〇NH N0H 3-N 43 Me Me H Me H · Me H • N 〇NH / ~ \ h 3-N 44 Me Et H 〇Me H 〇Me HN 〇NH 〇 3-N 45 Me Et H Me H Me HN 〇NH 3-N 46 Me Ac H 〇Me H 〇Me HN 〇NH OMe 3-N 47 Me Ac H Me H Me HN 〇 NH 〇Me 3-N 48 Me Ac HFHFH 'N 〇NH OMe 3 ~ N! 1 49 Me Ac H Cl H Cl HN 〇NH 1 OMe 3-N 1 50 Me Ac Me Me HHHN 〇NH OMe 3-N 1 51 Me Ac 〇Me HHH IT N 〇NH OMe 3-N 52 Me Ac H OH HHHN 〇NH OMe 3-N 53 Me Ac H 〇Me H 〇Me HNS NH: OMe! _ I 3-N 1 I t 54 Me Ac H Me H Me HNS NH OMe 3-NI 55 Me Ac H OH HHHN s NH OMe 3-N 56 Me OH human H 〇Me H 〇Me HN 〇NH OMe 3-N 57 Me OH human H Me H Me. HN 〇 NH OMe 3-N 58 Me OH Human Me Me HHHN 〇NH OMe 3-N 59 Me OH Human HFHFHN 〇NH OMe 3-N 60 Me OH Human H Cl H Cl HN 〇NH OMe 3-N 61 Me OH Human H Me HHHN 〇NH OMe 3-N 62 Me OH human H OH HHHN 〇NH OMe 3-N 63 Me OH human H 〇Me H 〇Me HN s NH OMe 3-N 64 Me OH human H Me H Me HN s NH OMe 3-N -14-This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling out this page) Binding-Order 575564 A7 B7 V. Description of Invention (10) Economy Printed by the Consumer Standards Cooperative of the Ministry of Standards

實施例 編號 Ri ! ! 1 i τ-\ R4 Rs Rg 1 Rv A Y 7 Y 65 Me 乂h i 1 Η 〇Me H OMe H M 0 NH OMe 3-N 66 Me XH Η Me H Me H N 〇 NH OMe 3-N 67 Me OH Η 〇Me H OMe H N 〇 NH OMe 3-N 68 Me OH Η Me H Me H N 〇 NH OMe 3-N 69 Me sc(=o )ch3 Η 〇Me H 0Me H N 〇 NH OMe 3-N 70 Me SC (=0 )ch3 Η Me H Me H N 〇 NH OMe 3-N 71 Me SH 人 Η 〇Me H OMe H N 〇 NH OMe 3-N 72 Me SH 人 Η Me H Me H ! .N h 〇 NH OMe 3-N ! 73 Me Vinyl Η OMe H OMe H N 〇 NH OMe 3-N 74 Me Vinyl Η Me H Me H N 〇 NH OMe 3-N i 75 Me Vinyl Η F H F H N 〇 NH OMe 3-N 76 Me 人 Η OMe H OMe H N 〇 NH OMe 3-N 77 Me 人 Η Me H Me H N 〇 NH OMe 3-N ] 1 78 Me ^OCH^OEt Η OMe H OMe H N 〇 NH OMe 1 1 3-N 79 Me 0 ^OCH^OEt Η OMe H OMe H N 〇 NH OMe 3-N 80 Me 0 OCHii〇Et 人 Η Me H Me H N 〇 NH OMe 1 3-N (請先閲讀背面之注意事項再填寫本頁) -裝· 訂 -15- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 575564Example number Ri!! 1 i τ- \ R4 Rs Rg 1 Rv AY 7 Y 65 Me 乂 hi 1 Η 〇Me H OMe HM 0 NH OMe 3-N 66 Me XH Η Me H Me HN 〇NH OMe 3-N 67 Me OH 〇 〇Me H OMe HN 〇NH OMe 3-N 68 Me OH Η Me H Me HN 〇NH OMe 3-N 69 Me sc (= o) ch3 〇 〇Me H 0Me HN 〇NH OMe 3-N 70 Me SC (= 0) ch3 Η Me H Me HN 〇NH OMe 3-N 71 Me SH human Η 〇Me H OMe HN 〇NH OMe 3-N 72 Me SH human Η Me H Me H! .N h 〇NH OMe 3-N! 73 Me Vinyl Η OMe H OMe HN 〇NH OMe 3-N 74 Me Vinyl Η Me H Me HN 〇NH OMe 3-N i 75 Me Vinyl Η FHFHN 〇NH OMe 3-N 76 Me human Η OMe H OMe HN 〇NH OMe 3-N 77 Me Human Η Me H Me HN 〇NH OMe 3-N] 1 78 Me ^ OCH ^ OEt Η OMe H OMe HN 〇NH OMe 1 1 3-N 79 Me 0 ^ OCH ^ OEt Η OMe H OMe HN 〇NH OMe 3-N 80 Me 0 OCHii〇Et person Η Me H Me HN 〇NH OMe 1 3-N (Please read the precautions on the back before filling out this page) -Pack · Order-15- This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) 575564

、發明説明( 11 經濟部中央標準局員工消費合作社印製 貝&例1) 1-[(5,6-二甲基-2-甲氧基口比口定-3_醯基)胺基 羰基]-4-(2-曱基硫代笨基)哌嗪 a) 苯基N-(5,6-二曱基_2_甲氧基吡啶_3_醯基)甲酸酯 基 將3-氨基-5,6-二甲基_2_甲氧基吡啶(152g,〇〇1莫 耳)與笨氯化曱酸酯(L52g,〇.〇i莫耳),溶解於二氯甲 烷中,並在室溫下攪拌2小時。然後利用減壓濃縮 將溶劑予以去除後,再利用管柱層析(乙基醋酸酯: 己烧=1:6),進行分離精製後便可獲得上述化合物。 收成率:92% 'H NMR(CDC13):2.18(3H5s)5 2.36(3H5s)5 4.〇〇(3H5s)? 7_31(5H,m),8.G7(1H,s) b) l-[(5,6-二甲基-2-甲氧基σ比啶醯基)氨基羰基] (2-甲基硫代苯基)哌嗉 將笨基N-(5,6-二曱基-2-曱氧基定-3-醯基)甲酸 醋(136mg,0.5毫莫耳)與^(2-甲硫苯基)哌嗪 (104mg,0.5耄莫耳),溶解於無水四氫a比喃中,並添 加DBU(76mg,0.5毫莫耳)後,於室溫下攪拌2小時, 然後再進行減壓濃縮而將四氫吡喃予以去除,利用 I柱層析(乙基醋酸醋:己烧=1:2),進行分離精製 後便可獲得上述化合物。 收成率:59%Description of the invention (11 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs & Example 1) 1-[(5,6-dimethyl-2-methoxy-l-methyl-3_fluorenyl) amino Carbonyl] -4- (2-fluorenylthiobenzyl) piperazine a) phenyl N- (5,6-diamidino_2_methoxypyridin_3_fluorenyl) formate group 3 -Amino-5,6-dimethyl-2-methoxypyridine (152 g, 0.001 mole) and benzyl chloride (L52 g, 0.01 mole) dissolved in dichloromethane And stirred at room temperature for 2 hours. Then, the solvent was removed by concentration under reduced pressure, and then column chromatography (ethyl acetate: hexane = 1: 6) was used for separation and purification to obtain the above compound. Yield: 92% 'H NMR (CDC13): 2.18 (3H5s) 5 2.36 (3H5s) 5 4.〇〇 (3H5s)? 7_31 (5H, m), 8.G7 (1H, s) b) l- [ (5,6-dimethyl-2-methoxyσ than pyridinyl) aminocarbonyl] (2-methylthiophenyl) piperidinyl N- (5,6-difluorenyl-2 -Methoxydine-3-fluorenyl) formate (136 mg, 0.5 mmol) and ^ (2-methylthiophenyl) piperazine (104 mg, 0.5 mmol), dissolved in anhydrous tetrahydroa pyran After adding DBU (76 mg, 0.5 mmol), the mixture was stirred at room temperature for 2 hours, and then concentrated under reduced pressure to remove tetrahydropyran. I column chromatography (ethyl acetate: hexane) Calcination = 1: 2), and the above compounds can be obtained after separation and purification. Yield: 59%

熔點:167〜169°C !H NMR(CDC13):2.21(3H?s)? 2.43(3H5s)5 3.06(4H?t), 16 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐 (請先閱讀背面之注意事項再填寫本頁} ;裝· 訂 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(12 ) 4.09(3H,s),6.89(lH,s),7_06(lH,m),7.14(3H,s), 8.26(lH,s) 實施例2) l-[(5,6-二曱基-2-甲氧基吡啶_3_醯基)胺基 罗炭基]-4-(2-異丙苯基苯)派σ秦 將苯基N-(5,6-二甲基-2-甲氧基吨咬-3-醯基)甲酸 酯與1-(2-異丙苯基苯)哌嗪,採行如同上述實施例i 相同的方法進行反應,而可獲得上述化合物。 收成率:62%Melting point: 167 ~ 169 ° C! H NMR (CDC13): 2.21 (3H? S)? 2.43 (3H5s) 5 3.06 (4H? T), 16 This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling out this page}; Binding and ordering 575564 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (12) 4.09 (3H, s), 6.89 (lH, s) , 7_06 (lH, m), 7.14 (3H, s), 8.26 (lH, s) Example 2) l-[(5,6-Difluorenyl-2-methoxypyridine_3_fluorenyl) amine Pyrocarbyl] -4- (2-cumenephenyl) pie sigma phenyl phenyl N- (5,6-dimethyl-2-methoxy-tol-3-fluorenyl) formate The above compound can be obtained by reacting with 1- (2-cumylphenyl) piperazine in the same manner as in Example i above. Yield: 62%

熔點:139〜140°C lR NMR(CDC13) δ :2.20(3H?s)5 2.21(6H5s)? 3.10(4H9t)5 3.64(4H,t),3.84(3H,s),5.07(lH,s),5.13(lH,s), 6.64(1J,S),6.98(lH,s),7.04(3H,dd),7.18(lH,d), 7.91(lH,s) 8.26(lH,s) 貫施例3) 1-[(5,6-二曱基-2-甲氧基0比咬-3_酉蓝基)胺基 羰基]-4-(2,3,5,6_四甲基苯基)哌嗪 將苯基N-(5,6-二曱基-2-曱氧基町be定-3-酿基)曱酸 酯與1-(2,3,5,6-四甲基苯基)哌嗪,採行如同上述實 施例1相同的方法進行反應,而可獲得上述化合物。 收成率:71%Melting point: 139 ~ 140 ° C lR NMR (CDC13) δ: 2.20 (3H? S) 5 2.21 (6H5s)? 3.10 (4H9t) 5 3.64 (4H, t), 3.84 (3H, s), 5.07 (lH, s ), 5.13 (lH, s), 6.64 (1J, S), 6.98 (lH, s), 7.04 (3H, dd), 7.18 (lH, d), 7.91 (lH, s) 8.26 (lH, s) Example 3) 1-[(5,6-Difluorenyl-2-methoxy-0 to bite-3_fluoranyl) aminocarbonyl] -4- (2,3,5,6-tetramethyl Phenyl) piperazinePhenyl N- (5,6-difluorenyl-2-methoxybenzidine-3-methyl) phosphonate and 1- (2,3,5,6-tetramethyl Phenyl) piperazine can be reacted in the same manner as in Example 1 to obtain the above compound. Yield: 71%

熔點·· 190〜192°C 'H NMR(CDC13) (5 :2.21(15H?s)? 2.42(3H?s)? 3.17(4H,t),3.61(4H,t),4.08(3H,s),6.84(lH,s), 8.26(lH,s) •17- 本紙張尺度適用中國國家標準(CNS ) A4規格(2IOX297公釐) (請先閲讀背面之注意事項再填寫本頁)Melting point 190 ~ 192 ° C 'H NMR (CDC13) (5: 2.21 (15H? S)? 2.42 (3H? S)? 3.17 (4H, t), 3.61 (4H, t), 4.08 (3H, s ), 6.84 (lH, s), 8.26 (lH, s) • 17- This paper size applies to China National Standard (CNS) A4 specification (2IOX297 mm) (Please read the precautions on the back before filling this page)

、1T 575564 Α7 Β7 經濟部中央標準局員工消費合作社印製 五、發明説明(13 ) 實施例4) 1-[(5-乙基-6-甲基-2-曱氧基吡啶-3-醯基) 胺基罗炭基]-4-(2-甲基硫代苯基)旅11 秦 將苯基N-(5-乙基-6-甲基-2-曱氧基吨咬-3-醯基)曱 酸酯與1-(2-甲基硫代苯基)哌嗪,採行如同上述實施 例1相同的方法進行反應,而可獲得上述化合物。 收成率:56% 熔點:160〜161°C !H NMR(CDCl3)(5:1.19(3H5t)? 2.43(3H?s)? 2.50(3H?s)? 2.58(2H,q),3.07(4H,t),3.69(4H,t),4.15(3H,S), 6.93(lH,s),7.06(lH,m),7.14(3H,m),8.35(lH,s) 貫施例5) l-[(5_乙基-6-甲基-2 -甲氧基0比咬_3_醯基) 月女基幾基]-4-(2_異丙苯基苯)吸嗪,採行如同上述實施 例1相同的方法進行反應,而可獲得上述化合物。 收成率:51% 熔點:185〜187°C !H NMR(CDC13) 5 :1.18(3H?t)5 2.21(3H?s)? 2.42(3H?s)?2.56(2H,q),3.08(4H,t),3.62(4H,t),4.〇3(3H,s),5.08 (lH,s),5.13(lH,S),6.90(lH,s),7.02(3H,m),7.18(3H,d), 8.25(1H?s) , ,, 實施例6) W(5-乙基-2-甲氧基-6_甲基吡啶_3_醯基) 胺基羰基]-4-(2,3,5,6-四甲基苯基)哌嗪 將本基N-(5 -乙基-2-甲氧基-6·甲基0比咬_3_醯基)甲 酸酯與1-(2,3,5,6-四甲基苯基)哌嗪’採行如同上述實 施例1相同的方法進行反應,而可獲得上述化合物。' -18 - 本紙張尺度適用中國國家德渔^ Δ應故/,丨Λ · --—-- Γ i (請先閱讀背面之注意事項再填寫本頁) :裝- 、11 575564 A7 __ B7 經濟部中央標準局員工消費合作社印製 五、發明説明(14 ) 收成率:69%熔點:176〜177°CW NMR(CDC13) 5 :1.19(3H,t),2.21(3H,S),2.44(3H,s), 2.57(2H,q),3.17(4H,t),3.62(4H,t),4.06(3H,s),6.84 (1H,s),6.92(1H,s),8.30(1H,s)實施例7) l-[(5_乙基-2_甲氧基-6-甲基吡啶-3-醯基) 胺基羰基]-4-(3-硫代苯基)哌嗪 將苯基N-(5-乙基-2-甲氧基-6-甲基。比啶-3-醯基)甲 酸酯與1-(3-硫代苯基)派嗔,採行如同上述實施例1 相同的方法進行反應,而可獲得上述化合物。 收成率:63% 熔點:108〜110°C'H NMR(CDC13)(5 :1.17(3H5t)5 2.37(3H5s)? 2.49(3H?q)? 3.28(4H,t),3.60(4H,t),3.98(3H,s),6.87(4H,m), 6.98(lH,s),8.18(lH,t) 貫施例8) l-[(2 -甲氧基-6-甲基-5-丙基吼唆-3-酿基) 胺基羰基]-4-(3,5-二曱氧基苯基)哌嗪 收成率:67% 熔點:82〜84°C 'H NMR(CDC13) δ :0.94(3H?t), 1.58(2H?m)5 2.37(3H5s)5 2_49(2H,q),3.25(4H,t),3.66(4H,t),3.78(6H,s),3·99 (3H,s),6.07(3H,m),6.88(lH,s),8.16(lH,s) Mass(EI) m/z:428.2447 計算值: 428.2423) -19- (請先閱讀背面之注意事項再填寫本頁) 【裝· 、?! -1¾ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564 Α7 Β7 五、發明説明(15 ) 實施例9)卜[(2-甲氧基-6-甲基-5-丙基。比啶-3-醯基) 胺基羰基]-4-(3,5-二甲基苯基)哌嗪 將苯基N-(2-甲氧基-6-甲基-5-丙基咄啶-3-醯基)甲 酸酯與1-(3,5-二甲基苯基)哌嗪,採行如同上述實施例 1相同的方法進行反應,而可獲得上述化合物。 收成率:6 4 %1T 575564 Α7 Β7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (13) Example 4) 1-[(5-ethyl-6-methyl-2-methoxypyridine-3- 醯Yl) aminocarbamoyl] -4- (2-methylthiophenyl) brigade 11 Qin will phenyl N- (5-ethyl-6-methyl-2-fluorenyl tonyl-3- The fluorenyl) phosphonate and 1- (2-methylthiophenyl) piperazine can be reacted in the same manner as in Example 1 to obtain the above compound. Yield: 56% Melting point: 160 ~ 161 ° C! H NMR (CDCl3) (5: 1.19 (3H5t)? 2.43 (3H? S)? 2.50 (3H? S)? 2.58 (2H, q), 3.07 (4H , T), 3.69 (4H, t), 4.15 (3H, S), 6.93 (lH, s), 7.06 (lH, m), 7.14 (3H, m), 8.35 (lH, s) Example 5) l-[(5_Ethyl-6-methyl-2 -methoxy0 than bite_3_fluorenyl) hydrazine and several yl] -4- (2_cumenephenyl) The reaction was performed in the same manner as in Example 1 above to obtain the above compound. Yield: 51% Melting point: 185 ~ 187 ° C! H NMR (CDC13) 5: 1.18 (3H? T) 5 2.21 (3H? S)? 2.42 (3H? S)? 2.56 (2H, q), 3.08 ( 4H, t), 3.62 (4H, t), 4.03 (3H, s), 5.08 (lH, s), 5.13 (lH, S), 6.90 (lH, s), 7.02 (3H, m), 7.18 (3H, d), 8.25 (1H? S), ,, Example 6) W (5-ethyl-2-methoxy-6-methylpyridine_3_fluorenyl) aminocarbonyl] -4 -(2,3,5,6-tetramethylphenyl) piperazine base N- (5-ethyl-2-methoxy-6 · methyl 0 than _3_fluorenyl) carboxylic acid The ester was reacted with 1- (2,3,5,6-tetramethylphenyl) piperazine 'in the same manner as in Example 1 above to obtain the above compound. '-18-This paper size applies to Chinese national German fishermen ^ Δ 应 / 丨 Λ · ----- Γ i (Please read the precautions on the back before filling this page): Packing-、 11 575564 A7 __ B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (14) Yield: 69% Melting point: 176 ~ 177 ° CW NMR (CDC13) 5: 1.19 (3H, t), 2.21 (3H, S), 2.44 (3H, s), 2.57 (2H, q), 3.17 (4H, t), 3.62 (4H, t), 4.06 (3H, s), 6.84 (1H, s), 6.92 (1H, s), 8.30 ( 1H, s) Example 7) l-[(5-ethyl-2_methoxy-6-methylpyridin-3-amidino) aminocarbonyl] -4- (3-thiophenyl) piper The hydrazine was substituted with phenyl N- (5-ethyl-2-methoxy-6-methyl.pyridin-3-fluorenyl) formate and 1- (3-thiophenyl). The reaction was carried out in the same manner as in Example 1 above to obtain the above compound. Yield: 63% Melting point: 108 ~ 110 ° C'H NMR (CDC13) (5: 1.17 (3H5t) 5 2.37 (3H5s)? 2.49 (3H? Q)? 3.28 (4H, t), 3.60 (4H, t ), 3.98 (3H, s), 6.87 (4H, m), 6.98 (lH, s), 8.18 (lH, t) Example 8) l-[(2-methoxy-6-methyl-5 -Propyl-3-amino) aminocarbonyl] -4- (3,5-dioxophenyl) piperazine Yield: 67% Melting point: 82 ~ 84 ° C 'H NMR (CDC13) δ: 0.94 (3H? t), 1.58 (2H? m) 5 2.37 (3H5s) 5 2_49 (2H, q), 3.25 (4H, t), 3.66 (4H, t), 3.78 (6H, s), 3 · 99 (3H, s), 6.07 (3H, m), 6.88 (lH, s), 8.16 (lH, s) Mass (EI) m / z: 428.2447 Calculated value: 428.2423) -19- (Please read the back first Please pay attention to this page before filling in this page) [Packing ·,?! -1¾ This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 575564 Α7 Β7 V. Description of the invention (15) Example 9) Bu [( 2-methoxy-6-methyl-5-propyl. Than pyridin-3-fluorenyl) aminocarbonyl] -4- (3,5-dimethylphenyl) piperazine Phenyl N- ( 2-methoxy-6-methyl-5-propylpyridin-3-amidino) formate and 1- (3,5-dimethylphenyl) piperazine were used as in Example 1 above. identical The reaction method, the above compound can be obtained. Yield: 64%

熔點·· 145〜146°C NMR(CDC13) 5 :0.95(3H,t),1.59(2H,m),2.29(6H,s), 2.41(3H,s),3.24(4H,t),3.67(4H,t),3.98(3H,s),6.59 (3H,m),6.98(3H,s),6.89(lH,s),8.17(lH,s) Mass(I)m/z:428.2385 (MH,C23H32N404 計算值: 428.2423) 實施例10) l-[(2-甲氧基-6-甲基-5-丙基吡啶-3-醯基) 胺基羰基]-4-(3,5-二氟化苯基)哌嗪 將苯基N-(2-曱氧基-6-曱基-5-丙基吡啶-3-醯基)甲 酸酯與1-(3,5-二氟化苯基)哌嗪,採行如同上述實施例 1相同的方法進行反應,而可獲得上述化合物。 收成率:57% 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁)Melting point: 145 ~ 146 ° C NMR (CDC13) 5: 0.95 (3H, t), 1.59 (2H, m), 2.29 (6H, s), 2.41 (3H, s), 3.24 (4H, t), 3.67 (4H, t), 3.98 (3H, s), 6.59 (3H, m), 6.98 (3H, s), 6.89 (lH, s), 8.17 (lH, s) Mass (I) m / z: 428.2385 ( MH, C23H32N404 Calculated: 428.2423) Example 10) l-[(2-methoxy-6-methyl-5-propylpyridin-3-amidino) aminocarbonyl] -4- (3,5- Difluorinated phenyl) piperazinePhenyl N- (2-methoxy-6-fluorenyl-5-propylpyridin-3-fluorenyl) formate and 1- (3,5-difluorinated The phenyl) piperazine can be reacted in the same manner as in Example 1 to obtain the above compound. Yield: 57% Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page)

熔點:121〜123°C 'H NMR(CDC13) δ :0.95(3H?t)? 1.59(2H?m)5 2.38(3H?s)? 2_50(2H,q),3.29(3H,t),3.66(3H,t),4.00(3H,s),6.28 (lH,m),6.36(2H,d),6.87(lH,s),8.17(lH,s) 實施例11) 1-[(2-曱氧基-6-甲基-5-丙基吡啶-3-醯基) 胺基羰基]-4·(2-曱氧基苯基)哌嗪 -20- 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇'乂297公釐) 575564 A7 _ B7 五、發明説明(16 ) 將本基N-(2-甲氧基-6-甲基-5-丙基咐定-3-酸基)甲 酸酯與1 -(2-甲氧基苯基)哌嗔,採行如同上述實施例! 相同的方法進行反應,而可獲得上述化合物。 收成率·· 71 %Melting point: 121 ~ 123 ° C 'H NMR (CDC13) δ: 0.95 (3H? T)? 1.59 (2H? M) 5 2.38 (3H? S)? 2_50 (2H, q), 3.29 (3H, t), 3.66 (3H, t), 4.00 (3H, s), 6.28 (lH, m), 6.36 (2H, d), 6.87 (lH, s), 8.17 (lH, s) Example 11) 1-[(2 -Methoxy-6-methyl-5-propylpyridine-3-amidino) aminocarbonyl] -4 · (2-Methoxyphenyl) piperazine-20- This paper applies Chinese national standards ( CNS) A4 specification (21〇'297 mm) 575564 A7 _ B7 V. Description of the invention (16) The N- (2-methoxy-6-methyl-5-propyl group) is specified as 3- Acid) formate and 1- (2-methoxyphenyl) piperidine, following the example described above! By performing the reaction in the same manner, the above-mentioned compound can be obtained. Yield · 71%

熔點:109〜110°C W NMR(CDCl3)(5:0.95(3H,t),1.59(2H,m),2.37(3H,s), 2.49(2H,q),3.12(4H,t),3.70(4H,t),3.89(3H,s),3.97 (3H,s),6.91(4H,m),6.95(lH,s),8.19(1H,S) 實施例12) l-[(6-乙基-2-甲氧基-5-甲基吡啶-3_醯基) 胺基羰基]-4-(3,5-二甲基苯基)哌嗪 將苯基N-(6-乙基-2-甲氧基-5-甲基。比咬冬醯基)甲 酸酯與1-(3,5-二曱氧基苯基)旅嗔,採行如同上述實施 例1相同的方法進行反應,而可獲得上述化合物。 收成率:65%Melting point: 109 ~ 110 ° CW NMR (CDCl3) (5: 0.95 (3H, t), 1.59 (2H, m), 2.37 (3H, s), 2.49 (2H, q), 3.12 (4H, t), 3.70 (4H, t), 3.89 (3H, s), 3.97 (3H, s), 6.91 (4H, m), 6.95 (lH, s), 8.19 (1H, S) Example 12) l-[(6- Ethyl-2-methoxy-5-methylpyridine-3_fluorenyl) aminocarbonyl] -4- (3,5-dimethylphenyl) piperazine Phenyl N- (6-ethyl -2-Methoxy-5-methyl. Bisorcinyl) formate and 1- (3,5-dimethoxyphenyl) triphenate were carried out in the same manner as in Example 1 above. Reaction to obtain the above compound. Yield: 65%

熔點:115〜116°C H NMR(CDC13) δ :1.21(3H,t),2.21(3H,s),2.65(2H,q), 3.27(4H,t),3.64(4H,t),3.79(6H,s),3.98(3H,s),6.09 (3H,m),6.86(lH,s),8.12(lH,s)Melting point: 115 ~ 116 ° CH NMR (CDC13) δ: 1.21 (3H, t), 2.21 (3H, s), 2.65 (2H, q), 3.27 (4H, t), 3.64 (4H, t), 3.79 ( 6H, s), 3.98 (3H, s), 6.09 (3H, m), 6.86 (lH, s), 8.12 (lH, s)

Mass(EI) m/z:414.2240 (MH,C22H3GN4〇4 計算值: 414.2267) 實施例13) M(6-甲基-2-甲氧基-5_甲基吡啶_3_醯基) 胺基羰基]-4-(3,5-二甲基苯基)哌嗪 將苯基N-(6-曱基-2-曱氧基-5-甲基。比啶_3_醯基)甲 酸酯與1-(3,5-—甲基本基)旅嗔,採行如同上述實施例 -21 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) $ -14 經濟部中央標準局員工消費合作社印製 經濟部中央標準局員工消費合作社印製 575564 Α7 ___ Β7 五、發明説明(17 ) 1相同的方法進行反應,而可獲得上述化合物。 收成率:61%Mass (EI) m / z: 414.2240 (MH, C22H3GN4104 calculated: 414.2267) Example 13) M (6-methyl-2-methoxy-5_methylpyridine_3_fluorenyl) amino group Carbonyl] -4- (3,5-dimethylphenyl) piperazinePhenyl N- (6-fluorenyl-2-fluorenyl-5-methyl.pyridine_3_fluorenyl) carboxylic acid Ester and 1- (3,5--methylbenzyl) group, adopt the same as the above Example-21-This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the note on the back first Please fill in this page again for details) $ -14 Printed by the Central Consumers ’Cooperative of the Ministry of Economic Affairs and printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs and printed by the Consumer ’s Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs and printed by 575564 The above compounds. Yield: 61%

熔點:135〜136°C !H NMR(CDC13) 5 :1.22(3H5t)5 2.21(3H5s)9 2.29(6H5s)? 2.65(2H,q),3.24(4H,t),3.66(4H,t),3.98(3H,s),6_59 (3H,m),6.87(lH,s),8.12(lH,s)Melting point: 135 ~ 136 ° C! H NMR (CDC13) 5: 1.22 (3H5t) 5 2.21 (3H5s) 9 2.29 (6H5s)? 2.65 (2H, q), 3.24 (4H, t), 3.66 (4H, t) , 3.98 (3H, s), 6_59 (3H, m), 6.87 (lH, s), 8.12 (lH, s)

Mass(EI) m/z:382.2376 (MH,C22H3()N402 計算值: 382.2368) 實施例14) l-[(6-乙基-2-曱氧基-5-曱基吡啶-3_醯基) 胺基羰基]-4-(3-羥苯基)哌嗪 將苯基N-(6-乙基-2-曱氧基-5-甲基吡啶_3_醯基)甲 酸酯與1-(3-羥苯基)哌嗪,採行如同上述實施例1相 同的方法進行反應,而可獲得上述化合物。 收成率:56%Mass (EI) m / z: 382.2376 (MH, C22H3 () N402 Calculated: 382.2368) Example 14) l-[(6-ethyl-2-fluorenyl-5-fluorenylpyridin-3-yl) ) Aminocarbonyl] -4- (3-hydroxyphenyl) piperazinePhenyl N- (6-ethyl-2-methoxy-5-methylpyridine_3_fluorenyl) formate with 1 -(3-hydroxyphenyl) piperazine can be reacted in the same manner as in Example 1 to obtain the above compound. Yield: 56%

熔點:168〜170°C W NMR(CDC13) 5:1.21(3H,t),2.20(2H,s),2.63(2H,t), 3.28(4H,t),3.68(4H,t),3.98(3H,s),6.41(lH,d),6.55 (lH,d),6.84(lH,m),6.87(lH,s),7.13(lH,t),8.10(lH,s) Mass(EI) m/z:370.1992 (MH,C2GH26N403 計算值: 370.2004) 實施例15) M(2_甲氧基_5-曱基-6-丙基吡啶_3_醯基) 胺基幾基]-4-(3,5-二甲氧基苯基)旅嘻 將苯基N-(2 -曱氧基-5·曱基_6_丙基σ比π定驢基)甲 酸酯與1-(3,5-二甲氧基苯基)派嘻,採行如同上述實施 -22- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝. 訂 575564 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(18 ) 例1相同的方法進行反應,而可獲得上述化合物。 收成率:57% 熔點:121〜122°C 4 NMR(CDC13) 6 :〇.96(3H,t),1.67(2H,m),2.21(3H,s), 2.58(2H,t),3.26(4H,t),3.68(4H,t),3.79(6H,s),3.97 (3H,s),6.14(3H,m),6.89(lH,s),8.11(lH,s) Mass(EI)m/z:428.2423 (MH,C23H32N404 計算值: 428.2423) 貝施例16) 1·[ (2-甲氧基-5-甲基-6-丙基σ比唆-3-醯基) 胺基羰基]-4-(3,5-二乙基苯基)哌嗪 將本基Ν-(2-曱氧基-5-甲基-6-丙基吼〇定-3-醯基)曱 酸酯與1-(3,5-二乙基苯基)哌嗪,採行如同上述實施例 1相同的方法進行反應,而可獲得上述化合物。 收成率:54% 熔點:138〜139°C W NMR(CDC13) (5 :0.96(3H,t),1.72(2H,m),2.21(6H,s), 2.30(3H,s),2.59(2H,t),3.28(4H,t),3.76(4H,t),3·97 (3H,s),6_70(3H,m),6.87(lH,s),8.11(ih,s)Mass(EI) m/z:396.2432 (MH,C23H32N4〇2 計算值: 396.2525) 實施例Π) l-[(2-甲氧基-5-曱基丙基吡啶_3_醯基) 胺基被基]-4-(3-¾基苯基)旅嘻 將苯基N-(2-曱氧基-5-曱基_6_丙基〇比啶_3_醯基)甲 酸醋與H3-羥基苯基)哌嗉,採行如同上述實施例i-23- (請先閱讀背面之注意事項再填寫本頁) :裝·Melting point: 168 ~ 170 ° CW NMR (CDC13) 5: 1.21 (3H, t), 2.20 (2H, s), 2.63 (2H, t), 3.28 (4H, t), 3.68 (4H, t), 3.98 ( 3H, s), 6.41 (lH, d), 6.55 (lH, d), 6.84 (lH, m), 6.87 (lH, s), 7.13 (lH, t), 8.10 (lH, s) Mass (EI) m / z: 370.1992 (MH, C2GH26N403 Calculated: 370.2004) Example 15) M (2-methoxy_5-fluorenyl-6-propylpyridine_3_fluorenyl) aminochiridine] -4- (3,5-dimethoxyphenyl) brigade combined the phenyl N- (2-fluorenyl-5 · fluorenyl-6-propylσ to π-donyl) formate with 1- (3 , 5-Dimethoxyphenyl), adopt the same implementation as above. 22- This paper size applies Chinese National Standard (CNS) A4 specification (210 × 297 mm) (Please read the precautions on the back before filling in this Page)-Binding. Order 575564 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (18) Example 1 The reaction was carried out in the same manner as in Example 1 to obtain the above compound. Yield: 57% Melting point: 121 ~ 122 ° C 4 NMR (CDC13) 6: 0.96 (3H, t), 1.67 (2H, m), 2.21 (3H, s), 2.58 (2H, t), 3.26 (4H, t), 3.68 (4H, t), 3.79 (6H, s), 3.97 (3H, s), 6.14 (3H, m), 6.89 (lH, s), 8.11 (lH, s) Mass (EI ) m / z: 428.2423 (MH, C23H32N404 Calculated: 428.2423) Example 16) 1 · [(2-methoxy-5-methyl-6-propylσ than fluoren-3-amidino) amino group Carbonyl] -4- (3,5-diethylphenyl) piperazine will be the base N- (2-methoxy-5-methyl-6-propylamido-3-amidino) phosphonic acid The ester was reacted with 1- (3,5-diethylphenyl) piperazine in the same manner as in Example 1 to obtain the above compound. Yield: 54% Melting point: 138 ~ 139 ° CW NMR (CDC13) (5: 0.96 (3H, t), 1.72 (2H, m), 2.21 (6H, s), 2.30 (3H, s), 2.59 (2H , T), 3.28 (4H, t), 3.76 (4H, t), 3.97 (3H, s), 6_70 (3H, m), 6.87 (lH, s), 8.11 (ih, s) Mass (EI ) m / z: 396.2432 (MH, C23H32N4O2 calculated: 396.2525) Example Π) l-[(2-methoxy-5-amidinopropylpyridine_3_fluorenyl) amino group]- 4- (3-¾ylphenyl) Liu He puts phenyl N- (2-fluorenyl-5-fluorenyl-6-propyl-pyridine_3_fluorenyl) carboxylic acid and H3-hydroxyphenyl ) Pipe pipe, adopt the same as the above embodiment i-23- (Please read the precautions on the back before filling this page):

,1T -1% 本紙張尺度適用中國國豕標準(CNS ) A4規格(210X Μ?公釐) 575564 經濟部中央標隼局員工消費合作社印製 A7 B7 五、發明説明(19 ) 相同的方法進行反應,而可獲得上述化合物。 收成率:52%, 1T -1% This paper size is applicable to China National Standard (CNS) A4 specification (210X Μ? Mm) 575564 Printed by A7 B7 of the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (19) The same method Reaction to obtain the above compound. Yield: 52%

熔點:153〜155°C 'H NMR(CDC13) 5 :0.95(3H,t),1.69(2H,m),2.19(3H,s), 2.59(2H,t),3.22(4H,t),3.68(4H,t),3.97(3H,s),6.52 (lH,d),6.87(lH,s),7.12(lH,t),8.09(lH,s)Melting point: 153 ~ 155 ° C 'H NMR (CDC13) 5: 0.95 (3H, t), 1.69 (2H, m), 2.19 (3H, s), 2.59 (2H, t), 3.22 (4H, t), 3.68 (4H, t), 3.97 (3H, s), 6.52 (lH, d), 6.87 (lH, s), 7.12 (lH, t), 8.09 (lH, s)

Mass(EI) m/z:384.2153 (MH,C21H28N403 計算值: 384.2161) 實施例18) 1-[Ν_(2·曱氧基_6,7_二氫-5H-環戊基[b]吡 啶-3-醯基)胺基羰基]-4-(3,5-二曱氧基苯基)哌嗪 將本基N-(2-曱氧基-6,7-二氫-5H-環戊基[b]%b咬-3_酿基)甲酸酯與1-(3,5-二甲氧基苯基)旅嗪,採行如 同上述實施例1相同的方法進行反應,而可獲得上述 化合物。 收成率:59%Mass (EI) m / z: 384.2153 (MH, C21H28N403 calculated: 384.2161) Example 18) 1- [N_ (2 · fluorenyloxy_6,7_dihydro-5H-cyclopentyl [b] pyridine- 3-fluorenyl) aminocarbonyl] -4- (3,5-dioxophenyl) piperazine will be the base N- (2-fluorenyl-6,7-dihydro-5H-cyclopentyl [b]% b bite-3_vinyl) formate and 1- (3,5-dimethoxyphenyl) trazine can be reacted in the same manner as in Example 1 above to obtain the above. Compounds. Yield: 59%

熔點:143〜144°C W NMR(CDC13) 5 :2.10(2H,m),2.87(4H,m),3.12(4H,t), 3.70(4H,t),3.78(6H,s),4.00(3H,s),6.08(3H,m),6.90 (1H,s)5 8.24(lH,s) 實施例I9) WN-(2-甲氧基-6,7_二氳_5h_環戊基[b]吡 啶-3-醯基)胺基羰基]-4-(3,5-二甲基苯基)哌嗉 將苯基N_(2-曱氧基-6,7-二氫-5H-環戊基[b]吡啶-3-醯基)甲酸酯與1-(3,5-二甲基苯基)哌嗪,採行如同 上述貫施例1相同的方法進行反應,而可獲得上述化 -24- ^紙張尺度適用中國國家標準(CNS ) A4規格( ---~^ (請先閱讀背面之注意事項再填寫本頁) 裝·Melting point: 143 ~ 144 ° CW NMR (CDC13) 5: 2.10 (2H, m), 2.87 (4H, m), 3.12 (4H, t), 3.70 (4H, t), 3.78 (6H, s), 4.00 ( 3H, s), 6.08 (3H, m), 6.90 (1H, s) 5 8.24 (lH, s) Example I9) WN- (2-methoxy-6,7_difluorene_5h_cyclopentyl [b] Pyridin-3-fluorenyl) aminocarbonyl] -4- (3,5-dimethylphenyl) piperidinium Phenyl N_ (2-fluorenyl-6,7-dihydro-5H- Cyclopentyl [b] pyridin-3-fluorenyl) formate and 1- (3,5-dimethylphenyl) piperazine can be reacted in the same manner as in Example 1 above to obtain The above-mentioned -24- ^ paper size applies to China National Standard (CNS) A4 specifications (--- ~ ^ (Please read the precautions on the back before filling this page).

、1T 575564 A7 _______B7 五、發明説明(2〇 ) 合物。 收成率·· 55%1T 575564 A7 _______B7 V. Description of the invention (20) Compound. Yield · 55%

熔點:183〜185°C H NMR(CDC13) (5 :2.08(2H,m),2.28(6H,m),2.872(4H,m), 3.22(4H,t),3.67(4H,t),4.00(3H,s),6.57(3H,m),6.89 (1H,s)5 8.24(lH,s) 實施例20) l-[(2-甲氧基-5,6,7,8-四氳喳啉-3-醯基)胺 基羰基]-4-(3,5-二甲氧基苯基)哌嗪 將苯基N-(2-甲氧基-5,6,7,8-四氫。奎琳-3-醯基)甲 酸酯與1-(3,5-二甲氧基苯基)哌嗔,採行如同上述實施 例1相同的方法進行反應,而可獲得上述化合物。 收成率:54%Melting point: 183 ~ 185 ° CH NMR (CDC13) (5: 2.08 (2H, m), 2.28 (6H, m), 2.872 (4H, m), 3.22 (4H, t), 3.67 (4H, t), 4.00 (3H, s), 6.57 (3H, m), 6.89 (1H, s) 5 8.24 (lH, s) Example 20) l-[(2-methoxy-5,6,7,8-tetramidine Pyridin-3-fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine Phenyl N- (2-methoxy-5,6,7,8-tetra The above compound can be obtained by reacting hydrogen, quinine-3-amidino) formate and 1- (3,5-dimethoxyphenyl) piperidine in the same manner as in Example 1 above. Yield: 54%

熔點:161〜163°C β NMR(CDC13) 5 :1.75(2H,m),1.84(2H,m),2.67(2H,t), 2.73(2H,t),3.27(4H,t),3.71(4H,t),3.79(6H,s),3.97 (3H5s),6.10(3H,m)56.90(lH,s)58.07(lH,s) 貫施例21) 甲氧基-5,6,7,8-四氫喳啉_3_醯基)胺 基羰基]-4-(3,5-二曱基苯基)哌嗪 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項耳填寫本頁) 將苯基Ν·(2-曱氧基-5,6,7,8-四氫口奎琳驢基)甲 酉欠酉曰與1 -(3,5-一甲基本基)派σ秦,採行如同上述實施例 1相同的方法進行反應,而可獲得上述化合物。 收成率·· 51%Melting point: 161 ~ 163 ° C β NMR (CDC13) 5: 1.75 (2H, m), 1.84 (2H, m), 2.67 (2H, t), 2.73 (2H, t), 3.27 (4H, t), 3.71 (4H, t), 3.79 (6H, s), 3.97 (3H5s), 6.10 (3H, m) 56.90 (lH, s) 58.07 (lH, s) Example 21) Methoxy-5,6,7 , 8-Tetrahydropyridoline_3_fluorenyl) aminocarbonyl] -4- (3,5-difluorenylphenyl) piperazine Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the note on the back first Matter ears fill in this page) Phenyl N · (2-fluorenyl-5,6,7,8-tetrahydroquinone quiline donkey base) formazan and 1- (3,5-monomethylbenzyl) Based on the method of σσ, the same method as in Example 1 was used for the reaction to obtain the above compound. Yield: 51%

熔點:143〜144°C H NMR(CDC13) δ : 1.75(2H5m)51.84(2H5m)? 2.30(2H?t)? -25 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564 Α7 _____________ 五、發明説明(21 ) 2.72(2H,t),3.26(4H,t),3.67(4H,t),3.97(3H,s),6.61 (3H,m),6.91(lH,s),8.07(lH,s) 貫施例22) 1 -[(5,6-二甲基-2 -甲氧基吼唆-3-醯基)胺 基羰基]-4-(3,5-二甲基苯基)哌嗪 將苯基N-(5,6-二甲氧基-2-甲氧基吼啶-3-醯基)甲 酸酯(200mg,0.7毫莫耳)與l-(3,5-二甲氧基苯基)派 嗪(154mg,0_7毫莫耳),溶解於無水四氫吡喃中,並 添加DBU(106mg)後,於室溫下攪拌2小時。然後利 用減壓濃縮將溶劑予以去除後,再利用管柱層析(乙 基醋酸酯:己烷=1:2),進行分離精製後便可獲得上 述化合物。 收成率:50%Melting point: 143 ~ 144 ° CH NMR (CDC13) δ: 1.75 (2H5m) 51.84 (2H5m)? 2.30 (2H? T)? -25-This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 575564 Α7 _____________ V. Description of the invention (21) 2.72 (2H, t), 3.26 (4H, t), 3.67 (4H, t), 3.97 (3H, s), 6.61 (3H, m), 6.91 (lH, s) , 8.07 (lH, s) Example 22) 1-[(5,6-Dimethyl-2-methoxymethoxy-3-methyl) aminocarbonyl] -4- (3,5-di Methylphenyl) piperazinePhenyl N- (5,6-dimethoxy-2-methoxypyrimidin-3-amidino) formate (200 mg, 0.7 mmol) and l- ( 3,5-Dimethoxyphenyl) pyrazine (154 mg, 0-7 mmol) was dissolved in anhydrous tetrahydropyran, and DBU (106 mg) was added, followed by stirring at room temperature for 2 hours. Then, the solvent was removed by concentration under reduced pressure, and then column chromatography (ethyl acetate: hexane = 1: 2) was used for separation and purification to obtain the above compound. Yield: 50%

熔點:192〜193°C iH NMR(CDC13) (5 :2.21(3H,s),2.29(6H,s),2.36(3H,s), 3.33(4H,t),3.96(3H,s),4.09(4H,t),6.57(3H,m),7.33 (1H,s),8.11(1H,s)Melting point: 192 ~ 193 ° C iH NMR (CDC13) (5: 2.21 (3H, s), 2.29 (6H, s), 2.36 (3H, s), 3.33 (4H, t), 3.96 (3H, s), 4.09 (4H, t), 6.57 (3H, m), 7.33 (1H, s), 8.11 (1H, s)

Mass(EI) m/z:384.1992 計算值: 384.1983) 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 貫施例23) ^[(5^二曱基_2-曱氧基吡啶_3-醯基)胺 基Ik基]-4-(3,5-二氟化苯基)σ辰嗪 將苯基Ν-(5,6-二曱基-2-甲氧基吡啶_3_醯基)甲酸 酉曰與1-(3,5-二氟化苯基)旅嗪,採行如同上述實施例 22相同的方法進行反應,而可獲得上述化合物。 收成率:47% -26 - 本紙張尺度適财S標準(CNS ) A4規格 575564 A7 經濟部中央標準局員工消費合作社印製 五、發明説明(22 ) 熔點:60〜62°C 4 NMR(CDC13) 5 :2_21(3H,s),2.36(3H,S),3.39(4H,t), 3.96(3H,s),4.10(3H,t),6.29(3H,m),7.33(lH,s),8.14(1H,S) 貝知例24) 二甲基-2-甲氧基吡啶_3_醯基)胺 基幾基]-4-(3-經苯基)呢嗔 將苯基N-(5,6-二甲基-2-甲氧基吡啶醯基)甲酸 酯與1_(3-羥苯基)哌嗪,採行如同上述實施例22相 同的方法進行反應,而可獲得上述化合物。 收成率:43% 熔點:185〜186°C 泔 NMR(CDC13) &2.14(3H,S),2.36(3H,s),3.25(4H,t), 3.89(3H,s),4.09(4H,t),6_30(lH,d),6.36(2H,m),7·03 (lH,t),7.48(lH,s),8.56(lH,s) 實施例25) l-[(2-甲氧基-6-甲基-5_丙基吡啶_3_醯基) 胺基羰基]-4-(3,5-二甲氧基苯基)哌嗪 將苯基N-(2-甲氧基_6_甲基-5-丙氧基吡啶醯基) 甲曰與1-(3,5-一甲氧基苯基)σ辰嘻,採行如同上述 實施例22相同的方法進行反應,而可獲得上述化合 物。 收成率:55% 熔點:143〜144°C W NMR(CDCl3)d:0.93(3H,t),l_66(2H,m),2.17(3H,S), 2.65(2H,t),3.85(4H,t),3.79(6H,s),3.98(3H,s),4.15,, (請先閲讀背面之注意事項再填寫本頁) ;衣· 、11 d 0 Bn —ii a -- -27- 575564 經濟部中央標準局員工消費合作社印製 A7 B7 i、發明説明(23 ) (4H,t),6.11(3H,m),7.43(lH,s),8.25(lH,s) 貫施例26) 1 - [(2-甲氧基-5 -甲基-6-丙基ϋ比咬-3-酿基) 胺基羰基]-4-(3,5-二甲氧基苯基)哌嗪 將苯基Ν-(2-曱氧基-5-甲基-6-丙氧基0比咬-3-醯基) 甲酸醋與1 -(3,5-一曱氧基苯基)σ底嗔,採行如同上述 實施例22相同的方法進行反應,而可獲得上述化合 物。 收成率:52%Mass (EI) m / z: 384.1992 Calculated value: 384.1983) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page). Example 23) ^ [(5 ^ 二 曱 基_2-Methoxypyridine_3-fluorenyl) amino Ik group] -4- (3,5-difluorinated phenyl) σchenazine Phenyl N- (5,6-difluorenyl-2 -Methoxypyridine_3_fluorenyl) carboxylic acid hydrazone is reacted with 1- (3,5-difluorinated phenyl) trazine in the same manner as in Example 22 to obtain the above compound. Yield: 47% -26-This paper is suitable for financial standard S (CNS) A4 specifications 575564 A7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (22) Melting point: 60 ~ 62 ° C 4 NMR (CDC13 ) 5: 2_21 (3H, s), 2.36 (3H, S), 3.39 (4H, t), 3.96 (3H, s), 4.10 (3H, t), 6.29 (3H, m), 7.33 (lH, s ), 8.14 (1H, S) Known Example 24) Dimethyl-2-methoxypyridin-3-yl) aminoamino] -4- (3-phenyl -(5,6-dimethyl-2-methoxypyridinyl) formate and 1- (3-hydroxyphenyl) piperazine can be reacted in the same manner as in Example 22 above to obtain The above compounds. Yield: 43% Melting point: 185 ~ 186 ° C 泔 NMR (CDC13) & 2.14 (3H, S), 2.36 (3H, s), 3.25 (4H, t), 3.89 (3H, s), 4.09 (4H , T), 6-30 (lH, d), 6.36 (2H, m), 7.03 (lH, t), 7.48 (lH, s), 8.56 (lH, s) Example 25) l-[(2- Methoxy-6-methyl-5_propylpyridine_3_fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine phenyl N- (2-methyl Oxy_6_methyl-5-propoxypyridinyl), methyl and 1- (3,5-monomethoxyphenyl) σ Chen He, the reaction was carried out in the same manner as in Example 22 above. , And the above compounds can be obtained. Yield: 55% Melting point: 143 ~ 144 ° CW NMR (CDCl3) d: 0.93 (3H, t), l_66 (2H, m), 2.17 (3H, S), 2.65 (2H, t), 3.85 (4H, t), 3.79 (6H, s), 3.98 (3H, s), 4.15, (Please read the precautions on the back before filling this page); clothing, 11 d 0 Bn —ii a--27- 575564 Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 i. Invention Description (23) (4H, t), 6.11 (3H, m), 7.43 (lH, s), 8.25 (lH, s) (Example 26) 1-[(2-methoxy-5 -methyl-6-propylpyridine-3-amino) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine Phenyl N- (2-fluorenyl-5-methyl-6-propoxy group 0-methyl-3-fluorenyl) formic acid with 1- (3,5-monomethoxyphenyl) σ base The reaction was carried out in the same manner as in Example 22 above to obtain the above compound. Yield: 52%

熔點:183〜184°C NMR(CDCl3)6:0.98(3H,t),1.72(2H,m),2.17(3H,s), 2.62(2H,t),3.39(4H,t),3.79(6H,s),3.96(3H,s),4·19 (4H,t),6.15(3H,m),7.42(lH,s),8.08(lH,s)Melting point: 183 ~ 184 ° C NMR (CDCl3) 6: 0.98 (3H, t), 1.72 (2H, m), 2.17 (3H, s), 2.62 (2H, t), 3.39 (4H, t), 3.79 ( 6H, s), 3.96 (3H, s), 4.19 (4H, t), 6.15 (3H, m), 7.42 (lH, s), 8.08 (lH, s)

Mass(EI) m/z:444.2171 (ΜΗ/υΗηΚΟΑ 計算值: 444.2195) 貫施例27) l-[(2-甲氧基-5-甲基-6-丙基0比咬_3_醯基) 胺基羰基]-4-(3,5-二曱基苯基)哌嗪 將苯基N-(2-甲氧基_5_甲基-6-丙氧基α比咬醯基) 曱酸酯與1-(3,5-二甲基苯基)哌嗪,採行如同上述實 施例22相同的方法進行反應,而可獲得上述化合 物。 收成率·· 49%Mass (EI) m / z: 444.2171 (Calculated value of ΜΚ / υ 计算 ηΚΟΑ: 444.2195) Example 27) l-[(2-methoxy-5-methyl-6-propyl0 is more specific than 3-methyl group ) Aminocarbonyl] -4- (3,5-difluorenylphenyl) piperazine converts phenyl N- (2-methoxy-5_methyl-6-propoxyα to pyrenyl) 曱The ester was reacted with 1- (3,5-dimethylphenyl) piperazine in the same manner as in Example 22 above to obtain the above compound. Yield: 49%

熔點:195〜197°C !H NMR(CDC13) δ :0.98(3H?t)5 1.73(2H?m)? 2.18(6H,s)? 2.34(3H,s),2.62(2H,t),3.47(4H,t),3.96(3H,s),4·〇ΐ -28- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 、τ 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(24 ) (3H,m),6.59(3H,m),7.02(lH,s),7.99(lH,s)Melting point: 195 ~ 197 ° C! H NMR (CDC13) δ: 0.98 (3H? T) 5 1.73 (2H? M)? 2.18 (6H, s)? 2.34 (3H, s), 2.62 (2H, t), 3.47 (4H, t), 3.96 (3H, s), 4 · 〇ΐ -28- This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) (Please read the precautions on the back before filling in this Page), τ 575564 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (24) (3H, m), 6.59 (3H, m), 7.02 (lH, s), 7.99 (lH, s)

Mass(EI) m/z:412.2266 計算值: 412.2296) 貫施例28) 曱氧基-5-甲基-6-丙基吨。定-3-酿基) 胺基羰基]-4-(3-羥苯基)哌嗪 將苯基N_(2-甲氧基-5-曱基-6-丙氧基α比啶_3_醯基) 甲酸酯與1-(3-經苯基)娘嘻,採行如同上述實施例22 相同的方法進行反應,而可獲得上述化合物。 收成率:48%Mass (EI) m / z: 412.2266 Calculated value: 412.2296) Example 28) Benzyl-5-methyl-6-propyl ton. Ding-3-amino) aminocarbonyl] -4- (3-hydroxyphenyl) piperazine will be phenyl N_ (2-methoxy-5-fluorenyl-6-propoxyα than pyridin_3_ The fluorenyl) formate was reacted with 1- (3-transphenyl) nitro, in the same manner as in Example 22 above, to obtain the above compound. Yield: 48%

熔點:160〜162°C 1HNMR(CDCl3)5:0.98(3H?t)? 1.72(2H9m)5 2.22(3H5s)5 2_61(3H,t),3.31(4H,t),3.95(3H,s),4_10 (4H,t),6.45 (3H,m),7.12(lH,t),7.41(lH,s),8.08(lH,s)Melting point: 160 ~ 162 ° C 1HNMR (CDCl3) 5: 0.98 (3H? T)? 1.72 (2H9m) 5 2.22 (3H5s) 5 2_61 (3H, t), 3.31 (4H, t), 3.95 (3H, s) , 4_10 (4H, t), 6.45 (3H, m), 7.12 (lH, t), 7.41 (lH, s), 8.08 (lH, s)

Mass(EEI) m/z:400.1969 計算值: 400.1932) 實施例29) W(2-甲氧基-6,7-二氳-5H-環戊基[b]咄啶 -3-醯基)胺基羰基]-4-(3,5-二曱氧基苯基)哌嗪 將苯基N-(2-甲氧基_6,7-二氫-5H-環戊基[b]咄啶_ 3-酿基)曱酸g旨與1-(3,5-二甲氧基苯基)σ辰嗔,採行如 同上述實施例22相同的方法進行反應,而可獲得上述 化合物。 收成率:55%Mass (EEI) m / z: 400.1969 Calculated: 400.1932) Example 29) W (2-methoxy-6,7-difluoren-5H-cyclopentyl [b] pyridin-3-fluorenyl) amine Carbonyl] -4- (3,5-dimethoxyphenyl) piperazine The phenyl N- (2-methoxy-6,7-dihydro-5H-cyclopentyl [b] piperidine_ The 3-bromoyl) phosphonic acid g is intended to react with 1- (3,5-dimethoxyphenyl) sigmaquinone in the same manner as in Example 22 above to obtain the above compound. Yield: 55%

熔點:169〜17(TC W NMR(CDC13) 5 :2.10(2H,m),2.89(4H,m),3.30(4H,t), -29- 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X297公釐) (請先閱讀背面之注意事項再填寫本頁) :裝_Melting point: 169 ~ 17 (TC W NMR (CDC13) 5: 2.10 (2H, m), 2.89 (4H, m), 3.30 (4H, t), -29- This paper size applies to China National Standard (CNS) A4 specifications (21〇X297 mm) (Please read the notes on the back before filling this page):

、1T 575564 經濟部中央標準局員工消費合作社印製 A7 、發明説明(25 3.77(6H,s),3.98(3H,s),4.20(4H,t),6.05(3H,m),7.37 (lH,s),8_25(lH,s) 實施例30) l-[N-(2-甲氧基-6,7-二氫-5H-環戊基[b]吡 唆-3-醯基)胺基羰基]-4-(3,5-二甲基苯基辰嗔 將本基N-(2-甲氧基-6,7_二氫-5H-環戊基[|^比咬_ 3-醯基)甲酸酯與1-(3,5-二甲基苯基)哌嗪,採行如同 上述實施例22相同的方法進行反應,而可獲得上述化 合物。 收成率:53%1T 575564 A7 printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, Invention Description (25 3.77 (6H, s), 3.98 (3H, s), 4.20 (4H, t), 6.05 (3H, m), 7.37 (lH S), 8-25 (lH, s) Example 30) l- [N- (2-methoxy-6,7-dihydro-5H-cyclopentyl [b] pyridin-3-amidino) amine Carbonyl group] -4- (3,5-dimethylphenyl phenyl phenyl group N- (2-methoxy-6,7-dihydro-5H-cyclopentyl group The fluorenyl) formate and 1- (3,5-dimethylphenyl) piperazine were reacted in the same manner as in Example 22 above to obtain the above compound. Yield: 53%

熔點:159〜161°C iH NMR(CDC13) 5 :2.09(2H,m),2.28(6H,m),2.87(4H,m), 3.67(4H,t),4.00(3H,s),4.21(4H,t),6.57(3H,m), 6.93(lH,s),8.24(lH,s) 實施例31) l-[(2-曱氧基-5,6,7,8_四氫喳啉-3-醯基)胺 基羰基]-4-(3,5-二曱氧基苯基)哌嗪 將苯基N-(2-甲氧基-5,6,7,8-四氳喧琳-3_酸基)甲 酸酯與1-(3,5-二甲氧基苯基)哌嗪,採行如同上述實施 例22相同的方法進行反應,而可獲得上述化合物。 收成率:56%Melting point: 159 ~ 161 ° C iH NMR (CDC13) 5: 2.09 (2H, m), 2.28 (6H, m), 2.87 (4H, m), 3.67 (4H, t), 4.00 (3H, s), 4.21 (4H, t), 6.57 (3H, m), 6.93 (lH, s), 8.24 (lH, s) Example 31) l-[(2-fluorenyl-5,6,7,8_tetrahydro Pyridin-3-fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine Phenyl N- (2-methoxy-5,6,7,8-tetra The above compound can be obtained by carrying out the reaction in the same manner as in Example 22 above, and carrying out the reaction in the same manner as in Example 22 above. Yield: 56%

熔點:160〜161°C 泔 NMR(CDC13) 5 :1.77(2H,m),1.83(2H,m),2.70(2H,t), 2.76(2H,t),3.38(4H,t),3.79(6H,s),3.96(3H,s),4·16 (4H,m),6.12(3H,m),7.45(lH,s),8.03(lH,s) 實施例32) l-[(2-甲氧基-5,6,7,8-四氫喳啉-3-醯基)胺 30 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 575564 五、 發明説明(26 經濟部中央標準局員工消費合作社印製 基羰基]-4-(3,5-二甲基苯基)哌嗪 將苯基N-(2-甲氧基-5,6,7,8-四氫喳啉醯基)甲 酸酯與1-(3,5-二甲基苯基)哌嗪,採行如同上述實施例 22相同的方法進行反應,而可獲得上述化合物。 收成率:54% 熔點:200〜201°C 泔 NMR(CDC13)(5:1.77(2H,m),184(2H,m),2 34(6h,s), 2.71(3H,t),2.75(3H,t),3.47(4H,t),3.97(3H,s),4.42 (4H,t),6.35(3H,m),6.91(lH,s),7.91(lH,s) 實施例33) l-[(5,6-二甲基·2-甲胺基吡啶_3_醯基)胺 基羰基>4-(3,5-二甲基苯基)哌嗉 將苯基N-(5,6-二甲氧基-2-甲胺基吡啶_3_醯基)甲 酉文酉曰與1-(3,5-一甲氧基苯基)旅嗔,採行如同上述實 施例1相同的方法進行反應,而可獲得上述化合物。 收成率:53% 熔點:150〜 H NMR(CDC13) δ :2.29(3H5s)?2.48(3H?s)5 3.29(3H?s)? 3.45(3H,s),3.77(6H,s),3.79(4H,t),6.10(3H,m),7.40 (1H,S) 實施例34) l-[(5,6-二曱基-2-甲胺基吡啶-3_醯基)胺 基羰基]_4_(3,5-二曱基苯基)哌嗉 將笨基N-(5,6-二甲基-2-甲胺基吡啶_3_醯基)甲酸 酯與1-(3,5-二甲基苯基)哌嗪,採行如同上述實施例 1相同的方法進行反應,而可獲得上述化合物。 (請先閲讀背面之注意事項再填寫本頁) :裝· -1% -31 - 經濟部中央標準局員工消費合作社印製 575564 A7 B7 五、發明説明(27 ) 收成率·· 52%Melting point: 160 ~ 161 ° C 泔 NMR (CDC13) 5: 1.77 (2H, m), 1.83 (2H, m), 2.70 (2H, t), 2.76 (2H, t), 3.38 (4H, t), 3.79 (6H, s), 3.96 (3H, s), 4.16 (4H, m), 6.12 (3H, m), 7.45 (lH, s), 8.03 (lH, s) Example 32) l-[( 2-methoxy-5,6,7,8-tetrahydrofluorolin-3-amidino) amine 30 This paper size applies to China National Standard (CNS) A4 (210X297 mm) (Please read the Note for this page, please fill in this page) Order 575564 V. Description of the invention (26 Printed carbonyl group of the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs] -4- (3,5-dimethylphenyl) piperazine will be phenyl N- ( 2-methoxy-5,6,7,8-tetrahydrofluorinylfluorenyl) formate and 1- (3,5-dimethylphenyl) piperazine were used in the same manner as in Example 22 above. The reaction is carried out by the method to obtain the above compounds. Yield: 54% Melting point: 200 ~ 201 ° C 泔 NMR (CDC13) (5: 1.77 (2H, m), 184 (2H, m), 2 34 (6h, s ), 2.71 (3H, t), 2.75 (3H, t), 3.47 (4H, t), 3.97 (3H, s), 4.42 (4H, t), 6.35 (3H, m), 6.91 (lH, s) , 7.91 (lH, s) Example 33) l-[(5,6-dimethyl · 2-methylaminopyridin-3-yl) ) Aminocarbonyl > 4- (3,5-dimethylphenyl) piperidine N- (5,6-dimethoxy-2-methylaminopyridine_3_fluorenyl) formamidine The above compound can be obtained by reacting with 1- (3,5-monomethoxyphenyl) group in the same manner as in Example 1 above to obtain the above compound. Yield: 53% Melting point: 150 ~ H NMR (CDC13) δ: 2.29 (3H5s)? 2.48 (3H? S) 5 3.29 (3H? S)? 3.45 (3H, s), 3.77 (6H, s), 3.79 (4H, t), 6.10 (3H, m), 7.40 (1H, S) Example 34) l-[(5,6-Difluorenyl-2-methylaminopyridine-3_fluorenyl) aminocarbonyl] _4_ (3,5-difluorenyl Phenyl) piperazineA benzyl N- (5,6-dimethyl-2-methylaminopyridine_3_fluorenyl) formate and 1- (3,5-dimethylphenyl) piperazine The reaction was carried out in the same manner as in Example 1 above to obtain the above compound. (Please read the notes on the back before filling out this page): Packing · -1% -31-Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 B7 V. Description of the invention (27) Yield · 52%

熔點:160〜162°C NMR(CDC13) 5 :2.30(9H,s),2.48(3H,s),3.31(4H,t), 3.46(3H,s),3.78(4H,t),6.60(3H,m),7.41(lH,s) 實施例35) 1-[(5·乙基-6-甲基-2-甲胺基吡啶-3_醯基) 月女基魏基]-4-(3,5 -二曱基苯基)σ底σ秦 將苯基Ν-(5-乙基-6-甲基-2-甲胺基咐^。定_3_酿基)甲 酸酯與1-(3,5-二甲基苯基)旅嘻,採行如同上述實施 例1相同的方法進行反應,而可獲得上述化合物。 收成率:56%Melting point: 160 ~ 162 ° C NMR (CDC13) 5: 2.30 (9H, s), 2.48 (3H, s), 3.31 (4H, t), 3.46 (3H, s), 3.78 (4H, t), 6.60 ( 3H, m), 7.41 (lH, s) Example 35) 1-[(5 · Ethyl-6-methyl-2-methylaminopyridine-3_fluorenyl) Womenylweilyl] -4- (3,5-Difluorenylphenyl) σ bottom σ Qin will be a phenyl N- (5-ethyl-6-methyl-2-methylamino) ^. __3_ ethyl group formate and 1- (3,5-dimethylphenyl) is used to carry out the reaction in the same manner as in Example 1 to obtain the above compound. Yield: 56%

熔點:143〜145°C !Η NMR(CDC13) δ :1.22(3H5t)? 2.28(6H?s)5 2.52(3H5s)? 2.72(2H,q),3.29(4H,t),3.45(3H,s),3.78(4H,t), 6.59(3H,m),7.41(lH,s) 實施例36) 1_[(2_曱胺基-6,7-二氫-5H-環戊基[b]吡啶 -3-醯基)胺基羰基]-4-(3,5-二曱氧基苯基)哌嗪 將苯基Ν-(2·甲胺基_6,7-二氫-5H-環戊基[b]。比啶-3-醯基)曱酸酯與l-(3,5-二曱氧基苯基)哌嗪,採行如 同上述實施例1相同的方法進行反應,而可獲得上述 化合物。 收成率·· 49%Melting point: 143 ~ 145 ° C! Η NMR (CDC13) δ: 1.22 (3H5t)? 2.28 (6H? S) 5 2.52 (3H5s)? 2.72 (2H, q), 3.29 (4H, t), 3.45 (3H, s), 3.78 (4H, t), 6.59 (3H, m), 7.41 (lH, s) Example 36) 1 _ [(2-amido-6-6,7-dihydro-5H-cyclopentyl [b ] Pyridine-3-fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyoxyphenyl) piperazine Phenyl N- (2.methylamino-6,7-dihydro-5H- Cyclopentyl [b]. Pyridin-3-amidino) phosphonate and l- (3,5-dioxophenyl) piperazine were reacted in the same manner as in Example 1 above, and The above compounds can be obtained. Yield: 49%

熔點·· 148〜150°C NMR(CDC13) 5:2.09(2H,m),2-95(4H,m),3.30(4H,t), 3.47(3H,s),3.77(4H,t),3.80(6H,s),6.10(3H,m),7·49 -32- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁) ;裝. 訂 575564 經濟部中央標隼局員工消費合作社印製 五、發明説明((1H,S) 實施例37) H(2_曱胺基_6,7_二氣.環戊基_。定 -3-醯基)胺基羰基卜4_(3,5_二甲基苯基)哌嗪 將苯基N_(2-甲胺基環戍基[叶比唆_ 3邊,)曱酸醋與H3,5.二甲基苯基)呢嘻,採行如同 上述實施例1相同的方法進行反應,而可獲得上 合物。收成率:48% 熔點:185〜187°C W >JMR(CDC13) (5 :2.14(2H,m),2.29(6H,s),2.95(4H,m), 3.32(4H,t),3.47(3H,s),3.79(4H,t),6.59(3H,m),7.私, (1H,S) 實施例38) l-{[5,6-二甲基_2-(4,-t-丁基羰基哌嗪),比 啶-3-醯基)胺基羰基]-4-(3,5-二甲氧基苯基)哌嘻 將苯基N_[5,6_二甲基_2_(4,-t-丁基羰基哌嗪比咬_ 3-酉&基]曱酸酯與i-(3,5-二甲氧基苯基底嗔,採行如 同上述實施例1相同的方法進行反應,而可獲得上述 化合物。收成率:58% 熔點:74〜75°C 4 NMR(CDC13) 6 :1.46(9H,s),2.20(3H,s),2.21(2H,S), 2.90(4H,t),3.20(4H,t),3.55(4H,t),3.65(4H,t),3.98(3H,s),6.02(3H,m),8.20(lH,s)實施例39) l-{[5,6-二甲基-2-(4’-t-丁基羰基哌嗪),比 -33 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐)Melting point: 148 ~ 150 ° C NMR (CDC13) 5: 2.09 (2H, m), 2-95 (4H, m), 3.30 (4H, t), 3.47 (3H, s), 3.77 (4H, t) , 3.80 (6H, s), 6.10 (3H, m), 7.49 -32- This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) (Please read the precautions on the back before filling in this Page); Pack. Order 575564 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs. 5. Description of the invention ((1H, S) Example 37) H (2_amido_6,7_digas.cyclopentyl _. D-3--3-yl) aminocarbonyl group 4_ (3,5_dimethylphenyl) piperazine will be phenyl N_ (2-methylaminocyclofluorenyl [leaf ratio 3 3 sides,) 曱The acid and vinegar were reacted with H3,5.dimethylphenyl) hexyl by the same method as in Example 1 above to obtain a complex. Yield: 48% Melting point: 185 ~ 187 ° CW > JMR (CDC13) (5: 2.14 (2H, m), 2.29 (6H, s), 2.95 (4H, m), 3.32 (4H, t), 3.47 (3H, s), 3.79 (4H, t), 6.59 (3H, m), 7.private, (1H, S) Example 38) l-{[5,6-dimethyl_2- (4, -t-butylcarbonylpiperazine), than pyridin-3-amidino) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine phenyl N_ [5,6_dimethyl The group _2_ (4, -t-butylcarbonylpiperazine is more specific than the 3-3- & yl] phosphonate ester and i- (3,5-dimethoxyphenyl substrate, as in Example 1 above. The above-mentioned compound can be obtained by performing the reaction in the same method. Yield: 58% Melting point: 74 ~ 75 ° C 4 NMR (CDC13) 6: 1.46 (9H, s), 2.20 (3H, s), 2.21 (2H, S ), 2.90 (4H, t), 3.20 (4H, t), 3.55 (4H, t), 3.65 (4H, t), 3.98 (3H, s), 6.02 (3H, m), 8.20 (lH, s) Example 39) l-{[5,6-dimethyl-2- (4'-t-butylcarbonylpiperazine), than -33 This paper size is applicable to China National Standard (CNS) A4 specification (210X 297 male %)

-----J (請先閱讀背面之注意事項再填寫本頁) -裝· -訂 ·η0 經濟部中央標準局員工消費合作社印製 575564 A7 ------ ----B7 五、發明~— σ疋_3-醯基)胺基羰基]-4_(3,5_二甲氧基苯基)哌嗪 將苯基Ν-[5,6-二甲基-2-(4,-t-丁基羰基哌嗪)咣啶一 3-醯基]甲酸酯與1-(3,5-二曱氧基苯基)哌嗪,採行如 同上述貫施例1相同的方法進行反應,而可獲得上述 化合物。 收成率:5 6 %----- J (Please read the notes on the back before filling out this page) -Installation · -Order · η0 Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 ------ ---- B7 5 、 Invention ~ —σ 疋 _3-fluorenyl) aminocarbonyl] -4_ (3,5_dimethoxyphenyl) piperazine will be phenyl N- [5,6-dimethyl-2- (4 , -T-butylcarbonylpiperazine) piperidine-3-fluorenyl] formate and 1- (3,5-dioxophenyl) piperazine were carried out in the same manner as in Example 1 above. The reaction is performed to obtain the above-mentioned compound. Yield: 56%

熔點:155〜156°C NMR(CDC13) ^ :1.48(9H5s)?2.22(3H?s)? 2.29(6H?s)5 2_35(3H,s),2.95(4H,t),3.25(4H,t),3.57(4H,t),3.67 (4H,t),6.59(3H,m),8.21(lH,s) 貫施例40) l-{[5-乙基-6-曱基-2-(4,-t-丁基羰基哌嗪) 吡啶-3-醯基)胺基羰基]-4_(3,5-二甲氧基苯基)哌嗪 將苯基N-[5-乙基·6·甲基-2-(4,-t-丁基羰基哌嗪) °比啶-3-醯基]甲酸酯與1-(3,5-二甲氧基苯基)哌嗪,採 行如同上述實施例1相同的方法進行反應,而可獲得 上述化合物。 收成率:52%Melting point: 155 ~ 156 ° C NMR (CDC13) ^: 1.48 (9H5s)? 2.22 (3H? S)? 2.29 (6H? S) 5 2_35 (3H, s), 2.95 (4H, t), 3.25 (4H, t), 3.57 (4H, t), 3.67 (4H, t), 6.59 (3H, m), 8.21 (lH, s) (Example 40) l-{[5-ethyl-6-fluorenyl-2 -(4, -t-butylcarbonylpiperazine) pyridine-3-amidino) aminocarbonyl] -4_ (3,5-dimethoxyphenyl) piperazine Phenyl N- [5-ethyl · 6 · methyl-2- (4, -t-butylcarbonylpiperazine) ° pyridin-3-amidino] formate and 1- (3,5-dimethoxyphenyl) piperazine, The reaction was carried out in the same manner as in Example 1 above to obtain the above compound. Yield: 52%

熔點:119〜120°C 泔 NMR(CDC13) 5 丄25(3H,t),1.48(9H,s),2.38(3H,s), 2.51(2H,q),2.96(4H,t),3.27(4H,t),3.58(8H,m),3.78 (6H,s),6.08(3H,m),8.24(lH,s) 貫施例41) l-{[5-乙基-6-甲基-2-(4’-t-丁基幾基σ底嗪) 吡啶-3-醯基)胺基羰基]-4-(3,5_二甲基苯基)哌嗪 將苯基Ν-[5 -乙基-6-曱基- 2-(4’-t-丁基幾基σ底嗪) -34- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁} -訂· 經濟部中央標準局員工消費合作社印製 575564 A7 ___ B7 五、發明説明(3〇 ) 吡啶-3-醯基]甲酸酯與i-(3,5-二甲基苯基)哌嗪,採行 如同上述實施例1相同的方法進行反應,而可獲得上 述化合物。 收成率:50%Melting point: 119 ~ 120 ° C 泔 NMR (CDC13) 5 丄 25 (3H, t), 1.48 (9H, s), 2.38 (3H, s), 2.51 (2H, q), 2.96 (4H, t), 3.27 (4H, t), 3.58 (8H, m), 3.78 (6H, s), 6.08 (3H, m), 8.24 (lH, s) Example 41) l-{[5-ethyl-6-formaldehyde 2- (4'-t-butyl-jiki-sigma-zine), pyridin-3-fluorenyl) aminocarbonyl] -4- (3,5-dimethylphenyl) piperazine, phenyl N- [5 -Ethyl-6-fluorenyl- 2- (4'-t-butyl-chiki-sigma diazine) -34- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) ( Please read the notes on the back before filling out this page} -Order · Printed by the Consumer Cooperatives of the Central Bureau of Standards, Ministry of Economic Affairs 575564 A7 ___ B7 V. Description of the Invention (3〇) Pyridine-3-fluorenyl] formate and i- (3,5-Dimethylphenyl) piperazine can be reacted in the same manner as in Example 1 above to obtain the above compound. Yield: 50%

熔點:126〜128°C NMR(CDC13) δ :1.20(3H?t)51.49(9H?s)5 2.29(6H5s)3 2.39(3H,s),2_52(2H,q),2.98(4H,t),3.23(4H,t), 3·59 (8H,m),6.59(3H,m),7.5 8(lH,s),8.26(lH,s) 實施例42) 1_[(5,6-二甲基-2-哌嗪吡啶-3_醯基)胺基 罗炭基]-4-(3,5-二甲氧基苯基)σ底σ秦 將1-{[5,6-一甲基-2-(4’-t-丁基幾基口底嘻)口比咬_3_酸 基)胺基羰基]-4-(3,5-二甲氧基苯基)哌嗪(〇.218g,〇4 宅莫耳)’浴解於'一氯甲烧·石肖基甲烧= 2:1(10ml)中, 並逐漸加入茴香醚(0.26g,2.4毫莫耳)與氯化鋁(〇.3g, 2·4毫莫耳)後,在於室溫下攪拌2〇分鐘。然後添加 蒸鶴水(50ml),並以飽和的重碳酸鈉施行驗基化後, 利用一氯甲烧進行举取’以減壓濃縮將溶劑予以去 除後,再利用管柱層析(甲醇:二氯曱烷=8:1),進 行分離精製後便可獲得上述化合物。 收成率:89% 熔點:油狀 泔 NMR(CDC13口.21(3H,s),2.35(3H,S),3.02(4H,t), 3.34(4H,t),3.59(4H,t),3.62(4H,t),3.78(6H,s),6.08 (3H,m),8.18(lH,s) -35 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 • 575564 A7 B7 五、發明説明(31 ) ~~— (1H,S) 貫施例43) 1-[(5,6_二甲基_24嗪吡唆-3邊基)胺基 羰基]-4-(3,5-二甲基苯基)哌嗪 將苯基則[5,6-二曱基_2_(4,_t_丁基羰基哌嗔)吡 啶-3-醯基]胺基羰基卜4-(3,5_二甲基苯基)哌嗪,採行 如同上述實施例42相同的方法進行反應,而可獲得上 述化合物。 收成率:85%Melting point: 126 ~ 128 ° C NMR (CDC13) δ: 1.20 (3H? T) 51.49 (9H? S) 5 2.29 (6H5s) 3 2.39 (3H, s), 2_52 (2H, q), 2.98 (4H, t ), 3.23 (4H, t), 3.59 (8H, m), 6.59 (3H, m), 7.58 (lH, s), 8.26 (lH, s) Example 42) 1 _ [(5,6- Dimethyl-2-piperazinepyridine-3_fluorenyl) aminocarbanyl] -4- (3,5-dimethoxyphenyl) σbaseσQin Jiang1-{[5,6- 一Methyl-2- (4'-t-butyl-Chlorochi), mouth-to-mouth bite_3_acid) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine ( 〇.218g, 〇4 house mol) 'baked in' monochloromethane · Shishoki melamine = 2: 1 (10ml), and gradually add anisole (0.26g, 2.4mmol) and aluminum chloride (0.3 g, 2.4 mmol), and then stirred at room temperature for 20 minutes. Then add steamed crane water (50ml), and perform the test with saturated sodium bicarbonate. Then use chloroform to extract the solvent, remove the solvent by concentration under reduced pressure, and then use column chromatography (methanol: two Chloropane = 8: 1). After separation and purification, the above compounds can be obtained. Yield: 89% Melting point: Oily NMR (CDC13.21 (3H, s), 2.35 (3H, S), 3.02 (4H, t), 3.34 (4H, t), 3.59 (4H, t), 3.62 (4H, t), 3.78 (6H, s), 6.08 (3H, m), 8.18 (lH, s) -35-This paper size applies to China National Standard (CNS) A4 (210X297 mm) (please first Read the notes on the back and fill out this page) Order • 575564 A7 B7 V. Description of the invention (31) ~~ — (1H, S) Implementation Example 43) 1-[(5,6_dimethyl_24 hydrazine唆 -3 side group) aminocarbonyl] -4- (3,5-dimethylphenyl) piperazine the phenyl group [5,6-difluorenyl_2_ (4, _t_butylcarbonylpiperazine) ) Pyridine-3-amidino] aminocarbonyl 4- (3,5-dimethylphenyl) piperazine, which was reacted in the same manner as in Example 42 above to obtain the above compound. Yield: 85%

熔點:103〜105°C H NMR(CDC13) 5 :2.16(3H,s),2.24(6H,s),2.40(3H,s), 3.30(4H,t),3.44(4H,t),3.50(4H,t),3_81(4H,t),6.95 (3H,m),7.72(lH,s) 實施例44) 乙基-6-曱基-2-哌嗪。比啶_3_醯基)胺 基羰基]-4-(3,5-二甲氧基苯基)哌嗪 將苯基N-{[5-乙基-6-曱基_2-(4,-t-丁基羰基哌嗪) 响啶-3-醯基]胺基羰基}-4-(3,5-二甲氧基苯基)派嗉, 採行如同上述實施例42相同的方法進行反應,而可獲 得上述化合物。 收成率:88%Melting point: 103 ~ 105 ° CH NMR (CDC13) 5: 2.16 (3H, s), 2.24 (6H, s), 2.40 (3H, s), 3.30 (4H, t), 3.44 (4H, t), 3.50 ( 4H, t), 3-81 (4H, t), 6.95 (3H, m), 7.72 (1H, s) Example 44) Ethyl-6-fluorenyl-2-piperazine. Pyridine_3_fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine Phenyl N-{[5-ethyl-6-fluorenyl_2- (4 , -T-butylcarbonylpiperazine) amidin-3-fluorenyl] aminocarbonyl} -4- (3,5-dimethoxyphenyl) pyridine, following the same method as in Example 42 above The reaction is performed to obtain the above-mentioned compound. Yield: 88%

熔點:68〜70°C !H NMR(CDC13) δ :1.20(3H,t),2.40(3H,s),2.52(2H,q), 2.75(4H,t),3.32(4H,t),3.70(8H,m),3.78(6H,s),6.09 (3H,m),7.68(lH,s),8.23(lH,s) 貫施例45) 1 -[(5-乙基-6-曱基-2-旅嘻。比唆_酸基)胺 -36- 本紙張尺度適用中國國家標準(CNS ) Μ規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝· 訂 經濟部中央標準局員工消費合作社印製 經濟部中央標準局員工消費合作社印製 575564 A7 ' --^ ___B7 五、發明( 321 ^^ -- 基羰基]-4-(3,5-二甲基苯基)哌嗉 將苯基N-{[5-乙基-6-甲基外,何基幾基料) 口比唆-3-醯基]胺基徵基}-4-(3,5_二甲基苯基)派嗔,採 行如同上述實施例42相同的方法進行反應,而可獲得 上述化合物。 收成率:85%Melting point: 68 ~ 70 ° C! H NMR (CDC13) δ: 1.20 (3H, t), 2.40 (3H, s), 2.52 (2H, q), 2.75 (4H, t), 3.32 (4H, t), 3.70 (8H, m), 3.78 (6H, s), 6.09 (3H, m), 7.68 (lH, s), 8.23 (lH, s) Example 45) 1-[(5-ethyl-6-曱 基 -2- 旅 嘻. Than 唆 _acid) amine-36- This paper size applies to the Chinese National Standard (CNS) M specifications (210X297 mm) (Please read the precautions on the back before filling out this page)-Install · Ordered by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs and printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs and printed by 575564 A7 '-^ ___B7 V. Invention (321 ^^-carbonyl) -4- (3,5-II Methylphenyl) piperidine will be phenyl N-{[5-ethyl-6-methyl, Hokiji base) mouth ratio 唆 -3-fluorenyl] amino group} -4- (3 , 5-Dimethylphenyl) hydrazone, the same method as described in Example 42 above was used for the reaction to obtain the above compound. Yield: 85%

熔點:100〜102°C NMR(CDC13) ^ :1.20(3H,t),2.28(6H,s), 2.39(3H,s), 2.65(2H?q)?2.76(4H!>t)?3.00(4H?t)?3.23(4H?t),3.70(4H?t)? 6.58 (3H,m), 7.66(lH,s),8.24(1H,S) ? 實施例46) l-[(5-乙醯基-2-甲氧基_6_甲基吡啶醯 基)胺基羰基]-4-(3,5-二甲氧基苯基)哌嗪 將苯基N-(5-乙醯基-2-曱氧基_6_甲基吡啶_3_醯基) 甲酸酯(200mg,0_67毫莫耳)與l-(3,5-二甲氧基苯基)旅 嗪(150mg,0.67毫莫耳),溶解於無水四氳,比喃(15ml) 中’並添加DBU(100mg,0.67毫莫耳)後,於室溫下授 拌2小時。然後利用減壓濃縮將溶劑予以去除後,再 利用管柱層析(乙基醋酸酯:己烧=1:2),進行分離精 製後便可獲得上述化合物。 收成率:83%Melting point: 100 ~ 102 ° C NMR (CDC13) ^: 1.20 (3H, t), 2.28 (6H, s), 2.39 (3H, s), 2.65 (2H? Q)? 2.76 (4H! ≫ t)? 3.00 (4H? T)? 3.23 (4H? T), 3.70 (4H? T)? 6.58 (3H, m), 7.66 (lH, s), 8.24 (1H, S)? Example 46) l-[( 5-ethenyl-2-methoxy-6-methylpyridinium) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine Phenyl N- (5-ethyl Fluorenyl-2-fluorenyloxy-6-methylpyridine_3_fluorenyl) formate (200mg, 0_67 mmol) and l- (3,5-dimethoxyphenyl) travelazine (150mg , 0.67 millimolar), dissolved in anhydrous tetrahydrofuran (15ml), and added DBU (100mg, 0.67 millimolar), and then stirred at room temperature for 2 hours. Then, the solvent was removed by concentration under reduced pressure, and the above compound was obtained after separation and purification by column chromatography (ethyl acetate: hexane = 1: 2). Yield: 83%

熔點:149〜151°C β NMR(CDC13) 5 :2.57(3H,m),2.65(3H,s),3.28(4H,t, J=4.65Hz),3.70(4H,t,J=4.65Hz),3.79(6H,s),4.06(3H,s), 6.09(lH,s),6.14(2H,d),6.94 (lH,s),8.87(lH,s) -37- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) ;裝_ 575564Melting point: 149 ~ 151 ° C β NMR (CDC13) 5: 2.57 (3H, m), 2.65 (3H, s), 3.28 (4H, t, J = 4.65Hz), 3.70 (4H, t, J = 4.65Hz ), 3.79 (6H, s), 4.06 (3H, s), 6.09 (lH, s), 6.14 (2H, d), 6.94 (lH, s), 8.87 (lH, s) -37- Applicable to this paper standard China National Standard (CNS) A4 specification (210X 297 mm) (Please read the precautions on the back before filling this page); Packing _ 575564

經濟部中央標準局員工消費合作社印製 貝例47) 1 -[(5 -乙酸基-2-甲氧基-6-甲基吨°定-3-醯 基)胺基羰基]-4-(3,5_二甲基苯基)哌嗪 將本基Ν_(5-乙驢基_2_甲氧基_6_甲基。比咬隨基)甲 酉欠酉曰與1-(3,5-二曱基苯基)哌嗔,採行如同上述實施例 46相同的方法進行反應,而可獲得上述化合物。 收成率:82% 熔點:66〜69〇C NMR(CDC13) 5 :2.31(6H?s)?2.57(3H?s)? 2.65(3H?s)? 3.〇8(4H,t),3.30(4H,t),4.10(3H,s),6.71(2H5d),6_94(lH,s), B.89(1H,s) 實施例48) 1_[(5-乙醯基-2-甲氧基-6_甲基吡啶_3_醯 基)胺基羰基]-4-(3,5-二氟化苯基)哌嗪 將苯基N-(5-乙醯基-2-甲氧基_6_甲基咣啶醯基)甲 酸酯與1-(3,5-二氟化苯基)哌嗪,採行如同上述實施例 46相同的方法進行反應,而可獲得上述化合物。 收成率:77% 溶點:180〜181°C ^ NMR(CDC13) d :2.57(3H,s),2.65(3H,s), 3.33(4H,t, J=5.0Hz), 3.74(4H,U=5.0Hz),4.07(3H,s), 6.37(1H,s), 6.46(2H5d),6.93(lH,s),8.85(1H,s) 貫施例49)丨-[(5-乙醯基-2-甲氧基甲基吡啶_3_醯 基)胺基幾基]-4-(3,5-二氯化苯基)π辰嗪 將苯基N-(5-乙醯基-2-甲氧基-6-甲基。比啶-3_醯基)甲 酸酯與1-(3,5-二氯化苯基)哌嗪,採行如同上述實施例 -38 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)一一-—~---*- (請先閱讀背面之注意事項再填寫本頁) ;裝_Printed by the Consumers' Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs, Example 47) 1-[(5 -Acetyl-2-methoxy-6-methyl tonidine-3-amidino) aminocarbonyl] -4- ( 3,5_Dimethylphenyl) piperazine converts the basic group N_ (5-ethyldonyl_2_methoxy_6_methyl.) More than 1- (3, 5-Difluorenylphenyl) piperidine was reacted in the same manner as in Example 46 to obtain the above compound. Yield: 82% Melting point: 66 ~ 69 ° C NMR (CDC13) 5: 2.31 (6H? S)? 2.57 (3H? S)? 2.65 (3H? S)? 3.〇8 (4H, t), 3.30 (4H, t), 4.10 (3H, s), 6.71 (2H5d), 6_94 (lH, s), B.89 (1H, s) Example 48) 1 _ [(5-ethylamido-2-methoxy -6-methylpyridine_3-fluorenyl) aminocarbonyl] -4- (3,5-difluorophenyl) piperazine Phenyl N- (5-ethylfluorenyl-2-methoxy The above-mentioned compound can be obtained by carrying out a reaction in the same manner as in Example 46 above for the methyl-6-methylpyridinyl) formate and 1- (3,5-difluorophenyl) piperazine. Yield: 77% Melting point: 180 ~ 181 ° C ^ NMR (CDC13) d: 2.57 (3H, s), 2.65 (3H, s), 3.33 (4H, t, J = 5.0Hz), 3.74 (4H, U = 5.0Hz), 4.07 (3H, s), 6.37 (1H, s), 6.46 (2H5d), 6.93 (lH, s), 8.85 (1H, s) (Example 49) 丨-[(5- 乙Fluorenyl-2-methoxymethylpyridine_3_fluorenyl) aminopropyl] -4- (3,5-dichlorinated phenyl) pyrazine phenyl N- (5-ethylfluorenyl 2-methoxy-6-methyl.pyridine-3_fluorenyl) formate and 1- (3,5-dichlorophenyl) piperazine were used as in Example -38 above-this Paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm)-one to one-----*-(Please read the precautions on the back before filling this page);

,1T d —5 *- 575564 經濟部中央標準局員工消費合作社印製 A7 五、發明説明(34 ) ^ 46相同的方法進行反應,而可獲得上述化合物。 收成率:8 1 % 少谷點:油狀 旧醒R(CDCl3) 5 :2 57(3H s),2 65(3H s),3 34(4H t), 3-78(4H,t),4.04(3H,s),6.93(3H,m),8.80(lH,s) 實施例50) l-[(5-乙醯基-2-甲氧基-6-甲基吡啶-3-醯 基)胺基羰基]-4-(2,3-二甲基苯基)哌嗪 將苯基Ν-(5·乙醯基-2-甲氧基-6-甲基α比啶-3-醯基)甲 酸酯與1-(2,3-二甲基苯基)哌嗉,採行如同上述實施例 46相同的方法進行反應,而可獲得上述化合物。 收成率:81 %, 1T d —5 *-575564 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 V. Description of the invention (34) ^ 46 The same method can be used to obtain the above compounds. Yield: 8 1% Few points: oily old wake R (CDCl3) 5: 2 57 (3H s), 2 65 (3H s), 3 34 (4H t), 3-78 (4H, t), 4.04 (3H, s), 6.93 (3H, m), 8.80 (lH, s) Example 50) l-[(5-ethylfluorenyl-2-methoxy-6-methylpyridine-3-fluorenyl ) Aminocarbonyl] -4- (2,3-dimethylphenyl) piperazine The phenyl N- (5 · ethylfluorenyl-2-methoxy-6-methyl alpha than pyridin-3- 醯The above-mentioned compound can be obtained by reacting the methyl) formate with 1- (2,3-dimethylphenyl) piperidine in the same manner as in Example 46 described above. Yield: 81%

溶點:173〜174°C !H NMR(CDC13) δ :2.29(6H?s)52.58(3H?s)? 2.65(3H5s), 2.98(4H,t),3.70(4H,t),4.06(3H,s),6.91(lH,d),6.97(lH,s), 7.1〇(lH,t),8_89(lH,s) 貫加例51) 1-[(5-乙酸基_2-曱氧基-6-甲基吼唆-3-驢 基)胺基羰基]-4-(2-甲氧基苯基)哌嗪 將本基N_(5-乙驢基-2-甲氧基-6-甲基η比咬-3-SI基)甲 酸酯與1 -(2-曱氧基苯基)旅嗔,採行如同上述實施例46 相同的方法進行反應,而可獲得上述化合物。 收成率:79%Melting point: 173 ~ 174 ° C! H NMR (CDC13) δ: 2.29 (6H? S) 52.58 (3H? S)? 2.65 (3H5s), 2.98 (4H, t), 3.70 (4H, t), 4.06 ( 3H, s), 6.91 (lH, d), 6.97 (lH, s), 7.10 (lH, t), 8-89 (lH, s) (Conventional Example 51) 1-[(5-acetoxy_2-fluorene Ethyl-6-methylamidine-3-donyl) aminocarbonyl] -4- (2-methoxyphenyl) piperazine will be the radical N_ (5-ethyldonyl-2-methoxy- The 6-methyl η-ratio-3-SI group) formate and 1- (2-methoxyoxyphenyl) amidine are reacted in the same manner as in Example 46 to obtain the above compound. Yield: 79%

熔點:153〜154°C lR NMR(CDC13) (5 :2.58(3H9s)?2.65(3H5s)?3.15(4H?t)? 3.73(4H,t)5 3.90(3H,s),4.06(3H,s),6.91(lH,d),6.96 -39- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) ;装- 575564 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(35 ) (lH,d),6.97(lH,s),7.10(lH,t),8.89(lH,s) 實施例52)卜[(5-乙醯基-2-曱氧基-6-曱基吡啶-3-醯 基)胺基羰基]-4-(3-羥苯基)哌嗪 將苯基N-(5-乙醯基-2-甲氧基-6-甲基咣啶-3-醯基)曱 酸酯與1-(3-羥苯基)哌嗪,採行如同上述實施例46相 同的方法進行反應,而可獲得上述化合物。 收成率:76% 熔點:油狀 iH NMR(CDC13) 5 :2.60(3H,s),2.72(3H,s),3.34(4H,t), 3.79(4H,t),3.98(3H,s),6.45(3H,m),6.98(lH,m),8.97 (lH,s) 實施例53) l-[(5-乙醯基-2-甲氧基_6-甲基咄啶-3-醯 基)胺基幾基]-4-(3,5-二曱氧基苯基)σ辰嘻 將苯基Ν-(5-乙醯基-2_甲氧基-6_曱基吡啶-3-醯基)甲 酸酯與1-(3,5-二甲氧基苯基)哌嗉,採行如同上述實施 例22相同的方法進行反應,而可獲得上述化合物。 收成率:77%Melting point: 153 ~ 154 ° C lR NMR (CDC13) (5: 2.58 (3H9s)? 2.65 (3H5s)? 3.15 (4H? T)? 3.73 (4H, t) 5 3.90 (3H, s), 4.06 (3H, s), 6.91 (lH, d), 6.96 -39- This paper size applies to China National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page); Packing-575564 Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards A7 B7 V. Description of Invention (35) (lH, d), 6.97 (lH, s), 7.10 (lH, t), 8.89 (lH, s) Example 52) [( 5-ethylfluorenyl-2-fluorenyloxy-6-fluorenylpyridin-3-fluorenyl) aminocarbonyl] -4- (3-hydroxyphenyl) piperazine Phenyl N- (5-ethylfluorenyl 2-methoxy-6-methylpyridin-3-amidino) phosphonate and 1- (3-hydroxyphenyl) piperazine were reacted in the same manner as in Example 46 above, but The above compound is obtained. Yield: 76% Melting point: Oily iH NMR (CDC13) 5: 2.60 (3H, s), 2.72 (3H, s), 3.34 (4H, t), 3.79 (4H, t), 3.98 (3H, s) , 6.45 (3H, m), 6.98 (lH, m), 8.97 (lH, s) Example 53) l-[(5-ethylamido-2-methoxy-6-methylpyridine-3- (Methenyl) aminoamino] -4- (3,5-dimethoxyphenyl) σ Chen Hei phenyl N- (5-ethenyl-2_methoxy-6_fluorenylpyridine- The 3-fluorenyl) formate and 1- (3,5-dimethoxyphenyl) piperidine were reacted in the same manner as in Example 22 above to obtain the above compound. Yield: 77%

熔點:167〜169°C 'Η NMR(CDC13) δ :2.58(3H,s),2.68(3H,s),3.47(4H,t), 3.81(6H,s),4.05(3H,s),4.36(4H,t),6.42(3H,m),7·49 (1H,s),9_05(1H,s) 實施例54) 1-[(5-乙醯基-2-曱氧基-6-甲基吡啶-3-醯 基)胺基魏基]-4-(3,5-二曱基苯基)σ辰嗔 將苯基Ν-(5-乙醯基-2-甲氧基-6-曱基吡啶-3-醯基)曱 -40- 本紙張尺度適财關家縣(CNS ) Α4·· ( 210X^97公^7 -~ (請先閲讀背面之注意事項再填寫本頁) ;裝- 經濟部中央標準局員工消費合作社印製 575564 A7 _____B7 五、發明説明(36 ) 酸酯與1-(3,5-二甲基苯基)π辰嘻,採行如同上述實施例 22相同的方法進行反應,而可獲得上述化合物。 收成率:75%Melting point: 167 ~ 169 ° C 'Η NMR (CDC13) δ: 2.58 (3H, s), 2.68 (3H, s), 3.47 (4H, t), 3.81 (6H, s), 4.05 (3H, s), 4.36 (4H, t), 6.42 (3H, m), 7.49 (1H, s), 9_05 (1H, s) Example 54) 1-[(5-Ethyl-2-yloxy-6 -Methylpyridin-3-fluorenyl) aminoweilyl] -4- (3,5-difluorenylphenyl) σphenyl, N- (5-ethylfluorenyl-2-methoxy- 6-Aminopyridine-3-Amino) 曱 -40- This paper is suitable for Guancai County (CNS) Α4 ·· (210X ^ 97 公 ^ 7-~ (Please read the precautions on the back before filling this page ); Equipment-printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 575564 A7 _____B7 V. Description of the invention (36) Ester and 1- (3,5-dimethylphenyl) π Chen Hee, the same as in the above examples The above-mentioned compound can be obtained by performing the reaction in the same manner as in Example 22. Yield: 75%

熔點:176〜177°C 4 NMR(CDC13) δ :2.34(6H,s),2.58(3H,s),2.68(3H,s), 3.48(4H,t),4.06(3H,s),4.43(4H,t),7.05(4H,t),7.05 (3H,m),7.52(lH,s),9.04(lH,s) 實施例55) l-[(5-乙醯基-2-甲氧基-6-甲基吡啶-3-醯 基)胺基羰基]-4-(3-羥苯基)哌嗪 將苯基N-(5 -乙醯基-2 -甲氧基-6·甲基吼咬-3-酸基)甲 酸酯與1_(3_羥苯基)旅嗪,採行如同上述實施例22相 同的方法進行反應,而可獲得上述化合物。 收成率:71%Melting point: 176 ~ 177 ° C 4 NMR (CDC13) δ: 2.34 (6H, s), 2.58 (3H, s), 2.68 (3H, s), 3.48 (4H, t), 4.06 (3H, s), 4.43 (4H, t), 7.05 (4H, t), 7.05 (3H, m), 7.52 (lH, s), 9.04 (lH, s) Example 55) l-[(5-ethylfluorenyl-2-methyl Oxy-6-methylpyridin-3-amidino) aminocarbonyl] -4- (3-hydroxyphenyl) piperazine Phenyl N- (5-ethylamido-2 -methoxy-6 · The above compound can be obtained by reacting methyl 3-methyl 3-carboxylate) with 1- (3-hydroxyphenyl) travelrazine in the same manner as in Example 22 above. Yield: 71%

熔點:114〜115°C 4 NMR(CDC13)心2.56(3H,S),2.75(3H,s),3.68(4H,t), 4.05(3H,s),4.45(4H,t),7.30(4H,m),9.03(lH,s)Melting point: 114 ~ 115 ° C 4 NMR (CDC13) Heart 2.56 (3H, S), 2.75 (3H, s), 3.68 (4H, t), 4.05 (3H, s), 4.45 (4H, t), 7.30 ( 4H, m), 9.03 (lH, s)

Mass(EI) m/z:458.2527 (MH,C23H3()N404 Si 計算值: 458.1987) 實施例56) 1-{[(5-(1·羥乙基)-2-曱氧基-6-曱基吡啶_ 3-酿基]胺基羰基}-4-(3,5-二曱氧基苯基)哌嗪 將苯基N-[(5-乙醯基-2-曱氧基-6-甲基吼π定-3-醯基) -4-(3,5-二曱氧基苯基)哌嘻(ioon^O.23毫莫耳),溶解 於無水乙醇(15ml)中’並添加石朋氮化納(gggmg)後,於 室溫下攪拌2小時。 -41 - 本紙張尺度_適用中國國家;^準(CNS ) A4規格(210X297公釐1 ---- (請先閱讀背面之注意事項再填寫本頁) 、11 -1¾. 575564 A7 B7 五、發明説明(37 ) 然後利用減壓濃縮將乙醇予以去除後,再利用管 柱層析(乙基醋酸酯:己烷= 2:1),進行分離精製後便 可獲得上述化合物。 收成率:97%Mass (EI) m / z: 458.2527 (MH, C23H3 () N404 Si Calculated: 458.1987) Example 56) 1-{[(5- (1 · hydroxyethyl) -2-fluorenyl-6-fluorene Pyridyl-3-amino] aminocarbonyl} -4- (3,5-dimethoxyphenyl) piperazine Phenyl N-[(5-ethylfluorenyl-2-fluorenyloxy-6- Methylpyridin-3-yl) -4- (3,5-dioxophenyl) piperazine (ioon ^ O.23 mmol), dissolved in absolute ethanol (15 ml) and added After the sodium pentoxide (gggmg) is stirred, stir at room temperature for 2 hours. -41-This paper size _ applicable to China; ^ (CNS) A4 size (210X297 mm 1 ---- (Please read the back first) Note for refilling this page), 11 -1¾. 575564 A7 B7 V. Description of the invention (37) Then the ethanol was removed by concentration under reduced pressure, and then column chromatography was used (ethyl acetate: hexane = 2 : 1), the above compound can be obtained after separation and purification. Yield: 97%

熔點:124〜126°C lH NMR(CDC13) 5 :1.48(3H5d)52.42(3H5s)5 3.27(4H?t)? 3.69(4H,t),3.79(6H,s),3.99(3H,s),5_03(lH,q),6.09 (lH,s),6.15 (2H,d),6.90(lH,s),8.46(lH,s) 實施例57) l-{[(5-(l-羥乙基)-2-甲氧基-6-甲基咄啶一 3-醯基]胺基羰基}-4-(3,5-二甲基苯基)哌嗪 將1-[(5-乙醯基-2-甲氧基-6-甲基响咬-3-醯基)胺 基幾基]-4-(3,5-二甲基苯基)旅嗔,採行如同上述實施 例56相同的方法進行反應,而可獲得上述化合物。 收成率:95%Melting point: 124 ~ 126 ° C lH NMR (CDC13) 5: 1.48 (3H5d) 52.42 (3H5s) 5 3.27 (4H? T)? 3.69 (4H, t), 3.79 (6H, s), 3.99 (3H, s) , 5_03 (lH, q), 6.09 (lH, s), 6.15 (2H, d), 6.90 (lH, s), 8.46 (lH, s) Example 57) l-{[((5- (l-hydroxyl Ethyl) -2-methoxy-6-methylpyridine-3-fluorenyl] aminocarbonyl} -4- (3,5-dimethylphenyl) piperazine 1-[(5-ethyl Fluorenyl-2-methoxy-6-methyl-2-methyl-3-amino) aminopropyl] -4- (3,5-dimethylphenyl), as described in Example 56 above. The reaction was performed in the same manner to obtain the above compound. Yield: 95%

熔點:153〜154°C H NMR(CDC13)占:1.48(3H,d),2.30(6H,s),2.42(3H,s), 3.26(4H,t),3.68(4H,t),3.99(3H,s)5 5.05(lH,q),6.71 (2H,d),6.96(lHg,s),8.46(lH,s) 經濟部中央標準局員工消費合作社印製 實施例58) l-{[(5-(l-羥乙基)-2-甲氧基_6_甲基,比啶_ 3-醯基]胺基羰基卜4_(2,3_二甲基苯基)哌嗪 將1-[(5-乙醯基-2-曱氧基-6-甲基吡啶醯基)胺 基羰基]-4-(2,3-二曱基苯基)哌嗪,採行如同上述實施 例5 6相同的方法進行反應,而可獲得上述化合物。 收成率:96%Melting point: 153 ~ 154 ° CH NMR (CDC13) accounts for: 1.48 (3H, d), 2.30 (6H, s), 2.42 (3H, s), 3.26 (4H, t), 3.68 (4H, t), 3.99 ( 3H, s) 5 5.05 (lH, q), 6.71 (2H, d), 6.96 (lHg, s), 8.46 (lH, s) Example 58 printed by the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. L-{[ (5- (l-hydroxyethyl) -2-methoxy-6-methyl, pyridin-3-amino] aminocarbonyl group 4- (2,3-dimethylphenyl) piperazine will be 1 -[(5-ethylfluorenyl-2-fluorenyloxy-6-methylpyridinyl) aminocarbonyl] -4- (2,3-difluorenylphenyl) piperazine, as in the above examples The above compounds can be obtained by reacting in the same manner as 5 6. Yield: 96%

575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(38 ) 熔點:100〜102°c iH NMR(CDC13) (5 :1.47(3H,d),l_59(3H,s),2.25(3H,S), 2.28(3H,s),2.43(3H,m),2.93(4H,t),3.66(4H,t),3.99 (3H,s),5.05(lH,q),6.93(3H5m),7.11(lH,m),8.48(lH,s) 實施例59) l-{[(5-(l-羥乙基)-2-甲氧基曱基吡啶· 3-醯基]胺基羰基}-4-(3,5-二氟化苯基)哌嗪 將1-[(5-乙酸基-2-曱氧基-6-甲基吼咬_3_醯基)胺 基幾基]-4-(3,5-二氟化苯基)旅嗔,採行如同上述實施 例56相同的方法進行反應,而可獲得上述化合物。 收成率:97%575564 Printed by A7 B7, Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs 5. Explanation of the invention (38) Melting point: 100 ~ 102 ° c iH NMR (CDC13) (5: 1.47 (3H, d), l_59 (3H, s), 2.25 (3H, S), 2.28 (3H, s), 2.43 (3H, m), 2.93 (4H, t), 3.66 (4H, t), 3.99 (3H, s), 5.05 (lH, q), 6.93 ( 3H5m), 7.11 (lH, m), 8.48 (lH, s) Example 59) l-{[((5- (l-hydroxyethyl) -2-methoxyfluorenylpyridine · 3-fluorenyl] amine Carbonyl} -4- (3,5-difluorinated phenyl) piperazine will be 1-[(5-acetoxy-2-amido-6-methyl-4-methyl-3-amino) amino The group] -4- (3,5-difluorinated phenyl) group was reacted in the same manner as in Example 56 to obtain the above compound. Yield: 97%

熔點:184〜186°C 4 NMR(CDC13) 5 :1.48(3H,d),2.50(3H,s),3.30(4H,t), 3.70(4H,t),4.11(3H,s),5_06(lH,q),6.33(1H,S),6.42 (lH,s),8.54(lH,s) 實施例60) 1 - {[(5-(1-羥乙基)·2-曱氧基_6-甲基吨唆- 3-醯基]胺基羰基}-4-(3,4-二氣化苯基)哌嗪 將1-[(5-乙醯基-2-甲氧基-6-甲基吡啶-3-醯基)胺 基魏基]-4-(3,4-二氣化苯基)旅嗔,採行如同上述實施 例56相同的方法進行反應,而可獲得上述化合物。 收成率:95%Melting point: 184 ~ 186 ° C 4 NMR (CDC13) 5: 1.48 (3H, d), 2.50 (3H, s), 3.30 (4H, t), 3.70 (4H, t), 4.11 (3H, s), 5_06 (lH, q), 6.33 (1H, S), 6.42 (lH, s), 8.54 (lH, s) Example 60) 1-{[(5- (1-hydroxyethyl) · 2-fluorenyloxy _6-Methyltoluene-3-fluorenyl] aminocarbonyl} -4- (3,4-digasified phenyl) piperazine 1-[(5-ethylfluorenyl-2-methoxy- The 6-methylpyridin-3-amidino) aminoweiyl] -4- (3,4-digasified phenyl) group is reacted in the same manner as in Example 56 above to obtain the above. Compound. Yield: 95%

熔點:197〜200°C 4 NMR(CDC13) H_46(3H,d),2.41(3H,s),3.28(4H,t), 3.66(4H,t),3.96(3H,s),5.20(lH,q),7.02(3H,m),8.42 (1H,S) -43- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 、1· 575564 A7 B7 五、發明説明(39 ) 實施例61) 1-{[(5-(1-羥乙基)-2-曱氧基-6-曱基吡啶- 3-¾&基]月女基幾基曱氧基苯基)派σ秦 將1 - [(5-乙&&基-2-甲氧基-6-甲基咐i唆-3-酸基)胺 基羰基]-4-(3-甲氧基苯基)哌嗪,採行如同上述實施例 56相同的方法進行反應,而可獲得上述化合物。 收成率:97%Melting point: 197 ~ 200 ° C 4 NMR (CDC13) H_46 (3H, d), 2.41 (3H, s), 3.28 (4H, t), 3.66 (4H, t), 3.96 (3H, s), 5.20 (lH , Q), 7.02 (3H, m), 8.42 (1H, S) -43- This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page) 1.575564 A7 B7 V. Description of the invention (39) Example 61) 1-{[((5- (1-hydroxyethyl) -2-fluorenyl-6-fluorenylpyridin-3--3- & yl] Alkyl quinolyloxyphenyl) sigma Qin will be 1-[(5-ethyl & & yl-2-methoxy-6-methyl sulfonyl-3-acid) aminocarbonyl ] -4- (3-methoxyphenyl) piperazine was reacted in the same manner as in Example 56 to obtain the above compound. Yield: 97%

熔點:88〜90°C W NMR(CDC13) (5 :1.47(3H,d),2.42(3H,s),3.11(4H,t), 3.70(4H,t),3.89(3H,s),3.99(3H,s),5.03(lH,q),6_89 (3H,m),6.94(1 H,s),7.05(lH,m),8.48(lH,s) 貫施例62) l-{[(5-(l-經乙基)-2 -甲氧基-6-甲基u比n定- 3-隨基]胺基幾基}-4-(3-經苯基)σ辰嘻 將1-[(5-乙醯基-2-甲氧基-6-甲基咄啶_3_醯基)胺 基幾基]-4-(3-羥苯基)派嗔,採行如同上述實施例56 相同的方法進行反應,而可獲得上述化合物。 收成率:87%Melting point: 88 ~ 90 ° CW NMR (CDC13) (5: 1.47 (3H, d), 2.42 (3H, s), 3.11 (4H, t), 3.70 (4H, t), 3.89 (3H, s), 3.99 (3H, s), 5.03 (lH, q), 6_89 (3H, m), 6.94 (1 H, s), 7.05 (lH, m), 8.48 (lH, s) Example 62) l-{[ (5- (l-Ethyl) -2-methoxy-6-methyl u is more than n-3-Synyl] amino-chino} -4- (3-Ethyl) σ Chen Hei 1-[(5-Ethylfluorenyl-2-methoxy-6-methylpyridin_3_fluorenyl) aminoquinyl] -4- (3-hydroxyphenyl) piperidine, as described above Example 56 The reaction was carried out in the same manner to obtain the above compound. Yield: 87%

熔點:191〜196°C 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) W NMR(CDC13) 5 :1.47(3H,d),2.41(3H,s),3.27(4H,t), 3.79(4H,t),3.98(3H,s),5.04(lH,q),6.57(3H,m),6.9〇 (lH,s),7.13(lH,t),8.41(lH,s) 實施例63) l-{[(5-(l-羥乙基)-2-曱氧基_6_曱基咄咬_ 3-臨基]胺基戴基}-4-(3,5-二曱氧基苯基)吸σ秦 將1 - [(5 -乙酸基-2-曱氧基-6-曱基响°定-3-Si基)胺 基魏基]-4-(3,5 -二甲氧基本基)旅1:7秦’採行如同上述實 -44- 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇ΧΜ7公釐) 575564 A7 ______ B7__ 五、發明説明(40 ) 施例5 6相同的方法進行反應,而可獲得上述化合物。 收成率:87%Melting point: 191 ~ 196 ° C Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) W NMR (CDC13) 5: 1.47 (3H, d), 2.41 (3H, s) , 3.27 (4H, t), 3.79 (4H, t), 3.98 (3H, s), 5.04 (lH, q), 6.57 (3H, m), 6.90 (lH, s), 7.13 (lH, t) , 8.41 (lH, s) Example 63) l-{[(((5- (l-hydroxyethyl) -2-oxo-6-fluorenylpyridinium_3-prolinyl] aminophenyl)}- 4- (3,5-Dimethoxyphenyl) sigma 1-[(5 -acetoxy-2-amidooxy-6-fluorenyl-2-phenyl-3-Si) aminoweiyl ] -4- (3,5 -dimethoxybenzyl) brigade 1: 7 Qin 'adopts the same as above-44- This paper size is applicable to Chinese National Standard (CNS) A4 specification (21 × 7mm) 575564 A7 ______ B7__ 5. Description of the invention (40) Example 5 6 The reaction was carried out in the same manner as described above to obtain the above compound. Yield: 87%

熔點:189〜190°C 'H NMR(CDC13) δ :1.47(3H?d)?2.43(3H?s)5 3.35(4H?t)? 3.78(6H,s),3.97(3H,s),4.09(4H,t),5.05(lH,q),6.07 (3H,m),7.35(lH,S),8.42(lH,s) 實施例64) 1-{[(5·(1-羥乙基)-2-甲氧基-6-甲基吡啶- 3-醯基]胺基羰基}-4-(3,5-二甲基苯基)哌嗪 將1-[(5-乙酷基-2-甲氧基-6-甲基。比咬-3-醯基)胺基魏 基]-4-(3,5-二甲基苯基)派嗔,採行如同上述實施例56 相同的方法進行反應,而可獲得上述化合物。 收成率:88%Melting point: 189 ~ 190 ° C 'H NMR (CDC13) δ: 1.47 (3H? D)? 2.43 (3H? S) 5 3.35 (4H? T)? 3.78 (6H, s), 3.97 (3H, s), 4.09 (4H, t), 5.05 (lH, q), 6.07 (3H, m), 7.35 (lH, S), 8.42 (lH, s) Example 64) 1-{[(5 · (1-hydroxyethyl ) -2-methoxy-6-methylpyridine-3-amino] aminocarbonyl} -4- (3,5-dimethylphenyl) piperazine 1-[(5-ethoxy -2-Methoxy-6-methyl. Titanium-3-fluorenyl) aminoweilyl] -4- (3,5-dimethylphenyl) pyridine, the same as in Example 56 above The reaction was carried out to obtain the above compound. Yield: 88%

熔點:170〜172QC W NMR(CDC13) (5 :1.46(3H,d),2.29(6H,s),2.43(3H,s), 3.43(4H,t),3.97(3H,s),4.10(4H,t),5.06(lH,q),6.60 (3H,m),7.37(lH,s),8.40(lH,s) 實施例65) l-{[(5-(l-羥基-1-甲乙基)_2_甲氧基_6_甲 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) d 基吡啶-3-醯基]胺基羰基卜4-(3,5-二曱氧基苯基)哌嗪 將1-[(5-乙醯基-2-甲氧基-6-甲基咄啶_3_醯基)胺 基羰基]-4-(3,5-二甲氧基苯基)哌嗪(214mg,〇 5〇毫莫 耳),溶解於四氫咄喃(10ml)中,並逐漸添加硼鎂甲浐 (〇.5〇mU.50毫莫耳)後,還流攪拌15分鐘,然後利^ 減壓濃縮將溶劑予以去除後,利用乙基醋酸酯予以共 取並乾燥過濾,然後再利用管柱層析(乙基醋酸酯:t己 -45- 本紙張尺度適用中國國家標f ( CNS ) A4規格(210Χ297Α4Υ〜*- ----_____ 經濟部中央標準局員工消費合作社印製 575564 A7 "^--- B7 ' ·μι·ι ............... ιι 丨丨 丨· ·ι ,, 五、發明説明(41 ) 烷=1:2),進行分離精製後便可獲得上述化合物。 收成率·· 84%Melting point: 170 ~ 172QC W NMR (CDC13) (5: 1.46 (3H, d), 2.29 (6H, s), 2.43 (3H, s), 3.43 (4H, t), 3.97 (3H, s), 4.10 ( 4H, t), 5.06 (lH, q), 6.60 (3H, m), 7.37 (lH, s), 8.40 (lH, s) Example 65) l-{[(5- (l-hydroxy-1- (Methylethyl) _2_methoxy_6_ Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) d-pyridine-3-fluorenyl] aminocarbonyl group 4- (3,5-Dioxophenyl) piperazine 1-[(5-ethylamido-2-methoxy-6-methylpyridin_3_fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine (214 mg, 050 mmol) was dissolved in tetrahydrofuran (10 ml), and boron magnesium formamidine (0.5 mU. 50 millimoles), and then stirred for 15 minutes, and then concentrated under reduced pressure to remove the solvent, co-take with ethyl acetate and dry filter, and then use column chromatography (ethyl acetate: t Ji-45- This paper size is applicable to China National Standard f (CNS) A4 specifications (210 × 297Α4Υ ~ *-----_____ Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 " ^ --- B7 '· μι · ι ............... ιι 丨 丨 丨 · · ι ,, 5. Description of the invention (41) Alkan = 1: 2), proceed The above compounds can be obtained after isolation and purification. Yield · 84%

熔點·· 146〜148°C H NMR(CDC13) 5 :l_64(6H,s),2.64(3H,s),3.25(4H,t), 3.67(4H,t),3.78(6H,s),3.99(3H,s),6.07(3H,m),6.86 (lH,s),8.47(lH,s) 貫施例66) 1_{[(5-(1-羥基-1-甲乙基)_2_甲氧基_6-甲 基0比啶-3-醯基]胺基羰基}_4_(3,5-二甲基苯基)哌嗔 將1-[(5-乙醯基-2-甲氧基-6-甲基吡啶-3-醯基)胺 基羰基]-4_(3,5-二甲基苯基)哌嗪,採行如同上述實施 例65相同的方法進行反應,而可獲得上述化合物。 收成率:81 % 熔點:油狀 W NMR(CDC13)(5:1.64(6H,s),2.29(6H,s),2.65(3H,s), 3.24(4H,t),3.67(4H,t),3.99(3H,s)5 6.59(3H,m),7.05 (1H,s)5 8.48(lH,s) 實施例67) 1_{[(5-(1-羥基-1-甲丙基)_2_甲氧基-6-甲 基吼啶-3-醯基]胺基羰基卜4-(3,5-二曱氧基苯基)哌嗪 將1-[(5-乙醯基-2-甲氧基-6-甲基吡啶_3_醯基)胺 基魏基]-4-(3,5-二甲氧基苯基)旅嘻(2img,〇.5〇毫莫 耳),溶解於四氫吡喃(10ml)中,並逐漸添加硼鎭曱院 (0 ·5 Oml, 1 ·5 〇宅莫耳)後’遂流授掉1 $分鐘,然後利用 減壓濃縮將溶劑予以去除後,利用乙基醋酸醋予以萃 取並乾燥過濾,然後再利用管柱層析(乙基醋酸醋:己 -46- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) i裝_Melting point: 146 ~ 148 ° CH NMR (CDC13) 5: l_64 (6H, s), 2.64 (3H, s), 3.25 (4H, t), 3.67 (4H, t), 3.78 (6H, s), 3.99 (3H, s), 6.07 (3H, m), 6.86 (lH, s), 8.47 (lH, s) Example 66) 1 _ {[(5- (1-hydroxy-1-methylethyl) _2_form Oxy_6-methyl0-pyridin-3-fluorenyl] aminocarbonyl} 4- (3,5-dimethylphenyl) piperidinium will be 1-[(5-ethylfluorenyl-2-methoxy -6-methylpyridin-3-amidino) aminocarbonyl] -4_ (3,5-dimethylphenyl) piperazine can be reacted in the same manner as in Example 65 to obtain the above compound. Yield: 81% Melting point: Oily W NMR (CDC13) (5: 1.64 (6H, s), 2.29 (6H, s), 2.65 (3H, s), 3.24 (4H, t), 3.67 (4H, t), 3.99 (3H, s) 5 6.59 (3H, m), 7.05 (1H, s) 5 8.48 (lH, s) Example 67) 1 _ {[(5- (1-hydroxy-1-methylpropyl ) _2_methoxy-6-methylmethylpyridin-3-fluorenyl] aminocarbonyl group 4- (3,5-dimethoxyphenyl) piperazine 1-[(5-ethylfluorenyl- 2-methoxy-6-methylpyridine_3_fluorenyl) aminoweilyl] -4- (3,5-dimethoxyphenyl) brittle (2img, 0.50 mmol) , Dissolved in tetrahydropyran (10ml), and gradually add After boring the courtyard (0.5ml, 1.5ml house mole), it was shed for 1 minute, and then the solvent was removed by concentration under reduced pressure, and then it was extracted with ethyl acetate and dried. Then use column chromatography (ethyl acetate: hexano-46-) This paper size applies the Chinese National Standard (CNS) A4 size (210X297 mm) (Please read the precautions on the back before filling this page) i__

-、1T 575564-, 1T 575564

、發明説明( 經濟部中央標準局員工消費合作社印製 垸=1:2),進行分離精製後便可獲得上述化合物。 收成率:76%Description of the invention (printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 垸 = 1: 2), the above compounds can be obtained after separation and purification. Yield: 76%

熔點·· 127〜129°C 泔 NMR(CDC13) (^0.83(3H,t),1.63(3H,s),1.94(2H,m), 2.61(3H,s),3.26(4H,t),3.68(4H,t),3.79(6H,S),3_99 (3H,s), 6.08(3H,m),6.86(lH,s),8.44(lHG,s) 實施例68) l-{[(5-(l-羥基·1-甲丙基)-2-甲氧基-6·甲 基吼啶-3_醯基]胺基羰基卜4-(3,5·二甲基苯基)哌嘻 將1-[(5-乙醯基-2-曱氧基-6-曱基σ比咬-3-酿基)胺 基羰基]-4-(3,5-二曱基苯基)派嗔,採行如同上述實施 例67相同的方法進行反應,而可獲得上述化合物。 收成率:74%Melting point: 127 ~ 129 ° C 泔 NMR (CDC13) (^ 0.83 (3H, t), 1.63 (3H, s), 1.94 (2H, m), 2.61 (3H, s), 3.26 (4H, t), 3.68 (4H, t), 3.79 (6H, S), 3-99 (3H, s), 6.08 (3H, m), 6.86 (lH, s), 8.44 (lHG, s) Example 68) l-[[( 5- (l-hydroxy · 1-methylpropyl) -2-methoxy-6 · methylcarbamidine-3_fluorenyl] aminocarbonyl group 4- (3,5 · dimethylphenyl) piper Hei 1-[(5-ethylfluorenyl-2-fluorenyloxy-6-fluorenyl σ is more than 3-amino) aminocarbonyl] -4- (3,5-difluorenylphenyl) Alas, the same method as described in Example 67 was used for the reaction to obtain the above compound. Yield: 74%

熔點:164〜165°C iH NMR(CDC13)心0.83(3H,t),1.60(3H,s),1.95(2H,m), 2.29(6H,s),2.61(3H,s),3.23(4H,t),3.67(4H,t),3.99 (3H,s),6.59(3H,m),6_87(lH,s),8.45(lH,s) 實施例69) l-[5-({[4-(3,5-二甲氧基苯基)哌嗪]羰基} 胺基)-6-甲氧基-2-甲基0比唆-3-基]乙基乙硫醇酯 將三苯化碗(262mg,1.0mmol)溶解於四氫。比喃 (15ml)中’並添加二乙基偶氮二羧酸醋(157 α ΐ,ι·〇毫 莫耳)後,於0°C下攪拌30分鐘。將1-{[5_(1_羥乙基)_ 2-—甲氧基-6 -曱基°比石定-3-醮基]胺基魏基卜4-(3,5-二甲 氧基苯基)旅嗔(213mg,0.5毫莫耳)與硫醇醋酸酯(72 // 1,1 ·0毫莫耳),溶解於四氫。比喃(15mi)中,並逐漸添 -47- 本紙張尺度適财麵家轉(CNS ) A视格(21GX297公釐厂 ----- (請先閱讀背面之注意事項再填寫本頁) i裝- 訂 575564 A7 —------ Β7 五、發明説明(43 ) 一 (請先閲讀背面之注意事項再填寫本頁) 加後,於Ot:下攪拌1小時,並於室溫下攪拌丨小時, 然後利用減壓濃縮將溶劑予以去除後,利用乙基醋酸 酯予以萃取並乾燥過濾,然後再利用管柱層析(乙基醋 酸酯··己烷=1:2),進行分離精製後便可獲得上述化 合物。 收成率:62% 熔點:油狀 4 NMR(CDC13)5:1.55(3H,s),2.20(3H,s),2.39(3H,s), 3.15(4H,t),3.57(4H,t),3.69(6H,s),3.90(3H,s),4.74(lH,q), 6.01(3H,m),6.89(lH,s),8.33(lH,s) 實施例70) l-[5-({[4_(3,5-二甲基苯基)哌嗪]羰基} 胺基)-6-甲氧基-2-甲基咣啶-3-醯基]乙基乙硫醇酯 將1-{[(5-(1-羥乙基)-2-曱氧基-6-甲基吡啶-3-醯基] 胺基羰基} -4-(3,5-二甲基苯基)哌嗪,採行如同上述實 施例69相同的方法進行反應,而可獲得上述化合物。 收成率:60% 熔點:油狀 W NMR(CDC13) (5 :1.60(3H,d),2.26(6H,s),2.52(3H,s), 經濟部中央標準局員工消費合作社印製 3.20(4H,t),3.64(4H,t),3.96(3H,s),4.80(lH,q),6.56(3H,m), 6.91(lH,s),8.38(lH,s) 實施例71) l-{[2-甲氧基_6-甲基-5-(1-磺胺甲氧)]胺 基魏基}-4-(3,5-二甲氧基苯基)派嘻 將l-[5-({[4-(3,5-二甲氧基苯基)哌嗪]羰基}胺基 6-甲氧基-2-甲基σ比石定_3-S&基]乙基乙硫醇醋(180mg, -48- 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨〇'乂297公釐) 575564 A7 ____ B7 五、發明説明(44 ) 0_37宅莫耳)’溶解於四氫σ比喃(15mi)中,於〇。〇下添 加鋁氫化鋰(15mg,0.4亳莫耳)後,攪拌20分鐘,然後 添加2N鹽酸後,然後利用減壓濃縮將溶劑予以去除 後’利用二氯甲烷予以萃取並乾燥過濾後,然後再施 行減壓濃縮,並以管柱層析(乙基醋酸酯:己烷=U), 進行分離精製後便可獲得上述化合物。 收成率:88% 點·油狀 β NMR(CDCl3)5:1.42(3H,d),2.39(3H,s),3.25(4H,t), 3.66(4H,t),3.76(6H,s),3.96(3H,s),5.02(lH,q),6.17(3H,m), 6.87(1H,s),8.41(1H,s) 實施例72) 甲氧基-6-甲基-5-(1-磺胺甲氧)]胺 基羰基卜4-(3,5-二甲基苯基)哌嗪 將1_[5-({[4_(3,5-二甲基苯基)派嘻憤基}胺基)_6-甲氧基-2-甲基吡碇-3-醯基]乙基乙硫醇酯,採行如同 上述實施例71相同的方法進行反應,而可獲得上述化 合物。 收成率:87% 熔點:油狀 NMR(CDC13) ά :1.43(3H?d)52.28(6H5s)5 2.40(3H?s)? 3.25(4H,t),3.72(4H,t),5.03(lH,q),6.64(3H,m),6.88(lH,s), 8.42(1H?s) 實施例73) l-[(2-甲氧基-6-甲基-5-乙烯基吡啶_3_醯 基)胺基羰基}-4-(3,5-二曱氧基苯基)哌嗪 -49- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 、\呑 經濟部中央標準局員工消費合作社印製 564 五 '發明説明( 45 A7 B7 經濟部中央標準局員工消費合作社印製 將1 {[5 (1-羥乙基)_2_甲氧基_6_甲基吡啶-3•醯基) 胺基魏基}_4-(3,5-二甲氧基苯基)呢嗪,溶解於氯化甲 酸(15ml)中,並添加咄啶對甲苯磺酸酯(6〇mg,〇23毫 莫耳),還流16小時,然後利用減壓濃縮將氯化甲酸 予以去除後,再以管柱層析(乙基醋酸醋··己燒=1 _2), 進行分離精製後便可獲得上述化合物。收成率:93% 熔點:140〜141°C H NMR(CDC13) 5 :2.43(3H,s),3.27(4H,t),3.69(4H,t), 3.79(6H,s),4.00(3H,s),5.25(lH,d),5.65(lH,d),6.08(lH,s), 6.13(2H,d),6.82(lH,d),6_91(lH,s),8.53(lH,s) Mass(I) m/z:412.2119 (MH,C22H28N404 計算值: 412.2110) 貫施例74) 1_[(2-甲氧基-6-曱基-5-乙烯基吡啶_3_醯 基)胺基魏基}_4-(3,5-二甲基苯基)旅嘻 將1-{[5-(1-羥乙基)·2-甲氧基-6-甲基吡啶-3-醯基) 胺基魏基卜4-(3,5-二甲基苯基)旅嘻,採行如同上述實 施例73相同的方法進行反應,而可獲得上述化合物。 收成率:94% 熔點:131〜132°C !H NMR(CDC13) 5 :1.57(3H?s)52.31(6H5s)? 2.43(1H?s)?3.25(4H,t),3.68(4H,t),4.00(3H,s),5.25(lH,d),5.65(lH,d), 6.60(3H,m),6.82(lH,d),6.92(lH,s),8.53(lH,s) Mass(EI) m/z:380_2236 (MH,C22H28N402 計算值: (請先閱讀背面之注意事項再填寫本頁) i I— — f— -裝· .4 -50- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 575564 A7 s------ 五、發明説明(46 ) 380.2212) 實施例75) M(2-甲氧基-6-甲基-5_乙烯基吡啶_3_醯 基)胺基羰基}-4-(3,5-二氟化苯基)哌口秦 將1-{[5-(1-羥乙基)—2-甲氧基-6_甲基吡啶_3_醯基) 月女基.基}-4-(3,5_ 一氟化苯基)旅嗪,採行如同上述實 施例73相同的方法進行反應,而可獲得上述化合物。 收成率:93%Melting point: 164 ~ 165 ° C iH NMR (CDC13) core 0.83 (3H, t), 1.60 (3H, s), 1.95 (2H, m), 2.29 (6H, s), 2.61 (3H, s), 3.23 ( 4H, t), 3.67 (4H, t), 3.99 (3H, s), 6.59 (3H, m), 6_87 (lH, s), 8.45 (lH, s) Example 69) l- [5-({ [4- (3,5-Dimethoxyphenyl) piperazine] carbonyl} amino) -6-methoxy-2-methyl0 than fluoren-3-yl] ethyl ethyl mercaptan ester A benzene bowl (262 mg, 1.0 mmol) was dissolved in tetrahydro. Bran (15 ml) was added with diethyl azodicarboxylic acid vinegar (157 α ΐ, ι · 〇mmol), and the mixture was stirred at 0 ° C for 30 minutes. Add 1-{[5_ (1_hydroxyethyl) _ 2--2-methoxy-6-fluorenyl ° bipyridin-3-fluorenyl] amino weibeb 4- (3,5-dimethoxy Phenyl phenyl) hydrazone (213 mg, 0.5 mmol) and thiol acetate (72 // 1, 1.0 mmol), dissolved in tetrahydro. Than (15mi), and gradually added -47- This paper size is suitable for wealth and wealth (CNS) A Vision grid (21GX297 mm factory ----- (Please read the precautions on the back before filling this page) I pack-order 575564 A7 ------- Β7 V. Description of the invention (43) First (please read the precautions on the back before filling this page) After adding, stir under Ot: for 1 hour, and at room temperature After stirring for 丨 hours, the solvent was removed by concentration under reduced pressure, and then extracted with ethyl acetate, dried and filtered, and then subjected to column chromatography (ethyl acetate · hexane = 1: 2). The above compounds can be obtained after isolation and purification. Yield: 62% Melting point: Oily 4 NMR (CDC13) 5: 1.55 (3H, s), 2.20 (3H, s), 2.39 (3H, s), 3.15 (4H, t), 3.57 (4H, t), 3.69 (6H, s), 3.90 (3H, s), 4.74 (lH, q), 6.01 (3H, m), 6.89 (lH, s), 8.33 (lH, s Example 70) l- [5-({[4_ (3,5-dimethylphenyl) piperazine] carbonyl} amino) -6-methoxy-2-methylpyridine-3-fluorene Ethyl] ethyl thiol ester 1-{[(((5- (1-hydroxyethyl) -2-methoxy-6-methylpyridin-3-amidino] aminocarbonyl} -4- (3 , 5-dimethylbenzene Piperazine was reacted in the same manner as in Example 69 to obtain the above compound. Yield: 60% Melting point: Oily W NMR (CDC13) (5: 1.60 (3H, d), 2.26 (6H , S), 2.52 (3H, s), 3.20 (4H, t), 3.64 (4H, t), 3.96 (3H, s), 4.80 (lH, q), 6.56 (3H, m), 6.91 (lH, s), 8.38 (lH, s) Example 71) l-{[2-methoxy-6-methyl-5- (1-sulfamethoxy)] amino Weicyl} -4- (3,5-dimethoxyphenyl) Pytyl will l- [5-({[4- (3,5-dimethoxyphenyl) piperazine] carbonyl} amino 6-methoxy-2-methylsigmadol_3-S & yl] ethyl ethyl mercaptan vinegar (180mg, -48-) This paper size applies Chinese National Standard (CNS) A4 specification (2 丨 〇 '乂 297 mm) 575564 A7 ____ B7 V. Description of the invention (44) 0_37 House Morr) 'Dissolved in tetrahydro σ biran (15mi), lithium lithium hydride (15 mg, 0.4 morr) ), Stir for 20 minutes, then add 2N hydrochloric acid, and then remove the solvent by concentration under reduced pressure. 'Extracted with dichloromethane and dried and filtered, Concentrated under reduced pressure and then applied to the row and by column chromatography (ethyl acetate: hexane = U), obtained was separated and purified after the above compounds. Yield: 88% dots, oily β NMR (CDCl3) 5: 1.42 (3H, d), 2.39 (3H, s), 3.25 (4H, t), 3.66 (4H, t), 3.76 (6H, s) , 3.96 (3H, s), 5.02 (lH, q), 6.17 (3H, m), 6.87 (1H, s), 8.41 (1H, s) Example 72) Methoxy-6-methyl-5- (1-Sulfamethoxy)] aminocarbonyl 4- (3,5-dimethylphenyl) piperazine angered 1_ [5-({[4_ (3,5-dimethylphenyl) Group} amino group) -6-methoxy-2-methylpyridin-3-fluorenyl] ethyl ethyl mercaptan ester, which was reacted in the same manner as in Example 71 above to obtain the above compound. Yield: 87% Melting point: Oily NMR (CDC13) ά: 1.43 (3H? D) 52.28 (6H5s) 5 2.40 (3H? S)? 3.25 (4H, t), 3.72 (4H, t), 5.03 (lH , Q), 6.64 (3H, m), 6.88 (lH, s), 8.42 (1H? S) Example 73) l-[(2-methoxy-6-methyl-5-vinylpyridine_3 _Fluorenyl) aminocarbonyl} -4- (3,5-dioxophenyl) piperazine-49- This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) (Please read the back first Please note this page, please fill in this page), \ 呑 Printed by the Central Consumers ’Cooperative of the Ministry of Economic Affairs 564 Five-Year Invention Description (45 A7 B7 Printed by the Consumer ’s Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs shall print 1 {[5 (1-hydroxyethyl Group) _2_methoxy_6_methylpyridine-3 • fluorenyl) aminoweilyl} _4- (3,5-dimethoxyphenyl) morphazine, dissolved in chloroformic acid (15ml) After adding pyridine p-toluenesulfonate (60mg, 〇23mmol), the solution was flowed for 16 hours, and then the chloroformic acid was removed by concentration under reduced pressure, and then column chromatography (ethyl acetate) was performed. ·· Hexane = 1 _2), the above compounds can be obtained after separation and purification. Yield: 93% Melting point: 140 ~ 141 ° CH NMR (CDC13) 5: 2.43 (3H, s), 3.27 (4H, t), 3.69 (4H, t), 3.79 (6H, s), 4.00 (3H, s), 5.25 (lH, d), 5.65 (lH, d), 6.08 (lH, s), 6.13 (2H, d), 6.82 (lH, d), 6_91 (lH, s), 8.53 (lH, s) ) Mass (I) m / z: 412.2119 (MH, C22H28N404 Calculated: 412.2110) Example 74) 1 _ [(2-methoxy-6-fluorenyl-5-vinylpyridine_3_fluorenyl) amine Weilyl} _4- (3,5-dimethylphenyl) brigade 1-{[5- (1-hydroxyethyl) · 2-methoxy-6-methylpyridin-3-yl ) Amino-Weiquib 4- (3,5-dimethylphenyl) brittle, the same method as described in Example 73 above was used to perform the reaction to obtain the above compound. Yield: 94% Melting point: 131 ~ 132 ° C! H NMR (CDC13) 5: 1.57 (3H? S) 52.31 (6H5s)? 2.43 (1H? S)? 3.25 (4H, t), 3.68 (4H, t ), 4.00 (3H, s), 5.25 (lH, d), 5.65 (lH, d), 6.60 (3H, m), 6.82 (lH, d), 6.92 (lH, s), 8.53 (lH, s) Mass (EI) m / z: 380_2236 (MH, C22H28N402 Calculated value: (Please read the precautions on the back before filling in this page) i I — — f — —Package · .4 -50- This paper size applies to Chinese national standards (CNS) A4 specification (210X 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 s ------ 5. Description of the invention (46) 380.2212) Example 75) M (2-methoxy -6-methyl-5_vinylpyridine_3_fluorenyl) aminocarbonyl} -4- (3,5-difluorinated phenyl) piperin 1-{[5- (1-hydroxyethyl Group) —2-methoxy-6_methylpyridine_3_fluorenyl group] methynyl. Group} -4- (3,5_ monofluorinated phenyl) travelazine, the same as in Example 73 above The reaction is carried out to obtain the above compounds. Yield: 93%

熔點:160〜161°C H NMR(CDC13) 3 :2.44(3H,s),3.30(4H,t,J=5.52Hz), 3.68(4H,t,J=5.5Hz),4.01(3H,s),5.26(lH,d),5.65(lH,d), 6.30(lH,s),6.39(2H,d),6.81(lH,d),8.53(lH,s)Melting point: 160 ~ 161 ° CH NMR (CDC13) 3: 2.44 (3H, s), 3.30 (4H, t, J = 5.52Hz), 3.68 (4H, t, J = 5.5Hz), 4.01 (3H, s) , 5.26 (lH, d), 5.65 (lH, d), 6.30 (lH, s), 6.39 (2H, d), 6.81 (lH, d), 8.53 (lH, s)

Mass(EI) m/z:412.2102 (MH,C22H28N404 計算值: 412.2110) 貝施例76) ^[(^-異丙苯基-^-甲氧基-石-甲基响咬·^- 醯基)胺基羰基}-4-(3,5-二曱氧基苯基)哌嗪 將1-{[5-(1-羥基-1-曱乙基)-2_甲氧基_6_甲基吡啶、 3-醯基)胺基羰基}-4-(3,5-二曱氧基苯基)哌嗪,採行如 同上述實施例73相同的方法進行反應,而可獲得上述 化合物。 收成率:96%Mass (EI) m / z: 412.2102 (MH, C22H28N404 Calculated value: 412.2110) Example No. 76) ^ [(^-Isopropylphenyl-^-methoxy-stone-methyl ring bite ^ -fluorenyl group ) Aminocarbonyl} -4- (3,5-dimethoxyphenyl) piperazine 1-{[5- (1-hydroxy-1-fluorenethyl) -2_methoxy_6_methyl Pyridyl, 3-fluorenyl) aminocarbonyl} -4- (3,5-dioxophenyl) piperazine can be reacted in the same manner as in Example 73 to obtain the above compound. Yield: 96%

熔點:83〜85°C iH NMR(CDC13)5:2.01(3H,s),2.38(3H,s),3.25(4H,t), 3.66(4H,t),3.78(6H,s),3.99(3H,s),4.86(lH,s),5.30(lH,s), 6.11(3H,m),6.90(lH,d),8.18(lH,s) -51 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁j i裝· 經濟部中央標準局員工消費合作社印製 575564 A7 ___ B7 _ 五、發明説明(47 ) —^ 實施例77) 1-[(5-異丙苯基-2-甲氧基甲基咣啶_3_ 酿基)胺基幾基}-4-(3,5 -二甲基苯基)i7辰嘻 將1-{[5-(1-羥基-1-甲乙基)-2_甲氧基甲基吡啶一 3-醯基)胺基羰基}-4-(3,5-二甲基苯基)哌嗪,採行如同 上述貫施例73相同的方法進行反應,而可獲得上述化 合物。 收成率:93%Melting point: 83 ~ 85 ° C iH NMR (CDC13) 5: 2.01 (3H, s), 2.38 (3H, s), 3.25 (4H, t), 3.66 (4H, t), 3.78 (6H, s), 3.99 (3H, s), 4.86 (lH, s), 5.30 (lH, s), 6.11 (3H, m), 6.90 (lH, d), 8.18 (lH, s) -51-This paper size applies to Chinese national standards (CNS) A4 specification (210X297 mm) (Please read the notes on the back before filling out this page. • Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 ___ B7 _ V. Description of the invention (47) — ^ Implementation Example 77) 1-[(5-Isopropylphenyl-2-methoxymethylpyridine_3_vinyl) aminoamino} -4- (3,5-dimethylphenyl) i7 Add 1-{[5- (1-hydroxy-1-methylethyl) -2_methoxymethylpyridine-3-fluorenyl) aminocarbonyl} -4- (3,5-dimethylphenyl) Piperazine was reacted in the same manner as in Example 73 described above to obtain the above compound. Yield: 93%

熔點:140〜142°C lH NMR(CDC13)5 :2.01(3H?s)52.29(6H5s)5 2.28(3H?s)? 3.23(4H,t),3.66(4H,t),3_99(3H,s),4.86(lH,s),5· 1 8(1H,s), 6.59(3H,m),6.91(lH,S),8.18(lH,s) 實施例78)乙基-2-{l_[5-({[4-(3,5-二甲氧基苯基)哌 嗔]羰基}胺基)-6-曱氧基-2-甲基0比啶-3-醯基)乙氧基} 醋酸酯 將1-{[5-(1-羥基)-2-曱氧基-6-甲基吼啶-3-醯基]胺 基魏基}-4-(3,5-二曱氧基苯基)派嗔(〇·5毫莫耳),溶解 於二甲基甲醯胺(15ml)中,添加氫化鈉(18.5mg,0.5毫 莫耳)後’於室溫下攪拌15分鐘,然後利用減壓濃縮 將溶劑予以去除後,並以管柱層析(乙基醋酸酯:己院 =1:2),進行分離精製後便可獲得上述化合物。 收成率:89% 熔點:油狀 NMR(CDC13) 5 :1.25(3H,t),1.34(3H,d),2.42(3H,s), 3.00(4H,t),3.29(4H,t),3.74(6H,s),3_97(3H,S),4.16(4H,s), -52- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) i裝- 、·!! 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(48 ) 4.53(lH,q),6.〇3(3H,m),7_58(lH,s) 實施例79) 4-{1-[5-({[4-(3,5-二甲氧基苯基)哌嗪]幾 基}胺基)-6-甲氧基-2-甲基扯啶-3-醯基)乙氧基卜‘氧 化丁酸 將1- {[5-(1 -經乙基)-2 -甲氧基-6·甲基0比咬-3-酸基] 胺基幾基}-4-(3,5-二甲氧基苯基)哌嗉(i〇7mg,〇.25毫莫 耳)與二甲胺吡啶(3mg,〇_〇25毫莫耳),溶解於吡啶中, 添加無水琥珀酸(5〇mg,〇.5毫莫耳)後,於室溫下攪拌 5小時’添加蒸顧水後採用二氯甲烧施行萃取後,將 有機層以1N鹽酸予以洗淨,然後利用減壓濃縮將溶 劑予以去除後,並以管柱層析(二氯甲烷:甲醇= 20:1) ’進行分離精製後便可獲得上述化合物。 收成率:78%Melting point: 140 ~ 142 ° C lH NMR (CDC13) 5: 2.01 (3H? S) 52.29 (6H5s) 5 2.28 (3H? S)? 3.23 (4H, t), 3.66 (4H, t), 3_99 (3H, s), 4.86 (lH, s), 5.18 (1H, s), 6.59 (3H, m), 6.91 (lH, S), 8.18 (lH, s) Example 78) ethyl-2- { l_ [5-({[4- (3,5-dimethoxyphenyl) piperidinium] carbonyl} amino) -6-fluorenyloxy-2-methyl Oxy} acetate will be 1-{[5- (1-hydroxy) -2-fluorenyloxy-6-methylmethylpyridin-3-amidino] aminoweiyl} -4- (3,5-di (Methoxyphenyl) pyrazine (0.5 mmol), dissolved in dimethylformamide (15 ml), and sodium hydride (18.5 mg, 0.5 mmol) was added. 'Stir at room temperature for 15 After minutes, the solvent was removed by concentration under reduced pressure, and the above-mentioned compound was obtained after separation and purification by column chromatography (ethyl acetate: Kojiri = 1: 2). Yield: 89% Melting point: Oily NMR (CDC13) 5: 1.25 (3H, t), 1.34 (3H, d), 2.42 (3H, s), 3.00 (4H, t), 3.29 (4H, t), 3.74 (6H, s), 3_97 (3H, S), 4.16 (4H, s), -52- This paper size is applicable to China National Standard (CNS) A4 specification (210X 297 mm) (Please read the notes on the back first (Fill in this page again.) I installed-、 ... !! 575564 Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Invention Description (48) 4.53 (lH, q), 6.03 (3H, m), 7_58 (lH, s) Example 79) 4- {1- [5-({[4- (3,5-dimethoxyphenyl) piperazine] amido} amino) -6-methoxy- 2-methylpyridin-3-fluorenyl) ethoxybutyric acid'butyric acid will 1-{[5- (1- -Ethyl) -2 -methoxy-6 · methyl 0 to bite -3 -Acid group] amine group} -4- (3,5-dimethoxyphenyl) piperidine (107 mg, 0.25 mmol) and dimethylaminopyridine (3 mg, 〇_〇25 Millimolar), dissolved in pyridine, added anhydrous succinic acid (50mg, 0.5mmol), and stirred at room temperature for 5 hours. 'After adding distilled water, extraction with dichloromethane was performed. The organic layer was washed with 1N hydrochloric acid, and then After the solvent was removed by reduced pressure to be concentrated and purified by column chromatography (dichloromethane: methanol = 20: 1) 'obtained was separated and purified after the above compounds. Yield: 78%

熔點:158〜160°C W NMR(CDC13) δ :1.42(3H,d),2.43(3H,s),2.61(4H,m), 3.24(4H,t),3.66(4H,t),3.76(6H,s),3.95(3H,s),5.94(lH,q), 6.04(3H,m),6.89(lH,s),8.13(lH,s) 實施例80) 4-{1-[5-({[4-(3,5-二曱基苯基)旅嗪]幾基} 胺基)-6-曱氧基-2-甲基响啶-3-醯基)乙氧基}-4_氧化丁 酸 將1-{[5-(1_羥乙基)-2-曱氧基-6-曱基吡啶-3-醯基]胺基 罗炭基}-4-(3,5-二曱基苯基)旅嘻,採行如同上述實施例 79相同的方法進行反應,而可獲得上述化合物。 收成率:76% -53- 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇χ297公釐) (請先閲讀背面之注意事項再填寫本頁) i裝_ 訂 575564 A7 B7 1、發明説明(49 )Melting point: 158 ~ 160 ° CW NMR (CDC13) δ: 1.42 (3H, d), 2.43 (3H, s), 2.61 (4H, m), 3.24 (4H, t), 3.66 (4H, t), 3.76 ( 6H, s), 3.95 (3H, s), 5.94 (lH, q), 6.04 (3H, m), 6.89 (lH, s), 8.13 (lH, s) Example 80) 4- {1- [5 -({[4- (3,5-Difluorenylphenyl) trazine] Jinyl} amino) -6-fluorenyloxy-2-methylaronidine-3-fluorenyl) ethoxy}- 4-Oxybutyric acid will be 1-{[5- (1_hydroxyethyl) -2-fluorenyloxy-6-fluorenylpyridin-3-fluorenyl] aminocarbanyl} -4- (3,5 -Difluorenylphenyl), and the reaction was performed in the same manner as in Example 79 above to obtain the above compound. Yield: 76% -53- This paper size is in accordance with Chinese National Standard (CNS) A4 specification (21 × 297 mm) (Please read the precautions on the back before filling this page) i__Order 575564 A7 B7 1. Invention Instructions (49)

熔點:138〜140°C 4 NMR(CDC13) (5 :1.43(3H,d),2.27(6H,s),2.55(3H,s), 2.65(4H,m),3.24(4H,t),3.69(4H,t),3.95(3H,s),5.95(lH,q), 6.60(3H,m),6.88(lH,s),8.11(lH,s) (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 54 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564Melting point: 138 ~ 140 ° C 4 NMR (CDC13) (5: 1.43 (3H, d), 2.27 (6H, s), 2.55 (3H, s), 2.65 (4H, m), 3.24 (4H, t), 3.69 (4H, t), 3.95 (3H, s), 5.95 (lH, q), 6.60 (3H, m), 6.88 (lH, s), 8.11 (lH, s) (Please read the precautions on the back before (Fill in this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 54 This paper size applies to China National Standard (CNS) A4 (210X297 mm) 575564

A B 五、發明説明(50 ) 經濟部中央標準局員工消費合作社印裂 m 實施例 :編號 | Ri and R2 R3 R1 R5 Rg R? Re A i Z - Y I 81 -CH=CH-CH=CH- H OMe H OMe H H N 〇 OMe 3-N 82 -CH=CH-CH=CH- H Me H Me H H N 〇 OMe 3-N 83 - CH=CH-CH=CH- Me Me H H H H N 〇 OMe 3-N 84 -CH=CH-CH=CH- H F. H F H H N 〇 I OMe 3-N 85 -C-H=CH-CH=CH- H Cl H Cl H H N I 〇 OMe 3-N 86 -CH=CH-CH=CH- F H H H H H N 〇 OMe 3-N 87 -CH=CH-CH=CH- Cl H H H H H N 〇 OMe 3-N 88 -CH=CH-CH=CH- H Cl H H H H N 〇 OMe 3-N 89 -CH=CH-CH=CH - H OH H H • H H N 〇 OMe 3-N 90 -CH=CH-CH=CH- 〇Me H H H H H N 〇 OMe 3-N | 91 -CH=CH-CH=CH- SMe H H H H H N 〇 OMe 3-N 92 -CH 二 CH-CH=CH- H 。丫 H H ^ H H N 〇 OMe 3-N 93·^ -CH=CH-CH=CH- H H H H H N 〇 OMe 3-N 94 - CH=CH-CH=CH- OMe H H Me H H N 〇 OMe 3-N 95 -CH=CH-CH=CH- 〇Me H H Ph H H N 〇 OMe 3-N 96 -CH=CH-CH=CH- Me H H OMe H H N 〇 OMe 3-N 97 -CH=CH-CH=CH- -Benzo- H H H H N 〇 OMe 3-N 98 -CH=CH-CH=CH- H OMe H OMe H Me N 〇 OMe 3-N 99 -CH:CH-CH=CH- H OMe H OMe H Et N 〇 OMe 3-N 100 -CH=CH-CH=CH- H OMe H OMe H iPr N 〇 OMe 3-N 101 -CH=CH-CH=CH- H OMe H OMe H N 〇 OMe 3-N 102 -CH=CH-CH=CH- H OMe H OMe H Benzyl N 〇 OMe 3-N 103 -CH=CH-CH=CH- H Me H Me H Me N 〇 OMe 3-N 104 -CH=CH-CH=CH- H Me H Me H Et N 〇 OMe 3-N 105 -CH=CH-CH=CH- H Me H Me H iPr N 0 OMe :3-N (請先閲讀背面之注意事項再填寫本頁) -55- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 575564 A7 B7 五、發明説明(51 經 濟 部 t 標 準 局 員 工 消 費 合 作 社 印 製AB V. Description of the invention (50) Employees' cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs of the People's Republic of China m: Example: number | Ri and R2 R3 R1 R5 Rg R? Re A i Z-YI 81 -CH = CH-CH = CH- H OMe H OMe HHN 〇OMe 3-N 82 -CH = CH-CH = CH- H Me H Me HHN 〇OMe 3-N 83-CH = CH-CH = CH- Me Me HHHHN 〇OMe 3-N 84 -CH = CH-CH = CH- H F. HFHHN 〇I OMe 3-N 85 -CH = CH-CH = CH- H Cl H Cl HHNI 〇OMe 3-N 86 -CH = CH-CH = CH- FHHHHHN 〇OMe 3-N 87 -CH = CH-CH = CH- Cl HHHHHN 〇OMe 3-N 88 -CH = CH-CH = CH- H Cl HHHHN 〇OMe 3-N 89 -CH = CH-CH = CH-H OH HH • HHN 〇OMe 3-N 90 -CH = CH-CH = CH- 〇Me HHHHHN 〇OMe 3-N | 91 -CH = CH-CH = CH- SMe HHHHHN 〇OMe 3-N 92 -CH di-CH- CH = CH-H. AHH ^ HHN 〇OMe 3-N 93 · ^ -CH = CH-CH = CH- HHHHHN 〇OMe 3-N 94-CH = CH-CH = CH- OMe HH Me HHN 〇OMe 3-N 95 -CH = CH-CH = CH- 〇Me HH Ph HHN 〇OMe 3-N 96 -CH = CH-CH = CH- Me HH OMe HHN 〇OMe 3-N 97 -CH = CH-CH = CH- -Benzo- HHHHN 〇 OMe 3-N 98 -CH = CH-CH = CH- H OMe H OMe H Me N 〇OMe 3-N 99 -CH: CH-CH = CH- H OMe H OMe H Et N 〇OMe 3-N 100- CH = CH-CH = CH- H OMe H OMe H iPr N 〇OMe 3-N 101 -CH = CH-CH = CH- H OMe H OMe HN 〇OMe 3-N 102 -CH = CH-CH = CH- H OMe H OMe H Benzyl N 〇OMe 3-N 103 -CH = CH-CH = CH- H Me H Me H Me N 〇OMe 3-N 104 -CH = CH-CH = CH- H Me H Me H Et N 〇OMe 3-N 105 -CH = CH-CH = CH- H Me H Me H iPr N 0 OMe : 3-N (Please read the notes on the back before filling this page) -55- This paper size is applicable to China National Standard (CNS) A4 Specification (210X 297 mm) 575564 A7 B7 V. Invention Description (51 Printed by the Consumers' Cooperative of the Standards Bureau of the Ministry of Economic Affairs

實施例 編號 Ri and R2 R3 R4 Rg f Rs A X z Y 106 -CH=CH-CH=CH- H Me H Me H Benzyl N 〇 OMe 3-N 107 -CH=CH-CH=CH- H Y H H H Me N 〇 OMe 3-N 108 -CH=CH-CH=CH - H 。丫 H H H Et N 〇 OMe 3-N 109 -C.H=CH-CH 二 C.H- H OMe' H OMe H H N S OMe 3-N 110 -CH=CH-CH=CH- H Me H丨 Me H H N S OMe 3-N 111 -CH=CH-CH=CH- H F H F H H N s OMe 3-N 112 -CH=CH-CH=CH- H Cl H Cl H H N s OMe 3-N 113 -CH=CH-CH=CH- H 〇Me H H H H N s OMe 3-N 114 -CH=CH-CH=CH- H 〇Me H OMe H • H N 〇 Me 3-N 115 -CH=CH-CH=CH- H Me H Me H H N 〇 Me 3-N 116 - CH=CH-CH=CH- Me Me H H H H N 〇 Me 3-N 117 -CH=CH-CH=CH- H F H F H H N 〇 Me 3-N 118〆 -CH=CH-CH=CH- H Cl H Cl H H N 〇 Me 3-N 119 -CH=CH-CH=CH- 〇Me H H H H H N 〇 Me 3-N 120 -CH=CH-CH=CH- F H H H H H N 〇 Me 3-N 121 -CH=CH-CH=CH- Cl H H H H H N 〇 Me 3-N 122 -CH=CH-CH=CH- SMe H H H H H N 〇 Me I 3-N 123 -CH=CH - CH=CH- 〇Me H H Me H H N 〇 Me 3-N 124 -CH=CH-CH=CH- -Benzo- H H H H N 〇 Me 3-N 125 -CH=CH-CH=CH- H OMe H OMe H H N s Me 3-N 126 -CH=CH-CH=CH- H Me H Me H H N s Me 3-N 127 -CH=CH-CH=CH- H F H F H H N s Me 3-N 128 -CH=CH-CH=CH- H OMe H OMe H H N 〇 2 - Py 4-N 129 - CH=CH-CH=CH - H OMe H OMe H H N 〇 3-Pv 4-N 130 -CH=CH-CH=CH- H OMe H OMe H H N 〇 2-Tienyl .4-N 131 -CH=CH-CH=CH- H Me H Me H H N 〇 3-Py 4-N -56- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請 先 閲 讀 背 面 注 意 事 項 再 填 寫 本 頁 575564 A7 經濟部中央標準局員工消費合作社印製 五、發明説明(52 ) 實施例81) 1-[(2-甲氧基喳啉_3_醯基)胺基羰基]_4_ (3,5-«一甲氧基苯基)π辰σ秦 a) 將苯基Ν-(2-曱氧基喳啉—3-醯基)甲酸酯-3-胺基-2-甲氧基喹啉(4g,23毫莫耳)與苯基氯化甲酸酯 (4.04g,25耄莫耳),溶解於二氯化甲烷中,於室溫下 授拌2小時。然後利用減壓濃縮將二氯甲烷予以去除 後’再利用管柱層析(己烷:乙醚=8:1),進行分離精 製後便可獲得上述化合物。 收成率:75% 熔點:油狀 >iMR(CDCl3) 5 :4.01(3H,s),7.30(5H,s),7.41(lH,t), 7.70(lH,d),7.71(lH,d),8.71(lH,s) b) l-[(2-甲氧基喹啉-3-醯基)胺基羰基;|_4_(3,5_二甲 氧基苯基)旅Π秦 將苯基N-(2-甲氧基α奎琳-3-醯基)甲酸酯 (148mg,〇.5毫莫耳)與1-(3,5-二甲氧基苯基)哌嗪 (112mg,0.5宅莫耳)’溶解於無水四氫σ比喃中,並添加 DBU(117mg,0.75毫莫耳)後,於室溫下攪拌2小時。 然後利用減壓濃縮將四氫α比喃予以去除後,再利用管 柱層析(己烧:乙醚=5 : 1 ),進行分離精製後便可獲得 上述化合物。 收成率·· 81% 熔點:200〜201°C ιϋ NMR(CDC13) ^ :3.31(4H?tJ-5.0Hz)?3.74(4H?t)5 -57- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)Example number Ri and R2 R3 R4 Rg f Rs AX z Y 106 -CH = CH-CH = CH- H Me H Me H Benzyl N 〇OMe 3-N 107 -CH = CH-CH = CH- HYHHH Me N 〇 OMe 3-N 108 -CH = CH-CH = CH-H. Ah HHH Et N 〇OMe 3-N 109 -CH = CH-CH Di-CH- H OMe 'H OMe HHNS OMe 3-N 110 -CH = CH-CH = CH- H Me H 丨 Me HHNS OMe 3-N 111 -CH = CH-CH = CH- HFHFHHN s OMe 3-N 112 -CH = CH-CH = CH- H Cl H Cl HHN s OMe 3-N 113 -CH = CH-CH = CH- H 〇Me HHHHN s OMe 3-N 114 -CH = CH-CH = CH- H 〇Me H OMe H • HN 〇Me 3-N 115 -CH = CH-CH = CH- H Me H Me HHN 〇Me 3-N 116-CH = CH-CH = CH- Me Me HHHHN 〇Me 3-N 117 -CH = CH-CH = CH- HFHFHHN 〇Me 3-N 118〆-CH = CH-CH = CH- H Cl H Cl HHN 〇Me 3 -N 119 -CH = CH-CH = CH- 〇Me HHHHHN 〇Me 3-N 120 -CH = CH-CH = CH- FHHHHHN 〇Me 3-N 121 -CH = CH-CH = CH- Cl HHHHHN 〇Me 3-N 122 -CH = CH-CH = CH- SMe HHHHHN 〇Me I 3-N 123 -CH = CH-CH = CH- 〇Me HH Me HHN 〇Me 3-N 124 -CH = CH-CH = CH --Benzo- HHHHN 〇Me 3-N 125 -CH = CH-CH = CH- H OMe H OMe HHN s Me 3-N 126 -CH = CH-CH = CH- H Me H Me HHN s Me 3-N 127 -CH = CH-CH = CH- HFHFHHN s Me 3-N 128 -CH = CH-CH = CH- H OMe H OMe HHN 〇 2-Py 4-N 129-CH = CH-CH = CH-H OMe H OMe HHN 〇3-Pv 4-N 130 -CH = CH-CH = CH- H OMe H OMe HHN 〇2-Tienyl .4-N 131 -CH = CH-CH = CH- H Me H Me HHN 〇 3- Py 4-N -56- This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) Please read the notes on the back before filling out this page 575564 A7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Explanation (52) Example 81) 1-[(2-methoxyfluorinoline_3_fluorenyl) aminocarbonyl] _4_ (3,5- «monomethoxyphenyl) πασσa) will Phenyl N- (2-methoxyoxoline-3-amino) formate-3-amino-2-methoxyquinoline (4g, 23 mmol) and phenyl chloride formate (4.04 g, 25 mol), dissolved in methylene chloride, and stirred at room temperature for 2 hours. Then, the dichloromethane is removed by concentration under reduced pressure, and the compound is obtained by column chromatography (hexane: diethyl ether = 8: 1) and separation and purification. Yield: 75% Melting point: oily> iMR (CDCl3) 5: 4.01 (3H, s), 7.30 (5H, s), 7.41 (lH, t), 7.70 (lH, d), 7.71 (lH, d) ), 8.71 (lH, s) b) l-[(2-methoxyquinolin-3-amidino) aminocarbonyl; | _4_ (3,5_dimethoxyphenyl) N- (2-methoxyα-quinolin-3-amidino) formate (148 mg, 0.5 mmol) and 1- (3,5-dimethoxyphenyl) piperazine (112 mg (0.5 mol), was dissolved in anhydrous tetrahydro σ ratio, and DBU (117 mg, 0.75 mmol) was added, followed by stirring at room temperature for 2 hours. Then the tetrahydro-α-pyran is removed by concentration under reduced pressure, and then column chromatography (hexane: ether = 5: 1) is used for separation and purification to obtain the above compound. Yield ·· 81% Melting point: 200 ~ 201 ° C ιϋ NMR (CDC13) ^: 3.31 (4H? TJ-5.0Hz)? 3.74 (4H? T) 5 -57- This paper applies Chinese national standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page)

、1T .— In -, 1T .— In-

I -ί I 575564 A7 B7 五、發明説明(53 ) 3.79(6H,s),4.17(3H,s),6.09(lH,s),6_17(2H,s),7.35(lH,t), 7.49(lH,t),7.71(lH,d),7.78(lH,d),8.78(m,S)I-ί I 575564 A7 B7 V. Description of the invention (53) 3.79 (6H, s), 4.17 (3H, s), 6.09 (lH, s), 6_17 (2H, s), 7.35 (lH, t), 7.49 (lH, t), 7.71 (lH, d), 7.78 (lH, d), 8.78 (m, S)

Mass(EI) m/z:390.2066 (MH,C23H26N402 計算值: 390.2055) 實施例82) l-[(2-甲氧基η奎琳-3-醯基)胺基羰基]-4- (3,5-二曱基苯基)哌嗪 將苯基N-(2-甲氧基η奎琳-3-g篮基)甲酸酯與ι_(3,5-二甲基苯基)旅嗔,採行如同上述實施例81相同的方 法進行反應’而可獲得上述化合物。 收成率:79%Mass (EI) m / z: 390.2066 (MH, C23H26N402 Calculated: 390.2055) Example 82) l-[(2-methoxyn-quinolin-3-amidino) aminocarbonyl] -4- (3, 5-Difluorenylphenyl) piperazine is a compound of phenyl N- (2-methoxyn quinine-3-g-branyl) formate and ι_ (3,5-dimethylphenyl). The reaction was carried out in the same manner as in Example 81 above to obtain the above compound. Yield: 79%

熔點:143〜145°C 4 NMR(CDC13) (5 :2.30(6H,s),3.29(4H,t),3.80(4H,t), 4.18(3H5s),6.62(3H,m)57.36(lH,t),7.49(lH,t),7.71(lH,d), 7.78(lH,d),8.79(lH,s)Melting point: 143 ~ 145 ° C 4 NMR (CDC13) (5: 2.30 (6H, s), 3.29 (4H, t), 3.80 (4H, t), 4.18 (3H5s), 6.62 (3H, m) 57.36 (lH , T), 7.49 (lH, t), 7.71 (lH, d), 7.78 (lH, d), 8.79 (lH, s)

Mass(EI) m/z:390.2066 (MH,C23H26N402 計算值: 390.2055) 實施例83) l-[(2-甲氧基喹啉·3-醯基)胺基羰基]_4_ (2,3-二甲基苯基)哌嗪 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 將苯基N-(2-曱氧基嗜琳-3-醢基)甲酸酯與1-(2,3-一甲基苯基)旅唤,採行如同上述實施例81相同的方 法進行反應,而可獲得上述化合物。 收成率:83%Mass (EI) m / z: 390.2066 (MH, C23H26N402 Calculated: 390.2055) Example 83) l-[(2-methoxyquinoline · 3-fluorenyl) aminocarbonyl] _4_ (2,3-di Methylphenyl) Piperazine Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) The acid ester is reacted with 1- (2,3-monomethylphenyl) and reacted in the same manner as in Example 81 to obtain the above compound. Yield: 83%

熔點:174〜175°C ]H NMR(CDC13) 5 :2.20(3H?s)?2.39(3H5s)?3.28(4H5t), -58- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564Melting point: 174 ~ 175 ° C] H NMR (CDC13) 5: 2.20 (3H? S)? 2.39 (3H5s)? 3.28 (4H5t), -58- This paper size is applicable to China National Standard (CNS) A4 specification (210X297) Centimeter) 575564

經濟部中央標準局員工消費合作社印製 •69(4H,t),3_93(3H,S)55.98(lH,S),6.30(lH,t),6.37(lH,S),6.39(1H,s),6.63(1H,s) 實施例84) l-[(2-甲氧基喹啉-3_醯基)胺基羰基>4_ (3,5-二氟化苯基)σ辰嗪 將本基甲氧基σ奎琳-3-醯基)甲酸酯與ΐ-(3,5-二氟化苯基)哌嗪,採行如同上述實施例8丨相同的方 法進行反應,而可獲得上述化合物。 收成率:78% 熔點:158〜159°C !H NMR(CDC13) δ :3.32(4H5tJ=5.0Hz)53.72(4H5t? J=5.0Hz),4.19(3H,s),6.29(1 H,s),6.39(2H,d),7.36(lH,t), 7.50(lH,t),7_71(lH,d),7.81(1 H,d),8_78(lH,s) 實施例85) 1-[(2-曱氧基喹啉-3-醯基)胺基羰基]-4- (3,5_二氯化苯基)哌嗉 將苯基N-(2-甲氧基喹啉-3-醯基)曱酸酯與1-(3,5_ 一氣化苯基)ϋ瓜嘻,採行如同上述實施例81相同的方 法進行反應,而可獲得上述化合物。 收成率:56% 熔點:156〜158°C lH NMR(CDC13) δ :3.33(4H?t)?3.73(4H5t)54.21(3H?s)5 6.79(lH,s),6.83(lH,d),6.93(lH,t),7.26(lH,t),7.3 8(lH,t), 7.52(1 H,t),7.71(lH,d),7.83(lH,d) Mass(EI) m/z_.430.0977 (MH,C21H2()N402 Cl 計算值·· 430.0963) -59- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) i裝· 訂 4 575564 A7 B7 五、發明説明( 55 經濟部中央標準局員工消費合作社印製 張 一紙 本 實施例86) l-[(2-甲氧基喳啉-3-醯基)胺基羰基]-4- (2 -氣化笨基)Ϊ7辰17秦 將苯基N-(2-甲氧基嗜琳-3-醯基)甲酸酯與卜(2-氟 化苯基)哌嗪,採行如同上述實施例81相同的方法進 行反應,而可獲得上述化合物。 收成率:81% 溶點· 15 6〜15 8 °CW NMR(CDCl3)(5:3.18(4H,t),3.74(4H,t),4.18(3H,s), 6.99(2H,q)J.〇7(2H,m),7.35(2H,m),7.50(lH,t),7.70(lH,d),7.77(lH,d) 實施例87) l-[(2-甲氧基喳啉-3-醯基)胺基羰基]-4- (2 -氣化笨基)σ底嘻 將本基N-(2-甲氧基u奎琳-3-醯基)曱酸酯與ι_(2-氣 化苯基)娘嗪,採行如同上述實施例81相同的方法進 行反應,而可獲得上述化合物。 收成率:78% 熔點:79〜80°Gw NMR(CDC13) (5 :3.32(4H,t),3_74(4H,t),4.20(3H,s),6.82(2H,q),6.94(2H,m),7.34(2H,m),7.48(lH,d),7.70(lH,d),7.78(lH,d)κ施例88) l-[(2-曱氧基嗜琳-3-醯基)胺基羰基]-4-(3-氯化苯基)哌嗪 將苯基N_(2-甲氧基喹啉-3-醯基)曱酸酯與i-(3-氯 化苯基)派嗪,採行如同上述實施例81相同的方法進 (請先閱讀背面之注意事項再填寫本頁) i裝- 、訂 —Am -60- 經濟部中央標準局員工消費合作社印製 575564 A7 ___B7 _ 五、發明説明(^ )Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs • 69 (4H, t), 3_93 (3H, S) 55.98 (lH, S), 6.30 (lH, t), 6.37 (lH, S), 6.39 (1H, s ), 6.63 (1H, s) Example 84) l-[(2-methoxyquinoline-3_fluorenyl) aminocarbonyl > 4- (3,5-difluorophenyl) σchenazine Benzomethoxy sigmaquinine-3-fluorenyl) formate and fluorene- (3,5-difluorophenyl) piperazine can be reacted in the same manner as in Example 8 丨 above, but The above compound is obtained. Yield: 78% Melting point: 158 ~ 159 ° C! H NMR (CDC13) δ: 3.32 (4H5tJ = 5.0Hz) 53.72 (4H5t? J = 5.0Hz), 4.19 (3H, s), 6.29 (1 H, s ), 6.39 (2H, d), 7.36 (lH, t), 7.50 (lH, t), 7_71 (lH, d), 7.81 (1 H, d), 8_78 (lH, s) Example 85) 1- [(2-Methoxyquinolin-3-amidino) aminocarbonyl] -4- (3,5-dichlorophenyl) piperidine Phenyl N- (2-methoxyquinoline-3 -Fluorenyl) phosphonate and 1- (3,5_ mono-gasified phenyl) quinone, which were reacted in the same manner as in Example 81 above, to obtain the above compound. Yield: 56% Melting point: 156 ~ 158 ° C lH NMR (CDC13) δ: 3.33 (4H? T)? 3.73 (4H5t) 54.21 (3H? S) 5 6.79 (lH, s), 6.83 (lH, d) , 6.93 (lH, t), 7.26 (lH, t), 7.38 (lH, t), 7.52 (1H, t), 7.71 (lH, d), 7.83 (lH, d) Mass (EI) m / z_.430.0977 (calculated value of MH, C21H2 () N402 Cl · · 430.0963) -59- This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page) Packing and ordering 4 575564 A7 B7 V. Description of the invention (55 Printed sheet of paper by the Consumer Cooperative of the Central Standards Bureau, Ministry of Economic Affairs, Example 86) l-[(2-methoxypyridin-3-fluorenyl) amine Carbonyl] -4- (2-Gasated benzyl) Ϊ7Ϊ1717 will be phenyl N- (2-methoxylin-3-yl) formate with (2-fluorinated phenyl) Piperazine was reacted in the same manner as in Example 81 to obtain the above compound. Yield: 81% Melting point 15 6 ~ 15 8 ° CW NMR (CDCl3) (5: 3.18 (4H, t), 3.74 (4H, t), 4.18 (3H, s), 6.99 (2H, q) J .07 (2H, m), 7.35 (2H, m), 7.50 (lH, t), 7.70 (lH, d), 7.77 (lH, d) Example 87) l-[(2-methoxyfluorene Phenolin-3-amidino) aminocarbonyl] -4- (2-gasified benzyl) σdihexyl radical N- (2-methoxyuquinolin-3-amidino) phosphonate and ι_ The (2-gasified phenyl) methanazine was reacted in the same manner as in the above Example 81 to obtain the above compound. Yield: 78% Melting point: 79 ~ 80 ° Gw NMR (CDC13) (5: 3.32 (4H, t), 3_74 (4H, t), 4.20 (3H, s), 6.82 (2H, q), 6.94 (2H , M), 7.34 (2H, m), 7.48 (lH, d), 7.70 (lH, d), 7.78 (lH, d) κ Example 88) l-[(2-Methoxylin-3- Fluorenyl) aminocarbonyl] -4- (3-chlorophenyl) piperazinePhenyl N_ (2-methoxyquinolin-3-amidino) fluorenate and i- (3-chlorobenzene Base) Pyrazine, followed the same method as in Example 81 above (please read the precautions on the back before filling out this page) i Packing-, ordering-Am -60- Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 ___B7 _ 5. Explanation of the Invention (^)

JO 行反應,而可獲得上述化合物。 收成率:73%The JO reacts to obtain the above compounds. Yield: 73%

熔點:97〜98°C W NMR(CDC13)心3.31(4H,t),3.73(4H,t),4.18(3H,s), 6.82(lH,d),6.87(lH,d),6.92(lH,s),7.21(lH,t),7.32(lH,s), 7.37(lH,t),7.51(lH,t),7.70(lH,d),7.78(lH,d),8.80(lH,s) 實施例89) l-[(2-曱氧基喳啉-3-醯基)胺基羰基]-4- (3-羥苯基)哌嗪 將苯基N-(2-甲氧基u奎琳-3-醯基)曱酸酯與1-(3-經 苯基)旅嗪,採行如同上述實施例81相同的方法進行 反應,而可獲得上述化合物。 收成率:75%Melting point: 97 ~ 98 ° CW NMR (CDC13) core 3.31 (4H, t), 3.73 (4H, t), 4.18 (3H, s), 6.82 (lH, d), 6.87 (lH, d), 6.92 (lH , S), 7.21 (lH, t), 7.32 (lH, s), 7.37 (lH, t), 7.51 (lH, t), 7.70 (lH, d), 7.78 (lH, d), 8.80 (lH, s) Example 89) l-[(2-Methoxyfluorin-3-yl) aminocarbonyl] -4- (3-hydroxyphenyl) piperazine Phenyl N- (2-methoxy u Quineline-3-fluorenyl) phosphonate and 1- (3-transphenyl) trazine can be reacted in the same manner as in Example 81 to obtain the above compound. Yield: 75%

熔點:190〜191°C lU NMR(CDC13)5 :3.33(4H?t)?3.80(4H?t)?4.19(3H5s)? 6.47(lH,d),6.82(2H,d)J.16(lH,t),7.32(lH,S),7.37(lH,t), 7.51(lH,s),7.72(lH,d),7.78(lH,d),8.78(lH,s) 實施例90) l-[(2-甲氧基喹啉-3-醯基)胺基羰基]_4_ (2-羥苯基)哌嗉 將苯基N-(2-曱氧基嗜琳-3-醯基)曱酸酯與1_(2_輕 苯基)哌嗪,採行如同上述實施例81相同的方法進行 反應,而可獲得上述化合物。 收成率:88%Melting point: 190 ~ 191 ° C lU NMR (CDC13) 5: 3.33 (4H? T)? 3.80 (4H? T)? 4.19 (3H5s)? 6.47 (lH, d), 6.82 (2H, d) J.16 ( lH, t), 7.32 (lH, S), 7.37 (lH, t), 7.51 (lH, s), 7.72 (lH, d), 7.78 (lH, d), 8.78 (lH, s) Example 90) l-[(2-methoxyquinolin-3-amidino) aminocarbonyl] -4_ (2-hydroxyphenyl) piperidinylphenyl N- (2-methyloxylin-3-yl) The acetic acid ester and 1- (2- light phenyl) piperazine were reacted in the same manner as in Example 81 to obtain the above compound. Yield: 88%

熔點:159〜161°C W NMR(CDC13)心3.28(4H,t),3.71(4H,t),3.81(3H,s), -61 - 本紙張尺度適用巾國國家標準丨^^以槻格㈠歐撕公瘦) '— (請先閲讀背面之注意事項再填寫本頁)Melting point: 159 ~ 161 ° CW NMR (CDC13) 3.28 (4H, t), 3.71 (4H, t), 3.81 (3H, s), -61-This paper is applicable to national standards of the country ㈠Europe tears thin) '— (Please read the precautions on the back before filling this page)

575564 A7575564 A7

經濟部中央標準局員工消費合作社印製 4.18(3H,s),6.52(2H5s),6.62(lH,s),7.23(lH,t),7.31-7.53(3H,m),7.72(2H,m),8.81(lH,s) 貫施例91) l-[(2-曱氧基喳啉_3-醯基)胺基羰基]_4_ (2-曱基硫代苯基)哌嗪 將苯基Ν·(2-曱氧基喳啉-3-醯基)甲酸酯與1-(2-甲 基硫代苯基)派唤,採行如同上述實施例81相同的方 法進行反應,而可獲得上述化合物。 收成率:78% 熔點:147〜149°C iH NMR(CDC13) δ :2.44(3H,s),3.07(4H,t),3.75(4H,t), 4.18(3H,S),7.13(3H,m),7.18(lH,d),7.39(2H,m),7.70(3H, m)?8.81(lH?s) 實施例92) l-[(2-曱氧基喹啉-3-醯基)胺基羰基]·4- (3-異丙氧苯基)旅嘻 將苯基N-(2-曱氧基喳啉-3-醯基)甲酸酯與1-(3-異 丙氧苯基)哌嗪,採行如同上述實施例81相同的方法 進行反應,而可獲得上述化合物。 收成率:93% 熔點:111〜113°C 'H NMR(CDC13) 5 :1.34(6H,d),3.30(4H,t),3.74(4H,t), 4.18(3H,s),4.55(lH,m),6.49(2H,s),7.05(lH,s),7.20(lH,t), 7-32(lH,s),7e37(lH,t),7.50(lH,t),7.70(lH,d),7.77(lH,d), 8.80(1H,s) 實施例93) l-[(2-曱氧基喹啉-3-醯基)胺基羰基]-4- -62- 本紙張尺度適用中國國家標準(CNS ) A4規格(2ΐ〇χ 297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝.Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 4.18 (3H, s), 6.52 (2H5s), 6.62 (lH, s), 7.23 (lH, t), 7.31-7.53 (3H, m), 7.72 (2H, m ), 8.81 (lH, s) throughout Example 91) l-[(2-methoxyoxoline_3-fluorenyl) aminocarbonyl] _4_ (2-fluorenylthiophenyl) piperazine Ν · (2-methoxyoxoline-3-fluorenyl) formate and 1- (2-methylthiophenyl) group were reacted by the same method as in Example 81 above, but The above compound is obtained. Yield: 78% Melting point: 147 ~ 149 ° C iH NMR (CDC13) δ: 2.44 (3H, s), 3.07 (4H, t), 3.75 (4H, t), 4.18 (3H, S), 7.13 (3H , M), 7.18 (lH, d), 7.39 (2H, m), 7.70 (3H, m)? 8.81 (lH? S) Example 92) l-[(2-methoxyquinoline-3- 醯(Amino) aminocarbonyl] · 4- (3-isopropoxyphenyl) branched phenyl N- (2-methoxyoxoline-3-fluorenyl) formate with 1- (3-isopropyl The oxyphenyl) piperazine was reacted in the same manner as in Example 81 to obtain the above compound. Yield: 93% Melting point: 111 ~ 113 ° C 'H NMR (CDC13) 5: 1.34 (6H, d), 3.30 (4H, t), 3.74 (4H, t), 4.18 (3H, s), 4.55 ( lH, m), 6.49 (2H, s), 7.05 (lH, s), 7.20 (lH, t), 7-32 (lH, s), 7e37 (lH, t), 7.50 (lH, t), 7.70 (lH, d), 7.77 (lH, d), 8.80 (1H, s) Example 93) l-[(2-methoxyoxyquinolin-3-amidino) aminocarbonyl] -4- -62- This paper size applies the Chinese National Standard (CNS) A4 specification (2ΐ〇χ 297 mm) (Please read the precautions on the back before filling this page)-Pack.

、1T d 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(58 ) (3-環丙基甲基氧化苯基)哌嗪 將苯基N-(2-甲氧基4琳-3-醯基)甲酸酯與1-(3-環 丙基甲基氧化苯基)哌嗪,採行如同上述實施例81相 同的方法進行反應,而可獲得上述化合物。 收成率:90%1T d 575564 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (58) (3-Cyclopropylmethyloxyphenyl) piperazine Phenyl N- (2-methoxy4lin The above-mentioned compound can be obtained by reacting 3--3-methyl) formate with 1- (3-cyclopropylmethyloxyphenyl) piperazine in the same manner as in Example 81 described above. Yield: 90%

熔點:146〜147°C 4 NMR(CDC13) 6:0.36(2H,t),0.65(2H,m),1.28(lH,m), 3.31(4H,t),3.75(4H,t),3_80(2H,d),4.18(3H,s),6.50(lH,s), 6.60(2H,s),7.19(lH,t),7.32(lH,s),7.37(lH,t),7.50(lH,t), 7.70(lH,d),7.77(lH,d),8.79(lH,s) 實施例94) l-[(2-曱氧基喹啉-3-醯基)胺基羰基]-4- (2-曱乳基-5-曱基苯基)旅嗔 將苯基N-(2-甲氧基σ奎琳-3_酸基)曱酸酯與1-(2-曱 氧基-5-甲基苯基)旅嘻,採行如同上述實施例8丨相同 的方法進行反應,而可獲得上述化合物。 收成率:76%Melting point: 146 ~ 147 ° C 4 NMR (CDC13) 6: 0.36 (2H, t), 0.65 (2H, m), 1.28 (lH, m), 3.31 (4H, t), 3.75 (4H, t), 3_80 (2H, d), 4.18 (3H, s), 6.50 (lH, s), 6.60 (2H, s), 7.19 (lH, t), 7.32 (lH, s), 7.37 (lH, t), 7.50 ( lH, t), 7.70 (lH, d), 7.77 (lH, d), 8.79 (lH, s) Example 94) l-[(2-methoxyquinolin-3-amidino) aminocarbonyl] The 4- (2-fluorenyl-5-methylphenyl) phenyl group is a mixture of phenyl N- (2-methoxyσquinine-3_acid) phosphonate and 1- (2-fluorenyloxy) The methyl-5-methylphenyl group can be reacted in the same manner as in Example 8 above to obtain the above compound. Yield: 76%

熔點:115〜116°C iH NMR(CDC13) 6 :2.30(3H,s),3.14(4H,t),3.75(4H,t), 3.87(3H,s),4.18(3H,s),6.79(2H,m),6.84(lH,d),7.3 5(2H, m),7.50(lH,t),7.72(lH,d),7.77(lH,d),8_82(lH,s) 貫施例95) l-[(2-甲氧基。奎琳-3-醯基)胺基羰基]-4- (2-甲氧基-5-苯基苯基)哌嗪 將苯基N-(2-曱氧基u奎琳-3-St基)曱酸酯與ι_(2-曱 氧基-5-苯基苯基)旅嘻,採行如同上述實施例8丨相同 -63- 本紙張尺度適用中國國家標準(CNS ) Α4規格(2ι〇Χ297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝· 經濟部中央標準局員工消費合作社印製 575564 A7 -____ B7 五、發明説明(59 ) ~ 〜 的方法進行反應,而可獲得上述化合物。 收成率:77%Melting point: 115 ~ 116 ° C iH NMR (CDC13) 6: 2.30 (3H, s), 3.14 (4H, t), 3.75 (4H, t), 3.87 (3H, s), 4.18 (3H, s), 6.79 (2H, m), 6.84 (lH, d), 7.35 (2H, m), 7.50 (lH, t), 7.72 (lH, d), 7.77 (lH, d), 8_82 (lH, s) Example 95) l-[(2-methoxy.quinolin-3-amidino) aminocarbonyl] -4- (2-methoxy-5-phenylphenyl) piperazine and phenyl N- ( 2-Methoxy u-quelin-3-St-yl) phosphonate and ι_ (2-Methoxy-5-phenylphenyl), which are the same as in Example 8 丨 -63- The standard applies to China National Standard (CNS) Α4 specification (2ι〇 × 297 mm) (please read the precautions on the back before filling out this page)-Equipment · Printed by the Central Consumers Bureau of the Ministry of Economic Affairs Consumer Cooperative 575564 A7 -____ B7 V. DESCRIPTION OF THE INVENTION The methods (59) ~~ can be reacted to obtain the above compounds. Yield: 77%

熔點:122〜123°C 4 NMR(CDC13) (5 :3.38(4H,t),3.86(4H,t),4.97(3H,s), 4.18(3H,s),7.05(2H,m),7.34-7.45(6H,m),7.50(lH,t), 7.56(2H,d),7.71(2H,d),7.78(2H,d)58.88(lH,s) 實施例96) l-[(2-曱氧基喳啉-3-醯基)胺基羰基] (5-甲氧基-2-甲基苯基)哌嗉 將苯基N-(2-甲氧基4琳-3-醯基)甲酸酯與1_(5_甲 氧基-2-甲基苯基)哌嗪,採行如同上述實施例81相同 的方法進行反應,而可獲得上述化合物。 收成率:82%Melting point: 122 ~ 123 ° C 4 NMR (CDC13) (5: 3.38 (4H, t), 3.86 (4H, t), 4.97 (3H, s), 4.18 (3H, s), 7.05 (2H, m), 7.34-7.45 (6H, m), 7.50 (lH, t), 7.56 (2H, d), 7.71 (2H, d), 7.78 (2H, d) 58.88 (lH, s) Example 96) l-[( 2-Methoxyphosphonium-3-fluorenyl) aminocarbonyl] (5-methoxy-2-methylphenyl) piperazine Phenyl N- (2-methoxy4-lin-3-ol The above-mentioned compound can be obtained by the same method as described in Example 81 above, in which the formic acid ester and 1- (5-methoxy-2-methylphenyl) piperazine are reacted. Yield: 82%

熔點:128〜130°C 1H NMR(CDC13) δ :2.30(3H,s),3.37(4H,t),4.84(4H,t), 3.78(3H,s),3.97(3H,s),7.05(2H,m),7.13(lH,d),7·3 8(3Η, m),7.62(lH,d),7.80(lH,s),8.88(lH,s) 實施例97) 1-[(2-甲氧基喹啉-3-醯基)胺基羰基]-4- (1-萘基)派嘻 將苯基N-(2-甲氧基喳啉-3-醯基)曱酸酯與1-(1-萘 基)哌嗪,採行如同上述實施例81相同的方法進行反 應,而可獲得上述化合物。 收成率:68%Melting point: 128 ~ 130 ° C 1H NMR (CDC13) δ: 2.30 (3H, s), 3.37 (4H, t), 4.84 (4H, t), 3.78 (3H, s), 3.97 (3H, s), 7.05 (2H, m), 7.13 (lH, d), 7.38 (3mm, m), 7.62 (lH, d), 7.80 (lH, s), 8.88 (lH, s) Example 97) 1- [ (2-methoxyquinolin-3-amidino) aminocarbonyl] -4- (1-naphthyl) pyridine Phenyl N- (2-methoxyfluorin-3-yl) fluorenic acid The ester was reacted with 1- (1-naphthyl) piperazine in the same manner as in Example 81 to obtain the above compound. Yield: 68%

熔點:158〜160°C NMR(CDC13) 6 :3.22(4H,t),3.86(4H,t),4.20(3H,s), -64- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) .1 I!丨丨·0 (請先閲讀背面之注意事項再填寫本頁} •裝· -訂_ 經濟部中央標準局員工消費合作社印製 575564 A7 __________B7 五、發明説明(60 ) 7.13(lH,d),7.38(2H,m),7.43(lH,t),7.53(3H,m),7.62(lH, d),7.72(lH,d),7.80(lH,d),7.86(lH,d),8.24(lH,s),8.84 (1H,S) 實施例98) 1-[Ν-(2-甲氧基喳啉-3-醯基)-N-甲胺基幾 基]·4-(3,5-二甲氧基苯基)派嘻 將1[(2-甲氧基喳啉-3-醯基)胺基羰基]-4-(3,5·二甲 氧基苯基)旅嘻(106mg,0.25毫莫耳),溶解於二甲基甲 醯胺(15ml)中,並添加氫化鈉(6.〇mg,〇.25毫莫耳),於 室溫下擾拌15分鐘後,再添加埃化甲烧(35mg,〇.25毫 莫耳)’於室溫下攪拌16小時。然後利用減壓濃縮將 二曱基曱醯胺予以去除後,再利用管柱層析(乙基醋酸 酯:己烷=1:2),進行分離精製後便可獲得上述化合 物。 收成率:93%Melting point: 158 ~ 160 ° C NMR (CDC13) 6: 3.22 (4H, t), 3.86 (4H, t), 4.20 (3H, s), -64- This paper size is applicable to China National Standard (CNS) A4 specifications ( 210X 297mm) .1 I! 丨 丨 · 0 (Please read the precautions on the back before filling out this page} • Installation ·-Order _ Printed by the Central Consumers Bureau of the Ministry of Economy Staff Consumer Cooperative 575564 A7 __________B7 V. Description of the invention ( 60) 7.13 (lH, d), 7.38 (2H, m), 7.43 (lH, t), 7.53 (3H, m), 7.62 (lH, d), 7.72 (lH, d), 7.80 (lH, d) , 7.86 (lH, d), 8.24 (lH, s), 8.84 (1H, S) Example 98) 1- [N- (2-methoxypyridin-3-fluorenyl) -N-methylamino A few bases] · 4- (3,5-dimethoxyphenyl) Pyridine 1 [(2-methoxyfluorin-3-yl) aminocarbonyl] -4- (3,5 · di Methoxyphenyl) Luhe (106 mg, 0.25 mmol), dissolved in dimethylformamide (15 ml), and sodium hydride (6.0 mg, 0.25 mmol) was added to the chamber. After stirring at room temperature for 15 minutes, add melamine (35 mg, 0.25 mmol) and stir at room temperature for 16 hours. The difluorenamide is then removed by concentration under reduced pressure, and then column chromatography (ethyl acetate: hexane = 1: 2) is used for separation and purification to obtain the above compound. Yield: 93%

熔點:88〜89°C iH NMR(CDCl3)5:2.93(4H,t),3.17(3H,s),3.34(4H,t), 3.72(6H,s),4.15(3H,t),5.95(2H,s),5.98(lH,s),7.40(lH,t), 7.61(2H,m),7.73(lH,s),7.84(lH,d) 貝施例99) 1-[N-乙基-N-(2-甲氧基口奎琳-3-酸基)胺基 羰基]-4-(3,5-二甲氧基苯基)哌嗪 將1-[(2-甲氧基喹啉-3-醯基)胺基羰基]_4-(3,5-二 甲氧基苯基)旅嗪(106mg,0.25毫莫耳),溶解於二甲基 甲酉监月女(15ml)中’並添加氫化納(6.〇mg,0.25毫莫耳)。 於室溫下攪拌16小時。然後利用減壓濃縮將二甲 -65- 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X297公釐) I--------— (請先閲讀背面之注意事項再填寫本頁) 訂 575564 A7 B7 五、發明説明(61 ) (請先閲讀背面之注意事項再填寫本頁) 基甲驢胺予以去除後,再利用管柱層析(乙基醋酸酯: 己烷=1:2),進行分離精製後便可獲得上述化合物。 收成率:91%Melting point: 88 ~ 89 ° C iH NMR (CDCl3) 5: 2.93 (4H, t), 3.17 (3H, s), 3.34 (4H, t), 3.72 (6H, s), 4.15 (3H, t), 5.95 (2H, s), 5.98 (lH, s), 7.40 (lH, t), 7.61 (2H, m), 7.73 (lH, s), 7.84 (lH, d) Example 99) 1- [N- Ethyl-N- (2-Methoxyquinolin-3-acid) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine 1-[(2-methoxy Quinoline-3-amidino) aminocarbonyl] _4- (3,5-dimethoxyphenyl) travelazine (106mg, 0.25 mmol), dissolved in dimethyl formamidine (15ml) ) 'And sodium hydride (6.0 mg, 0.25 mmol) was added. Stir at room temperature for 16 hours. Then use reduced pressure concentration to apply Dijia-65- this paper size to Chinese National Standard (CNS) A4 specifications (21 × 297 mm) I --------— (Please read the precautions on the back before filling This page) Order 575564 A7 B7 V. Description of the invention (61) (Please read the precautions on the back before filling in this page) After the methamidamine is removed, use column chromatography (ethyl acetate: hexane = 1: 2). After separation and purification, the above compound can be obtained. Yield: 91%

熔點:118〜120°C NMR(CDC13) (5 :1.16(3H,t),2.89(4H,t),3.30(4H,t), 3.63(2H,m),3.71(6H,s),4· 13(3 H,s),5.93 (2H,s),5.98(1 H,s), 7.41(lH,t),7.60(lH,t),7.66(lH,d),7.71(lH,s),7.84(lH,d) Mass(EI) m/z:450.2206 (MH,C25H3GN404 計算值: 450.2227) 實施例100) 1-[(N-異丙基-N-(2-甲氧基喹啉-3-醯基) 胺基羰基]-4-(3,5-二甲氧基苯基)哌嗪 經濟部中央標準局員工消費合作社印製 將1[(2-曱氧基喳啉-3-醯基)胺基羰基]_4-(3,5-二甲 氧基苯基)派唤(106mg,0.25毫莫耳),溶解於二甲基甲 醯胺(15ml)中,並添加氫化鈉(6.0mg,0.25毫莫耳),於 室溫下授拌15分鐘後,再添加2-峨化丙烧(42mg,0.25 毫莫耳),於室溫下攪拌16小時。然後利用減壓濃縮 將二甲基甲醯胺予以去除後,再利用管柱層析(乙基酷 酸酉旨·己院=1:2)’進行分離精製後便可獲得上述化 合物。 收成率:87%Melting point: 118 ~ 120 ° C NMR (CDC13) (5: 1.16 (3H, t), 2.89 (4H, t), 3.30 (4H, t), 3.63 (2H, m), 3.71 (6H, s), 4 13 (3 H, s), 5.93 (2H, s), 5.98 (1 H, s), 7.41 (lH, t), 7.60 (lH, t), 7.66 (lH, d), 7.71 (lH, s ), 7.84 (lH, d) Mass (EI) m / z: 450.2206 (MH, C25H3GN404 calculated: 450.2227) Example 100) 1-[(N-isopropyl-N- (2-methoxyquinoline -3-fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine Printed by the Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs, 1 [(2-fluorenyloxyline-3 -Fluorenyl) aminocarbonyl] _ (4- (3,5-dimethoxyphenyl)) (106 mg, 0.25 mmol), dissolved in dimethylformamide (15 ml), and sodium hydride was added (6.0 mg, 0.25 mmol), and stir at room temperature for 15 minutes, then add 2-Ehuan propylene (42 mg, 0.25 mmol), and stir at room temperature for 16 hours. Then concentrated under reduced pressure After removing the dimethylformamide, and then separating and purifying it by column chromatography (Ethyl Acetate, Kiyain = 1: 2) ', the above compound can be obtained. Yield: 87%

熔點:123〜125°C W NMR(CDC13) H.21(6H,d),2.79(4H,t),3.29(4H,t), 3.70(6H,s),4.08(3H,s),4.41(lH,m),5.90(2H,s),5.96(lH,s), 7.43(lH,t),7,63(lH,t),7.69(lH,d),7.75(lH,S),7.83(lH,d) -66 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(62 ) 實施例101) 1-[(N-環丙基甲基_ν-(2·甲氧基喹啉-3- 醯基)胺基羰基]-4-(3,5-二曱氧基苯基)哌嗉 將1 [(2-甲氧基α奎琳-3-醯基)胺基羰基]_4-(3,5-二甲 氧基苯基)哌嗉(106mg,0.25毫莫耳),溶解於二甲基曱 醯胺(15ml)中,並添加氫化鈉(62mg,0.26毫莫耳),於 至溫下授拌15分鐘後’再添加漠化甲基環丙烧(22mg, 0·26毫莫耳),於室溫下授拌16小時。然後利用減壓 ?辰縮將一甲基甲酸胺予以去除後,再利用管柱層析(乙 基醋酸酯:己烷=1:2),進行分離精製後便可獲得上 述化合物。 收成率·· 78%Melting point: 123 ~ 125 ° CW NMR (CDC13) H.21 (6H, d), 2.79 (4H, t), 3.29 (4H, t), 3.70 (6H, s), 4.08 (3H, s), 4.41 ( lH, m), 5.90 (2H, s), 5.96 (lH, s), 7.43 (lH, t), 7,63 (lH, t), 7.69 (lH, d), 7.75 (lH, S), 7.83 (lH, d) -66-This paper size is in accordance with Chinese National Standard (CNS) A4 (210X 297 mm) 575564 Printed by A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (62) Example 101) 1-[(N-Cyclopropylmethyl_v- (2.methoxyquinolin-3-fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperidine 1 [(2-methoxyαquinine-3-amidino) aminocarbonyl] 4- (3,5-dimethoxyphenyl) piperidine (106 mg, 0.25 mmol), dissolved in dimethyl Methylamine (15 ml), and sodium hydride (62 mg, 0.26 mmol) was added, and after 15 minutes of incubation at room temperature, then desertified methylcyclopropane (22 mg, 0.26 mmol) was added. ), And allowed to stir at room temperature for 16 hours. Then, the monomethyl formate was removed by decompression and pressure reduction, and then separated by column chromatography (ethyl acetate: hexane = 1: 2). After refining Obtain the above compound. 78% harvest rate ··

熔點:118〜120°C iH NMR(CDC13) (5 :0.41(2H,m),0.85(2H,m),1.28(lH,m), 2.88(4H,t),3.24(4H,t),3.42(2H,d),3.71(6H,s),4.13(3H,s), 5.94(3H,s),7.44(lH,d),7.62(lH,d),7-78(3H,m) 實施例102) 1-[(N-苄基-N-(2-曱氧基喳啉_3_醯基)胺 基羰基]-4-(3,5-二甲氧基苯基)哌嗪 將1[(2-甲氧基喳啉-3-醯基)胺基羰基]_4-(3,5-二甲 氧基苯基)哌嗔(114mg,0.27毫莫耳),溶解於二曱基甲 酸胺(15ml)中,並添加氫化鈉(6.6mg,0.27毫莫耳),於 室溫下攪拌15分鐘後,再添加溴化节(46mg,〇_27毫 莫耳)’於室溫下攪拌16小時。然後利用減壓濃縮將 一曱基甲fe胺予以去除後,再利用管柱層析(乙基醋酸 酯:己烷=1:2),進行分離精製後便可獲得上述化合 -67- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝_ 575564 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(63 ) 物。 收成率:90% 熔點:油狀 NMR(CDC13) 5 :2.92(4H,t),3.39(4H,t),3.72(6H,s), 4.13(3H,s),4.79(2H,s),6.01(3H,m),7.21(lH,m),7.25(2H, m),7.25(2H,m),7.33(3H,m),7.51(2H,s),7.57(2H,m),7.81( 2H,d) 實施例103) l-[N-(2-甲氧基喹啉-3-醯基)-N-甲基胺 基罗厌基]-4-(3,5 -二甲乳基苯基)旅嘻 將1[(2-甲氧基唤琳-3-酸基)胺基魏基]-4-(3,5-二甲 氧基苯基)派嗓,採行如同上述實施例9相同的方法進 行反應,而可獲得上述化合物。 收成率:92%Melting point: 118 ~ 120 ° C iH NMR (CDC13) (5: 0.41 (2H, m), 0.85 (2H, m), 1.28 (lH, m), 2.88 (4H, t), 3.24 (4H, t), 3.42 (2H, d), 3.71 (6H, s), 4.13 (3H, s), 5.94 (3H, s), 7.44 (lH, d), 7.62 (lH, d), 7-78 (3H, m) Example 102) 1-[(N-benzyl-N- (2-methoxyoxoline_3_fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine 1 [(2-methoxyfluorin-3-yl) aminocarbonyl] 4- (3,5-dimethoxyphenyl) piperidine (114 mg, 0.27 mmol) was dissolved in difluorene Carbamate (15ml), sodium hydride (6.6mg, 0.27mmol) was added, and after stirring at room temperature for 15 minutes, bromide (46mg, 〇_27mmol) was added at room temperature The mixture was stirred for 16 hours. The monomethyl feamine was removed by concentration under reduced pressure, and then column chromatography (ethyl acetate: hexane = 1: 2) was used for separation and purification to obtain the above compound. -67- This paper size applies to China National Standard (CNS) A4 (210X297mm) (Please read the precautions on the back before filling this page)-Packing _575564 Employees ’Central Bureau of Standards, Ministry of Economic Affairs, Consumer Consumption Cooperation Printed A7 B7 V. Invention description (63) Yield: 90% Melting point: Oily NMR (CDC13) 5: 2.92 (4H, t), 3.39 (4H, t), 3.72 (6H, s), 4.13 (3H, s), 4.79 (2H, s), 6.01 (3H, m), 7.21 (lH, m), 7.25 (2H, m), 7.25 (2H, m), 7.33 (3H, m), 7.51 ( 2H, s), 7.57 (2H, m), 7.81 (2H, d) Example 103) l- [N- (2-methoxyquinolin-3-amidino) -N-methylaminorozine Yl] -4- (3,5 -dimethyllactylphenyl) bridging 1 [(2-methoxycarbin-3-acyl) aminoweiyl] -4- (3,5-di Methoxyphenyl) was used to carry out the reaction in the same manner as in Example 9 to obtain the above compound. Yield: 92%

熔點:142〜143°C NMR(CDC13)心2.27(6H,d),2.90(4H,t),3.17(3H,s), 3.34(4H,t)54.15(3H,s),6.41(2H,s),6_49(lH,s),7.40(lH,t) 7.63(lH,t),7.65(lH,d),7.73(lH,s),7.84(lH,d) 貫施例104) 1-[N-乙基-N_(2-曱氧基σ奎琳驗基)一^ 曱基胺基羰基]-4-(3,5-二曱基苯基)哌嗪 將1 [(2-甲氧基喹啉-3-醯基)胺基羰基]-‘(3,5_二甲 基苯基)派嗪,採行如同上述實施例99相同的方法進 行反應,而可獲得上述化合物。 收成率:89%Melting point: 142 ~ 143 ° C NMR (CDC13) 2.27 (6H, d), 2.90 (4H, t), 3.17 (3H, s), 3.34 (4H, t) 54.15 (3H, s), 6.41 (2H, s), 6_49 (lH, s), 7.40 (lH, t) 7.63 (lH, t), 7.65 (lH, d), 7.73 (lH, s), 7.84 (lH, d) Example 104) 1- [N-ethyl-N_ (2-fluorenyloxy quinine molybdenum group) -Aminomethylaminocarbonyl] -4- (3,5-diamidinophenyl) piperazine will be 1 [(2-methyl The oxyquinoline-3-amido) aminocarbonyl]-'(3,5-dimethylphenyl) pyrazine was reacted in the same manner as in Example 99 to obtain the above compound. Yield: 89%

熔點:84〜86°C -68 _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐厂一"""' ^^^ f請先閱讀背面之注意事項再填寫本頁;} •裝 575564 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(64 )iH NMR(CDCl3)(5:1.16(3H,t)52.21(6H,s),2.87(4H,t), 3.30(4H,t),3.64(2H,q),4.13(3H,t),6.40(2H,s),6.48(lH,s), 7.40(1 H,t),7.62(1 H,t),7.66(lH,d),7.71(lH,s),7.84(lH,d) 實施例105) 1-[Ν·異丙基-N-(2-甲氧基喳啉-3-醯基)- N-曱基胺基羰基]·4-(3,5-二甲基苯基)哌嗉 將1 [(2-甲氧基嗜琳-3-驢基)胺基魏基]-4-(3,5-二甲 基苯基)哌嗉,採行如同上述實施例1〇〇相同的方法進 行反應,而可獲得上述化合物。 收成率:84% 熔點:114〜115°CW NMR(CDC13)6 :1.21(6H,d),2_20(6H,s),2.77(4H,t), 3.28(4H,t),4_08(3H,s),4_39(lH,m),6.37(2H,s),6.46(lH,s),7.41(lH,t),7.63(lH,t),7.69(lH,d),7.75(lH,s),7.83(lH,d) 實施例106) 1-[N_苄基-N-(2-甲氧基喳啉-3_醯基)-N- 甲基胺基羰基]-4-(3,5·二甲基苯基)哌嗉 將1[(2-甲氧基喳啉-3-醯基)胺基羰基]-4-(3,5-二甲 基苯基)旅嗔,採行如同上述實施例102相同的方法進 行反應’而可獲得上述化合物。 收成率:90% 熔點:油狀iH NMR(CDC13) 5:2.24(6H,s),2.87(4H,t),3.31(4H,t), 4.13(3H,S),4.80(2H,s),6.42(3H,s),7.49(lH,t),7.62(2H,m), 7.72(2H,m) 實施例107) l-[N-(2-曱氧基喳啉-3-醯基)-N-曱基胺 -69- 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) i裝· 訂 4 575564 A7 B7 五、發明説明(65 ) 基幾基]-4-(3-異丙氧苯基)σ辰嗪 將1[(2-甲氧基喳啉-3-醯基)胺基羰基]-‘(3_異丙 氧苯基)哌嗪,採行如同上述實施例98相同的方法進 行反應,而可獲得上述化合物。 收成率:92% 熔點:油狀 W NMR(CDC13) (5 :l_28(6H,d),2.97(4H,t),3.18(3H,s), 3.37(4H,t),4.14(3H,s),4.49(lH,m),6.41 (3H,m),7.13( 1 Η, m),7.40(lH,t),7.62(lH,t),7.66(lH,d),7.74(lH,s),7.84(lH, d) ? ’ 實施例108) 1 _[N_乙基善(2·甲氧基喳啉_3_醯基)_Ν· 甲基胺基羰基]-4-(3-異丙氧苯基)旅嘻 將1[(2-曱氧基喳啉-3-醯基)胺基羰基]-4-(3-異丙 氧苯基)哌嗪,採行如同上述實施例99相同的方法進 行反應’而可獲得上述化合物。 收成率:87% 熔點:油狀 W NMR(CDC13)(5 :1.16(3H,t),1.34(6H,d),2.89(4H,t), 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁)Melting point: 84 ~ 86 ° C -68 _ This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm factory one " " " '^^^ f Please read the precautions on the back before filling in this page ;} • Printed 575564 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (64) iH NMR (CDCl3) (5: 1.16 (3H, t) 52.21 (6H, s), 2.87 (4H, t ), 3.30 (4H, t), 3.64 (2H, q), 4.13 (3H, t), 6.40 (2H, s), 6.48 (lH, s), 7.40 (1 H, t), 7.62 (1 H, t), 7.66 (lH, d), 7.71 (lH, s), 7.84 (lH, d) Example 105) 1- [N · Isopropyl-N- (2-methoxypyridin-3- 喳) -)-N-fluorenylaminocarbonyl] · (4- (3,5-dimethylphenyl) piperidine] [[(2-Methoxylin-3-donyl) aminoweilyl]- 4- (3,5-dimethylphenyl) piperidine was reacted in the same manner as in Example 100 above to obtain the above compound. Yield: 84% Melting point: 114 ~ 115 ° CW NMR (CDC13) 6: 1.21 (6H, d), 2-20 (6H, s), 2.77 (4H, t), 3.28 (4H, t), 4_08 (3H, s), 4_39 (lH, m), 6.37 (2H , S), 6.46 (lH, s), 7.41 (lH, t), 7.63 (lH, t), 7.69 (lH d), 7.75 (lH, s), 7.83 (lH, d) Example 106) 1- [N_benzyl-N- (2-methoxypyridin-3-yl) -N-methylamine Carbonyl] -4- (3,5 · dimethylphenyl) piperazine 1 [(2-methoxyfluorin-3-yl) aminocarbonyl] -4- (3,5-dimethyl The above compound can be obtained by reacting the same method as in Example 102 above. Yield: 90% Melting point: Oily iH NMR (CDC13) 5: 2.24 (6H, s), 2.87 (4H, t), 3.31 (4H, t), 4.13 (3H, S), 4.80 (2H, s) , 6.42 (3H, s), 7.49 (lH, t), 7.62 (2H, m), 7.72 (2H, m) Example 107) l- [N- (2-methoxyoxoline-3-fluorenyl ) -N-fluorenylamine-69- This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page) i Order 4 575564 A7 B7 5 2. Description of the invention (65) kikyridyl] -4- (3-isopropoxyphenyl) σchenazine 1 [(2-methoxyfluorin-3-yl) aminocarbonyl]-'(3 Isopropoxyphenyl) piperazine can be reacted in the same manner as in Example 98 to obtain the above compound. Yield: 92% Melting point: Oily W NMR (CDC13) (5: l_28 (6H, d), 2.97 (4H, t), 3.18 (3H, s), 3.37 (4H, t), 4.14 (3H, s ), 4.49 (lH, m), 6.41 (3H, m), 7.13 (1 μm, m), 7.40 (lH, t), 7.62 (lH, t), 7.66 (lH, d), 7.74 (lH, s) ), 7.84 (lH, d)? Example 108) 1 _ [N_Ethylthio (2.methoxymethoxyline_3_fluorenyl) _N · methylaminocarbonyl] -4- (3- Isopropoxyphenyl) Luhe uses 1 [(2-methoxyoxoline-3-fluorenyl) aminocarbonyl] -4- (3-isopropoxyphenyl) piperazine as in the above examples The reaction can be carried out in the same manner as above to obtain the above compound. Yield: 87% Melting point: Oily W NMR (CDC13) (5: 1.16 (3H, t), 1.34 (6H, d), 2.89 (4H, t), printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please (Read the notes on the back before filling out this page)

3.30(4H,t),3.63(2H,m),4.13(3H,s),4.55(lH,m),6.49(2H,S ),7.05(lH,s),7.20(lH,t),7.32(lH,s),7.37(lH,t),7.50(lH,t ),7.70(lH,d),7.77(lH,d),8.80(lH,s) 實施例109) 1-[(2-曱氧基琳-3-醯基)胺基硫代羰 基]-4-(3,5-二甲氧基苯基)旅嘻 將苯基N-(2-甲氧基喹啉-3-醯基)硫代甲酸酯(56mg, -70- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564 A7 66 五、發明説明( 〇·5笔莫耳)與i-(3,5-一甲氧基苯基)σ辰π秦(Himg,0.5毫 莫耳)’溶解於無水四氫吼喃中,並添加DBU(117mg, 0·75毫莫耳)後,於室溫下攪拌2小時。然後利用減壓 濃縮將四氫吡喃予以去除後,再利用管柱層析(己烷: 乙醚= 5:1),進行分離精製後便可獲得上述化合物。 收成率:76%3.30 (4H, t), 3.63 (2H, m), 4.13 (3H, s), 4.55 (lH, m), 6.49 (2H, S), 7.05 (lH, s), 7.20 (lH, t), 7.32 (lH, s), 7.37 (lH, t), 7.50 (lH, t), 7.70 (lH, d), 7.77 (lH, d), 8.80 (lH, s) Example 109) 1-[(2- (Methoxylin-3-fluorenyl) aminothiocarbonyl] -4- (3,5-dimethoxyphenyl) brittle phenyl N- (2-methoxyquinoline-3- 醯Base) thioformate (56mg, -70-) This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 575564 A7 66 5. Description of the invention (0.5 pen mole) and i- (3 , 5-monomethoxyphenyl) σ Chen π Qin (Himg, 0.5 mmol) was dissolved in anhydrous tetrahydrofuran, and DBU (117 mg, 0.75 mmol) was added, and at room temperature The mixture was stirred for 2 hours. Then the tetrahydropyran was removed by concentration under reduced pressure, and then the column compound (hexane: ether = 5: 1) was used for separation and purification to obtain the above compound. Yield: 76 %

熔點:171〜172°C 4 NMR(CDCl3)5:3.41(4H,t),3.81(6H,s),4.17(3H,s), 4.2l(4H,t),6.21(lH,s),6.20(lH,d),7.38(1 H,t),7.54(lH,t), 7.74( lH,d),7.81(lH,d),8.96(lH,s) 貫施例110) l-[(2-甲氧基嗅琳-3-醯基)胺基硫代羰 基]-4-(3,5-二甲基苯基)σ辰嘻 將苯基Ν-(2-曱氧基喳啉-3-醯基)硫代甲酸酯與1_ (3,5-一甲基苯基)α辰嗔,採行如同上述實施例1〇9相同 的方法進行反應,而可獲得上述化合物。 收成率:79%Melting point: 171 ~ 172 ° C 4 NMR (CDCl3) 5: 3.41 (4H, t), 3.81 (6H, s), 4.17 (3H, s), 4.2l (4H, t), 6.21 (lH, s), 6.20 (lH, d), 7.38 (1H, t), 7.54 (lH, t), 7.74 (lH, d), 7.81 (lH, d), 8.96 (lH, s) Example 110) l- [ (2-Methoxyline-3-fluorenyl) aminothiocarbonyl] -4- (3,5-dimethylphenyl) σ Chen Hei Phenyl N- (2-methoxyoxoline The above-mentioned compound can be obtained by reacting 3--3-methyl) thioformate with 1- (3,5-monomethylphenyl) α-phenylene in the same manner as in Example 109 above. Yield: 79%

熔點:170〜171°C β NMR(CDC13) d :2.30(6H,s),3_38(4H,t),4.09(3H,s), 4.l7(4H,t),6_63(3H,m),7.3 8(lH,t),7.54(lH,t),7.72(lH,d), 7.81(lH,d),8.96(lH,s) 實施例111) l-[(2-曱氧基喳啉-3-醯基)胺基硫代羰 基]-4-(3,5-二氟化苯基)哌嗪 將苯基N-(2_甲氧基喳啉_3-醯基)硫代甲酸酯與卜 (3,5-二氟化苯基)呢嗔,採行如同上述實施例1〇9相同 71- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) —---------衣-- (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 575564 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(67 ) 的方法進行反應,而可獲得上述化合物。 收成率:78% 熔點:140〜142°C 4 NMR(CDC13) 5 :3.44(4H,t),4.20(4H,t),4.25(3H,s),6.33(2H,m),6.45(lH,d),7.41(lH,t),7.56(lH,m),7.72(lH,m),7_97(lH,m),8.96(lH,s) 實施例112) l-[(2-曱氧基喹啉-3-醯基)胺基硫代羰 基]-4-(3,5-二氯化苯基)i嘻 將苯基N-(2-曱氧基α奎琳-3-S&基)硫代曱酸酯與1-(3,5-二氯化苯基)旅嗔,採行如同上述實施例1〇9相同 的方法進行反應,而可獲得上述化合物。 收成率:62% 熔點:181〜183°C iH NMR(CDCl3)5:3.44(4H,t),4.20(4H,t),4.26(3H,s), 6.77(lH,s),6.88(2H,t),7.41(lH,t),7.59(lH,t),7.70(2H,m), 8.01(lH,t),8.11(lH,s),8.93(lH,s) 實施例113) 1-[(2-甲氧基喹啉-3-醯基)胺基硫代羰 基>4-(3-曱氧基苯基)哌嗪 將苯基N-(2-曱氧基喹啉-3-醯基)硫代曱酸酯與1-(3-曱氧基苯基)哌嗉,採行如同上述實施例1〇9相同 的方法進行反應,而可獲得上述化合物。 收成率:81% 熔點:油狀 W NMR(CDCl3)5:3.17(4H,t),3.89(3H,s),4.17(4H,t), -72- 本紙張尺度適财麵家標準(CNS ) A4規格(公釐) 一~"' (請先閱讀背面之注意事項再填寫本頁) :裝·Melting point: 170 ~ 171 ° C β NMR (CDC13) d: 2.30 (6H, s), 3_38 (4H, t), 4.09 (3H, s), 4.l7 (4H, t), 6_63 (3H, m) , 7.38 (lH, t), 7.54 (lH, t), 7.72 (lH, d), 7.81 (lH, d), 8.96 (lH, s) Example 111) l-[(2-fluorenyloxyfluorene) Phenolin-3-amidino) aminothiocarbonyl] -4- (3,5-difluorinated phenyl) piperazine Phenyl N- (2-methoxyfluorinoline_3-fluorenyl) thio The formate and the (3,5-difluorinated phenyl) sulfonium are used in the same manner as in the above-mentioned Example 109. 71- This paper size applies to the Chinese National Standard (CNS) A4 (210 X 297 mm). —--------- Clothing-(Please read the precautions on the back before filling out this page) Order printed by the Central Consumers Bureau of the Ministry of Economic Affairs, printed by the Consumer Cooperative 575564 A7 B7 5. The method of invention description (67) is carried out to obtain the above compounds. Yield: 78% Melting point: 140 ~ 142 ° C 4 NMR (CDC13) 5: 3.44 (4H, t), 4.20 (4H, t), 4.25 (3H, s), 6.33 (2H, m), 6.45 (lH , D), 7.41 (lH, t), 7.56 (lH, m), 7.72 (lH, m), 7_97 (lH, m), 8.96 (lH, s) Example 112) l-[(2-fluorene Quinoline-3-fluorenyl) aminothiocarbonyl] -4- (3,5-dichlorinated phenyl) i-phenyl N- (2-fluorenyloxyquinine-3-S & The above-mentioned compound can be obtained by the same method as in the above-mentioned Example 109, in which the thio-thiophosphonate and 1- (3,5-dichlorophenyl) amidine are reacted. Yield: 62% Melting point: 181 ~ 183 ° C iH NMR (CDCl3) 5: 3.44 (4H, t), 4.20 (4H, t), 4.26 (3H, s), 6.77 (lH, s), 6.88 (2H , T), 7.41 (lH, t), 7.59 (lH, t), 7.70 (2H, m), 8.01 (lH, t), 8.11 (lH, s), 8.93 (lH, s) Example 113) 1 -[(2-methoxyquinolin-3-amidino) aminothiocarbonyl> 4- (3-methoxyoxyphenyl) piperazine will be phenyl N- (2-methoxyquinoline- The above-mentioned compound can be obtained by reacting the 3-fluorenyl) thiophosphonate with 1- (3-methoxyoxyphenyl) piperidine in the same manner as in the above-mentioned Example 109. Yield: 81% Melting point: Oily W NMR (CDCl3) 5: 3.17 (4H, t), 3.89 (3H, s), 4.17 (4H, t), -72- This paper is suitable for financial standards (CNS) ) A4 specification (mm) 1 ~ " '(Please read the precautions on the back before filling this page):

、1T d 575564 A7 B7 五 、發明説明(68 經濟部中央標準局員工消費合作社印製 6.90(4H,m),7.34(lH,t),7.48(lH,t),7.70(lH,d),7.77(lH,d), 8.80(1H,s) 實施例114) 1-[(2-甲基喹啉-3-醯基)胺基羰基]-4- (3,5-二甲氧基苯基)哌嗪 a) 將本基N_(2-甲基嗜琳-3··基)甲酸酯-3-胺基-2-曱基喳啉(4g,25毫莫耳)與苯基氯化甲酸酯(4.04g,25毫 莫耳),溶解於二氯甲烷中,於室溫下攪拌2小時。然 後利用減壓濃縮將二氯曱烷予以去除後,再利用管柱 層析(乙基醋酸酯:己烷=1:10),進行分離精製後便 可獲得上述化合物。 收成率:88% 4 NMR(CDC13) (5 :2.77(3H,s),7.3G-7.53(9H,m),8.67(1H,S) b) l-[(2-甲基喳啉-3-醯基)胺基羰基]-4_(3,5_二曱氧 基苯基)唆α秦 將苯基Ν-(2-甲基喳啉醯基)甲酸酯(14〇mg,〇5 毫莫耳)與1-(3,5-二甲氧基苯基)哌嗪(11211^,〇.5毫莫 溶解於無水四氫吡喃中,並添加DBu(ii7mg,〇 75 先莫耳)後’於至皿下擾拌2小時。然後利用減壓濃縮 ?四氫吡喃予以去除後,再利用管柱層析(乙基醋酸 酗己⑥―1:2),進行分離精製後便可獲得上述化合 物1T d 575564 A7 B7 V. Description of the invention (68 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 6.90 (4H, m), 7.34 (lH, t), 7.48 (lH, t), 7.70 (lH, d), 7.77 (lH, d), 8.80 (1H, s) Example 114) 1-[(2-methylquinolin-3-amidino) aminocarbonyl] -4- (3,5-dimethoxybenzene Group) Piperazine a) The basic N_ (2-methyl cylinol-3 ·· yl) formate-3-amino-2-amidinophosphonium (4 g, 25 mmol) and phenyl chloride The formate (4.04 g, 25 mmol) was dissolved in dichloromethane and stirred at room temperature for 2 hours. The dichloromethane was removed by concentration under reduced pressure, and then column chromatography (ethyl acetate: hexane = 1: 10) was used for separation and purification to obtain the above compounds. Yield: 88% 4 NMR (CDC13) (5: 2.77 (3H, s), 7.3G-7.53 (9H, m), 8.67 (1H, S) b) l-[(2-methylpyridin-3-3 -Fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) fluorene α-phenylene N- (2-methylfluorinylfluorenyl) formate (14 mg, 〇5 Mol) and 1- (3,5-dimethoxyphenyl) piperazine (11211 ^, 0.5 mol was dissolved in anhydrous tetrahydropyran, and DBu (ii7mg, 075 premol ) 'And stir for 2 hours under the dish. Then use concentrated under reduced pressure? Tetrahydropyran to remove it, and then use column chromatography (ethyl acetate hexanox ⑥-1: 2) to separate and purify it. The above compounds can be obtained

收成率:84% 熔點:199〜200°C -73-Yield: 84% Melting point: 199 ~ 200 ° C -73-

(請先閱讀背面之注意事項再填寫本頁) ;裝· 、言 4 575564 A7 B7 五 發明説明(69 W NMR(CDCl3)5:2.81(3H,s),3.30(4H,t),3.76(4H,t), 3.80(6H,s),6.08(lH,s),6.12(2H,d),7.48(lH,t),7·62 (lH,t),7.71(lH,d),8.03(lH,d),8.59(lH,s)(Please read the precautions on the reverse side before filling out this page); Equipment · Introduction 4 575564 A7 B7 Five Invention Instructions (69 W NMR (CDCl3) 5: 2.81 (3H, s), 3.30 (4H, t), 3.76 ( 4H, t), 3.80 (6H, s), 6.08 (lH, s), 6.12 (2H, d), 7.48 (lH, t), 7.62 (lH, t), 7.71 (lH, d), 8.03 (lH, d), 8.59 (lH, s)

Mass(EI) m/z:390.2066 (MH,C23H26N402 計算值: 390.2055) 實施例115) 1-[(2-曱基喳啉-3-醯基)胺基羰基]-4- (3,5-二甲基苯基)哌嗪 將苯基N-(2-曱基唤琳-3-醯基)硫代甲酸酯與1-(3,5-二曱基苯基)哌嗪,採行如同上述實施例114相同 的方法進行反應,而可獲得上述化合物。 收成率:86%Mass (EI) m / z: 390.2066 (MH, C23H26N402 Calculated: 390.2055) Example 115) 1-[(2-Amidinofluorin-3-yl) aminocarbonyl] -4- (3,5- Dimethylphenyl) piperazinePhenyl N- (2-fluorenyl-3-methyl) thioformate and 1- (3,5-difluorenylphenyl) piperazine were used. The reaction was carried out in the same manner as in the above Example 114 to obtain the above compound. Yield: 86%

熔點:230〜232°C 4 NMR(CDCl3)c5:2.31(6H,s),2.82(3H,s),3.29(4H,t), 3.76(4H,t),6.60(3H,s),7.49(lH,t),7.63(lH,t),7.73(lH,d), 8.05(lH,d),8.61(lH,s) 實施例116) l-[(2-甲基喳啉-3-醯基)胺基羰基]-4- (2,3-一曱基苯基)派嘻 將苯基N-(2-曱基η奎琳基)硫代甲酸醋與ι_ (2,3-二曱基苯基)哌嗔,採行如同上述實施例114相同 的方法進行反應,而可獲得上述化合物。 收成率:81%Melting point: 230 ~ 232 ° C 4 NMR (CDCl3) c5: 2.31 (6H, s), 2.82 (3H, s), 3.29 (4H, t), 3.76 (4H, t), 6.60 (3H, s), 7.49 (lH, t), 7.63 (lH, t), 7.73 (lH, d), 8.05 (lH, d), 8.61 (lH, s) Example 116) l-[(2-methylphosphonium-3- Fluorenyl) aminocarbonyl] -4- (2,3-monofluorenylphenyl) pyridine will combine phenyl N- (2-fluorenyl n quinolinyl) thioformate with ι_ (2,3-di The fluorenylphenyl) piperidine was reacted in the same manner as in the above Example 114 to obtain the above compound. Yield: 81%

熔點:169〜170°C Ή NMR(CDC13) (5 :2.28(6H,d),2.84(3H,s),3.30(4H,t), 3.76(4H,t),6.94(2H,m),7.11(lH,t),7.49(lH,t),7.63(lH,d), (請先閱讀背面之注意事項再填寫本頁) 經 濟 部 t 標 準 局 員 工 消 t 合 作 社 印 製 0 —mtt { In OMmmKaB —^f· -74 575564 五、 經濟部中央標準局員工消費合作社印製 A7 _______B7發明説明(7〇 ) 7.72(lH,d),8.64(lH,s) 實施例117) 1_[(2-曱基喹啉-3-醯基)胺基羰基]-4- (3,5-一氣化苯基)旅σ秦 將苯基Ν-(2-甲基喹啉-3-醯基)硫代甲酸酯與1-(3,5-二氟化苯基)哌嗪,採行如同上述實施例114相同 的方法進行反應,而可獲得上述化合物。 收成率:81% 熔點:238〜240°C NMR(CDC13) δ :2.81(3H,t),3.34(4H,t),3.77(4H,t), 6.32(lH,t),6_39(2H,d),7.49(lH,t),7.63(lH,t),7.72(lH,d), 8.03(lH,d),8.58(lH,s) 實施例118) l-[(2-曱基喹啉-3-醯基)胺基羰基]-4- (3,5-二氯化苯基)哌嗪 將苯基N-(2_甲基。奎琳-3-醯基)硫代甲酸酯與1一 (3,5-二氯化苯基)哌嗪,採行如同上述實施例114相同 的方法進行反應,而可獲得上述化合物。 收成率:65% 熔點:247〜249°C 1H NMR(CDC13) 5 :2.79(3H,s),3.33(4H,t),3.75(4H,t), 6.78(2H,s),6.87(lH,s),7.49(lH,t),7.63(lH,t),7.72(lH,d), 8.56(1H,s) 實施例119) 1-[(2_甲基喹啉-3-醯基)胺基羰基]-4-(2- 曱氧基苯基辰嘻 將苯基N-(2-甲基0奎琳-3-酸基)硫代甲酸酯與1-(2- -75- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) •裝· 訂 575564 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(71 ) 甲氧基苯基)派嘻,採行如同上述實施例114相同的方 法進行反應,而可獲得上述化合物。 收成率:83%熔點:135〜136°C!H NMR(CDC13) 5 :2.82(3H?s)?3.18(4H?t)?3.79(4H?t)5 3.91(3H,s),6.88(lH,d),6.97(2H,S),7.07(lH,m),7.48(lH,t), 7.62(lH,t),7.72(lH,d),8.04(lH,d),8.63(lH,s) 實施例120) 1-[(2-甲基喳啉-3-醯基)胺基羰基]-4-(2- 鼠化苯基)σ辰嗦 將苯基Ν-(2_甲基4琳-3-醯基)硫代甲酸酯與1-(2-氟化苯基)派嗔,採行如同上述實施例114相同的方法 進行反應,而可獲得上述化合物。 收成率:84%熔點:201〜203°CiH NMR(CDCl3)5:2.84(3H,s),3.20(4H,t),3.80(4H,t)5 6.99(2H,m),7_07(2H,m),7.49(lH,t),7.62(lH,t),7.71(lH,d ),8.04(lH,d),8.62(lH,s) 實施例121) l-[(2-曱基喹啉-3-醯基)胺基羰基]-4-(2- 氯化苯基)哌嗪 將苯基N-(2-甲基喳啉-3-醯基)硫代曱酸酯與1-(2-氯化苯基)旅嘻,採行如同上述實施例1丨4相同的方法 進行反應’而可獲得上述化合物。 收成率·· 72%熔點:180〜181°C -76- (請先閲讀背面之注意事項再填寫本頁) i裝· 訂 -4 本紙張尺度適用中國國標準(CNS ) M規格公董) 經濟部中央標準局員工消費合作社印製 575564 A7 -—-— ____ B7 五、發明説明(72 ) 1H NMR(CDC13) :2.83(3H,s),3.16(4H,t),3.80(4H,t), 7.04(3H,m),7.40(lH,d),7.49(lH,t),7.63(lH,t),7.71(lH,d), 8.05(lH,d),8.62(lH,s) 實施例122) 甲基喹啉-3-醯基)胺基羰基]-4-(2- 甲基硫代苯基)旅嗔 將苯基N-(2-甲基0奎琳-3-gt基)硫代曱酸酯與1-(2-甲基硫代苯基)哌嘻,採行如同上述實施例丨丨4相同的 方法進行反應,而可獲得上述化合物。 收成率:76%Melting point: 169 ~ 170 ° C Ή NMR (CDC13) (5: 2.28 (6H, d), 2.84 (3H, s), 3.30 (4H, t), 3.76 (4H, t), 6.94 (2H, m), 7.11 (lH, t), 7.49 (lH, t), 7.63 (lH, d), (Please read the notes on the back before filling out this page) Staff of the Bureau of Standards of the Ministry of Economic Affairs t Co-printed by cooperatives 0 —mtt {In OMmmKaB — ^ f · -74 575564 5. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 _______ B7 Invention Description (7〇) 7.72 (lH, d), 8.64 (lH, s) Example 117) 1 _ [(2- Fluorenylquinoline-3-fluorenyl) aminocarbonyl] -4- (3,5-mono-gasified phenyl) group σ-Phenyl N- (2-methylquinolin-3-fluorenyl) thio The formate and 1- (3,5-difluorophenyl) piperazine were reacted in the same manner as in Example 114 above to obtain the above compound. Yield: 81% Melting point: 238 ~ 240 ° C NMR (CDC13) δ: 2.81 (3H, t), 3.34 (4H, t), 3.77 (4H, t), 6.32 (lH, t), 6_39 (2H, d), 7.49 (lH, t), 7.63 (lH, t), 7.72 (lH, d), 8.03 (lH, d), 8.58 (lH, s) Example 118) l-[(2-fluorenylquine Phenolin-3-amidino) aminocarbonyl] -4- (3,5-dichlorophenyl) piperazine Phenyl N- (2-methyl.quinolin-3-amidino) thiocarboxylic acid The ester was reacted with 1- (3,5-dichlorophenyl) piperazine in the same manner as in Example 114 above to obtain the above compound. Yield: 65% Melting point: 247 ~ 249 ° C 1H NMR (CDC13) 5: 2.79 (3H, s), 3.33 (4H, t), 3.75 (4H, t), 6.78 (2H, s), 6.87 (lH , S), 7.49 (lH, t), 7.63 (lH, t), 7.72 (lH, d), 8.56 (1H, s) Example 119) 1-[(2-methylquinolin-3-fluorenyl ) Aminocarbonyl] -4- (2-methoxyoxyphenyl) Chen Hei Phenyl N- (2-methyl0 quinine-3-acid) thioformate and 1- (2- -75 -This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling out this page) • Binding and ordering 575564 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Description of the invention (71) Methoxyphenyl) Pyrex, the same method as described in Example 114 was used to obtain the above compound. Yield: 83% Melting point: 135 ~ 136 ° C! H NMR (CDC13 ) 5: 2.82 (3H? S)? 3.18 (4H? T)? 3.79 (4H? T) 5 3.91 (3H, s), 6.88 (lH, d), 6.97 (2H, S), 7.07 (lH, m) ), 7.48 (lH, t), 7.62 (lH, t), 7.72 (lH, d), 8.04 (lH, d), 8.63 (lH, s) Example 120) 1-[(2-methylfluoroline -3-fluorenyl) aminocarbonyl] -4- (2-ratified phenyl) σ嗦 Phenyl N- (2-methyl-4-lin-3-yl) thioformate and 1- (2-fluorinated phenyl) pie were reacted in the same manner as in Example 114 above. , And the above compounds can be obtained. Yield: 84% Melting point: 201 ~ 203 ° CiH NMR (CDCl3) 5: 2.84 (3H, s), 3.20 (4H, t), 3.80 (4H, t) 5 6.99 (2H, m), 7_07 (2H, m), 7.49 (lH, t), 7.62 (lH, t), 7.71 (lH, d), 8.04 (lH, d), 8.62 (lH, s) Example 121) l-[(2-fluorenylquine Phenolin-3-amidino) aminocarbonyl] -4- (2-chlorophenyl) piperazinePhenyl N- (2-methylfluorin-3-yl) thiophosphonate and 1- (2-Chlorophenyl) Lu He, the same method as described in Examples 1 to 4 above was used to perform the reaction to obtain the above compound. Yield ·· 72% Melting point: 180 ~ 181 ° C -76- (Please read the precautions on the back before filling in this page) i Binding · Order-4 This paper size applies to China National Standard (CNS) M specifications Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 ------ ____ B7 V. Description of the invention (72) 1H NMR (CDC13): 2.83 (3H, s), 3.16 (4H, t), 3.80 (4H, t ), 7.04 (3H, m), 7.40 (lH, d), 7.49 (lH, t), 7.63 (lH, t), 7.71 (lH, d), 8.05 (lH, d), 8.62 (lH, s) Example 122) Methylquinoline-3-fluorenyl) aminocarbonyl] -4- (2-methylthiophenyl) The above-mentioned compound can be obtained by the same method as in Example 4 above for the reaction of the thio) thioester with 1- (2-methylthiophenyl) piperidine. Yield: 76%

熔點:165〜166°C lR NMR(CDCl3)(5:2.45(3H?s)?2.85(3H5s)?3.11(4H?t)? 3.79(4H,t),7.05(lH,m),7.15(3H,d),7.49(lH,t),7.63(lH,t), 7.69( lH,d),8.07(lH,d),8.62(lH,s) 實施例123) 1-[(2-甲基喹啉-3-醯基)胺基羰基]-4-(2- 曱氧基-5-甲基苯基)哌嗪 將苯基N-(2-甲基喳啉-3_醯基)硫代曱酸酯與1-(2-甲氧基-5-甲基苯基)旅α秦,採行如同上述實施例Η 4 相同的方法進行反應,而可獲得上述化合物。 收成率:80% 熔點:油狀 1H NMR(CDC13) 5 :2.30(3H,s),2.72(3H,s),3.17(4H,t), 3.70(4H,t),3.87(3H,s),6.77(lH,s),6.82(2H,s),7.73(4H,m), B.60(1H5s) 實施例124) 1-[(2-曱基喳啉-3-醯基)胺基羰基]-4-(1- -77- 本紙張尺度適用中國國家標準—(CNS ) A4規格(210X297公釐)~~ (請先閲讀背面之注意事項再填寫本頁) k裝· d 經濟部中央標準局員工消費合作社印製 575564 A7 — B7___ 五、發明説明(73 ) 秦基)旅嗔 將苯基N-(2-甲基嗜琳-3-醯基)硫代甲酸酯與1 _(1 _ 萘基)哌嗪,採行如同上述實施例114相同的方法進行 反應,而可獲得上述化合物。 收成率:64%Melting point: 165 ~ 166 ° C lR NMR (CDCl3) (5: 2.45 (3H? S)? 2.85 (3H5s)? 3.11 (4H? T)? 3.79 (4H, t), 7.05 (lH, m), 7.15 ( 3H, d), 7.49 (lH, t), 7.63 (lH, t), 7.69 (lH, d), 8.07 (lH, d), 8.62 (lH, s) Example 123) 1-[(2-A Quinoline-3-fluorenyl) aminocarbonyl] -4- (2-fluorenyl-5-methylphenyl) piperazine Phenyl N- (2-methylfluorin-3-yl) The thiophosphonate is reacted with 1- (2-methoxy-5-methylphenyl) α-qin in the same manner as in Example VII 4 above to obtain the above compound. Yield: 80% Melting point: Oily 1H NMR (CDC13) 5: 2.30 (3H, s), 2.72 (3H, s), 3.17 (4H, t), 3.70 (4H, t), 3.87 (3H, s) , 6.77 (lH, s), 6.82 (2H, s), 7.73 (4H, m), B.60 (1H5s) Example 124) 1-[(2-Amidinofluorin-3-yl) amino Carbonyl] -4- (1- -77- This paper size applies to Chinese National Standards— (CNS) A4 Specification (210X297mm) ~~ (Please read the precautions on the back before filling out this page) k Pack · d Ministry of Economy Printed by the Consumer Standards Cooperative of the Central Bureau of Standards 575564 A7 — B7___ V. Description of the invention (73) Qin Ji) The brigade mixed phenyl N- (2-methylphilin-3-methyl) thioformate with 1 _ The (1-naphthyl) piperazine can be reacted in the same manner as in Example 114 above to obtain the above compound. Yield: 64%

熔點:220〜222°C !H NMR(CDC13)5 :2.83(3H5s)?3.23(4H?t)?3.80(4H?t)? 6.91(lH,s),7.12(lH,d)57.44(lH,d),7.50(3H,m),7.61(2H, m),7.73(lH,d),7.86(lH,d),8.05(lH,d),8.23(lH,d),8.64(l H,s) 實施例125) 1-[(2-曱基4琳-3-醯基)胺基硫代羰基]- 4-(3,5-二甲氧基苯基)旅嗔 a) 將苯基N-(2-甲基η奎琳-3-醯基)硫代甲酸酯-3-胺 基-2-甲基喹啉(4g,25毫莫耳)與苯基氯化甲酸酯 (4.32g,25毫莫耳),溶解於二氯甲烷中,於室溫下攪 拌2小時。然後利用減壓濃縮將二氯曱烷予以去除後, 再利用管柱層析(乙基醋酸酯:己烧=1:2),進行分離 精製後便可獲得上述化合物。 收成率·· 78% 'H NMR(CDC13) δ :2.77(3H,s)?7.09-7.90(9H5m)?9.14 (1H,S) b) W(2_T基喹啉-3-醯基)胺基硫代羰基]-4-(3,5-二 甲氧基苯基)旅嗔 將苯基N-(2-甲基喳啉-3-醯基)硫代甲酸酯 -78- 本紙張尺度適用中國國家標準(CNS )八4規格(210X 297公釐)Melting point: 220 ~ 222 ° C! H NMR (CDC13) 5: 2.83 (3H5s)? 3.23 (4H? T)? 3.80 (4H? T)? 6.91 (lH, s), 7.12 (lH, d) 57.44 (lH , D), 7.50 (3H, m), 7.61 (2H, m), 7.73 (lH, d), 7.86 (lH, d), 8.05 (lH, d), 8.23 (lH, d), 8.64 (l H S) Example 125) 1-[(2-fluorenyl4lin-3-fluorenyl) aminothiocarbonyl]-4- (3,5-dimethoxyphenyl) bridging a) Benzene N- (2-methyletaquinine-3-amidino) thioformate-3-amino-2-methylquinoline (4g, 25 mmol) with phenyl chloride (4.32 g, 25 mmol), dissolved in dichloromethane, and stirred at room temperature for 2 hours. The dichloromethane is removed by concentration under reduced pressure, and the above compound is obtained after separation and purification by column chromatography (ethyl acetate: hexane) = 1: 2. Yield · 78% 'H NMR (CDC13) δ: 2.77 (3H, s)? 7.09-7.90 (9H5m)? 9.14 (1H, S) b) W (2-Tylquinolin-3-amidino) amino group Thiocarbonyl] -4- (3,5-dimethoxyphenyl) bridging phenyl N- (2-methylfluorin-3-yl) thioformate-78- paper size Applicable to China National Standard (CNS) 8 4 specifications (210X 297 mm)

In -------- -- (請先閱讀背面之注意事項再填寫本頁) 訂 4 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(74 ) (147mg,0.5毫莫耳)與1-(3,5_二甲氧基苯基)哌嗔 (112mg,0.5毫莫耳),溶解於無水四氫吡喃中,並添加 DBU(117mg,0.75毫莫耳)後,於室溫下攪拌2小時。 然後利用減壓濃縮將四氮σ比喃予以去除後,再利用管 柱層析(乙基醋酸酯:己烷=1:2),進行分離精製後便 可獲得上述化合物。 收成率:86%In ---------(Please read the notes on the back before filling this page) Order 4 575564 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (74) (147mg, 0.5 Mmol) and 1- (3,5_dimethoxyphenyl) piperidine (112 mg, 0.5 mmol), dissolved in anhydrous tetrahydropyran, and DBU (117 mg, 0.75 mmol) Then, it stirred at room temperature for 2 hours. The tetranitrosigma thiopyran was removed by concentration under reduced pressure, and then column chromatography (ethyl acetate: hexane = 1: 2) was used for separation and purification to obtain the above compounds. Yield: 86%

熔點:199〜200°C W NMR(CDC13) 5 :2.81(3H,s),3.35(4H,t),3.79(6H,s), 4.14(4H,t),6.07(3H,s),7.49(2H,d),7.68(2H,m),8.01 (lH,s),8.07(lH,d) 實施例126) 1-[(2-曱基α奎琳-3-醯基)胺基硫代羰基]_ 4-(3,5-二甲基苯基)旅嗔 將苯基N-(2-甲基α奎琳-3-醯基)硫代甲酸酯與1-(3,5-二甲基苯基)旅嗔,採行如同上述實施例125相同 的方法進行反應,而可獲得上述化合物。 收成率:81%Melting point: 199 ~ 200 ° CW NMR (CDC13) 5: 2.81 (3H, s), 3.35 (4H, t), 3.79 (6H, s), 4.14 (4H, t), 6.07 (3H, s), 7.49 ( 2H, d), 7.68 (2H, m), 8.01 (lH, s), 8.07 (lH, d) Example 126) 1-[(2-fluorenylαquinolin-3-amidino) aminothio Carbonyl] _ 4- (3,5-dimethylphenyl) bridging phenyl N- (2-methylαquinolin-3-amidino) thioformate with 1- (3,5- Dimethylphenyl) was reacted in the same manner as in Example 125 above to obtain the above compound. Yield: 81%

熔點:196〜197°C lH NMR(CDC13) (5 :2.27(6H?s)?2.81(3H?s)93.31(4H?t)? 4.11(4H,t),6.53(2H,s),6.58(lH,s),7.48(2H,t),7.67(2H,m), 7.96(lH,s),8.04(lH,d) 實施例127) l-[(2-甲基喳啉-3-醯基)胺基硫代羰基> 4-(3,5-二敗化苯基)旅嘻 將苯基N-(2-曱基唤琳-3 -酿基)硫代甲酸酯與1 - -79- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝· 訂 575564 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(75 ) (2,3-二氟化苯基)哌嗪,採行如同上述實施例125相同 的方法進行反應,而可獲得上述化合物。 收成率:74% 熔點·· 211 〜213°CiH NMR(CDCl3)5:2.85(3H,s),3_43(4H,t),4.22(4H,t), 6.33(2H,m),7.49(lH5t),7.64(lH,d),7.72(lH,t),8.16(2H,m ) 實施例128) l-{[2_(吡啶醯基)喹啉-4-醯基]胺基硫 代羰基]-4-(3,5-二甲氧基苯基)哌嗉 將苯基N-[2-(ab唆- 2-S篮基)甲酸酯(17 lmg,0.5毫莫 耳)與1-(3,5-二曱氧基苯基)哌嗪(iiimg,〇.5毫莫耳), 溶解於無水四氫咄喃中,並添加DBU(117mg,0.75毫 莫耳)後,於室溫下攪拌2小時。然後利用減壓濃縮將 四氫0比喃予以去除後,再利用管柱層析(二氯甲烧:甲 醇= 20:1),進行分離精製後便可獲得上述化合物。 收成率:73% 熔點:97〜98°ClH NMR(CDC13) 5 :3.34(4H?t)?3.79(6H5s)? 3.90(4H5t)? 6.07(lH,s),6.12(2H,s),7.43(lH,t),7.50(lH,t),7.68 (lH,t),7.93(lH,t),8.26(lH,d),8.59(lH,d),8.80(lH,d),8.98(lH.s) Mass(EI) m/z:5 17.3244 (MH,C31H27N503 計算值: 517.2113) 實施例129) 1 - {[2-(吡啶-3-醯基)喳啉-4-醯基]胺基幾-80- (請先閱讀背面之注意事項再填寫本頁) 1· 項再填. 裝· 訂 4 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564 Α7 Β7 五、發明説明(76 ) 基]-4-(3,5-二甲氧基苯基)派嗔 將苯基N-[2-〇b啶-3-醯基)甲酸酯(171mg,0.5毫莫 耳)與1-(3,5-二甲氧基苯基)旅嘻(1 iimg’0.5毫莫耳), 溶解於無水四氫吡喃中,並添加DBU(117mg,0_75毫 莫耳)後,於室溫下攪拌2小時。然後利用減壓濃縮將 四氫吼喃予以去除後,再利用管柱層析(二氯甲烷:甲 醇= 20:1),進行分離精製後便可獲得上述化合物。 收成率:67%Melting point: 196 ~ 197 ° C lH NMR (CDC13) (5: 2.27 (6H? S)? 2.81 (3H? S) 93.31 (4H? T)? 4.11 (4H, t), 6.53 (2H, s), 6.58 (lH, s), 7.48 (2H, t), 7.67 (2H, m), 7.96 (lH, s), 8.04 (lH, d) Example 127) l-[(2-methylpyridin-3- Amidino) aminothiocarbonyl > 4- (3,5-didecyl phenyl) --79- This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297mm) (Please read the notes on the back before filling out this page)-Binding · 575564 A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Preparation 5. Description of the invention (75) (2,3-difluorophenyl) piperazine was reacted in the same manner as in Example 125 above to obtain the above compound. Yield: 74% Melting point 211 ~ 213 ° CiH NMR (CDCl3) 5: 2.85 (3H, s), 3_43 (4H, t), 4.22 (4H, t), 6.33 (2H, m), 7.49 (lH5t ), 7.64 (lH, d), 7.72 (lH, t), 8.16 (2H, m) Example 128) l-{[2_ (pyridinyl) quinolin-4-amidino] aminothiocarbonyl] 4- (3,5-Dimethoxyphenyl) piperidine is a phenyl N- [2- (ab 唆 -2-S-basket) formate (17 lmg, 0.5 mmol) and 1- (3,5-Dioxophenyl) piperazine (iiimg, 0.5 mmol), dissolved in anhydrous tetrahydrofuran, and added DBU (117 mg, 0.75 mmol) at room temperature Stir for 2 hours. The tetrahydro-0-bifuran was removed by concentration under reduced pressure, and then column chromatography (dichloromethane: methanol = 20: 1) was used for separation and purification to obtain the above compounds. Yield: 73% Melting point: 97 ~ 98 ° ClH NMR (CDC13) 5: 3.34 (4H? T)? 3.79 (6H5s)? 3.90 (4H5t)? 6.07 (lH, s), 6.12 (2H, s), 7.43 (lH, t), 7.50 (lH, t), 7.68 (lH, t), 7.93 (lH, t), 8.26 (lH, d), 8.59 (lH, d), 8.80 (lH, d), 8.98 ( lH.s) Mass (EI) m / z: 5 17.3244 (MH, C31H27N503 calculated: 517.2113) Example 129) 1-{[2- (pyridin-3-amidino) pyridin-4-amidino] amine Jiji-80- (Please read the precautions on the back before filling this page) 1. Fill in the items again. Binding · Order 4 This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) 575564 Α7 Β7 5. DESCRIPTION OF THE INVENTION The (76) yl] -4- (3,5-dimethoxyphenyl) pyridine is a phenyl N- [2-〇bpyridin-3-amidino) formate (171 mg, 0.5 mmol) Ear) and 1- (3,5-dimethoxyphenyl) Luhe (1 imimg'0.5 mmol), dissolved in anhydrous tetrahydropyran and added DBU (117 mg, 0_75 mmol) , And stirred at room temperature for 2 hours. Then, the tetrahydrohydrofuran was removed by concentration under reduced pressure, and then column chromatography (dichloromethane: methanol = 20: 1) was used for separation and purification to obtain the above compounds. Yield: 67%

熔點:95〜96°C 'H NMR(CDC13)5 :3.36(4H5t)53.87(6H5s)5 3.90(4H?t)? 6.08(1 H,s),6.12(2H,s),7.50(lH,t),7_71(lH,t),7.93 (lH,t),8.25(lH,d),8.53(lH,d),8.67(lH,s),8.73(lH,d), 9.53(1H.s) 貫施例130) 1 - {[2-(噻嗪-2-醯基)喹啉-4-醯基]胺基羰 基]-4-(3,5-二曱氧基苯基)哌嗪 將苯基N_[2-(噻嗪-2-醯基)甲酸酯(l73mg,0.5毫莫 耳)與1-(3,5-—甲氧基苯基)旅σ秦(11 img,0.5毫莫耳), 經濟部中央標準局員工消費合作社印製 -«批衣-- (請先閲讀背面之注意事項再填寫本頁) 溶解於無水四氫η比喃中,並添加DBU(117mg,0.75毫 莫耳)後,於室溫下攪拌2小時。然後利用減壓濃縮將 四氫吼喃予以去除後,再利用管柱層析(乙基醋酸酯: 己烧=1:1),進行分離精製後便可獲得上述化合物。 收成率:61% 熔點:油狀 'H NMR(CDC13) δ :3.37(4H5t)?3.59(6H5s)? 3.97(4H?t), -81 - 本紙張尺度適用中國ϋ標準(CNS ) A4規格(2ϋ公釐)一--—Melting point: 95 ~ 96 ° C 'H NMR (CDC13) 5: 3.36 (4H5t) 53.87 (6H5s) 5 3.90 (4H? T)? 6.08 (1 H, s), 6.12 (2H, s), 7.50 (lH, t), 7_71 (lH, t), 7.93 (lH, t), 8.25 (lH, d), 8.53 (lH, d), 8.67 (lH, s), 8.73 (lH, d), 9.53 (1H.s ) Example 130) 1-{[2- (thiazin-2-fluorenyl) quinolin-4-fluorenyl] aminocarbonyl] -4- (3,5-dioxophenyl) piperazine Phenyl N_ [2- (thiazin-2-fluorenyl) formate (173 mg, 0.5 mmol) and 1- (3,5--methoxyphenyl) sigma (11 img, 0.5 Millions), printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs-«batch of clothing-(Please read the precautions on the back before filling out this page) Dissolved in anhydrous tetrahydron πan, and added DBU (117mg, 0.75 mmol), and stirred at room temperature for 2 hours. Then, the tetrahydrofuran was removed by concentration under reduced pressure, and then the same was obtained after separation and purification by column chromatography (ethyl acetate: hexane = 1: 1). Yield: 61% Melting point: Oily 'H NMR (CDC13) δ: 3.37 (4H5t)? 3.59 (6H5s)? 3.97 (4H? T), -81-This paper is in accordance with the Chinese Standard (CNS) A4 ( 2ϋmm) a ---

7.01(3H,m),7.49(lH,t),7.69(lH,t),7.93(lH,t), 8.20 (lH,d),8.52(lH,d),8.64(iH,s),8.7l(lH,s),9.53(lH,s) 實施例131) l-{[2-(吡啶-3_醯基)喳啉_4_醯基]胺基幾 基]-4-(3,5-二甲基苯基)派嗪 將苯基N_[2十比啶_3_醯基)甲酸酯U71mg,0.5毫莫 耳)與1-(3,5- 一甲基苯基)派嗪(95mg,0.5毫莫耳),溶 解於無水四氳咄喃中,並添加DBU(117mg,0.75毫莫 耳)後,於室溫下攪拌2小時。然後利用減壓濃縮將四 氫吼喃予以去除後,再利用管柱層析(乙基醋酸酯:己 烧=1:1),進行分離精製後便可獲得上述化合物。 收成率:64%7.01 (3H, m), 7.49 (lH, t), 7.69 (lH, t), 7.93 (lH, t), 8.20 (lH, d), 8.52 (lH, d), 8.64 (iH, s), 8.7 l (lH, s), 9.53 (lH, s) Example 131) l-{[2- (pyridin-3_fluorenyl) fluorin-4-4-fluorenyl] aminochiridyl] -4- (3, 5-Dimethylphenyl) PyrazinePhenyl N_ [2 decapyridin_3_fluorenyl) formate U71mg, 0.5 mmol) and 1- (3,5-monomethylphenyl) pie Azine (95 mg, 0.5 mmol) was dissolved in anhydrous tetramethylfuran, and DBU (117 mg, 0.75 mmol) was added, followed by stirring at room temperature for 2 hours. After the tetrahydrofuran was removed by concentration under reduced pressure, column chromatography (ethyl acetate: hexane = 1: 1) was used for separation and purification to obtain the above compounds. Yield: 64%

熔點:211〜213°C lU NMR(CDC13) δ :2.31(6H?s)?3.32(4H5t)? 3.85(4H?t)? 6.6l(3H,s),7.47(lH,t),7.55(lH,t),7_72(lH,t),7.86 (lH,t),8.25(lH,d),8.53(lH,d),8.66(lH,s),8.72(lH,d), 9.37(lH.s) 本發明所提供結構式(1)化合物中,當Y係為-NR 情況時,可依照下列方程式Π進行製造而得。 (請先閱讀背面之注意事項再填寫本頁) -裝· 訂 經濟部中央標準局員工消費合作社印製Melting point: 211 ~ 213 ° C lU NMR (CDC13) δ: 2.31 (6H? S)? 3.32 (4H5t)? 3.85 (4H? T)? 6.6l (3H, s), 7.47 (lH, t), 7.55 ( lH, t), 7-72 (lH, t), 7.86 (lH, t), 8.25 (lH, d), 8.53 (lH, d), 8.66 (lH, s), 8.72 (lH, d), 9.37 (lH .s) In the case of the compound of the formula (1) provided by the present invention, when Y is -NR, it can be prepared according to the following equation Π. (Please read the precautions on the back before filling out this page)-Binding and printing Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

R 8 providing agent -82- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564R 8 providing agent -82- This paper size applies to China National Standard (CNS) A4 (210X297 mm) 575564

經 濟 部 中 標 準 消 f 合 作 社 印 製Printed by the Ministry of Economic Affairs, the Standard Consumer Council

Ri,R2,R3,R4,R5,R6,r?,R8,a,X5Z#^qi “在上述結構式㈤所示化合物申’採用R“共給為 樂,便可有效的製造結構式(lb)。 在該反應中所採用的Rs供給試藥,係指^一心的 低級烷基鹵化物、C1—Cs的低級烷基磺酸酯類、 的取代或非取代環烷基鹵化物、芳基_化物'、q3— 取代或非取代環烷基磺酸酯類、芳基磺酸酯類等。8而 所4 CrC8低級烷基鹵化物,係指氯化甲烷、溴化甲 烷、碘化甲烷、氯化乙烷、溴化乙烷、碘化乙烷、氯 化丁烷、溴化丁烷、碘化丁烷、氯化戊烷、溴化戊烷 蛾化戊烷、乙基溴化醋酸酯等。 所謂CrCg低級烧基績酸酯類,係指甲基績酸醋、 乙基磺酸酯、丙基磺酸酯、丁基磺酸酯、戊基碏酸酯 等。 ’、 所謂CfC8取代或非取代環烧基_化物,係指氯化 環丙烷、溴化環丙烷、碘化環丙烷、氯化環丁烷、溴 化環丁烷、碘化環丁烷、氯化環戊烷、溴化環戊烷、 -83- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)Ri, R2, R3, R4, R5, R6, r?, R8, a, X5Z # ^ qi "The compound shown in the above structural formula 申 applies" R "for mutual enjoyment, and the structural formula can be efficiently produced ( lb). The Rs supply reagent used in this reaction refers to the lower alkyl halides, C1-Cs lower alkyl sulfonates, substituted or unsubstituted cycloalkyl halides, and aryl radicals. ', Q3 — substituted or unsubstituted cycloalkyl sulfonates, aryl sulfonates and the like. 8 and 4 CrC8 lower alkyl halides refer to methylene chloride, bromide, iodide methane, ethane chloride, ethane bromide, ethane iodide, butane chloride, butane bromide, Butane iodide, pentane chloride, pentane bromide, pentane bromide, ethyl bromide acetate, and the like. The CrCg lower alkyl esters refer to methyl acetic acid, ethyl sulfonate, propyl sulfonate, butyl sulfonate, pentyl sulfonate, and the like. ', The so-called CfC8 substituted or unsubstituted cycloalkyl group refers to cyclopropane chloride, brominated cyclopropane, iodinated cyclopropane, cyclobutane chloride, brominated cyclobutane, cyclobutane iodide, chlorine Cyclopentane, brominated cyclopentane, -83- This paper size applies to China National Standard (CNS) A4 (210X297 mm)

經濟部中央標準局員工消費合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

575564 ' '^— ____ ________ B7 五、發明説明(79 ) 碘化環戊烷、氯化環己烷、溴化環己烷、碘化環己烷 虱化甲基環丙烷、溴化甲基環丙烷、碘化甲基環丙烷、 氯化甲基環丁烷、溴化甲基環丁烷、碘化甲基環丁烷、 氯化甲基環戊烷、溴化甲基環戊烷、碘化甲基環戊烷、 氯化甲基環己烷、溴化甲基環己烷、碘化甲基環己烷 等0 ^所謂芳基函化物,係指氯化苄、溴化苄、碘化苄、 氯化苯甲醯、溴化苯甲醯、碘化苯甲醯、氯化甲苯甲 fc、溴化甲苯甲醯、石典化甲苯甲醯等。 所謂CfC8取代或非取代環烷基磺酸酯類,係指環 丙基%酸酯、環丁基磺酸酯、環吩噻基磺酸酯、環己 基績酸S旨、甲基環丙基、甲基環了基場酸醋、 甲基環吩噻基磺酸酯、甲基環己基磺酸酯等。 所謂芳基磺酸酯類,係指苄基磺酸酯、苯甲醯基 磺酸酯、甲苯甲醯基磺酸酯等。 將上述構造式(la)所示化合物,以及烷基類、芳 基化劑,溶解於二甲基甲醯胺等溶劑中,並於25〜8〇 °c之溫度範圍内’施行30分鐘〜2〇小時的反應,便可 獲得屬於目的化合物的結構式⑴所示化合物。其中, 燒基類、芳基化劑的有效量為1〇當量起至15當量 為止。 在省反應中,通常所採用的有機溶劑,係最好使 用諸如四氫吡喃、二氯"完、乙腈、二甲基甲醯胺等。 上述反應物中,當反應進行之際,產生酸性物質575564 '' ^ — ____ ________ B7 V. Description of the Invention (79) Cyclodane iodide, cyclohexane chloride, cyclohexane bromide, cyclohexane iodide, methylcyclopropane, bromomethyl ring Propane, methylcyclopropane iodide, methylcyclobutane chloride, methylcyclobutane bromide, methylcyclobutane iodide, methylcyclopentane chloride, methylcyclopentane bromide, iodine ^ Methylcyclopentane, methylcyclohexane chloride, methylcyclohexane bromide, methylcyclohexane iodide, etc. ^ The so-called aryl functional compounds refer to benzyl chloride, benzyl bromide, iodine Benzyl chloride, benzamidine chloride, benzamidine bromide, benzamidine iodide, toluidine chloride fc, toluidine bromide, petrolatum toluene, and the like. The so-called CfC8 substituted or unsubstituted cycloalkylsulfonic acid esters refer to cyclopropyl% acid ester, cyclobutylsulfonic acid ester, cyclophenothiylsulfonic acid ester, cyclohexylsulfonic acid, methylcyclopropyl, The methyl ring has a base acid vinegar, a methyl ring phenothisulfonate, a methyl cyclohexyl sulfonate, and the like. The aryl sulfonates refer to benzyl sulfonate, benzamidine sulfonate, toluenyl sulfonate and the like. Dissolve the compound represented by the above structural formula (la), and the alkyl group and the arylating agent in a solvent such as dimethylformamide, and perform the operation for 30 minutes at a temperature range of 25 to 80 ° C. By reacting for 20 hours, a compound represented by the formula VII belonging to the target compound can be obtained. Among them, the effective amount of the calcining group and the arylating agent is from 10 equivalents to 15 equivalents. In the provincial reaction, the organic solvents generally used are preferably tetrahydropyran, dichlorin, acetonitrile, dimethylformamide and the like. When the reaction proceeds, an acidic substance is generated as the reaction proceeds.

本紙張尺度適财 575564 X- A7 發明説明(8() 氫氧化鈣、氫氧化鎂、基巧物係;^如氫氧化鈉、氫氧物、 碳酸鎂、重碳酸、乳化約、奴_、碳_、碳酸鉀、 化物、氧化物、碳酸^^納、重碳酸鉀等驗金屬或驗土金屬的氳氧 進行反應進行者為^^重碳酸鹽,以及有機胺基系統的鹼基存在下, 實施例 (請先閲讀背面之注意事項再填寫本頁} 依^^法,而可製得下列化合物The paper size is 575564 X-A7. Description of the invention (8 () Calcium hydroxide, magnesium hydroxide, basic materials; ^ Such as sodium hydroxide, hydroxide, magnesium carbonate, bicarbonate, emulsification, Carbon, potassium carbonate, compounds, oxides, sodium carbonate, sodium bicarbonate, potassium bicarbonate, and other metal-testing metals or soil-testing metals are reacted by ^^ bicarbonate, and the presence of bases in organic amine-based systems Example (Please read the precautions on the back before filling out this page} According to ^^ method, the following compounds can be prepared

經濟部中央標準局員工消費合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

Et Et e Μ e Μ 44 45Et Et e Μ e Μ 44 45

139 140 141 Me Me Me Me Me Me 142 Me Me 143 Me Et 本紙張尺度適用中國國家標準(CNS ) Α4規格U10X297公釐) 575564139 140 141 Me Me Me Me Me 142 Me Me 143 Me Et This paper size applies to Chinese National Standard (CNS) Α4 size U10X297 mm) 575564

A B 五、發明説明(81 經濟部中央標準局員工消費合作社印製A B V. Description of Invention (81 Printed by Staff Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs

實施例 編號 Rr R-2 1 ^ rV / 1 Flc j R? Rs | A I j ! x ! z y ! i 146 Me nPr I-I OMe H OMe H Me N 0 OMe 3-N 147 Et Me H 〇Me H OMe H Me N 〇 OMe 3-N 148 nPr Me I-I OMe H OMe H Me N 〇 OMe 3-N 149 Me Ac H OMe H OMe H Me N 〇 OMe 3-N 150 Me Ac I-I OMe I-I OMe H Et N 〇 OMe 3-N 151 Me Ac H Me H Me H Me N 〇 OMe 3-N 152 Me I-I OMe H OMe H Me N 〇 OMe 3-N 153 Me OH 人 H OMe H OMe H Et N 〇 OMe 3-N 154 Me OH I-I Me H Me H · Me N 〇 OMe 3-N 155 Me \ OH 乂 H OMe H OMe H Me N 〇 OMe 3-N 156 Me \ OH \X I-I Me H Me H Me N . 〇 OMe 13-N j 157 Me 0CH-, 人 H OMe H OMe H Me N 〇 1 OMe 3-N 158〆 Me Vinyl H OMe H OMe H Me N 〇 OMe 3-N I 159 Me Vinyl H Me H Me H Me N 〇 OMe -1 3-N 160 Me Vinyl H OMe H OMe H Et N 〇 OMe 3-N 161 Me 人 H OMe H OMe H Me N 〇 OMe 3-N 162 Me 人 H Me H Me H Me N 〇 OMe 3-N 163 Me Ac I-I OMe H OMe H 0 CH?t'〇Et N 〇' OMe 3-N 164 Me Ac I-I Me H Me H 0 CH?f〇Et N 〇 1— OMe 3-N 165 Me Ac H OMe H OMe H 0 CH2i'〇H N 〇 OMe 3-N 166 Me OH I-I OMe H OMe H 0 CH?f〇E 1 N 〇 OMe 3-N 167 Me H OMe H OMe H 0 CH^'OH N 〇 OMe 3-N 168 Me OH H Me H Me H 0 CH2t'〇Et N 〇 OMe 3-N 169 Me H Me , H Me H 0 ch/oh N 〇 OMe 3-N -86 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 575564 A7 B7 五 '發明説明( 82 實施例132) 1-[Ν-(5,6-二甲基_2-甲氧基吡啶_3_醯 基)-Ν_甲基胺基幾基]_4_(3,5_二甲氧基苯基)派嗪 將1-[(5,6-二甲基_2_甲氧基吡啶_3_醯基)胺基羰 基]-4-(3,5-二甲氧基苯基)旅嘻(i〇〇mg,〇_25毫莫耳), 溶解於二甲基甲醯胺(15ml)中,並添加氫化鈉 (6.0mg,0.25毫莫耳)後,於室溫下攪拌ι5分鐘後,再 添加蛾化甲烧(3 5mg,0.25毫莫耳),且於室溫下攪拌 16小日^。然後利用減壓濃縮將二甲基甲酸胺予以去除 後’再利用管柱層析(乙基醋酸酯··己烷=丨:2),進行 分離精製後便可獲得上述化合物。 收成率:94% 熔點:油狀物 W NMR(CDCl3)(5:2.17(3H,s),2.38(3H,s),2.92(4H,t), 3.〇4(3H5S),3.29(4H,t),3.74(6H,S),3.96(3H,S),6.00(3H,m), 7.08(1H9s) ? 實施例133) l-[N-(5,6-二甲基-2-甲氧基吡啶-3·醯 基)-Ν-乙基胺基羰基]-4-(3,5_二曱氧基苯基)哌嗪 將[(5,6-一曱基-2-曱氧基。比咬_3-St基)胺基幾 經濟部中央標準局員工消費合作社印製Example number Rr R-2 1 ^ rV / 1 Flc j R? Rs | AI j! X! Zy! I 146 Me nPr II OMe H OMe H Me N 0 OMe 3-N 147 Et Me H 〇Me H OMe H Me N 〇OMe 3-N 148 nPr Me II OMe H OMe H Me N 〇OMe 3-N 149 Me Ac H OMe H OMe H Me N 〇OMe 3-N 150 Me Ac II OMe II OMe H Et N 〇OMe 3 -N 151 Me Ac H Me H Me H Me N 〇OMe 3-N 152 Me II OMe H OMe H Me N 〇OMe 3-N 153 Me OH human H OMe H OMe H Et N 〇OMe 3-N 154 Me OH II Me H Me H · Me N 〇OMe 3-N 155 Me \ OH 乂 H OMe H OMe H Me N 〇OMe 3-N 156 Me \ OH \ X II Me H Me H Me N. 〇OMe 13-N j 157 Me 0CH-, human H OMe H OMe H Me N 〇1 OMe 3-N 158〆Me Vinyl H OMe H OMe H Me N 〇OMe 3-NI 159 Me Vinyl H Me H Me H Me N 〇OMe -1 3 -N 160 Me Vinyl H OMe H OMe H Et N 〇OMe 3-N 161 Me human H OMe H OMe H Me N 〇OMe 3-N 162 Me human H Me H Me H Me N 〇OMe 3-N 163 Me Ac II OMe H OMe H 0 CH? T'〇Et N 〇 'OMe 3-N 164 Me Ac II Me H Me H 0 CH? F〇Et N 〇1— OMe 3-N 165 Me Ac H OMe H OMe H 0 CH2i'〇HN 〇OMe 3-N 166 Me OH II OMe H OMe H 0 CH? F〇E 1 N 〇OMe 3-N 167 Me H OMe H OMe H 0 CH ^ 'OH N 〇OMe 3-N 168 Me OH H Me H Me H 0 CH2t' 〇Et N 〇OMe 3-N 169 Me H Me, H Me H 0 ch / oh N 〇OMe 3-N -86 (Please read the precautions on the back before filling out this page) This paper size applies to Chinese national standards (CNS ) A4 specification (210X 297 mm) 575564 A7 B7 Five 'invention description (82 Example 132) 1- [N- (5,6-dimethyl_2-methoxypyridine_3_fluorenyl) -N _Methylaminojiroyl] _4_ (3,5_dimethoxyphenyl) pyrazine 1-[(5,6-dimethyl_2_methoxypyridine_3_fluorenyl) amino Carbonyl group] -4- (3,5-dimethoxyphenyl) brittle (100 mg, 0-25 mmol), dissolved in dimethylformamide (15 ml), and sodium hydride was added (6.0 mg, 0.25 mmol), and then stirred at room temperature for 5 minutes, then add moth tofu (35 mg, 0.25 mmol), and stir at room temperature for 16 hours ^. Then, the dimethyl dimethylformate was removed by concentration under reduced pressure, and then the column was subjected to column chromatography (ethyl acetate · hexane = 丨: 2), and the compound was obtained after separation and purification. Yield: 94% Melting point: Oily matter NMR (CDCl3) (5: 2.17 (3H, s), 2.38 (3H, s), 2.92 (4H, t), 3.04 (3H5S), 3.29 (4H , T), 3.74 (6H, S), 3.96 (3H, S), 6.00 (3H, m), 7.08 (1H9s)? Example 133) l- [N- (5,6-dimethyl-2- Methoxypyridine-3 · fluorenyl) -N-ethylaminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine [(5,6-monofluorenyl-2-fluorene Oxygen-specific bite _3-St-based) Amine-based printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

(請先閱讀背面之注意事項再填寫本百C d 基]-4-(3,5-二曱氧基苯基)旅口秦(1〇〇11^,〇.25毫莫耳), 浴解於二曱基曱醯胺(15ml)中,並添加氳化鈉(6〇mg, 0.25毫莫耳)後,於室溫下攪拌15分鐘後,再添加碘 化曱:1:兀(39.211^,〇.25毫莫耳),且於室溫下攪拌16小 日守。然後利用減壓濃縮將二曱基甲醯胺予以去除後, 再利用管柱層析(乙基醋酸酯:己烷=丨:2),進行分離 私紙張尺度適用中國國家冗(CNS) -87- 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(Μ ) 83 精製後便可獲得上述化合物。 收成率:86% 熔點:油狀物 !H NMR(CDC13) δ :l.〇8(3H?t)?2.04(3H?s)?2.38(3H?s)5 2.90(4H,t),3.26(4H,t),3.52(2H,q),3.74(6H,s),5.99(3H,m), 7.06(1H,s) 實施例134) 1-[1^-(5,6-二甲基-2-曱氧基吡啶-3_醯 基)-N-丙基胺基羰基]-4-(3,5-二曱氧基苯基)哌嗪 將1-[(5,6-二曱基-2-甲氧基吡啶-3-醯基)胺基羰 基]-4-(3,5-二甲氧基苯基)口辰嗔(i〇〇mg,〇.25毫莫耳), 溶解於二曱基曱醯胺(15ml)中,並添加氫化鈉(6.〇mg, 0.25毫莫耳)後,於室溫下攪拌15分鐘後,且於室溫 下攪拌16小時。然後利用減壓濃縮將二曱基甲醯胺予 以去除後,再利用管柱層析(乙基醋酸酯:己烧=1:2), 進行分離精製後便可獲得上述化合物。 收成率·· 78% 熔點:油狀物 W NMR(CDCl3)6:1.13(6H,d),2.19(3H,s),2.38(3H,s), 2.82(4H,t),3.26(4H,t),3.74(6H,s),3.89(3H,s),4.27(lH,m), 6.06(lH,s),6.10(2H,d),7.07(lH,s),8.14(lH,s)(Please read the precautions on the back before filling in this hundred C d group] -4- (3,5-dimethoxyphenyl) Lvkou Qin (10011 ^, 0.25 mmol), bath Dissolve in diamidinofluorene (15ml), add sodium sulfide (60mg, 0.25mmol), and stir at room temperature for 15 minutes, then add iodide iodide: 1: wood (39.211) ^, 0.25 millimoles), and stirred at room temperature for 16 hours. Then dichloromethane was removed by concentration under reduced pressure, and then column chromatography (ethyl acetate: hexane) was used. Alkane = 丨: 2), for separation of private paper. Applicable to China National Redundancy (CNS) -87- 575564 Printed by A7 B7, Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs. 5. Description of the Invention (M) 83 The above compounds can be obtained after purification. Yield: 86% Melting point: oily! H NMR (CDC13) δ: 1.08 (3H? T)? 2.04 (3H? S)? 2.38 (3H? S) 5 2.90 (4H, t), 3.26 (4H, t), 3.52 (2H, q), 3.74 (6H, s), 5.99 (3H, m), 7.06 (1H, s) Example 134) 1- [1 ^-(5,6- 二Methyl-2-methoxypyridin-3-yl) -N-propylaminocarbonyl] -4- (3,5-dioxophenyl) piperazine 1-[(5,6- Dimethyl 2-methoxypyridin-3-fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) hydrazone (100 mg, 0.25 mmol), dissolved in Dimethylfluorenamine (15 ml) was added with sodium hydride (6.0 mg, 0.25 mmol), and the mixture was stirred at room temperature for 15 minutes and then at room temperature for 16 hours. Then, dimethylformamide is removed by concentration under reduced pressure, and then column chromatography (ethyl acetate: hexane = 1: 2) is used for separation and purification to obtain the above compound. Yield: 78% Melting point: oily matter W NMR (CDCl3) 6: 1.13 (6H, d), 2.19 (3H, s), 2.38 (3H, s), 2.82 (4H, t), 3.26 (4H, t), 3.74 (6H, s), 3.89 (3H, s), 4.27 (lH, m), 6.06 (lH, s), 6.10 (2H, d), 7.07 (lH, s), 8.14 (lH, s )

Mass(EI) m/z:442.2538 (MH,C24H34N404 計算值: 442.2580) 貫施例135)卜[N-(5,6-二甲基-2-甲氧基η比唆-3-酸 基)_N_甲基胺基羰基]_4-(3,5-二甲基苯基)呢嗪 -88- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) ^^衣· —. 575564 A7 B7 經濟部中央標準局員工消費合作社印製 1、發明説明(84 ) 將1-[(5,6-二甲基-2-甲氧基吡啶-3-醯基)胺基羰 基]-4-(3,5-二甲基苯基)哌嗉,採行如同上述實施例132 相同的方法進行反應,而可獲得上述化合物。收成率:97% 熔點:油狀 1H NMR(CDC13)占:2-15(6H,S),2.23(3H,S),2.37(3H,s), 2.89(4H,t),3.04(3H,s),3.30(4H,t),3.97(3H,s),6.46(3H,m), 7.08(1H,s) 貫施例136) WN-(5,6-二曱基-2-甲氧基吡啶-3-醯 基)-Ν-甲基胺基羰基]_4_(3,5_二甲氧基苯基)旅嗪 將1-[(5,6-二甲基-2-甲氧基咄啶_3_醯基)胺基羰 基]-4-(3,5-二甲氧基苯基)旅嗪,採行如同上述實施例 132相同的方法進行反應,而可獲得上述化合物。 收成率:94% 熔點:131〜132°C H NMR(CDC13) 5 :2.16(3H,s),2.38(3H,s),2_80(4H,t), 3-〇5(3H?s)53.05(4H?t)53.82(3H?s)53.97(3H?s)?6.83(4H5m)? 7.08(1H?s)實施例137) l-[N-(5,6-二甲基_2-甲氧基吡啶-3_醯基)-N-乙基胺基羰基]_4_(2_甲氧基笨基)哌嗉 將1-[(5,6-二甲基-2-甲氧基吡啶醯基)胺基羰 基]4-(2-甲氧基苯基)派嗔,採行如同上述實施例us 相同的方法進行反應,而可獲得上述化合物。收成率:87%-89- 本紙張尺度適财關家轉(CNS)从驗(21()><297公羡) (請先閱讀背面之注意事項再填寫本頁) ;衣· 訂 d 575564 A7 B7 經濟、部中央榡準局員工消費合作社印製 五、發明説明(85 ) 熔點:112〜113°C 4 NMR(CDC13) (5 :1.08(3H,t),2.16(3H,s),2.38(3H,s), 2.77(3H,s),3.31(4H,t),3.58(2H,q),3.81(3H,s),3.96(3H,s),6.88(lH,m),7.06(lH,s) 實施例13 8) 1-[N-苄基-N-(5,6-二甲基-2-甲氧基吡啶 -3-醯基)胺基羰基]-4-(2-甲氧基苯基)哌嗪 將1 -[(5,6-二甲基-2-甲氧基ϋ比唆-3-驢基)胺基罗炭 基]-4-(2 -曱氧基苯基)旅嗔(1 〇〇mg,0_27毫莫耳),溶解 於二甲基甲醯胺(15ml)中,並添加氫化鈉(6.5mg,0.27 毫莫耳)後,於室溫下攪拌16小時後,施行減壓濃縮, 並利用管柱層析(乙基醋酸酯:己烷=1:2),進行分離 精製後便可獲得上述化合物。 收成率:93% 熔點:油狀物 'H NMR(CDC13)(5 :2.08(3H5s)52.35(3H?s)?2.85(4H?t)? 3.32(4H,t),3.8 1 (3H,s),3.96(3H,s),4.76(2H,s),6.96(4H,m),7.41(5H,m) 實施例139) 1-[N-環丙基曱基-N-(5,6-二曱基i甲氧 基吡啶-3-醯基)胺基羰基]_4_(2_曱氧基苯基)哌嗪 將1 - [(5,6-一甲基-2 -曱氧基。比咬-3-酸基)胺基幾 基]-4-(2_甲氧基苯基)旅嗉(1〇〇mg,〇26毫莫耳),溶解 於二甲基甲醯胺(15ml)中,並添加氫化鈉(6.2mg,0.20 毫莫耳)後,於室溫下攪拌15分鐘後,再添加溴化甲 基環丙烷(21.8mg,0.26毫莫耳),且於室溫下攪拌16 (請先閱讀背面之注意事項再填寫本頁) :裝· 訂 4 -90- 575564 A7 B7 五、發明説明(86 ) 小時。然後利用減壓濃縮將二甲基甲醯胺予以去除後, 再利用管柱層析(乙基醋酸酯:己烷=1:2),進行分離 精製後便可獲得上述化合物。 收成率:78% 熔點:油狀物 iH NMR(CDCl3)5:0.34(2H,m),0.49(2H,m),1.35(lH,m), 2.85(4H,t),3.28(4H,t),3.40(2H,S),3_89(3H,S),3.97(3H,S), 6.97(4H,m),7.11(lH,s) 實施例140) 1-[Ν-(5,6-二曱基-2-甲氧基吡啶-3-醯 基)-N-甲基胺基羰基>4-(5_曱氧基-2_曱基苯基)哌嗪 將1 - [(5,6-二甲基-2-甲氧基吼σ定-3-醯基)胺基幾 基]-4-(5-甲氧基-2-甲基苯基)哌嗪,採行如同上述實施 例132相同的方法進行反應,而可獲得上述化合物。 收成率:74%Mass (EI) m / z: 442.2538 (MH, C24H34N404 Calculated: 442.2580) Example 135) [N- (5,6-dimethyl-2-methoxyeta ratio fluoren-3-acid group) _N_Methylaminocarbonyl] _4- (3,5-dimethylphenyl) neazine-88- This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) (Please read the note on the back first Please fill in this page for more information) ^^ 衣 · —. 575564 A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 1. Description of the invention (84) Will be 1-[(5,6-dimethyl-2-methoxy The pyridine-3-amidino) aminocarbonyl] -4- (3,5-dimethylphenyl) piperidine was reacted in the same manner as in Example 132 above to obtain the above compound. Yield: 97% Melting point: Oily 1H NMR (CDC13) Occupation: 2-15 (6H, S), 2.23 (3H, S), 2.37 (3H, s), 2.89 (4H, t), 3.04 (3H, s), 3.30 (4H, t), 3.97 (3H, s), 6.46 (3H, m), 7.08 (1H, s) (Example 136) WN- (5,6-diamidino-2-methoxy Pyridin-3-amidino) -N-methylaminocarbonyl] -4_ (3,5-dimethoxyphenyl) travelazine 1-[(5,6-dimethyl-2-methoxy The pyridine_3_fluorenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) trazine can be reacted in the same manner as in Example 132 above to obtain the above compound. Yield: 94% Melting point: 131 ~ 132 ° CH NMR (CDC13) 5: 2.16 (3H, s), 2.38 (3H, s), 2-80 (4H, t), 3-〇5 (3H? S) 53.05 ( 4H? T) 53.82 (3H? S) 53.97 (3H? S)? 6.83 (4H5m)? 7.08 (1H? S) Example 137) l- [N- (5,6-dimethyl_2-methoxy Pyridyl-3_fluorenyl) -N-ethylaminocarbonyl] -4_ (2-methoxybenzyl) piperidine 1-[(5,6-dimethyl-2-methoxypyridinyl) ) Aminocarbonyl] 4- (2-methoxyphenyl) pyridine, which can be reacted in the same manner as in Example us above to obtain the above compound. Yield: 87% -89- The paper size is suitable for wealth management (CNS) inspection (21 () > < 297 public envy) (Please read the precautions on the back before filling this page); d 575564 A7 B7 Printed by the Consumers' Cooperative of the Central Government Bureau of the Ministry of Economic Affairs and Ministry of Foreign Affairs 5. Description of the invention (85) Melting point: 112 ~ 113 ° C 4 NMR (CDC13) (5: 1.08 (3H, t), 2.16 (3H, s ), 2.38 (3H, s), 2.77 (3H, s), 3.31 (4H, t), 3.58 (2H, q), 3.81 (3H, s), 3.96 (3H, s), 6.88 (lH, m) , 7.06 (lH, s) Example 13 8) 1- [N-benzyl-N- (5,6-dimethyl-2-methoxypyridin-3-amidino) aminocarbonyl] -4- (2-methoxyphenyl) piperazine will be 1-[(5,6-dimethyl-2-methoxypyridinium-3-donyl) aminocarbanyl] -4- (2- (Methoxyphenyl) hydrazone (100 mg, 0-27 mmol), dissolved in dimethylformamide (15 ml), and sodium hydride (6.5 mg, 0.27 mmol) was added to the chamber. After stirring at room temperature for 16 hours, the solution was concentrated under reduced pressure, and column chromatography (ethyl acetate: hexane = 1: 2) was used for separation and purification to obtain the above compound. Yield: 93% Melting point: Oily substance 'H NMR (CDC13) (5: 2.08 (3H5s) 52.35 (3H? S)? 2.85 (4H? T)? 3.32 (4H, t), 3.8 1 (3H, s ), 3.96 (3H, s), 4.76 (2H, s), 6.96 (4H, m), 7.41 (5H, m) Example 139) 1- [N-cyclopropylfluorenyl-N- (5,6 -Difluorenyl imethoxypyridin-3-fluorenyl) aminocarbonyl] -4- (2-fluorenylphenyl) piperazine will be 1-[(5,6-monomethyl-2-fluorenyloxy. Titanium-3-acid) aminoamino] -4- (2-methoxyphenyl) amidine (100 mg, 026 mmol), dissolved in dimethylformamide (15 ml ), Sodium hydride (6.2 mg, 0.20 mmol) was added, and after stirring at room temperature for 15 minutes, bromomethylcyclopropane (21.8 mg, 0.26 mmol) was added, and at room temperature Stir 16 (Please read the precautions on the back before filling in this page): Binding and ordering 4 -90- 575564 A7 B7 5. Description of the invention (86) hours. Then, the dimethylformamide is removed by concentration under reduced pressure, and then column chromatography (ethyl acetate: hexane = 1: 2) is used for separation and purification to obtain the above compound. Yield: 78% Melting point: oily substance iH NMR (CDCl3) 5: 0.34 (2H, m), 0.49 (2H, m), 1.35 (lH, m), 2.85 (4H, t), 3.28 (4H, t ), 3.40 (2H, S), 3-89 (3H, S), 3.97 (3H, S), 6.97 (4H, m), 7.11 (lH, s) Example 140) 1- [N- (5,6- Difluorenyl-2-methoxypyridin-3-fluorenyl) -N-methylaminocarbonyl > 4- (5-Methoxy-2_fluorenylphenyl) piperazine 1-[(5 , 6-Dimethyl-2-methoxystilbidine-3-amidino) amido] -4- (5-methoxy-2-methylphenyl) piperazine, as described above The reaction was carried out in the same manner as in Example 132 to obtain the above-mentioned compound. Yield: 74%

熔點·· 91〜93°C iH NMR(CDC13) 5 :2.15(3H,S),2.18(3H,s),2.39(3H,S), 2.67(4H,t),3.05(3H,s),3.30(4H,t),3.75(3H,s),3.97(3H,s), 6.48(3H,m),7.10(lH,s) 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 實施例141) l-[N-(5,6-二曱基-2-甲氧基吡啶-3-醯 基)-N-乙基胺基羰基]-4-(5-曱氧基-2-甲基苯基)哌嗪 將1-[(5,6-^ —甲基-2-甲氧基吼σ定—3-酷基)胺基罗炭 基]-4-(5-甲氧基_2_甲基苯基)哌嗪,採行如同上述實施 例133相同的方法進行反應,而可獲得上述化合物。 收成率:94% -91 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公iT" -- 575564 經濟部中央標準局員工消費合作社印製 A7 B7 i、發明説明(87 ) 文谷點·油狀 !H NMR(GDCl3)(5:1.09(3H?t)52.15(3H?s)?2.18(3H?s)9 2.39(3H,S),2.60(4H,t),3.27(4H,t),3.59(2H,q),3.75(3H,S), 3.96(3H,s),6.45(3H,m),7.08(lH,s) 實施例142) 1-[N-苄基-N-(5,6-二甲基-2_甲氧基吡唆 -3-醯基)胺基羰基]-4-(2-甲氧基苯基)哌嗪 將1-[(5,6-二曱基-2-甲氧基吼唆-3-·基)胺基幾 基]-4-(5 -甲氧基-2-曱基苯基)旅嘻,採行如同上述實施 例138相同的方法進行反應,而可獲得上述化合物。 收成率:97% 熔點:油狀 iH NMR(CDC13)5 :1.25(3H,t),2.08(3H,S),2.14(3H,S), 2.35(3H,s),2.60(4H,t),3.32(4H,t),3.74(3H,s),3.95(3H,s), 4.66(2H,s),6.44(4H,m),6.96(5H,m),7.12(lH,s) 實施例143) 1-[Ν-(5·乙基-2-甲氧基-6-甲基吡啶-3- 醯基)-Ν-甲基胺基羰基]-4-(3,5_二曱氧基苯基)哌嗉 將1-[(5-乙基-2-甲氧基-6-甲基吡啶-3-醯基)胺基 罗炭基]-4-(3,5-二甲氧基苯基)派唤,採行如同上述實施 例132相同的方法進行反應,而可獲得上述化合物。 收成率:87%Melting point: 91 ~ 93 ° C iH NMR (CDC13) 5: 2.15 (3H, S), 2.18 (3H, s), 2.39 (3H, S), 2.67 (4H, t), 3.05 (3H, s), 3.30 (4H, t), 3.75 (3H, s), 3.97 (3H, s), 6.48 (3H, m), 7.10 (lH, s) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the Note: Please fill in this page again) Example 141) l- [N- (5,6-Difluorenyl-2-methoxypyridin-3-amidino) -N-ethylaminocarbonyl] -4- ( 5-Methoxy-2-methylphenyl) piperazine will be 1-[(5,6- ^ —methyl-2-methoxy-stilbidine —3-carbyl) aminocarbanyl]- 4- (5-methoxy-2-methylphenyl) piperazine was reacted in the same manner as in Example 133 described above to obtain the above compound. Yield: 94% -91-This paper size applies Chinese National Standard (CNS) A4 specifications (210X297 male iT "-575564 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, A7 B7 i, Invention Note (87) Wengu Dian · Oil! H NMR (GDCl3) (5: 1.09 (3H? T) 52.15 (3H? S)? 2.18 (3H? S) 9 2.39 (3H, S), 2.60 (4H, t), 3.27 (4H, t), 3.59 (2H, q), 3.75 (3H, S), 3.96 (3H, s), 6.45 (3H, m), 7.08 (lH, s) Example 142) 1- [N-benzyl-N -(5,6-dimethyl-2_methoxypyridin-3-fluorenyl) aminocarbonyl] -4- (2-methoxyphenyl) piperazine 1-[(5,6- Difluorenyl-2-methoxymethyl-3--3-yl) aminopropyl] -4- (5-methoxy-2-fluorenylphenyl), which is the same as that used in Example 138 above. The above-mentioned compound can be obtained by carrying out the reaction in the following manner. Yield: 97% Melting point: Oily iH NMR (CDC13) 5: 1.25 (3H, t), 2.08 (3H, S), 2.14 (3H, S), 2.35 ( 3H, s), 2.60 (4H, t), 3.32 (4H, t), 3.74 (3H, s), 3.95 (3H, s), 4.66 (2H, s), 6.44 (4H, m), 6.96 (5H , M), 7.12 (lH, s) Example 143) 1- [N- (5 · ethyl-2-methoxy-6-methylpyridin-3-fluorenyl) -N-formyl Aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperidine 1-[(5-ethyl-2-methoxy-6-methylpyridin-3-amidino) amino The carbamoyl] -4- (3,5-dimethoxyphenyl) group was reacted in the same manner as in Example 132 above to obtain the above compound. Yield: 87%

熔點:78〜79°C NMR(CDC13) 5 :1.14(3H,t),2.41(3H,S),2.52(2H,q), 2.91(4H,t),3.02(3H,s),3.28(4H,t),3.74(6H,s),3.98(3H,S), 5.98(3H,m),7.11(lHG,s) -92- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 裝· 、!. 575564 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(88 ) 實施例144) 1 -[N-(5-乙基-2-甲氧基_6_曱基吡啶-3_ 醯基)-N-甲基胺基羰基]-4-(3,5-二甲基苯基)哌嗪 將1-[(5-乙基-2-甲氧基-6-甲基吡啶_3_醯基)胺基 羰基]-4-(3,5-二甲基苯基)哌嗪,採行如同上述實施例 132相同的方法進行反應,而可獲得上述化合物。 收成率:84% 熔點:86〜87°C H NMR(CDC13) (5 :1.14(3H,t),2.23(6H,s),2.45(3H,s), 2_58(2H,q),2.87(4H,t),3.05(3H,s),3.30(4H,t),3.98(3H,s), 6.46(3H,m),7.11(lH,s) Mass(EI) m/z:396.2575 (MH,C23H32N402 計算值: 396.2525) 實施例145) l-[N-(5-乙基-2-甲氧基-6_甲基,比啶-3- 醯基)-N-乙基基胺基羰基]-4-(3,5-二甲基苯基)哌嗪 將1-[(5-乙基-2-曱氧基-6-曱基吼π定_3-g篮基)胺基 魏基]-4-(3,5-二甲基苯基)旅嗔,採行如同上述實施例 133相同的方法進行反應,而可獲得上述化合物。 收成率:86% 熔點:84〜85°C W NMR(CDC13) 5 :1.13(6H,m),2.23(6H,s),2.41(3H,s), 2.58(2H,q),2_85(4H,t),3.26(4H,t),3.46(2H,q),3.96(3H,s), 6.45(3H,m),7_08(lH,s) 貫施例146) 1-[!^-(2-甲氧基-6-曱基-5-丙基〇比。定-3· 醯基)_N-曱基胺基羰基]-4-(3,5-二曱基苯基)哌嗪 -93- (請先閲讀背面之注意事項再填寫本頁) •裝- 訂 XI_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(89 ) 將1-[(2-甲氧基-6-甲基-5-丙基吡啶-3-醯基)胺基 羰基]-4-(3,5-二甲基苯基)哌嗪,採行如同上述實施例 132相同的方法進行反應,而可獲得上述化合物。 收成率:89% 熔點:油狀 W NMR(CDC13) (5 :l.〇i(3H,t),1.78(2H,s),2.21(3H,s), 2.78(2H,t),3.87(6H,s),3.86(4H,t),3.99(3H,s),4.00(3H,s), 4.22(4H,t),6.01(3H,m),7.02(lH,s) 實施例147) l-[N-(6-乙基-2-甲氧基-5-曱基吡啶-3_ 醯基:甲基胺基羰基卜ζμ(3,5-二甲基苯基)哌嗪 將1-[(6-乙基-2-甲氧基-5-甲基吡啶-3-醯基)胺基 爹厌基]-4-(3,5-一甲基苯基)σ底嗔,採行如同上述實施例 132相同的方法進行反應,而可獲得上述化合物。 收成率:85% 熔點··油狀 !H NMR(CDC13) (5 :2.21(3H?t)52.21(3H5s)52.45(2H5q)? 3.21(4H,t),3.40(3H,s),3.67(4H,t),3_67(4H,t),3.77(6H,s), 4.01(3H,s),6.07(3H,m),6.96(lH,s),8.07(lH,s) 實施例148) l-[N-(2-甲氧基·5-曱基丙基咄啶-3_ 醯基)-N-曱基胺基羰基]_4_(3,5-二曱基苯基)哌嗪 將1-[(2-甲氧基-5-甲基-6-丙基咣啶-3-醯基)胺基 羰基]-4-(3,5_二甲基苯基)哌嗪,採行如同上述實施例 132相同的方法進行反應,而可獲得上述化合物。 收成率:86% -94- (請先閱讀背面之注意事項再填寫本頁) 裝· 訂Melting point: 78 ~ 79 ° C NMR (CDC13) 5: 1.14 (3H, t), 2.41 (3H, S), 2.52 (2H, q), 2.91 (4H, t), 3.02 (3H, s), 3.28 ( 4H, t), 3.74 (6H, s), 3.98 (3H, S), 5.98 (3H, m), 7.11 (lHG, s) -92- This paper size applies to China National Standard (CNS) A4 specification (210X 297 (Mm) (Please read the precautions on the back before filling this page.) 575564 A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (88) Example 144) 1-[N- (5-Ethyl-2-methoxy-6-fluorenylpyridine-3_fluorenyl) -N-methylaminocarbonyl] -4- (3,5-dimethylphenyl) piperazine will be 1- [(5-ethyl-2-methoxy-6-methylpyridin_3_fluorenyl) aminocarbonyl] -4- (3,5-dimethylphenyl) piperazine was implemented as described above The reaction was carried out in the same manner as in Example 132 to obtain the above-mentioned compound. Yield: 84% Melting point: 86 ~ 87 ° CH NMR (CDC13) (5: 1.14 (3H, t), 2.23 (6H, s), 2.45 (3H, s), 2_58 (2H, q), 2.87 (4H , T), 3.05 (3H, s), 3.30 (4H, t), 3.98 (3H, s), 6.46 (3H, m), 7.11 (lH, s) Mass (EI) m / z: 396.2575 (MH, C23H32N402 Calculated: 396.2525) Example 145) l- [N- (5-ethyl-2-methoxy-6-methyl, pyridin-3-fluorenyl) -N-ethylaminocarbonyl] -4- (3,5-Dimethylphenyl) piperazine will be 1-[(5-ethyl-2-fluorenyloxy-6-fluorenylsulfonyl-2-3-granyl) aminoweiyl ] -4- (3,5-dimethylphenyl) hydrazone was reacted in the same manner as in Example 133 above to obtain the above compound. Yield: 86% Melting point: 84 ~ 85 ° CW NMR (CDC13) 5: 1.13 (6H, m), 2.23 (6H, s), 2.41 (3H, s), 2.58 (2H, q), 2_85 (4H, t), 3.26 (4H, t), 3.46 (2H, q), 3.96 (3H, s), 6.45 (3H, m), 7_08 (lH, s) (Example 146) 1-[! ^-(2 -Methoxy-6-fluorenyl-5-propyl. Ratio of n-Methyl (fluorenyl) -N-fluorenylaminocarbonyl] -4- (3,5-diamidinophenyl) piperazine-93 -(Please read the precautions on the back before filling this page) • Binding-Order XI_ This paper size applies to China National Standard (CNS) A4 (210X297 mm) 575564 Printed by A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Description of the invention (89) 1-[(2-methoxy-6-methyl-5-propylpyridin-3-amidino) aminocarbonyl] -4- (3,5-dimethylphenyl ) Piperazine was reacted in the same manner as in Example 132 to obtain the above compound. Yield: 89% Melting point: Oily W NMR (CDC13) (5: 1.0 (3H, t), 1.78 (2H, s), 2.21 (3H, s), 2.78 (2H, t), 3.87 ( 6H, s), 3.86 (4H, t), 3.99 (3H, s), 4.00 (3H, s), 4.22 (4H, t), 6.01 (3H, m), 7.02 (lH, s) Example 147) l- [N- (6-ethyl-2-methoxy-5-fluorenylpyridine-3_fluorenyl: methylaminocarbonyl group ζμ (3,5-dimethylphenyl) piperazine will be 1- [(6-Ethyl-2-methoxy-5-methylpyridin-3-amidino) aminopyridinyl] -4- (3,5-monomethylphenyl) σbase, adopted The reaction was performed in the same manner as in Example 132 above to obtain the above compound. Yield: 85% Melting point · Oily! H NMR (CDC13) (5: 2.21 (3H? T) 52.21 (3H5s) 52.45 (2H5q) ? 3.21 (4H, t), 3.40 (3H, s), 3.67 (4H, t), 3_67 (4H, t), 3.77 (6H, s), 4.01 (3H, s), 6.07 (3H, m), 6.96 (lH, s), 8.07 (lH, s) Example 148) l- [N- (2-methoxy · 5-fluorenylpropylpyridin-3_fluorenyl) -N-fluorenylaminocarbonyl ] _4_ (3,5-Difluorenylphenyl) piperazine 1-[(2-methoxy-5-methyl-6-propylpyridin-3-amidino) aminocarbonyl] -4- (3,5-Dimethylphenyl) piperazine, as described above The above compound was obtained by reacting in the same manner as in Example 132. Yield: 86% -94- (Please read the precautions on the back before filling this page)

575564 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(90 )熔點:105〜107°CW NMR(CDC13)心0.98(3H,t),1.73(2H,q),2.18(3H,s), 2.63(2H,t),2.92(4H,t),3.05(3H,s),3.29(4H,t),3.74(6H,s),3.96(3H,s),6.00(3H,m),7.11(lH,s)Mass(EI) m/z:442.2543 (MH,C24H34N404 計算值: 442.2580) 貫施例149) 1 -[N-(5-乙酿基-2-甲氧基-6-甲基。比σ定_ 3-醯基)-Ν-甲基胺基羰基]-4-(3,5-二甲氧基苯基)哌嗪 將1 - [(5 -乙驢基-2-甲氧基-6-甲基吼咬-3-·基)胺 基魏基]-4-(3,5_二甲氧基苯基)派嗔,採行如同上述實 施例132相同的方法進行反應,而可獲得上述化合物。 收成率:89% 少谷點·油狀iH NMR(CDC13) 5 :2.50(3H,s),2.70(3H,s),2.97(4H,t), 3.09(3H,s),3.33(4H,t),3.75(6H,s),4.06(3H,S),6.03(3H,m), 7.72(1H5s) Mass(EI) m/z:442.2229 (MH,C23H3()N405 計算值: 442.2516) 實施例150) l-[N-(5-乙醯基-2·曱氧基_6-甲基,比,定_ 3-醯基)-N-乙基胺基羰基]_4-(3,5-二甲氧基苯基)哌嘻 將1 - [(5 -乙酸基-2-甲氧基-6-甲基σ比唆-3-酉篮基)胺 基癸厌基]-4-(3,5-^一甲氧基苯基)旅嘻,採行如同上述實 施例133相同的方法進行反應,而可獲得上述化合物。 收成率:87% -95-575564 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (90) Melting point: 105 ~ 107 ° CW NMR (CDC13) Heart 0.98 (3H, t), 1.73 (2H, q), 2.18 (3H, s), 2.63 (2H, t), 2.92 (4H, t), 3.05 (3H, s), 3.29 (4H, t), 3.74 (6H, s), 3.96 (3H, s), 6.00 (3H, m ), 7.11 (lH, s) Mass (EI) m / z: 442.2543 (MH, C24H34N404 Calculated: 442.2580) Example 149) 1-[N- (5-Ethyl-2-methoxy-6 -Methyl. More than σ- 3-Methyl) -N-methylaminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine will be 1-[(5 -ethonyl- 2-Methoxy-6-methylsulfan-3-yl) aminoweiyl] -4- (3,5-dimethoxyphenyl) pyridine, which is the same as that used in Example 132 above. The reaction is carried out by the method to obtain the above-mentioned compound. Yield: 89% Low valley point oily iH NMR (CDC13) 5: 2.50 (3H, s), 2.70 (3H, s), 2.97 (4H, t), 3.09 (3H, s), 3.33 (4H, t), 3.75 (6H, s), 4.06 (3H, S), 6.03 (3H, m), 7.72 (1H5s) Mass (EI) m / z: 442.2229 (MH, C23H3 () N405 Calculated value: 442.2516) Implementation Example 150) l- [N- (5-Ethylfluorenyl-2 · fluorenyloxy-6-methyl, ratio, n--3-fluorenyl) -N-ethylaminocarbonyl]] 4- (3,5 -Dimethoxyphenyl) piperidine 1-[(5-acetic acid-2-methoxy-6-methyl σ to fluoren-3-fluorenyl) aminodecdecyl] -4- ( 3,5-^-methoxyphenyl), which can be reacted in the same manner as in Example 133, to obtain the above compound. Yield: 87% -95-

(請先閱讀背面之注意事項再填寫本頁) -裝· 訂 k 575564 A7 B7 五、發明説明(91 ) 熔點:油狀 iH NMR(CDC13) (5 :1.09(3H,t),2.49(3H,S),2.70(3H,S), 3.00(4H,t),3.32(4H,t),3.77(6H,s),4.01(3H,S),4.09(2H,q), 5.98(3H,m),7.76(lH,s) 實施例151) l-[N-(5-乙醯基-2-甲氧基-6-甲基吡啶_ 3-醯基)-N-甲基胺基羰基]-4_(3,5-二甲基苯基)旅嗪 將1-[(5-乙醯基-2-甲氧基-6-甲基吡啶-3-醯基)胺 基幾基]-4-(3,5-二曱基苯基)派嗔,採行如同上述實施 例132相同的方法進行反應,而可獲得上述化合物。 收成率:88% 熔點:油狀 1H NMR(CDC13) (^2.24(6H,S),2.50(3H,S),2.70(3H,s), 2.93(4H,t),3.09(3H,s),3.28(4H,t),4.06(3H,S),6.46(3H,m), 7.73(1H?s) 貝施例152) 1-[N-(5-(1-¾乙基)-2 -曱氧基-6-曱基口比 啶-3-醯基)_N-甲基胺基羰基]-4-(3,5-二甲氧基苯基)哌 口秦 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 將1-[(5-(1-沒乙基)-2 -曱氧基-6-曱基σ比咬-3-醯基)胺 基羰基]_4-(3,5-二甲氧基苯基)哌嗪(0.47毫莫耳),溶解 於無水乙醇(15ml)中,並添加硼氫化鈉(17.3mg)後,於 室溫下攪拌2小時後,施行減壓濃縮,並利用管柱層 析(乙基醋酸酯:己烧=2:1 ),進行分離精製後便可獲 得上述化合物。 收成率:97% -96- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X297公釐) 575564 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(92 ) 熔點:油狀 W NMR(CDC13) 6 :1.14(3H,d),2.44(3H,s),2.93(4H,t), 3.06(3H,s),3.30(4H,t),3.74(6H,s),3.98(3H,s),5.03(lH,q), 6.02(3H,m),7.05(lH,s) 貫施例153) 1 ** {N-乙基-N-[5-(1-經乙基)-2-曱氧基_6- 甲基吡啶-3-醯基]胺基羰基}-4-(3,5-二甲氧基苯基)哌 嗪 將1- [N-(5-乙醯基-2-甲氧基-6-甲基吼咬-3-醯基)· N-乙基胺基魏基]-4-(3,5-二甲氧基苯基)派嗔,採行如 同上述實施例152相同的方法進行反應,而可獲得上 述化合物。 收成率:96% 熔點:油狀 1H NMR(CDC13) 5 :1.09(3H,t),1.41(3H,d),2.44(3H,s), 2.91(4H,t),3.27(4H,t),3.54(lH,q),3.74(6H,s),3.96(3H,s), 5.03(lH,q),6.02(3H,m),8.46(lH,s) 實施例154) 1-{Ν-[5-(1-羥乙基)-2-甲氧基-6_甲基吡 啶-3-醯基]-N-甲基胺基羰基}_4_(3,5-二曱基苯基)哌嗪 將1-[Ν-(5-乙醯基-2·曱氧基-6·曱基。比咬醯基)_n_ 甲基胺基羰基]-4-(3,5-二甲基苯基)哌嗪,採行如同上述 實施例152相同的方法進行反應,而可獲得上述化合 物。 收成率:97% 熔點:油狀 -97-(Please read the precautions on the back before filling in this page)-Binding and ordering k 575564 A7 B7 V. Description of the invention (91) Melting point: oily iH NMR (CDC13) (5: 1.09 (3H, t), 2.49 (3H , S), 2.70 (3H, S), 3.00 (4H, t), 3.32 (4H, t), 3.77 (6H, s), 4.01 (3H, S), 4.09 (2H, q), 5.98 (3H, m), 7.76 (lH, s) Example 151) l- [N- (5-Ethyl-2-methoxy-6-methylpyridin-3-yl) -N-methylaminocarbonyl ] -4_ (3,5-Dimethylphenyl) travelazine 1-[(5-ethylfluorenyl-2-methoxy-6-methylpyridin-3-amidino) aminopropyl]- 4- (3,5-Difluorenylphenyl) pyrene can be reacted in the same manner as in Example 132 above to obtain the above compound. Yield: 88% Melting point: Oily 1H NMR (CDC13) (^ 2.24 (6H, S), 2.50 (3H, S), 2.70 (3H, s), 2.93 (4H, t), 3.09 (3H, s) , 3.28 (4H, t), 4.06 (3H, S), 6.46 (3H, m), 7.73 (1H? S) Example 152) 1- [N- (5- (1-¾ethyl) -2 -Methoxy-6-Methylpyridyl-3-pyridyl) _N-methylaminocarbonyl] -4- (3,5-dimethoxyphenyl) Employees of the Central Standards Bureau of Piqin Economy Printed by the Consumer Cooperative (please read the precautions on the back before filling out this page) will be 1-[(5- (1-methylethyl) -2 -fluorenyl-6-fluorenyl σ than sulfanyl-3-fluorenyl ) Aminocarbonyl] _4- (3,5-dimethoxyphenyl) piperazine (0.47 mmol), dissolved in absolute ethanol (15 ml), and added sodium borohydride (17.3 mg), After stirring at room temperature for 2 hours, the solution was concentrated under reduced pressure, and the above compound was obtained after separation and purification by column chromatography (ethyl acetate: hexane = 2: 1). Yield: 97% -96- This paper size applies to Chinese National Standard (CNS) A4 (210 X297 mm) 575564 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (92) Melting point: oily W NMR (CDC13) 6: 1.14 (3H, d), 2.44 (3H, s), 2.93 (4H, t), 3.06 (3H, s), 3.30 (4H, t), 3.74 (6H, s), 3.98 (3H, s), 5.03 (lH, q), 6.02 (3H, m), 7.05 (lH, s) (Example 153) 1 ** {N-ethyl-N- [5- (1-B ) -2-Amino-6-methylpyridine-3-amidino] aminocarbonyl} -4- (3,5-dimethoxyphenyl) piperazine 1- [N- (5- Ethyl-2-methoxy-6-methylmethyl-3-methyl) · N-ethylaminoweiyl] -4- (3,5-dimethoxyphenyl) pyridine, The reaction was carried out in the same manner as in the above-mentioned Example 152 to obtain the above-mentioned compound. Yield: 96% Melting point: Oily 1H NMR (CDC13) 5: 1.09 (3H, t), 1.41 (3H, d), 2.44 (3H, s), 2.91 (4H, t), 3.27 (4H, t) , 3.54 (lH, q), 3.74 (6H, s), 3.96 (3H, s), 5.03 (lH, q), 6.02 (3H, m), 8.46 (lH, s) Example 154) 1- {N -[5- (1-hydroxyethyl) -2-methoxy-6-methylpyridine-3-fluorenyl] -N-methylaminocarbonyl}} __ 4_ (3,5-difluorenylphenyl) Piperazine will be 1- [N- (5-ethylfluorenyl-2 · fluorenyloxy-6 · fluorenyl. Specific to fluorenyl) _n_ methylaminocarbonyl] -4- (3,5-dimethylbenzene (Meth) piperazine. The same method as in Example 152 was used to perform the reaction to obtain the above compound. Yield: 97% Melting point: Oily -97-

(請先閱讀背面之注意事項再填寫本頁) •裝· 訂 ¾ 575564 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(93 ) 'H NMR(CDC13)(5 :1.41(3H?d)52.42(6H?s)52.44(3H5s)5 2.91(4H,t),3.06(3H,s),3.26(4H,t),3.99(3H,s),5_03(lH,q), 6.49(3H,m),7.50(lH,s) 實施例155) 1-{>^[5-(1-羥乙基-1—甲乙基)_2-甲氧基- 6-甲基呲啶-3-醯基]-N-甲基胺基羰基}-4-(3,5-二甲基 苯基)σ辰嘻 將1-[Ν-(5-乙醯基-2-甲氧基冬甲基吡啶-3-醯基)-Ν-曱基胺基羰基]_4-(3,5-二甲基苯基)哌嗪(221mg,〇.5〇毫莫 耳)徐緩添加後,還流攪拌15分鐘,然後利用減壓濃 縮將溶劑予以去除後,利用乙基醋酸酯予以萃取並乾 燥過濾,然後再利用管柱層析(乙基醋酸酯··己烧= 1:2),進行分離精製後便可獲得上述化合物。 收成率:92% 溶點:油狀 β NMR(CDC13) 5 :1.59(6H,s),2.66(3H,s),2.93(4H,t), 3.〇6(3H,s),3.30(4H,t),3.74(6H,S),3.99(3H,s),6.03(3H,m), 7.45(lH,s) 實施例156) 1-{1^[5-(1-羥基-1-甲丙基)_2-曱氧基-6_ 曱基°比喘;-3-酸基]-N-甲基胺基獄基}-4_(3,5_二甲基苯 基)17底嗔 將1 _[N-(5 -乙龜基-2 -曱氧基-6-甲基σ比淀-3·酸基)-N-曱基月女基羰基]-4_(3,5·二甲基苯基)旅嘻(2 i3mg,0.50毫莫) 溶解於四氫。比喃(10ml)中,並逐漸添加硼鎂曱烧(〇.5〇ml, 1 ·50毫莫耳)後,還流攪拌15分鐘,然後利用減壓濃 -98- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) !丨丨丨_ (請先閲讀背面之注意事項再填寫本頁) 裝· 、1Τ 575564 Α7 Β7 五、發明説明(94 ) 縮將溶劑予以去除後,利用乙基醋酸酯予以萃取並乾 燥過濾,然後再利用管柱層析(乙基醋酸酯:己烷= 2:1),進行分離精製後便可獲得上述化合物。 收成率:88% 溶點:油狀 NMR(CDC13) 5 :〇.79(3H5t)51.58(3H5s)?1.85(2H?q)5 2.61(3H,s),2.99(4H,t),3.07(3H,s),3.30(4H,t),3.76(6H,s), 6.12(3H,m),7.47(lH,s) 實施例157) 1-{Ν-[2-甲氧基-5-(1-甲氧基乙基-6-甲 基吼啶-3-醯基]-N-曱基胺基羰基}_4-(3,5-二甲氧基苯 基)σ辰嘻 將1-{Ν-[5-(1-羥乙基)-2-甲氧基-6-甲基吡啶_3_醯基]-胺基羰基}-4-(3,5-二曱氧基苯基)哌嗪,採行如同上述實 施例132相同的方法進行反應,而可獲得上述化合物。 收成率:95%(Please read the precautions on the back before filling in this page) • Binding and binding ¾ 575564 Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 Β7 V. Description of the invention (93) 'H NMR (CDC13) (5: 1.41 (3H ? d) 52.42 (6H? s) 52.44 (3H5s) 5 2.91 (4H, t), 3.06 (3H, s), 3.26 (4H, t), 3.99 (3H, s), 5_03 (lH, q), 6.49 (3H, m), 7.50 (lH, s) Example 155) 1-{> ^ [5- (1-hydroxyethyl-1-methylethyl) _2-methoxy-6-methylpyridine- 3-fluorenyl] -N-methylaminocarbonyl} -4- (3,5-dimethylphenyl) σ Chen Hei 1- [N- (5-Ethyl-2-methoxymethoxy) Methylpyridine-3-fluorenyl) -N-fluorenylaminocarbonyl] -4- (3,5-dimethylphenyl) piperazine (221 mg, 0.50 mmol) was slowly added, and the mixture was stirred under reflux. After 15 minutes, the solvent was removed by concentration under reduced pressure, and then extracted with ethyl acetate, dried and filtered, and then separated and purified by column chromatography (ethyl acetate · hexane = 1: 2). After that, the above compounds can be obtained. Yield: 92% Melting point: Oily β NMR (CDC13) 5: 1.59 (6H, s), 2.66 (3H, s), 2.93 (4H, t), 3.〇6 (3H, s), 3.30 ( 4H, t), 3.74 (6H, S), 3.99 (3H, s), 6.03 (3H, m), 7.45 (lH, s) Example 156) 1- {1 ^ [5- (1-hydroxy-1 -Methylpropyl) _2-fluorenyl-6-fluorenyl group Bibitan; -3-acid group] -N-methylaminopentyl} -4_ (3,5-dimethylphenyl) 17 substrate Add 1 _ [N- (5-Ethyl-2-yloxy-6-methyl sigma bideno-3 · acid group) -N- fluorenyltrisylcarbonyl] -4_ (3,5 · di Methylphenyl) Luhe (2 i3mg, 0.50 mmol) was dissolved in tetrahydro. Bran (10ml), and gradually add boron and magnesium sintered (0.50ml, 1.50 millimoles), and then stir for 15 minutes, and then use a reduced pressure concentration -98- This paper scale applies Chinese national standards (CNS) Α4 specification (210X297 mm)! 丨 丨 丨 _ (Please read the precautions on the back before filling out this page) Equipment, 1T 575564 Α7 Β7 V. Description of the invention (94) After removing the solvent, use Ethyl acetate is extracted, dried and filtered, and then column chromatography (ethyl acetate: hexane = 2: 1) is used for separation and purification to obtain the above compound. Yield: 88% Melting point: Oily NMR (CDC13) 5: 0.079 (3H5t) 51.58 (3H5s)? 1.85 (2H? Q) 5 2.61 (3H, s), 2.99 (4H, t), 3.07 ( 3H, s), 3.30 (4H, t), 3.76 (6H, s), 6.12 (3H, m), 7.47 (lH, s) Example 157) 1- {N- [2-methoxy-5- (1-methoxyethyl-6-methylpyrimidin-3-amidino] -N-fluorenylaminocarbonyl} _4- (3,5-dimethoxyphenyl) σ Chen Hei 1- {N- [5- (1-hydroxyethyl) -2-methoxy-6-methylpyridine_3_fluorenyl] -aminocarbonyl} -4- (3,5-dimethoxyphenyl ) Piperazine, which was reacted in the same manner as in Example 132 above to obtain the above compound. Yield: 95%

熔點:117〜119°C 1H NMR(CDC13) ά :1.34(3H,t),2.43(3H,s),2.94(4H,t), 3.06(3H,S),3.18(3H,S),3.30(4H,t),3.74(6H,S),3.99(3H,S), 4.44(1 H,q),6.02(3H,m),7.37(lH,s) 實施例158) 1 -[N-(2-曱氧基-6-乙烯基吡啶-3-醯基)- N-甲基月女基祿基}_4-(3,5 -二甲乳基苯基)ρ辰嘻 將1-[(2-曱氧基-6-甲基-5-乙細基扯咬-3-酿基)胺基幾 基}-4-(3,5-二甲氧基苯基)旅嘻,採行如同上述實施例132 相同的方法進行反應,而可獲得上述化合物。 -99- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 裝· 、1Τ 經濟部中央標準局員工消費合作社印製 575564 A7 B7 五、發明説明(95 ) 收成率:94% 溶點:油狀 1H NMR(CDC13) 3 :2.46(3H,s),2.93(4H,t),3.07(3H,s), 3.30(4H,t),3.73(6H,s),3.99(3H,s),5.25(lH,d),5.48(lH,d), 6_01(3H,m),6-78(lH,s),7.43(lH,s) 實施例159) l-[N-(2-甲氧基-6-曱基-5-乙烯基吡啶_ 3-醯基)-N-甲基胺基羰基}-4-(3,5_二甲基苯基)哌嗪 將1-[(2-甲氧基_6_甲基-5-乙晞基醯基)胺基魏 基}-4-(3,5-二甲基苯基)旅嗔,採行如同上述實施例〖32 相同的方法進行反應,而可獲得上述化合物。 收成率:89% 熔點:油狀 1H NMR(CDC13) δ :2.24(6H,S),2.43(3H,s),2.90(4H,t), 3.04(3H,S),3.27(4H,t),3_99(3H,S),5.23(lH,d),5.45(lH,d), 6.05(3H,m),6.77(lH,s),7.40(lH,s) 實施例160) l-[N-(2-甲氧基-6-甲基-5-乙烯基吡啶- 3-醯基)-N-甲基胺基羰基}-4-(3,5-二甲氧基苯基)哌嗪 將1-[(2-甲氧基-6-曱基-5-乙烯基吡啶-3-醯基)胺基羰 基}-4-(3,5-二曱氧基苯基)哌嗪,採行如同上述實施例132 相同的方法進行反應,而可獲得上述化合物。 收成率:92% 熔點:油狀 !H NMR(CDC13) 6:l_〇9(3H,t),2.43(3H,s),2.94(4H,t), 3.28(4H,t),3.77(6H,s),4.01(3H,s),4.11(2H,q),5.25(lH,d)5 -100- 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X297公釐) ·- i -i - - I -I ill am « • . Jm (請先閱讀背面之注意事項再填寫本頁) Λ衣· 經濟部中央標準局員工消費合作社印製 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(96 ) 5.49(lH,d),5.98(3H,m),6.77(lH,s),7.44(lH,s) 實施例161) 1-[Ν-(5-異丙苯基-2-甲氧基-6_甲基吡啶 -3-醯基)-Ν·曱基胺基羰基}_4-(3,5-二甲氧基苯基)哌嗪 將1-[(5-異丙苯基-2-甲氧基-6-曱基吡啶_3-醯基)胺基 罗厌基}-4-(3,5-一甲氧基苯基底嘻,採行如同上述實施例 1 32相同的方法進行反應,而可獲得上述化合物。 收成率:92% 熔點:油狀 iH NMR(CDC13) 5 :1.98(3H,s),2.43(3H,s),2.92(4H,t), 3.06(3H,S),3.29(4H,t),3.74(6H,S),3.99(3H,S),4.84(lH,S), 5.30(lH,s),6.01(3H,m),7.10(lH,s) 實施例162) 1·[Ν-(5-異丙苯基-2-甲氧基-6-甲基咄啶 -3-醯基)-Ν-甲基胺基羰基}-4-(3,5-二甲基苯基)哌嘻 將1-[(5-異丙苯基-2-甲氧基-6-甲基吡啶_3_醯基)胺基 羰基}-4-(3,5-二甲基苯基嘻,採行如同上述實施例132 相同的方法進行反應,而可獲得上述化合物。 收成率·· 9 1 % 熔點:油狀 NMR(CDC13) δ :1.98(3H5s)?2.24(6H?s)?2.43(3H?s)? 2.90(4H,t),3.06(3H,S),3.28(4H,t),4.00(3H,S),4.84(lH,S), 5.19(lH,s),6.46(3H,m),7.10(lH,s) 實施例163)乙基-2-({[4-(3,5-二甲氧基苯基)哌嗪]羰 基}(5-乙醯基-2_曱氧基-6-甲基咣啶-3-醯基)醋酸酯 將1-[(5-乙酸基-2-曱氧基-6-曱基吼唆_3-g篮基]胺 -101 - 本矣氏張尺度適用中國國家榡準(CNS ) A4規格(210 X 297公釐)'^~' ' I--------0^-- (請先閲讀背面之注意事項再填寫本頁)Melting point: 117 ~ 119 ° C 1H NMR (CDC13) ά: 1.34 (3H, t), 2.43 (3H, s), 2.94 (4H, t), 3.06 (3H, S), 3.18 (3H, S), 3.30 (4H, t), 3.74 (6H, S), 3.99 (3H, S), 4.44 (1H, q), 6.02 (3H, m), 7.37 (lH, s) Example 158) 1-[N- (2-Methoxy-6-vinylpyridin-3-amidino) -N-methyl-molylmethyl} _4- (3,5-dimethyllactylphenyl) ρ Chen Hei 1- [ (2-Methoxy-6-methyl-5-ethoxymethyl-3-amino) aminoamino} -4- (3,5-dimethoxyphenyl) The reaction was carried out in the same manner as in the above-mentioned Example 132 to obtain the above-mentioned compound. -99- This paper size is in accordance with Chinese National Standard (CNS) Α4 size (210X297 mm) (Please read the precautions on the back before filling in this page). · 1T Printed by the Central Consumers Bureau of the Ministry of Economic Affairs Consumer Cooperatives 575564 A7 B7 V. Description of the invention (95) Yield: 94% Melting point: Oily 1H NMR (CDC13) 3: 2.46 (3H, s), 2.93 (4H, t), 3.07 (3H, s), 3.30 (4H, t ), 3.73 (6H, s), 3.99 (3H, s), 5.25 (lH, d), 5.48 (lH, d), 6_01 (3H, m), 6-78 (lH, s), 7.43 (lH, s) s) Example 159) l- [N- (2-methoxy-6-fluorenyl-5-vinylpyridin-3-yl) -N-methylaminocarbonyl} -4- (3,5 _Dimethylphenyl) piperazine 1-[(2-methoxy-6_methyl-5-ethenylfluorenyl) aminoweilyl} -4- (3,5-dimethylbenzene Based on the method described above, the same method as in the above-mentioned Example [32] was used for the reaction to obtain the above compound. Yield: 89% Melting point: Oily 1H NMR (CDC13) δ: 2.24 (6H, S), 2.43 (3H, s), 2.90 (4H, t), 3.04 (3H, S), 3.27 (4H, t) , 3_99 (3H, S), 5.23 (lH, d), 5.45 (lH, d), 6.05 (3H, m), 6.77 (lH, s), 7.40 (lH, s) Example 160) l- [N -(2-methoxy-6-methyl-5-vinylpyridine-3-amino) -N-methylaminocarbonyl} -4- (3,5-dimethoxyphenyl) piperazine The 1-[(2-methoxy-6-fluorenyl-5-vinylpyridin-3-fluorenyl) aminocarbonyl} -4- (3,5-dimethoxyphenyl) piperazine is The reaction was carried out in the same manner as in the above-mentioned Example 132 to obtain the above-mentioned compound. Yield: 92% Melting point: oily! H NMR (CDC13) 6: 1.09 (3H, t), 2.43 (3H, s), 2.94 (4H, t), 3.28 (4H, t), 3.77 ( 6H, s), 4.01 (3H, s), 4.11 (2H, q), 5.25 (lH, d) 5 -100- This paper size applies to China National Standard (CNS) A4 (21 × 297 mm) ·- i -i--I -I ill am «•. Jm (Please read the notes on the back before filling out this page) Preparation A7 B7 V. Description of the invention (96) 5.49 (lH, d), 5.98 (3H, m), 6.77 (lH, s), 7.44 (lH, s) Example 161) 1- [N- (5-iso Propylphenyl-2-methoxy-6-methylpyridin-3-fluorenyl) -N · fluorenylaminocarbonyl}} 4- (3,5-dimethoxyphenyl) piperazine 1- [ (5-Isopropyl-2-methoxy-6-fluorenylpyridine_3-fluorenyl) aminorozinyl} -4- (3,5-monomethoxyphenyl dihexyl, adopted as The above compound was obtained by reacting in the same manner as in Example 132 above. Yield: 92% Melting point: Oily iH NMR (CDC13) 5: 1.98 (3H, s), 2.43 (3H, s), 2.92 (4H , T), 3.06 (3H, S ), 3.29 (4H, t), 3.74 (6H, S), 3.99 (3H, S), 4.84 (lH, S), 5.30 (lH, s), 6.01 (3H, m), 7.10 (lH, s) Example 162) [N- (5-Isopropyl-2-methoxy-6-methylpyridin-3-fluorenyl) -N-methylaminocarbonyl} -4- (3, 5-dimethylphenyl) piperidine 1-[(5-isopropylphenyl-2-methoxy-6-methylpyridine_3_fluorenyl) aminocarbonyl} -4- (3,5 -Dimethyphenyl, which can be reacted in the same manner as in Example 132 above. Yield ·· 9 1% Melting point: oily NMR (CDC13) δ: 1.98 (3H5s)? 2.24 (6H? S)? 2.43 (3H? S)? 2.90 (4H, t), 3.06 (3H, S), 3.28 (4H, t), 4.00 (3H, S), 4.84 (lH, S), 5.19 ( lH, s), 6.46 (3H, m), 7.10 (lH, s) Example 163) Ethyl-2-({[4- (3,5-dimethoxyphenyl) piperazine] carbonyl} ( 5-Ethyl-2-yloxy-6-methylpyridin-3-fluorenyl) acetate -g basket-based] amine-101-this scale is applicable to China National Standard (CNS) A4 (210 X 297 mm) '^ ~' 'I -------- 0 ^-( (Please read the notes on the back before filling out this page)

、1T -1¾ 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(97 ) 基羰基]-4-(3,5-二甲氧基苯基)哌嗪(2〇〇11^5〇.5毫莫 耳),溶解於二曱基曱醯胺(15ml)+,添加氫化鈉(185mg, 〇·5毫莫耳)後,於室溫下攪拌15分鐘。再添加乙基漠 化醋酸酯(83.5mg,0.5毫莫耳),並於室溫下攪拌3小 時。然後利用減壓濃縮將溶劑予以去除後,並以管柱 層析(乙基醋酸酯:己烷=1:2),進行分離精製後便可 獲得上述化合物。 收成率:84% 熔點:油狀 H NMR(CDC13) 5:1.26(3H,t),2.51(3H,s),2.69(3H,s), 3.04(4H,t),3.43(4H,t),3.75(6H,S),4.05(3H,S),4.15(2H,q), 4.19(2H,s),6.08(3H,m),7.96(lH,s) 實施例164)乙基-2-({[4-(3,5-二曱基苯基)哌嗪]羰 基}(5-乙酷基-2-甲氧基-6-甲基吼咬-3-驢基)醋酸酯 將1-[(5-乙醯基-2-甲氧基-6-甲基响。定_3_酸基]胺 基罗厌基]-4-(3,5-一甲基苯基)σ辰嘻,採行如同上述實施 例163相同的方法進行反應,而可獲得上述化合物。 收成率:80% 熔點:油狀 ln NMR(CDC13) 5:1. 25(3H, t), 2. 56(3H, s), 2. 69 (3H,s),3· 00(4H,t),3. 29(4H,t),3. 78(6H,s) 4. 06(3H,s),4· 18(2H,s),5· 99(3H,m),7· 98(1H,s) 實施例165) 2-({[4-(3,5-二甲基苯基)哌嗪]羰基}(5_ 乙醯基-2-甲氧基-6-甲基吡啶-3-醯基)胺基醋酸乙酯 -102- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁)1T -1¾ 575564 A7 B7 printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs V. Description of the invention (97) carbonylcarbonyl] -4- (3,5-dimethoxyphenyl) piperazine (20011 ^ 50.5 mmol), dissolved in dimethylfluorenamine (15 ml) +, and sodium hydride (185 mg, 0.5 mmol) was added, followed by stirring at room temperature for 15 minutes. Further ethyl acetate (83.5 mg, 0.5 mmol) was added and stirred at room temperature for 3 hours. Then, the solvent was removed by concentration under reduced pressure, and column chromatography (ethyl acetate: hexane = 1: 2) was used for separation and purification to obtain the above compound. Yield: 84% Melting point: Oily H NMR (CDC13) 5: 1.26 (3H, t), 2.51 (3H, s), 2.69 (3H, s), 3.04 (4H, t), 3.43 (4H, t) , 3.75 (6H, S), 4.05 (3H, S), 4.15 (2H, q), 4.19 (2H, s), 6.08 (3H, m), 7.96 (lH, s) Example 164) ethyl-2 -({[4- (3,5-Difluorenylphenyl) piperazine] carbonyl} (5-ethoxy-2-methoxy-6-methyl-4-methyl-3-donyl) acetate will 1-[(5-Ethylfluorenyl-2-methoxy-6-methylsulfonyl. Benzene-3_acidyl] amino-rodonyl] -4- (3,5-monomethylphenyl) σ Chen He, the same method as described in Example 163 was used for the reaction to obtain the above compound. Yield: 80% Melting point: oily ln NMR (CDC13) 5: 1.25 (3H, t), 2. 56 (3H, s), 2. 69 (3H, s), 3. 00 (4H, t), 3. 29 (4H, t), 3. 78 (6H, s) 4. 06 (3H, s), 4.18 (2H, s), 5.99 (3H, m), 7.98 (1H, s) Example 165) 2-({[4- (3,5-dimethylphenyl) piperazine ] Carbonyl} (5_ Ethyl-2-methoxy-6-methylpyridin-3-amidino) ethyl ethyl acetate-102- This paper size is applicable to China National Standard (CNS) A4 size (210X 297) %) (Please read the notes on the back before filling (Write this page)

、1T 4 575564 A7 B7 五 、發明説明( 經 濟 部 中 央 標 準 局 員 工 消 費 合 作 社 印 製1T 4 575564 A7 B7 V. Description of the invention

將({[4-(3,5-二甲氧基苯基)哌嗪;|羰基乙醯基_ 2甲氧基-6-甲基°比咬-3-酿基)胺基醋酸酯(2〇〇mg,〇.38 毫莫耳),溶解於二氧烷:蒸餾水=4:1 (15ml)中,並添 加鐘化氫水化物(48. lmg51.14毫莫耳),於室溫下授拌 3小時,然後添加1N鹽酸予以酸性化後,採用乙基醋 酸酯進行萃取並乾燥過濾。然後利用減壓濃縮將溶劑 予以去除後,以管柱層析(乙基醋酸酯:己烷=丨:2), 進行分離精製後便可獲得上述化合物。 收成率:94% 熔點:135〜137QC 1HNMR(CDC13)5:2.52(3H, s), 2.69(3H,s), 3.11(4H,t), 3. 49(411, t), 3. 74(6H, s), 4. 05(3H, s), 4.24(2H,s), 6-15(3H,m), 7.83(1H,s) 實施例166)乙基-2-({[4-(355-二曱氧基苯基)哌嗪]羰 基}(5-(l-羥乙基)-2-甲氧基-6-曱基吨啶醯基)胺基] 醋酸酯 將乙基-2-({[4_(3,5-二曱氧基苯基)哌嗪]羰基}(5_ 乙I基-2-甲氧基-6-甲基咄啶-3-醯基)胺基]醋酸酯,採 仃如同上述實施例152相同的方法進行反應,而可獲 传上述化合物。 收成率:97% 熔點:125〜127°C -103 本紙張尺度適用中國國家標準(CNS ) a4規格(210X 297公釐 (請先閱讀背面之注意事項再填寫本頁) 、11 d 575564 A7 B7 經濟部中央標準局員工消費合作社印製 i、發明説明(99 ) !H NMR(CDC13)(5 : 1.26(3H5t)? 1.42(3H5d)? 2.44(3H?s)? 3.04(4H,t,),3.31(4H,t),3.75(6H,s),3.97(3H,s),4.16(2H,q), 4.19(2H,s),6.15(3H,m),7.69(lH,s) 實施例I67) 2_({[4-(3,5-二甲氧基苯基)哌嗪]羰 基)(5-(1-¾乙基)-2 -甲氧基-6-甲基η比淀- 3-·基)胺基] 醋酸酯 將乙基-2-({[4_(3,5-二曱氧基苯基)派嗪]幾基}(5_ (1-經乙基)-2-甲氧基-6-甲基。比咬-3-酿基)胺基]醋酸 酉旨,採行如同上述實施例165相同的方法進行反應, 而可獲得上述化合物。 收成率:92% 熔點:油狀 4 NMR(CDC13) (5 : 1.41(3H.d),2.44(3H,s),2.98(4H,t), 3.36(4H,t),3.74(6H,s),3.98(3H,s),4.40(2H,s),5.00(lH,q), 6.08(3H,m),7.69(lH,s) 實施例168)乙基2-({[4-(3,5-二曱基苯基)派唤]幾 基}(5-(1-羥乙基)-2-甲氧基-6-甲基。比啶-3-醯基)胺基] 醋酸酯 將乙基-2-({[4-(3,5-二甲基苯基)旅嗓]羰基}(5_乙 驢基-2-甲氧基-6-甲基吡啶-3-醯基)胺基]醋酸酯,採行 如同上述實施例15 2相同的方法進行反應,而可獲得 上述化合物。 收成率:94% 熔點·· 68〜70°C -104- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝· 、11 d 575564 A7 _______ B7 五、發明説明(100) !H NMR(CDC13)5 : 1.13(3H,t) 1.47(3H,d), 2. 33(6H, s), 2.44(3H,s), 2.95(4H,t), 3. 30(4H, t), 3. 98(3H, s), 4.10(2H,q), 5.01(lH,q), 6. 46(3H, m), 7. 71 (1H, s) 貫施例169) 2-({[4-(3,5-二曱基苯基)派嗔]魏基}(5_ (1-經乙基)-2-甲氧基-6-甲基响唆_3-醯基)胺基]醋酸酯 將乙基-2-({[4-(3,5-二甲基苯基)哌嗪]羰基}(5-乙 酿基-2-甲氧基-6-甲基啦咬-3-醯基)胺基]醋酸酯,採行 如同上述實施例165相同的方法進行反應,而可獲得 上述化合物。 收成率:92%The ({[4- (3,5-dimethoxyphenyl) piperazine; | carbonylacetamido-2methoxy-6-methyl ° specificity-3-vinyl) aminoacetate ( 200 mg, 0.38 mmol), dissolved in dioxane: distilled water = 4: 1 (15 ml), and bell hydrate (48.1 mg 51.14 mmol) was added at room temperature After stirring for 3 hours, 1N hydrochloric acid was added to acidify the mixture, followed by extraction with ethyl acetate and drying and filtering. Then, the solvent was removed by concentration under reduced pressure, and column chromatography (ethyl acetate: hexane = 丨: 2) was used for separation and purification to obtain the above compound. Yield: 94% Melting point: 135 ~ 137QC 1HNMR (CDC13) 5: 2.52 (3H, s), 2.69 (3H, s), 3.11 (4H, t), 3. 49 (411, t), 3. 74 ( 6H, s), 4.05 (3H, s), 4.24 (2H, s), 6-15 (3H, m), 7.83 (1H, s) Example 166) ethyl-2-(((4- (355-Dioxophenyl) piperazine] carbonyl} (5- (l-hydroxyethyl) -2-methoxy-6-fluorenyltoxylpyridinyl) amino] acetate 2-({[4_ (3,5-Dioxophenyl) piperazine] carbonyl} (5_ethlyl-2-methoxy-6-methylpyridin-3-fluorenyl) amino] Acetic acid esters can be reacted in the same manner as in Example 152 above, and the above compounds can be obtained. Yield: 97% Melting point: 125 ~ 127 ° C -103 This paper applies the Chinese National Standard (CNS) a4 specification ( 210X 297mm (please read the notes on the back before filling this page), 11 d 575564 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs, i. Description of the invention (99)! H NMR (CDC13) (5: 1.26 (3H5t)? 1.42 (3H5d)? 2.44 (3H? S)? 3.04 (4H, t,), 3.31 (4H, t), 3.75 (6H, s), 3.97 (3H, s), 4.16 (2H, q ), 4.19 (2H, s), 6.15 (3H, m), 7.69 (lH, s) Example I67) 2 _ ({[4- (3,5-dimethyl Oxyphenyl) piperazine] carbonyl) (5- (1-¾ethyl) -2 -methoxy-6-methylηβ-3-yl) amino] acetate ethyl-2 -({[4_ (3,5-Dioxophenyl) pyrazine] Jinyl} (5_ (1-Ethyl) -2-methoxy-6-methyl. Titanium-3-vinyl The above compound was obtained by the same method as in Example 165 above to obtain the above compound. Yield: 92% Melting point: Oily 4 NMR (CDC13) (5: 1.41 (3H.d ), 2.44 (3H, s), 2.98 (4H, t), 3.36 (4H, t), 3.74 (6H, s), 3.98 (3H, s), 4.40 (2H, s), 5.00 (lH, q) , 6.08 (3H, m), 7.69 (lH, s) Example 168) Ethyl 2-({[4- (3,5-Difluorenylphenyl) yl] quinyl} (5- (1- Hydroxyethyl) -2-methoxy-6-methyl. Pyridin-3-amidino) amino] acetate ethyl-2-({[4- (3,5-dimethylphenyl ) Travel] carbonyl} (5-ethynyl-2-methoxy-6-methylpyridin-3-amidino) amino] acetate, which was reacted in the same manner as in Example 15 2 above, The above compounds can be obtained. Yield: 94% Melting point 68 ~ 70 ° C -104- This paper size is applicable to China National Standard (CNS) A4 (210 X 297 mm) (Please read the precautions on the back before filling this page)-Packing ·, 11 d 575564 A7 _______ B7 V. Description of the invention (100)! H NMR (CDC13) 5: 1.13 (3H, t) 1.47 (3H, d), 2. 33 (6H, s), 2.44 (3H, s ), 2.95 (4H, t), 3. 30 (4H, t), 3. 98 (3H, s), 4.10 (2H, q), 5.01 (lH, q), 6. 46 (3H, m), 7. 71 (1H, s) Example 169) 2-({[4- (3,5-Difluorenylphenyl) pyrazine] Weiji} (5_ (1-Ethyl) -2-form Oxy-6-methyl-2-methyl-3-amino) amino] acetate ethyl-2-({[4- (3,5-dimethylphenyl) piperazine] carbonyl} (5- Ethyl-2-methoxy-6-methyllazin-3-amidino) amino] acetate was reacted in the same manner as in Example 165 above to obtain the above compound. Yield: 92%

熔點:114〜116°C β NMR(CDC13) 5 :1· 40(3H,d),2. 23(6H,s), 2. 40(3H,s),2. 91(4H,t),3· 21(4H,t),3. 98(3H,s), 4. 〇6(2H,s),4. 90(lH,q),6· 50(3H,m) 6. 5i(iH,s) (請先閱讀背面之注意事項再填寫本頁) 、一'll 經濟部中央標準局員工消費合作社印製 準 標 I家 -國 國 I中 用 一適 -尺 I張 紙 本 05 I釐 公 575564 A7 B7Melting point: 114 ~ 116 ° C β NMR (CDC13) 5: 1.440 (3H, d), 2.23 (6H, s), 2. 40 (3H, s), 2. 91 (4H, t), 3.21 (4H, t), 3.98 (3H, s), 4.〇6 (2H, s), 4.90 (lH, q), 6.50 (3H, m) 6. 5i (iH , S) (Please read the notes on the back before filling this page), I'll print the standard I family-Guo Guo I in a standard-size I sheet of paper 05 I Cm 575564 A7 B7

發明説明(101 ) 蠢Invention Description (101)

實施例 編號 Ri R-2 H3 R4 R5 R6 R? P^8 A X z • Y 170 Me Me H H H H H H CH 〇 OMe 3-N 171 Me Me H OMe H OMe H H CH 〇 OMe 3-N 172 Me Me H Me H Me H H CH 〇 OMe 3-N 173 Me Me Me Me H H H H CH 〇 OMe 3-N 174 Me Me Me Me H Me Me H CH 〇 OMe 3-N 175 Me Me H F H F H H CH 〇 OMe 3-N 176 Me Me Cl H H H H H CH 〇 OMe 3-N 177 Me Me H Cl H H H H CH 〇 OMe 3-N 178 Me Me OH H H H H . H CH 〇 OMe 3-N 179 Me Me H OH H H H H CH 〇 OMe 3-N ί j 180 Me Me H SH H H H H CH 〇 OMe 3-N 181 Me Me 〇Ac H H H H H CH 〇 OMe 3-Ni I 182产 Me Me H 〇Ac H H H H CH 〇 OMe 3-N 183 Me Me OMe H H H H H CH 〇 OMe 3-N 184 Me Me H Me H H OMe H CH 〇 OMe丨 1 |3-N! 1 1 185 Me Me H OMe H H Me H CH 〇 OMe 3-N 186 Me Me H OMe H H Ph H CH 〇 OMe 3-N 187 Me Me 人 H H H H H CH 〇 OMe 3-N 188 Me Me Benzo H H H H CH 〇 OMe 3-N 189 Me Me Naphto H H H H CH 0 OMe 3-N __________j 190 Me Me H OMe H OMe H Me CH 〇 OMe 3-N 1 191 Me Me H Me H Me H Me CH 〇 OMe ----1 3-N 192 Me Me H F H F H Me CH 〇 'OMe 3-N 193 Me Me H OMe H OMe H Et CH 〇 OMe 3-N 194 Me Me H Me H Me H Et CH 〇 OMe 3-N -106 - I尺度適用中國國家標準(CNS ) A4規格(21〇'乂297公釐) (請先閲讀背面之注意事項再填寫本頁) '裝-- 、訂------- 8 I - - —a - — - !. 575564 五、發明説明(102)Example number Ri R-2 H3 R4 R5 R6 R? P ^ 8 AX z • Y 170 Me Me HHHHHH CH 〇OMe 3-N 171 Me Me H OMe H OMe HH CH 〇OMe 3-N 172 Me Me H Me H Me HH CH 〇OMe 3-N 173 Me Me Me HHHH CH 〇OMe 3-N 174 Me Me Me H Me Me H CH 〇OMe 3-N 175 Me Me HFHFHH CH 〇OMe 3-N 176 Me Me Cl HHHHH CH 〇OMe 3-N 177 Me Me H Cl HHHH CH 〇OMe 3-N 178 Me Me OH HHHH. H CH 〇OMe 3-N 179 Me Me H OH HHHH CH 〇OMe 3-N ί j 180 Me Me H SH HHHH CH 〇OMe 3-N 181 Me Me 〇Ac HHHHH CH 〇OMe 3-Ni I 182 Me Me H 〇Ac HHHH CH 〇OMe 3-N 183 Me Me OMe HHHHH CH 〇OMe 3-N 184 Me Me H Me HH OMe H CH 〇OMe 丨 1 | 3-N! 1 1 185 Me Me H OMe HH Me H CH 〇OMe 3-N 186 Me Me H OMe HH Ph H CH 〇OMe 3-N 187 Me Me human HHHHH CH 〇 OMe 3-N 188 Me Me Benzo HHHH CH 〇OMe 3-N 189 Me Me Naphto HHHH CH 0 OMe 3-N __________j 190 Me Me H OMe H OMe H Me CH 〇OMe 3-N 1 191 Me Me H Me H Me H Me CH 〇OMe ---- 1 3-N 192 Me Me HFH FH Me CH 〇'OMe 3-N 193 Me Me H OMe H OMe H Et CH 〇OMe 3-N 194 Me Me H Me H Me H Et CH 〇OMe 3-N -106-I standard is applicable to Chinese national standards (CNS ) A4 specification (21〇 '乂 297mm) (Please read the precautions on the back before filling out this page) V. Invention Description (102)

A B 經濟部中央標準局員工消費合作社印製 實施例 編號 、―' I τ~\ Κ} j Κ2 j Rs R4 Rs Rv j j P^8 1 A ! xl ! z .η 1 195 Me Me H F H F H Et CH 〇 OMe 3-N 196 Me Me H F H H iPr CH 〇 OMe 3-N 197 Me Me H OMe H OMe H H CH s OMe 3-N 198 Me Me H Me H Me H H CH s OMe 3-N 199 Me Me Me Me .H H H H CH s OMe 3-N 200 Me Me H F H F H H CH s OMe 3-N 201 Me Me H Cl H ! Cl H H CI-I s OMe 3-N 202 Me Me F H H H H H CH s OMe 3-N 203 Me Me Cl H H H H H CH s OMe 3-N 204 Me Me OMe H H H H H CH s OMe 3-N 205 Me Me SMe H H H H· H CH s OMe 3-N 1 206 Me Me H OH H H H H CH s OMe 3-N- 207 Me Me 〇Ph H H H H H CH s OMe 3-N j 208 Me Me 人 H H H Ή H CH s ! OMe 1 3-N| 1 209’ Me Me H OMe H H Me H CH s ----j---j OMe |3-N 1 i 210 Me Me Benzo H H H H CH s OMe 3-N| 211 Me Acetyl H OMe H OMe H H CH 〇 OMe 3-N 1 _j 212 Me Acetyl H Me H Me H H CH 〇 OMe 3-N 213 Me Acetyl H Cl H Cl H H CH 〇 OMe 3-N 214 Me' OH H OMe H OMe H H CH 〇 ONie 1 3-N I 215 Me OH H Me H Me H H CH 〇 OMe ! i P-n! ! ; I_____ 216 Me Vinyl H OMe H OMe H H CH 〇 OMe 3-N 217 Me Vinyl H Me H Me H H CH 〇 OMe 3-N 218 Me Acetyl H OMe H OMe H H CH s OMe 3-N 219 Me Acetyl H Me H Me H H CH s OMe 3-N 220 Me Acetyl H Cl H Cl H H CH s OMe 3-N 221 Me OH H OMe H OMe H 1 H CH s OMe 3-N ! -107- (請先閱讀背面之注意事項再填寫本頁)AB Consumer Council of the Central Standards Bureau, Ministry of Economic Affairs, printed the serial number of the embodiment, ― 'I τ ~ \ Κ} j Κ2 j Rs R4 Rs Rv jj P ^ 8 1 A! Xl! Z .η 1 195 Me Me HFHFH Et CH 〇 OMe 3-N 196 Me Me HFHH iPr CH 〇OMe 3-N 197 Me Me H OMe H OMe HH CH s OMe 3-N 198 Me Me H Me H Me HH CH s OMe 3-N 199 Me Me Me Me .HHHH CH s OMe 3-N 200 Me Me HFHFHH CH s OMe 3-N 201 Me Me H Cl H! Cl HH CI-I s OMe 3-N 202 Me Me FHHHHH CH s OMe 3-N 203 Me Me Cl HHHHH CH s OMe 3-N 204 Me Me OMe HHHHH CH s OMe 3-N 205 Me Me SMe HHHH · H CH s OMe 3-N 1 206 Me Me H OH HHHH CH s OMe 3-N- 207 Me Me 〇Ph HHHHH CH s OMe 3-N j 208 Me Me Human HHH Ή H CH s! OMe 1 3-N | 1 209 'Me Me H OMe HH Me H CH s ---- j --- j OMe | 3-N 1 i 210 Me Me Benzo HHHH CH s OMe 3-N | 211 Me Acetyl H OMe H OMe HH CH 〇OMe 3-N 1 _j 212 Me Acetyl H Me H Me HH CH 〇OMe 3-N 213 Me Acetyl H Cl H Cl HH CH 〇OMe 3-N 214 Me 'OH H OMe H OMe HH CH 〇ONie 1 3-NI 215 Me OH H Me H Me HH CH 〇OMe! I Pn!!; I_____ 216 Me Vinyl H OMe H OMe HH CH 〇OMe 3-N 217 Me Vinyl H Me H Me HH CH 〇OMe 3-N 218 Me Acetyl H OMe H OMe HH CH s OMe 3 -N 219 Me Acetyl H Me H Me HH CH s OMe 3-N 220 Me Acetyl H Cl H Cl HH CH s OMe 3-N 221 Me OH H OMe H OMe H 1 H CH s OMe 3-N! -107- (Please read the notes on the back before filling this page)

本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 575564This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 575564

AA

7 B 五、發明説明(103) %7 B V. Description of invention (103)%

實施例 編號 Ri .μ R5 Re R7 Kg A x| 1 ! ! ! Z ^ Y I 丨丨.1 i 222 Me H Me H Me H 1 H 1 CH s 1 OMe 3-N 223 Me OH H Cl H Cl H H CH s OMe 3-N 224 Me Me H 〇Me H ϊ 〇Me H 0 CH^OEt CH 〇 OMe 3-N 225 Me Me H Me H Me H 0 CH^'oEt CH 〇 OMe 3-N 226 Me Me H 〇Me H 〇Me H 0 CH^OH CH 〇 OMe 3-N j 227 Me Me H Me H Me H 0 CH^OH CH 〇 OMe 3-N 228 Me Me H 〇Me H 〇Me H H CH 〇 OH 3-N 229 Me Me H Me H Me H H CH 〇 OH 3-N 230’ ^ Me Me H F H F H H CH 〇 OH 3-N 231 Me Me H Cl H Cl H H CH 〇 OH 3-N I!丨丨"· (請先閱讀背面之注意事項再填寫本頁) 、tr 4 經濟部中央標準局員工消費合作社印製 -108- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 575564 A7 五 經濟部中央標準局員工消費合作社印製 發明説明(104) 實施例170) H(4,5二甲基j甲氧基苯基)胺基羰 基]-4 -苯基派嘻 a) 3,4-二甲基茴香_ 將3,4-二曱基苯(19.3^〇.16毫莫耳),添加曱醇 (15〇ml),並添加氫氧化鉀(9.65g,0.25毫莫耳),還流2 小時。然後再添加碘化甲烷(36e5g,0.25毫莫耳),還流 3小時。添加水(15〇1111),利用乙基醋酸酯進行萃取後, 再以管柱層析法進行分離精製後,便可獲得上述化合 物。 收成率:81% !H NMR(500MHz5CDC13) ά :2.20(3H?s)? 2.24(3H?s)? 3.77(3H,s),6.71(2H,m),6.97(lH,s) b) 4,5 - <一曱基-2 ·石肖基菌香鱗 將3,4-二曱基茴香醚(17.lg,0.13毫莫耳),添加三 氟醋酸(25〇1111),並以水槽徐緩添加亞氮酸鈉(16.6&〇24 毫莫耳),於室溫下攪拌14小時。將三氟醋酸予以去 除後,再添加水(150ml),利用乙醚進行萃取後,再以 管柱層析法進行分離精製後,便可獲得上述化合物。 收成率:55% 4 NMR(500MHz,CDC13) (5 :2.25(3H,s),2.32(3fl,s), 3.94(3H,s),6.85 (1H,s),7.70(1H,s) e) 4,5 *·—曱基-2-甲氧基茵香鍵 將4,5-二曱基-2-石肖基菌香(7.80g,〇 〇43莫耳), 添加四氳吡喃(100ml)與乙醇(4〇ml),並以徐緩添加麵 -109- 本紙張尺度適用中國國家標準(CNS ) a4規格(210X 297公釐) (請先閱讀背面之注意事項存填寫本頁) 一装· 訂 4 575564 A7 發明説明 105 /活性碳(〇.57g),進行5小時的氫化反應。待利用相 同方法進行反應結束後,以管柱層析法進行分離精製 後,便可獲得上述化合物。 μ衣收成率:82% Ή NMR(500MHz,CDC13) 5 :2.23(3H,s),2.27(3H,s), 3.90 (3H,s), 6.80(lH,s),7.68(lH,s) d) 苯基N-(4,5-二甲基-2-甲氧基苯基)甲酸酯 於4,5-二甲基-2-甲氧基茴香醚(4.5〇g,0 〇3莫耳) 中三添加二氯乙烷(100ml),一邊攪拌同時徐緩添加苯 基氯化甲酸酯(4.80g,0.03莫耳),待攪拌2小時後,利 用二氯f烷予以進行萃取,並以管柱層析法進行分離 精製後,便可獲得上述化合物。收成率:98%1H NMR(5〇〇MHz?CDC13) 5 :2. 24(3H, s), 2. 27(3H, s),3. 89(3H5 s), 6. 85( 1H, s), 7. 20(5H, in), 7. 90(1H, s) e) 1[(4,5-二甲基-2-甲氧基苯基)胺基幾基苯基派 嗪 (請先閱讀背面之注意事項再填寫本頁) ί裝· 、1Τ 經濟部中央榡準局員工消費合作社印製Example number Ri .μ R5 Re R7 Kg A x | 1!!! Z ^ YI 丨 丨 .1 i 222 Me H Me H Me H 1 H 1 CH s 1 OMe 3-N 223 Me OH H Cl H Cl HH CH s OMe 3-N 224 Me Me H 〇Me H ϊ 〇Me H 0 CH ^ OEt CH 〇OMe 3-N 225 Me Me H Me H Me H 0 CH ^ 'oEt CH 〇OMe 3-N 226 Me Me H 〇Me H 〇Me H 0 CH ^ OH CH 〇OMe 3-N j 227 Me Me H Me H Me H 0 CH ^ OH CH 〇OMe 3-N 228 Me Me H 〇Me H 〇Me HH CH 〇OH 3- N 229 Me Me H Me H Me HH CH 〇OH 3-N 230 '^ Me Me HFHFHH CH 〇OH 3-N 231 Me Me H Cl H Cl HH CH 〇OH 3-NI! 丨 丨 " (Please first Read the notes on the back and fill out this page), tr 4 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs -108- This paper size applies to China National Standard (CNS) A4 (210X 297 mm) 575564 A7 Printed by the Bureau of Consumers of the Bureau of Standards (104) Example 170) H (4,5dimethyljmethoxyphenyl) aminocarbonyl] -4 -phenylpyridine) 3,4-dimethyl Fennel_ 3,4-Difluorenylbenzene (19.3 ^ 0.16 mmol), add methanol (150 ml), and add Potassium hydroxide (9.65g, 0.25 mmol), a reflux for 2 hours. Methane iodide (36e5g, 0.25 millimoles) was then added and allowed to flow for 3 hours. The above compound can be obtained by adding water (1501011), extracting with ethyl acetate, and then separating and purifying by column chromatography. Yield: 81%! H NMR (500MHz5CDC13) ά: 2.20 (3H? S)? 2.24 (3H? S)? 3.77 (3H, s), 6.71 (2H, m), 6.97 (lH, s) b) 4 , 5-< Monosyl-2 · Schizophyllum spp. 3,4-Difluorenyl anisole (17.lg, 0.13 millimoles), trifluoroacetic acid (25〇1111) was added, and slowly Sodium nitrite (16.6 & mmol) was added and stirred at room temperature for 14 hours. After removing trifluoroacetic acid, water (150 ml) was added, extraction was performed with diethyl ether, and then column chromatography was used for separation and purification to obtain the above compound. Yield: 55% 4 NMR (500MHz, CDC13) (5: 2.25 (3H, s), 2.32 (3fl, s), 3.94 (3H, s), 6.85 (1H, s), 7.70 (1H, s) e ) 4,5 *-fluorenyl-2-methoxyindocyanine bond 4,5-Difluorenyl-2-stone scent base (7.80g, 0.0043 moles), add tetrapyran (100ml) ) And ethanol (40ml), and slowly add the surface -109- This paper size applies the Chinese National Standard (CNS) a4 specifications (210X 297 mm) (Please read the precautions on the back first and fill in this page) · Order 4 575564 A7 Description of the Invention 105 / activated carbon (0.57 g), hydrogenation reaction is performed for 5 hours. After the completion of the reaction by the same method, separation and purification by column chromatography can obtain the above compounds. Yield: 82% Ή NMR (500MHz, CDC13) 5: 2.23 (3H, s), 2.27 (3H, s), 3.90 (3H, s), 6.80 (lH, s), 7.68 (lH, s) d) Phenyl N- (4,5-dimethyl-2-methoxyphenyl) formate in 4,5-dimethyl-2-methoxyanisole (4.50 g, 0.3 Mole) Dichloroethane (100ml) was added, and phenyl chloride (4.80g, 0.03 mole) was slowly added while stirring. After stirring for 2 hours, dichlorofane was used for extraction. After separation and purification by column chromatography, the above compounds can be obtained. Yield: 98% 1H NMR (500MHz? CDC13) 5: 2.24 (3H, s), 2. 27 (3H, s), 3.89 (3H5 s), 6. 85 (1H, s ), 7. 20 (5H, in), 7. 90 (1H, s) e) 1 [(4,5-Dimethyl-2-methoxyphenyl) aminojipinylpyrazine (please (Please read the notes on the back before filling in this page.) Printed by 1 消费 Printed by the Consumers' Cooperative of the Central Government Bureau of the Ministry of Economic Affairs

將苯基N-(4,5-二甲基甲氧基苯基)甲酸酯 2g’〇.〇2莫耳)與1-苯基σ底嗪(344g,〇〇2莫耳), /合解於四氫,比喃(10ml)中,並添加DBU(3 04g,0 M 莫耳)後’於室溫下攪拌2小時,將反應物予以濃縮 後利用官柱層析法進行分離精製後,便可獲得上 述化合物。 收成率:85% • Bn I -i m 的 丨 -110-▲張尺細 II - - g-- 經濟部中央榡準局員工消費合作社印製 575564 A7 ________ B7 五、發明説明(1〇6)Phenyl N- (4,5-dimethylmethoxyphenyl) formate 2g'.002mol) and 1-phenylσ-diazine (344g, 002mol), / Combined in tetrahydro, biran (10ml), and added DBU (304g, 0 M Mol), and then stirred at room temperature for 2 hours, the reaction was concentrated, and then separated and purified by column chromatography. After that, the above compound can be obtained. Yield: 85% • Bn I -i m 丨 -110- ▲ Zhang Rulen II--g-- Printed by the Employees' Cooperatives of the Central Procurement Bureau of the Ministry of Economic Affairs 575564 A7 ________ B7 V. Description of the invention (106)

熔點:143〜144°C lR NMR(500MHz?CDC13):2. 20(3H, s), 2. 21(3H, s), 3. 25(4H,t),3· 67(4H,t),3· 85(3H,s),6. 64(1H,s), 6.94(3H,m),6.99(lH,s) ’ 貫施例171) l-[(4,5-二甲基-2·甲氧基苯基)胺基羰 基]-4-(3,5-二甲氧基苯基)哌嗪 將本基Ν-(4,5-一甲基-2-甲氧基苯基)甲酸酯與卜 (3,5-二曱氧基苯基)哌嗪,採行如同上述實施例17〇相 同的方法進行反應,而可獲得上述化合物。 收成率·· 85%Melting point: 143 ~ 144 ° C lR NMR (500MHz? CDC13): 2. 20 (3H, s), 2. 21 (3H, s), 3. 25 (4H, t), 3.67 (4H, t) , 3.85 (3H, s), 6.64 (1H, s), 6.94 (3H, m), 6.99 (lH, s) 'Example 171) l-[(4,5-dimethyl- 2 · methoxyphenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine will be the base N- (4,5-monomethyl-2-methoxyphenyl ) The formate and di (3,5-dioxophenyl) piperazine can be reacted in the same manner as in Example 170 above to obtain the above compound. Yield · 85%

熔點:119〜120°C ^ NMR(500MHz5CDC13) d :2. 20(3H, s), 2. 21(3H, s), 3.27(4H,t),3.70(4H,t),3.79(6H,s),3.85(3H,s), 6.65(1H,s),6.98(1H,s),7.90(1H,S)Melting point: 119 ~ 120 ° C ^ NMR (500MHz5CDC13) d: 2.20 (3H, s), 2. 21 (3H, s), 3.27 (4H, t), 3.70 (4H, t), 3.79 (6H, s), 3.85 (3H, s), 6.65 (1H, s), 6.98 (1H, s), 7.90 (1H, S)

Mass(EI) m/z:399.2168 (MH,C22H2GN3〇4 計算值: 399.2158) 貫施例172) M(4,5-二曱基-2-甲氧基苯基)胺基羰 基]-4-(3,5-二曱基苯基)哌嗪 將苯基N-(4,5-二甲基-2-甲氧基苯基)甲酸酯與i_ (3,5-二甲基苯基)σ辰嗔,採行如同上述實施例17〇相同 的方法進行反應,而可獲得上述化合物。 收成率:88%Mass (EI) m / z: 399.2168 (MH, C22H2GN3104 calculated: 399.2158) Example 172) M (4,5-diamidino-2-methoxyphenyl) aminocarbonyl] -4- (3,5-Dimethylphenyl) piperazinePhenyl N- (4,5-dimethyl-2-methoxyphenyl) formate and i_ (3,5-dimethylphenyl ) Chen Chen, the same method as in Example 170 above was used to perform the reaction to obtain the above compound. Yield: 88%

熔點:177〜178°C -111 - (請先閲讀背面之注意事項再填寫本頁)Melting point: 177 ~ 178 ° C -111-(Please read the precautions on the back before filling this page)

、1T — 本紙張尺度適用巾國國家檩準(CNS) A4規格 (210X297公釐) 575564 A7 B7 五、發明説明( 107 經濟部中央標準局員工消費合作社印製 ln NMR(500MHz5CDC13)(?:2. 20(3H, s), 2. 21(3H, s),2.29(6H,s), 3.23(4H,t),3.66(4H,t),3.85(3H,s),6. 58(2H, m), 6. 65(1H, s), 6. 99(1H, s), 7. 92(1H, s) Mass(EI) m/z:367.2290 (MH,C22H29N302 計算值·· 367.2259) 實施例173) l-[(4,5_二甲基-2-甲氧基苯基)胺基羰 基]-4-(2,3-二甲基苯基)哌嗪 將苯基N-(4,5-二甲基_2_甲氧基苯基)甲酸酯與卜 (2,3-二甲基苯基)哌嗪,採行如同上述實施例17〇相同 的方法進行反應,而可獲得上述化合物。 收成率:95% 熔點:140〜142°C lHNMR(500MHz,CDCl3H: 2.21(3H,S),2 22(3H,S)2.27(3H,s),2.29(3H,s),2.95(4H,t),3.67(4H,t),3二 85(3H,s),6.65(lH,s),7.〇l(3H,m),7.93(lH,s) 貫施例174) l-[(4,5-二甲基_2_甲氧基苯基)胺基羰 基]-4_(2,3,5,6_四甲基苯基辰口秦 將笨基N-(4,5-二曱基-2-甲氧基苯基)曱酸酯與1-(2,3,5,6-四甲基苯基)哌嗪,採行如同上述實施例17〇 相同的方法進行反應,而可獲得上述化合物。 收成率:93% 少谷點·油狀 -112-, 1T — This paper is applicable to the national standard (CNS) A4 size of the paper country (210X297mm) 575564 A7 B7 V. Description of the invention (107 Printed by ln NMR (500MHz5CDC13) by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 20 (3H, s), 2. 21 (3H, s), 2.29 (6H, s), 3.23 (4H, t), 3.66 (4H, t), 3.85 (3H, s), 6. 58 (2H , m), 6. 65 (1H, s), 6. 99 (1H, s), 7. 92 (1H, s) Mass (EI) m / z: 367.2290 (MH, C22H29N302 calculated value 367.2259) Implementation Example 173) l-[(4,5-Dimethyl-2-methoxyphenyl) aminocarbonyl] -4- (2,3-dimethylphenyl) piperazine and phenyl N- (4 , 5-Dimethyl-2-methoxyphenyl) formate and di (2,3-dimethylphenyl) piperazine can be reacted in the same manner as in Example 17 above, but can The above compound is obtained. Yield: 95% Melting point: 140 ~ 142 ° C lHNMR (500MHz, CDCl3H: 2.21 (3H, S), 2 22 (3H, S) 2.27 (3H, s), 2.29 (3H, s), 2.95 (4H, t), 3.67 (4H, t), 325 (3H, s), 6.65 (lH, s), 7.01 (3H, m), 7.93 (lH, s) Example 174 ) l-[(4,5-dimethyl-2-methoxyphenyl) aminocarbonyl] -4_ (2,3,5,6-tetramethylphenyl Qin used benzylic N- (4,5-diamidino-2-methoxyphenyl) acetate and 1- (2,3,5,6-tetramethylphenyl) piperazine as follows The above-mentioned compound was reacted in the same manner as in Example 170 to obtain the above-mentioned compound. Yield: 93%.

---------^^装-- (請先閲讀背面之注意事項再填寫本頁) 訂 d 經濟部中央標準局員工消費合作社印製 575564 A7 ____ B7 五、發明説明(108) lH NMR(500MHz5CDC13)5: 2. 20(9H, s), 2.21(9H, s), 3.17(4H,t),3.63(4H,t),3.84(3H,s),6.64(1H,s), 6.84(1H,s),7.95(lH,s) 實施例175) l-[(4,5_二甲基-2-甲氧基苯基)胺基羰 基]_4-(3,5-二氟化苯基)哌嗪 將苯基N-(4,5-二曱基-2-甲氧基苯基)甲酸酯與1-(3,5-二氟化苯基)哌嗉,採行如同上述實施例17〇相同 的方法進行反應,而可獲得上述化合物。 收成率:89%--------- ^^ 装-(Please read the precautions on the back before filling out this page) Order d Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 ____ B7 V. Description of Invention (108) lH NMR (500MHz5CDC13) 5: 2. 20 (9H, s), 2.21 (9H, s), 3.17 (4H, t), 3.63 (4H, t), 3.84 (3H, s), 6.64 (1H, s) , 6.84 (1H, s), 7.95 (lH, s) Example 175) l-[(4,5-Dimethyl-2-methoxyphenyl) aminocarbonyl] 4- (3,5-di Fluorinated phenyl) piperazinePhenyl N- (4,5-difluorenyl-2-methoxyphenyl) formate and 1- (3,5-difluorinated phenyl) piperazine The reaction was carried out in the same manner as in the above Example 17 to obtain the above compound. Yield: 89%

熔點:102〜103°C 4 NMR(500MHz,CDC13) 6 :2. 20(3H,s),2. 22(3H,s), 3.29(4H,t),3.68(4H,t),3.85(3H,s),6.65(lH,s), 6.97(3H,m),7.89(lH,s) 實施例176) l-[(4,5-二甲基-2-甲氧基苯基)胺基羰 基]-4-(2-氯化苯基)σ底口秦 將苯基Ν-(4,5-二甲基-2-甲氧基苯基)曱酸酯與卜 (2-氯化苯基辰嘻,採行如同上述實施例17〇相同的 方法進行反應,而可獲得上述化合物。 收成率:90%Melting point: 102 ~ 103 ° C 4 NMR (500MHz, CDC13) 6: 2.20 (3H, s), 2.22 (3H, s), 3.29 (4H, t), 3.68 (4H, t), 3.85 ( 3H, s), 6.65 (lH, s), 6.97 (3H, m), 7.89 (lH, s) Example 176) l-[(4,5-dimethyl-2-methoxyphenyl) amine Carbonyl] -4- (2-chlorinated phenyl) σ bottom phenyl phenyl N- (4,5-dimethyl-2-methoxyphenyl) phosphonate and (2-chlorinated Phenyl chenchi was reacted in the same manner as in Example 17 above to obtain the above compound. Yield: 90%

熔點:176〜177°C 'H NMR(5〇〇MHz?CDC13) δ : 2. 21(3Η, s), 2. 22(3Η, s), 3.l〇(4H,t,J = 5.0 Ηζ),3.69(4H,t,J = 5.0Hz), 3.85(3H,S),6.65(lH,s),7.02(2H,m),7·24(ΐΗ,ιη), 7.39(IH,d,J = 4.0Hz),7.92(lH,s) 本紙張尺度適用中國國家標準(CNS ) Μ規格(210X297公釐j I. c.ir (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 575564 A7 B7 五、發明説明(1〇9) — ' — ·一" 貫化例177) 1-[(4,5-二曱基_2-甲氧基苯基)胺基羰 基]-4-(3 -氣化苯基)呢嗪 ^將苯基N-(4,5-二曱基_2-曱氧基苯基)甲酸酯與卜 (3-氯化苯基)哌嗉,採行如同上述實施例i7〇相同的 方法進行反應,而可獲得上述化合物。 收成率·· 84%Melting point: 176 ~ 177 ° C 'H NMR (500MHz? CDC13) δ: 2. 21 (3Η, s), 2. 22 (3Η, s), 3.10 (4H, t, J = 5.0 Ηζ), 3.69 (4H, t, J = 5.0Hz), 3.85 (3H, S), 6.65 (lH, s), 7.02 (2H, m), 7.24 (ΐΗ, ιη), 7.39 (IH, d , J = 4.0Hz), 7.92 (lH, s) This paper size is applicable to Chinese National Standard (CNS) M specifications (210X297mm j I. c.ir (Please read the precautions on the back before filling this page) Ministry of Economy Printed by the Consumer Standards Cooperative of the Central Bureau of Standards 575564 A7 B7 V. Description of the invention (109) — '— · 一 " 化 化 例 177) 1-[(4,5-Difluorenyl_2-methoxybenzene (Amino) aminocarbonyl] -4- (3-gasified phenyl) morphazine ^ Phenyl N- (4,5-diamidino_2-methoxyphenyl) formate and (3- The phenyl) piperidine chloride was reacted in the same manner as in Example i70 above to obtain the above compound. Yield · 84%

熔點:75〜76〇C 'H NMR(500MHz5CDC13)5: 2. 20(3H, s), 2. 22(3H, s), 3.27(4H,L,J=S.0HZ ),3.68(4H,t,J = 5.0Hz), 3.85(3H,s),6.65(lH,s),6.90(3H,m),7.21(lH,t), 7· 90(1H,s)Melting point: 75 ~ 76 ° C'H NMR (500MHz5CDC13) 5: 2.20 (3H, s), 2.22 (3H, s), 3.27 (4H, L, J = S.0HZ), 3.68 (4H, t, J = 5.0 Hz), 3.85 (3H, s), 6.65 (lH, s), 6.90 (3H, m), 7.21 (lH, t), 7.90 (1H, s)

Mass(EI) m/z:373.1590 (MH,C2GH24N302 Cl 計算值: 373.1557) 實施例178) l-[(4,5-二甲基-2-甲氧基苯基)胺基羰 基]-4-(2-經苯基)旅嘻 將苯基N-(4,5-二甲基-2-甲氧基苯基)甲酸酯與1-(2-羥苯基)哌嗪’採行如同上述實施例1相同的方法 進行反應,而可獲得上述化合物。 收成率:87%Mass (EI) m / z: 373.1590 (MH, C2GH24N302 Cl calculated: 373.1557) Example 178) l-[(4,5-dimethyl-2-methoxyphenyl) aminocarbonyl] -4- (2-Vinyl) Lv Hei uses phenyl N- (4,5-dimethyl-2-methoxyphenyl) formate and 1- (2-hydroxyphenyl) piperazine 'as The reaction was carried out in the same manner as in Example 1 to obtain the compound. Yield: 87%

熔點:197〜199°C !H NMR(500MHz?CDC13)5:2. 20(3H, s), 2. 21(3H, s), 2.98(4H, t), 3.72C4H, t), 3. 84(3H, s), 6.65(1H, s), 6. 89(1 H, t), 7. 00(2H, m), 7. 1. 3(2H, m), 7. 89(1H, s) 實施例179) 1_[(4,5-二甲基-2-甲氧基苯基)胺基羰 -114- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) ;裝· 、tr 發明説明(n〇 ) 基]·4-(3-經苯基)派嗦 將苯基N-(4,5-二甲基_2_甲氧基苯基)甲酸酯與l (3-.苯基)旅嘻,採行如同上述實施例丨7〇相同的方 法進行反應,而可獲得上述化合物。 收成率:88% 熔點:177〜178。(: !H NMR(500MHz?CDC13)5:2. 19(3H, s), 2.21 (3H, s) 3.24(4H,t),3.68(4H,t),3.85(3H,s),6.41(3H,m), 6.65(1H,s),6.98(lH,s)7.13(lH,t),7.88(lH,s) 實施例180) l-[(4,5-二甲基-2-甲氧基苯基)胺基羰 基]-4-(3-硫代苯基)σ底嗔 將苯基Ν-(4,5-二甲基-2-甲氧基苯基)甲酸酯與κ (3-硫代苯基)哌嗉,採行如同上述實施例17〇相同的 方法進行反應,而可獲得上述化合物。 收成率:79%Melting point: 197 ~ 199 ° C! H NMR (500MHz? CDC13) 5: 2. 20 (3H, s), 2. 21 (3H, s), 2.98 (4H, t), 3.72C4H, t), 3. 84 (3H, s), 6.65 (1H, s), 6. 89 (1 H, t), 7. 00 (2H, m), 7. 1. 3 (2H, m), 7. 89 (1H, s) Example 179) 1 _ [(4,5-Dimethyl-2-methoxyphenyl) aminocarbonyl-114- This paper size applies to China National Standard (CNS) A4 (210X297 mm) (Please Read the precautions on the back before filling out this page); install ·, tr Description of invention (n〇) group] · 4- (3-Transphenyl) Send phenyl N- (4,5-dimethyl_ The 2-methoxyphenyl) formate was reacted with 1 (3-.phenyl) to carry out the reaction in the same manner as in Example 1.7 above to obtain the above compound. Yield: 88% Melting point: 177 ~ 178. (:! H NMR (500MHz? CDC13) 5: 2.19 (3H, s), 2.21 (3H, s) 3.24 (4H, t), 3.68 (4H, t), 3.85 (3H, s), 6.41 ( 3H, m), 6.65 (1H, s), 6.98 (lH, s) 7.13 (lH, t), 7.88 (lH, s) Example 180) l-[(4,5-dimethyl-2-methyl Oxyphenyl) aminocarbonyl] -4- (3-thiophenyl) σsubstituted phenyl N- (4,5-dimethyl-2-methoxyphenyl) formate with κ (3-thiophenyl) piperazine can be reacted in the same manner as in Example 170 above to obtain the above compound. Yield: 79%

熔點:108〜110°C ^ NMR(500MHz?CDC13) 5 :2. 20(3H, s), 2. 21. (3H, s) 3.26(4H,t,),3.65(4H,t),3.84(3H,s),6.64(1H,S) 6.97(4H,m),7.05(lH,s),7.89(lH,s) 實施例181) l-[(4,5-二曱基-2-甲氧基苯基)胺基羰 基]-4-(2-乙氧基苯基)旅嗪 將苯基Ν-(4,5-二甲基-2-甲氧基苯基)甲酸酯與κ (2-乙氧基苯基)哌嗪,採行如同上述實施例17〇相同 的方法進行反應,而可獲得上述化合物。 -115- 575564 經濟部中央標準局員工消費合作杜印製 A7 —______ _ B7 五、發明説明~^ ~~~~ 收成率·· 84% 熔點:129〜131°C 'H NMR(500MHz,CDC13) ,5 :2. 2〇(3H, s), 2. 21(3H, s) 2.32(3H,s), 3.05(4H,t), 3.63(41f,t), 3. 85(3H, s), 6.64(1H,s), 6.99(1H,s), 7.〇4(lH,m), 7.17(2H,m), 7. 22(lH,m),7· 90(1H, s) ’ 實施例182) WW:甲基_2_甲氧基苯基)胺基幾 基]-4-(3-乙氧基苯基)哌嗪 將苯基Ν-(4,5-二甲基甲氧基苯基)甲酸醋與κ (3-乙氧基苯基)哌嗪,採行如同上述實施例17〇相同 的方法進行反應,而可獲得上述化合物。 收成率:87% 熔點:154〜156°C !H NMR(500MHz,CDC13) 5 :2. 20(3H, s), 2. 21(3H, s) 2.29(3H,s), 3.27 (4H, t), 3. 68(4H, t), 3. 85(3H, s), 6.64(1H,s), 6.66(2H,m), 6.82(lH,m), 6.98(lH,s) ' 7. 90(1H, s) ’ 實施例183) 1_[(4,5-二曱基-2-曱氧基苯基)胺基羰 基]_4-(2-曱氧基苯基)哌嗪 將苯基Ν-(4,5-二甲基-2-甲氧基苯基)甲酸酯與κ (2-甲氧基苯基)哌嗪,採行如同上述實施例丨7〇相同 的方法進行反應,而可獲得上述化合物。 收成率:90% 熔點:144〜145°C -116- 本紙張尺度適用中國國家標準(CNS ) A4規格(210乂297公^~~^ - (請先閱讀背面之注意事項再填寫本頁) -裝- -訂_ 4 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(112) NMR(500MHz,CDC13) 5 :2. 20(3H, s), 2. 22(3H, s), 2. 26(3H, s), 2. 95(4H, t, J = 5. OHz), 3. 65(4H, t, J=5. 0Hz), 3.78(3H,s), 3. 85(3H, s), 6. 59(1H, s), 6.65(lH,s), 6.65(1H,s), 7.00(1H,s),7.11(1H,s),7.93(1H,s) 實施例m) 1-[(4,5_二甲基i甲氧基苯基)胺基羰 基]-4-(5-甲氧基-2_甲基苯基)哌嗪 將苯基N-(4,5-二甲基-2-曱氧基苯基)甲酸酯與^ (5-甲氧基-2-曱基苯基)哌嗪,採行如同上述實施例17〇 相同的方法進行反應,而可獲得上述化合物。 收成率:88%Melting point: 108 ~ 110 ° C ^ NMR (500MHz? CDC13) 5: 2.20 (3H, s), 2. 21. (3H, s) 3.26 (4H, t,), 3.65 (4H, t), 3.84 (3H, s), 6.64 (1H, S) 6.97 (4H, m), 7.05 (lH, s), 7.89 (lH, s) Example 181) l-[(4,5-Difluorenyl-2- Methoxyphenyl) aminocarbonyl] -4- (2-ethoxyphenyl) trazine is a phenyl N- (4,5-dimethyl-2-methoxyphenyl) formate with κ (2-ethoxyphenyl) piperazine can be reacted in the same manner as in Example 170 above to obtain the above compound. -115- 575564 Consumption cooperation by employees of the Central Bureau of Standards, Ministry of Economic Affairs, Du printed A7 —______ _ B7 V. Description of the invention ~ ^ ~~~~ Yield · 84% Melting point: 129 ~ 131 ° C ), 5: 2. 2 (3H, s), 2. 21 (3H, s) 2.32 (3H, s), 3.05 (4H, t), 3.63 (41f, t), 3. 85 (3H, s ), 6.64 (1H, s), 6.99 (1H, s), 7.〇4 (lH, m), 7.17 (2H, m), 7.22 (lH, m), 7.90 (1H, s) '' Example 182) WW: methyl_2_methoxyphenyl) aminochiridyl] -4- (3-ethoxyphenyl) piperazine phenyl N- (4,5-dimethyl The methoxyphenyl) carboxylic acid vinegar and kappa (3-ethoxyphenyl) piperazine were reacted in the same manner as in Example 170 above to obtain the above compound. Yield: 87% Melting point: 154 ~ 156 ° C! H NMR (500MHz, CDC13) 5: 2. 20 (3H, s), 2. 21 (3H, s) 2.29 (3H, s), 3.27 (4H, t), 3. 68 (4H, t), 3. 85 (3H, s), 6.64 (1H, s), 6.66 (2H, m), 6.82 (lH, m), 6.98 (lH, s) '7 90 (1H, s) 'Example 183) 1 _ [(4,5-Difluorenyl-2-fluorenylphenyl) aminocarbonyl] 4- (2-fluorenylphenyl) piperazine N- (4,5-dimethyl-2-methoxyphenyl) formate and κ (2-methoxyphenyl) piperazine were carried out in the same manner as in the above-mentioned Example 丨 70. Reaction to obtain the above compound. Yield: 90% Melting point: 144 ~ 145 ° C -116- This paper size is applicable to China National Standard (CNS) A4 specifications (210 公 297cm ^ ~~ ^-(Please read the precautions on the back before filling this page) -装--Order_ 4 575564 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (112) NMR (500MHz, CDC13) 5: 2. 20 (3H, s), 2. 22 (3H, s), 2. 26 (3H, s), 2. 95 (4H, t, J = 5. OHz), 3. 65 (4H, t, J = 5.0 Hz), 3.78 (3H, s), 3 85 (3H, s), 6.59 (1H, s), 6.65 (lH, s), 6.65 (1H, s), 7.00 (1H, s), 7.11 (1H, s), 7.93 (1H, s ) Example m) 1-[(4,5-Dimethylimethoxyphenyl) aminocarbonyl] -4- (5-methoxy-2-methylphenyl) piperazine -(4,5-dimethyl-2-methoxyphenyl) formate and ^ (5-methoxy-2-fluorenylphenyl) piperazine were used in the same manner as in Example 17 above. The reaction is carried out by the method to obtain the above-mentioned compound. Yield: 88%

少谷點· 140〜141 C !H NMR(500MHz?CDC13) 5 :2. 20(3H, s), 2. 22(3H? s), 2. 26(3H,s),2. 95(4H,t,J = 5· 0Hz),3. 65(4H,t,J:5· 0Hz), 3.78(3H,s),3.85(3H,s),6.59(1H,s),6.65(lH,s), 7· 〇〇(lH,s),7· 11(1H,s),7. 93(1H,s) 實施例185) l-[(4,5-二曱基-2-甲氧基苯基)胺基羰 基]-4-(2-甲氧基-5_曱基苯基)哌嗪 將苯基N-(4,5-二曱基-2-曱氧基苯基)甲酸酯與1-(2_曱氧基-5-曱基苯基)哌嗪,採行如同上述實施例17〇 相同的方法進行反應,而可獲得上述化合物。 收成率:88%Shao point · 140 ~ 141 C! H NMR (500MHz? CDC13) 5: 2.20 (3H, s), 2. 22 (3H? S), 2. 26 (3H, s), 2. 95 (4H , T, J = 5.0 Hz), 3. 65 (4H, t, J: 5.0 Hz), 3.78 (3H, s), 3.85 (3H, s), 6.59 (1H, s), 6.65 (lH, s), 7.0 (lH, s), 7.11 (1H, s), 7.93 (1H, s) Example 185) l-[(4,5-Difluorenyl-2-methoxy Phenyl) aminocarbonyl] -4- (2-methoxy-5_fluorenylphenyl) piperazinePhenyl N- (4,5-difluorenyl-2-fluorenylphenyl) methyl The above-mentioned compound can be obtained by reacting the acid ester with 1- (2-methoxy-2-methylphenyl) piperazine in the same manner as in Example 170 above. Yield: 88%

熔點:107〜l〇8°C ln NMR(5〇〇MHz?CDCl3) 5 :2. 20(3H, s), 2. 21 (3H, s), 2· 29(3H,s),3· 10(4H,t,J = 5· 0Hz),3· 69(4H,t,J = 5· 0Hz), -117- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) • <*· ΜΗΜΜΙ ΗΒΗΜΜν ·Η·ΗΜ·ι· I i m_i —m —·1Ηϋ ·ϋϋ iml mr tMK§Mt amfi (請先閱讀背面之注意事項再填寫本頁) 575564 經濟部中央標準局員工消費合作社印製 A7 發明説明(_ — 3. 85(3H, s), 3. 86(3H, s), 6. 55(1Η, s), 6. 79(2H, m), 7.01(1H,s),9.94(lH,s) 只施例186) ^ΙΧ4,5-二甲基-2-甲氧基苯基)胺基羰 基]-4-(2-甲氧基-5-苯基苯基)哌嗪 將笨基N-(4,5-二曱基-2-甲氧基苯基)曱酸酯與 (2-曱氧基-5-苯基苯基)哌嗪,採行如同上述實施例17〇 相同的方法進行反應,而可獲得上述化合物。 收成率:91%Melting point: 107 ~ 108 ° C ln NMR (500MHz? CDCl3) 5: 2.20 (3H, s), 2. 21 (3H, s), 2.29 (3H, s), 3. · 10 (4H, t, J = 5.0 Hz), 3. 69 (4H, t, J = 5.0 Hz), -117- This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) • < * · ΜΗΜΜΙ ΗΒΗΜΜν · Η · ΗΜ · ι · I i m_i —m — · 1Ηϋ · ϋϋ iml mr tMK§Mt amfi (Please read the precautions on the back before filling out this page) 575564 Employee Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs Printed A7 invention description (_ — 3. 85 (3H, s), 3. 86 (3H, s), 6. 55 (1Η, s), 6. 79 (2H, m), 7.01 (1H, s) , 9.94 (lH, s) only Example 186) ^ Ιχ4,5-dimethyl-2-methoxyphenyl) aminocarbonyl] -4- (2-methoxy-5-phenylphenyl) Piperazine The benzyl N- (4,5-difluorenyl-2-methoxyphenyl) phosphonate and (2-fluorenyl-5-phenylphenyl) piperazine were implemented as described above. The reaction was carried out in the same manner as in Example 170 to obtain the above compound. Yield: 91%

熔點:139〜140°C 4 NMR(500MHz,CDC13)心2· 21(3H,s),2· 22(3H,s), 2. 22(3H,s),3· 20(4H,t),3. 74(4H,t),3. 85(1H,s), 3.94(3H,s),6.65(lH,s),7.02(2H,m),7.32(2H,m), 7.49(2H,t),7.55(2H,d),7.93(lH,s) 實施例187) l-[(4,5-二甲基_2-甲氧基苯基)胺基羰 基]-4-(2-異丙苯基)哌嗪 將苯基Ν-(4,5-二甲基-2-甲氧基苯基)甲酸酯與1-(2-異丙苯基)哌嘻,採行如同上述實施例17〇相同的 方法進行反應,而可獲得上述化合物。 收成率:80%Melting point: 139 ~ 140 ° C 4 NMR (500MHz, CDC13) heart 2.21 (3H, s), 2.22 (3H, s), 2.22 (3H, s), 3.20 (4H, t) , 3.74 (4H, t), 3.85 (1H, s), 3.94 (3H, s), 6.65 (lH, s), 7.02 (2H, m), 7.32 (2H, m), 7.49 (2H , T), 7.55 (2H, d), 7.93 (lH, s) Example 187) l-[(4,5-dimethyl_2-methoxyphenyl) aminocarbonyl] -4- (2 -Isopropylphenyl) piperazine The phenyl N- (4,5-dimethyl-2-methoxyphenyl) formate and 1- (2-cumyl) piperazine were used as The reaction was carried out in the same manner as in Example 170 above to obtain the above compound. Yield: 80%

熔點:134〜135°C 4 NMR(500MHz,CDC13) 5 _·2· 20(3H, s),2· 21(6H, s), 3-l〇(4H,t),3.64(4H,t),3.85(3H,s),5.08(lH,s), 5.14(1H,s),6.64(lH,s),7.05(3H,m),7·70(1Η,πι), 7· 92(1H,s) -118- (請先閱讀背面之注意事項再填寫本頁) k裝· -訂 本紙張尺度適用中國國家標準(CNs ) A4規格(210X297公釐 575564 A7Melting point: 134 ~ 135 ° C 4 NMR (500MHz, CDC13) 5 — · 2 · 20 (3H, s), 2.21 (6H, s), 3-l0 (4H, t), 3.64 (4H, t ), 3.85 (3H, s), 5.08 (lH, s), 5.14 (1H, s), 6.64 (lH, s), 7.05 (3H, m), 7.70 (1Η, π), 7.92 ( 1H, s) -118- (Please read the notes on the back before filling out this page) k-pack ·-The size of the paper is applicable to Chinese National Standards (CNs) A4 (210X297 mm 575564 A7

經濟部中央標準局員工消費合作社印製 實施例188) l-[(4,5-二甲基-2-甲氧基苯基)胺基羰 基]-4-(1-萘基)派嗪 將苯基N-(4,5-二甲基-2-甲氧基苯基)曱酸酯與^ (1-萘基)派嗪,採行如同上述實施例17〇相同的方法 進行反應,而可獲得上述化合物。 收成率:92%Printed by the Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs, Example 188) l-[(4,5-dimethyl-2-methoxyphenyl) aminocarbonyl] -4- (1-naphthyl) pyrazine Phenyl N- (4,5-dimethyl-2-methoxyphenyl) phosphonate and ^ (1-naphthyl) pyrazine were reacted in the same manner as in Example 17 above, and The above compounds can be obtained. Yield: 92%

熔點:160〜162°C 'H NMR(500MHz?CDC13) 5 :2. 20(3H, s), 2. 24(3H, s), 3.31(4H,t.,J = 5.0ffz),3.83(3H,s),4.04(4fl,t), 6.39(2H,m),6.69(lH,s),7.13(lH,t),7.30(lH,s), 7· 46(1H,s) 實施例189) 1_[(4,5-二甲基-2-甲氧基苯基)胺基羰 基鄰胺苯甲醯基)哌嗪 將笨基N-(4,5-二甲基_2_甲氧基苯基)甲酸酯與^ (1-鄰胺苯曱醯基)哌嗪,採行如同上述實施例17〇相 同的方法進行反應,而可獲得上述化合物。 收成率:94%Melting point: 160 ~ 162 ° C 'H NMR (500MHz? CDC13) 5: 2.20 (3H, s), 2. 24 (3H, s), 3.31 (4H, t., J = 5.0ffz), 3.83 ( 3H, s), 4.04 (4fl, t), 6.39 (2H, m), 6.69 (lH, s), 7.13 (lH, t), 7.30 (lH, s), 7.46 (1H, s) Examples 189) 1 _ [(4,5-Dimethyl-2-methoxyphenyl) aminocarbonylo-aminobenzyl) piperazine will be N- (4,5-dimethyl_2_methyl The oxyphenyl) formate and (1-o-aminophenylphenyl) piperazine were reacted in the same manner as in Example 170 above to obtain the above compound. Yield: 94%

溶點:74〜75°C 3.24(4H,t), 3.70(4H,t), 3. 86(3H, s)/6. 70(1H, s)/ U5(3H,m),7.45(5H,m),8.00(2H,m) 貝轭例190) 1-[N_(4,5-二甲基-2-甲氧基苯基)胺基羰 基]-4_(3,5-二甲氧基苯基)哌嗪 -119- 本紙張尺度適用中國國家標準(CNS )八4規格(2l〇X^97公釐) (請先閲讀背面之注意事項再填寫本頁) -5 4 575564 A7Melting point: 74 ~ 75 ° C 3.24 (4H, t), 3.70 (4H, t), 3. 86 (3H, s) / 6. 70 (1H, s) / U5 (3H, m), 7.45 (5H , M), 8.00 (2H, m) yoke example 190) 1- [N_ (4,5-dimethyl-2-methoxyphenyl) aminocarbonyl] -4_ (3,5-dimethoxy Phenyl) piperazine-119- This paper size is applicable to China National Standard (CNS) 8-4 (2lOx ^ 97mm) (Please read the precautions on the back before filling this page) -5 4 575564 A7

將l-[(4,5-二甲基-2_甲氧基苯基)胺基魏基]_4々,5-二甲 氧基苯基)派嗪(0.2g,0.5毫莫耳),溶解於二甲基甲酿胺 (15ml),再徐緩添加氫化鈉(12mg,〇5毫莫耳)後,於室 溫下攪拌15分鐘。然後再添加破化甲烷(71mg,0.5毫 莫耳),,於室溫下攪拌16小時。進行減壓濃縮去除溶 f ’亚利用二氯曱烧進行萃取、乾燥、過濾後,再以 官柱層析法進行分離精製後,便可獲得上述化合物。 收成率:92%L-[(4,5-dimethyl-2_methoxyphenyl) aminoweiyl] _4 ', 5-dimethoxyphenyl) pyrazine (0.2 g, 0.5 mmol), It was dissolved in dimethylformamide (15 ml), and sodium hydride (12 mg, 0.05 mmol) was slowly added, followed by stirring at room temperature for 15 minutes. Then, decomposed methane (71 mg, 0.5 mmol) was added, and the mixture was stirred at room temperature for 16 hours. The above compound can be obtained by concentrating under reduced pressure to remove the solvent and extracting it with dichloromethane, extracting, drying, filtering, and then separating and purifying it by column chromatography. Yield: 92%

熔點:86〜88°C ^HNMRCSOOMHz^CDCU^: 2.21(3H,S), 2. 24(3H, s), 2.92C4H, t), 3.06(3H, s), 3.31(4H,t), 3. 75(6H, s)} 3.83(3H,s),6.00(lH,m),6.71(1H,s),6.83(1H,S)Melting point: 86 ~ 88 ° C ^ HNMRCSOOMHz ^ CDCU ^: 2.21 (3H, S), 2. 24 (3H, s), 2.92C4H, t), 3.06 (3H, s), 3.31 (4H, t), 3 75 (6H, s)} 3.83 (3H, s), 6.00 (lH, m), 6.71 (1H, s), 6.83 (1H, S)

Mass(EI) m/z:413.2293 (MH,C23H31N304 計算值: 413.2314) 實施例191) MN-(4,5-二甲基_2_甲氧基苯基)_N_曱 基胺基羰基]-4-(3,5-二甲基苯基)哌嗪 將1-[(4,5-二甲基-2-曱氧基苯基)胺基羰基]_4_(3 $ 二曱基苯基)哌嗪,採行如同上述實施例19〇相同的方 法進行反應,而可獲得上述化合物。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁} 、=口 收成率:90%Mass (EI) m / z: 413.2293 (MH, C23H31N304 calculated: 413.2314) Example 191) MN- (4,5-dimethyl_2_methoxyphenyl) _N_fluorenylaminocarbonyl]- 4- (3,5-dimethylphenyl) piperazine will be 1-[(4,5-dimethyl-2-methoxyphenyl) aminocarbonyl] _4_ (3 $ dimethylphenyl) Piperazine was reacted in the same manner as in Example 190 above to obtain the above compound. Printed by the Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the notes on the back before filling this page} 、 = 口 Yield: 90%

熔點:137〜138°C lHNMR(500MHz?CDCl3)(J: 2.15(3H,s), 2. 24(3H, s) 2.88(4H,t),3.06(3H,s),3.29(4H,t),3.83(3H,S) ’ 6.45(3H,s),6.71(lH,m),6.83(lH,s) ’ -120- 本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公釐) 575564 經濟部中央標準局員工消費合作社印製 A7 五、發明説明(116)Melting point: 137 ~ 138 ° C lHNMR (500MHz? CDCl3) (J: 2.15 (3H, s), 2. 24 (3H, s) 2.88 (4H, t), 3.06 (3H, s), 3.29 (4H, t ), 3.83 (3H, S) '6.45 (3H, s), 6.71 (lH, m), 6.83 (lH, s)' -120- This paper size applies to China National Standard (CNS) A4 (210x297 mm) 575564 A7 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs V. Description of Invention (116)

Mass(EI) m/z:381.2436 (MH,C23H29N302 計算值: 381.2416) 實施例192) 二甲基冬曱氧基苯基甲 基胺基魏基]-4-(3,5-二氟化苯基)旅嗔 將1-[(4,5-二甲基-2-甲氧基苯基)胺基羰基;]_4_(3,5_ 二氟化苯基)哌嗪,採行如同上述實施例19〇相同的方 法進行反應,而可獲得上述化合物。 收成率:87%Mass (EI) m / z: 381.2436 (MH, C23H29N302 Calculated: 381.2416) Example 192) Dimethyl benzyloxyphenylmethylaminoweilyl] -4- (3,5-difluorobenzene Group) The 1-[(4,5-dimethyl-2-methoxyphenyl) aminocarbonyl group;] _ 4_ (3,5_difluorinated phenyl) piperazine was used as in the examples The above-mentioned compound can be obtained by performing the reaction in the same manner as in the above. Yield: 87%

熔點:98〜100°C !H NMR(500MHz5CDC13)5: 2.16(3H,s), 2. 25(3H, s), 2.92(4H, t), 3.06(3H, s), 3. 29(4H, t), 3.83(3H, s), 6. 23(3H, m), 6. 72(1H, s), 6. 83(1H, s) 實施例193) 1_[N-乙基-N-(4,5-二甲基-2-甲氧基苯基) 胺基羰基]-4-(3,5-二甲氧基苯基)哌嗪 將1-[(4,5-二曱基-2·甲氧基苯基)胺基羰基>4_(3,5_ 二甲氧基苯基)哌嗪(〇·2§,〇·5毫莫耳),溶解於二甲基甲 醯月女(15ml),再徐緩添加氫化鈉(12mg,〇 5毫莫耳)後, 於室溫下攪拌15分鐘。然後再添加碘化乙烷(78mg,〇.5 :莫耳),於室溫下攪拌丨6小時。進行減壓濃縮去除 /合Μ,並利用二氯甲烷進行萃取、乾燥、過濾後,再 以管柱層析法進行分離精製後,便可獲得上述化合物。 收成率·· 89% 炼點:油狀 (請先閱讀背面之注意事項再填寫本頁) 裝. 訂 121 - 575564 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(117) !H NMR(500MHz5CDC13)^: 1. 09(3H, t), 2. 16 (3H, s), 2.24(3H,s),2.75(4H,t),3.28(4 H,t),3.52(2H,q) 3. 75(6H,s),3· 81(3H, s),5. 98(3H,m),6· 70(1H,s), 6.80(1H,s) ’ 實施例194) l-[N-(4,5_二甲基_2_甲氧基苯基)_N_乙 基胺基羰基]-4_(3,5-二曱基苯基)哌嘻 將1-[(4,5-二甲基-2-甲氧基苯基)胺基羰基]-4_(3,5_ 二甲基苯基)哌嗪,採行如同上述實施例193相同的方 法進行反應,而可獲得上述化合物。 收成率:93% 熔點:80〜82°C !H NMR(500MHz?CDC13) 5 :1. 21(3H, t), 2. 15(3H, s), 2.23(9H,s),2.90(4H,t),3.25(4H,t),3.59(lH,q), 3.81(3H,s),6.45(3H,m),6.69(lH,s),6.81(1H,S) 實施例195) l-[N-(4,5-二甲基-2-甲氧基苯基)_N-乙 基胺基幾基]-4-(3,5-二氟化苯基)σ辰嗪 將1-[(4,5-二曱基-2_甲氧基苯基)胺基羰基] 二氟化苯基)哌嗔,採行如同上述實施例193相同的方 法進行反應,而可獲得上述化合物。 收成率:87% 熔點:油狀 ^NMRCSOOMHz^DC^)^: 1.09(3H,t), 2.16(3H,s) 2.25(3H,s),2.90(4H,t),3.27(4H,t),3.52(2H,q)’ 3.81(3H,s), 6.24(3H,m) ’ -122- 本紙張尺度適用中國國家標準(CNS) M規格(2丨0><297公羞) (請先閱讀背面之注意事 I# 項再填. 裝-- :寫本頁) 4 575564 經濟部中央標準局員工消費合作社印製 A7 ----------------B7 五、發明説明(118) 貫施例196) 1-[Ν-(4,5-二甲基-2-甲氧基苯基)-N-異 丙基胺基羰基]-4-(3,5-二氟化基苯基)哌嗪 尸將1-[(4,5-二甲基_2_曱氧基苯基)胺基羰基>4_(3,5_ 二氟化基苯基)哌嗪(〇.2g,〇2毫莫耳),溶解於二甲基甲 醯胺(lml)中,並徐緩添加氫化鈉(12.48mg,0.52毫莫耳) 後,於室溫下攪拌15分鐘。再添加碘化異丙烷(87.88mg, 0·52笔莫耳),於室溫下攪拌2小時。減壓濃縮去除溶 ,,亚利用二氯曱烷進行萃取、乾燥、過濾後,再以 官柱層析法進行分離精製後,便可獲得上述化合物。 收成率·· 84% 熔點1油狀 lH NMR(500MHz,CDCl3H : 1.10(3H,s),L 26(现 s), 2.20(3H,s), 2.25(3H,s), 2. 86(4H, t), 3. 26(4H, t), 3.77(3H,s), 4.25(lH,m), 6.17(3H,m)> 6. 68(1H, s), 6·82(1H,s) λ鉍例197) SIX4,5·二甲基-2-甲氧基苯基)胺基硫代 羰基]-4-(3,5-二甲氧基苯基)哌嗪 a)苯基N-(4,5-:甲基_2_甲氧基苯基)硫代甲酸酯 於4,5-—曱基_2_甲氧基苯胺(4 5〇g,〇 〇3莫耳)中, 添加二氣甲院(1〇〇ml) ’ 一邊授拌同時徐緩添加苯基氯 化硫代甲酸酿(5.16g,0.03莫耳)後。待授摔2小時後, 添加水(15_),並以二氯f貌進行進行萃取後,再以 管柱層析法進行分離精製後,便可獲得上述化合物。 收成率:92% (請先閱讀背面之注意事項再填寫本頁) 裝·Melting point: 98 ~ 100 ° C! H NMR (500MHz5CDC13) 5: 2.16 (3H, s), 2. 25 (3H, s), 2.92 (4H, t), 3.06 (3H, s), 3. 29 (4H , t), 3.83 (3H, s), 6. 23 (3H, m), 6. 72 (1H, s), 6. 83 (1H, s) Example 193) 1_ (N-ethyl-N- (4,5-Dimethyl-2-methoxyphenyl) aminocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine 1-[(4,5-difluorenyl -2 · methoxyphenyl) aminocarbonyl> 4- (3,5_dimethoxyphenyl) piperazine (0.2§, 0.5mmol) dissolved in dimethylformamidine A female (15 ml) was added with sodium hydride (12 mg, 0.05 mmol) slowly, followed by stirring at room temperature for 15 minutes. Then, ethane iodide (78 mg, 0.5: mole) was added, and the mixture was stirred at room temperature for 6 hours. The above-mentioned compound can be obtained after concentration removal under reduced pressure, extraction with methylene chloride, drying, filtration, and separation and purification by column chromatography. Yield · 89% Refining point: oily (please read the precautions on the back before filling out this page) Pack. Order 121-575564 A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs V. Invention Description (117)! H NMR (500MHz5CDC13) ^: 1. 09 (3H, t), 2. 16 (3H, s), 2.24 (3H, s), 2.75 (4H, t), 3.28 (4 H, t), 3.52 (2H , Q) 3.75 (6H, s), 3.81 (3H, s), 5.98 (3H, m), 6.70 (1H, s), 6.80 (1H, s) 'Example 194) l- [N- (4,5_dimethyl_2_methoxyphenyl) _N_ethylaminocarbonyl] -4_ (3,5-difluorenylphenyl) piperidine 1-[( 4,5-dimethyl-2-methoxyphenyl) aminocarbonyl] -4_ (3,5_dimethylphenyl) piperazine was reacted in the same manner as in Example 193 above, but The above compound is obtained. Yield: 93% Melting point: 80 ~ 82 ° C! H NMR (500MHz? CDC13) 5: 1. 21 (3H, t), 2. 15 (3H, s), 2.23 (9H, s), 2.90 (4H , T), 3.25 (4H, t), 3.59 (lH, q), 3.81 (3H, s), 6.45 (3H, m), 6.69 (lH, s), 6.81 (1H, S) Example 195) l -[N- (4,5-Dimethyl-2-methoxyphenyl) _N-ethylaminoquinyl] -4- (3,5-difluorinated phenyl) [(4,5-Difluorenyl-2-methoxyphenyl) aminocarbonyl] Difluorophenyl) piperidine was reacted in the same manner as in Example 193 above to obtain the above compound. Yield: 87% Melting point: Oily ^ NMRCSOOMHz ^ DC ^) ^: 1.09 (3H, t), 2.16 (3H, s) 2.25 (3H, s), 2.90 (4H, t), 3.27 (4H, t) , 3.52 (2H, q) '3.81 (3H, s), 6.24 (3H, m)' -122- This paper size applies to China National Standard (CNS) M specification (2 丨 0 > < 297 public shame) (please Read the note I # on the back before filling. Install-: Write this page) 4 575564 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 ---------------- B7 V. Description of the invention (118) Example 196) 1- [N- (4,5-dimethyl-2-methoxyphenyl) -N-isopropylaminocarbonyl] -4- (3, 5-difluorophenyl) piperazine 1-[(4,5-dimethyl_2_methoxyphenyl) aminocarbonyl > 4- (3,5_difluorophenyl) Piperazine (0.2 g, 0.2 mmol) was dissolved in dimethylformamide (1 ml), and sodium hydride (12.48 mg, 0.52 mmol) was slowly added, followed by stirring at room temperature for 15 minutes. . Isopropane iodide (87.88 mg, 0.52 moles) was added thereto, followed by stirring at room temperature for 2 hours. The above compound can be obtained by concentrating under reduced pressure to remove the solvent, subdividing with dichloromethane, extracting, drying, filtering, and then separating and refining the product by column chromatography. Yield · 84% Melting point 1 Oily lH NMR (500MHz, CDCl3H: 1.10 (3H, s), L 26 (now s), 2.20 (3H, s), 2.25 (3H, s), 2. 86 (4H , t), 3. 26 (4H, t), 3.77 (3H, s), 4.25 (lH, m), 6.17 (3H, m) > 6. 68 (1H, s), 6.82 (1H, s) Example of lambda bismuth 197) SIX4,5 · dimethyl-2-methoxyphenyl) aminothiocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine a) phenyl N- (4,5-: methyl-2-methoxyphenyl) thioformate in 4,5--fluorenyl-2-methoxyaniline (450 g, 〇03mol ), Add Erqijiayuan (100ml) 'while mixing, and slowly add phenyl chloride thioformic acid (5.16g, 0.03 mole). After being taught for 2 hours, water (15_) was added, and extraction was performed with dichloro f, followed by separation and purification by column chromatography to obtain the above compounds. Yield: 92% (Please read the precautions on the back before filling this page)

、1T 4 -123- 本紙張尺舰财關家標^TcNS ) Α4規格(210X29iJ7 575564、 1T 4 -123- The paper ruler of the financial institution ^ TcNS) Α4 size (210X29iJ7 575564

經濟部中央標準局員工消費合作社印製 1H NMR(500MHz?CDC13) 5 : 2. 21(3H, s), 2. 25(3H, s), 6.80(1H,s), 6.93(5H,m), 7.31(lH,s) b) l-(4,5·二曱基-2-甲氧基苯基)胺基硫代羰基]-4_(3,5_ 一'甲氧基苯基)。底嘻 將苯基N-(4,5-二曱基-2-曱氧基苯基)硫代甲酸酯 (〇.2g,〇.7毫莫耳)與1_(3,5_二曱氧基苯基)哌嗪(〇16g, 〇·7毫莫耳),溶解於四氫吡喃(1〇1111)中,並添加 DBU(0.11g,〇·7毫莫耳)後,於室溫下攪拌2小時。將 反應物與以濃縮後,再利用管柱層析法進行分離精製 後’便可獲得上述化合物。 收成率:84%1H NMR (500MHz? CDC13) 5: 2.21 (3H, s), 2. 25 (3H, s), 6.80 (1H, s), 6.93 (5H, m) , 7.31 (lH, s) b) l- (4,5 · Difluorenyl-2-methoxyphenyl) aminothiocarbonyl] -4_ (3,5 _- '' methoxyphenyl). Di Hei made phenyl N- (4,5-difluorenyl-2-methoxyoxyphenyl) thioformate (0.2 g, 0.7 mmol) and 1_ (3,5_difluorene) Oxyphenyl) piperazine (〇16g, 0.7mmol), dissolved in tetrahydropyran (101111), and added DBU (0.11g, 0.7mmol) Stir at warm for 2 hours. After concentrating the reaction mixture with the reaction mixture and then separating and purifying it by column chromatography ', the above compound can be obtained. Yield: 84%

熔點:128〜129°C 'HNMRCSOOMHz^DC^)^: 2.20(3H)S), 2.24(3H,s), 2.32(6H,s), 3.37(4H,t), 3. 83(3H, s), 4. 08(4H, t), 6.69(3H,m), 7.39(lH,m), 7.47(lH,s)Melting point: 128 ~ 129 ° C 'HNMRCSOOMHz ^ DC ^) ^: 2.20 (3H) S), 2.24 (3H, s), 2.32 (6H, s), 3.37 (4H, t), 3. 83 (3H, s ), 4. 08 (4H, t), 6.69 (3H, m), 7.39 (lH, m), 7.47 (lH, s)

Mass(EI) m/z:415.1912 (MH,C22H29N303 Si 計算值: 415.1929) 貫施例198) ^[(斗,^二甲基-2-曱氧基苯基)胺基硫代 羰基]-4-(3,5-二曱基苯基)哌嗪 將苯基N-[(4,5-二曱基-2-甲氧基苯基)硫代甲酸酯 與1-(3,5-二甲基苯基)哌嗪,採行如同上述實施例197 相同的方法進行反應,而可獲得上述化合物。 收成率:90%Mass (EI) m / z: 415.1912 (MH, C22H29N303 Si Calculated: 415.1929) Example 198) ^ [(bucket, ^ dimethyl-2-methoxyoxyphenyl) aminothiocarbonyl] -4 -(3,5-Difluorenylphenyl) piperazinePhenyl N-[(4,5-Difluorenyl-2-methoxyphenyl) thioformate with 1- (3,5- Dimethylphenyl) piperazine can be reacted in the same manner as in Example 197 above to obtain the above compound. Yield: 90%

熔點:164〜165°C -124- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) I-------^裝------訂 (請先閲讀背面之注意事項再填寫本頁) 575564 經濟部中央標準局員工消費合作社印製 A7 五、發明説明(12〇) 'H NMR(500MHz?CDC13) 5 : 2.20(3H,s), 2. 24(3H, s), 2.32(6H,s), 3.37(4H,t), 3. 83(3H, s), 4. 08(4H, t), 6.69(3H,m), 7.39(lH,m), 7.47(lH,s)Melting point: 164 ~ 165 ° C -124- This paper size is applicable to China National Standard (CNS) A4 specification (210X297mm) I ------- ^ Packing ------ Order (please read the first Note: Please fill in this page again) 575564 Printed by A7, Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the Invention (12) 'H NMR (500MHz? CDC13) 5: 2.20 (3H, s), 2. 24 (3H, s), 2.32 (6H, s), 3.37 (4H, t), 3.83 (3H, s), 4. 08 (4H, t), 6.69 (3H, m), 7.39 (lH, m), 7.47 (lH, s)

Mass(EI) m/z:383.2086 計算值: 383.2031) 實施例199) l-[(4,5-二甲基-2-甲氧基苯基)胺基硫代 羰基]-4-(2,3_二曱基苯基)旅嘻 將苯基N-[(4,5-二甲基-2-甲氧基苯基)硫代甲酸酯 與1-(2,3-二甲基苯基)哌嗪,採行如同上述實施例197 相同的方法進行反應,而可獲得上述化合物。 收成率:89%Mass (EI) m / z: 383.2086 Calculated: 383.2031) Example 199) l-[(4,5-dimethyl-2-methoxyphenyl) aminothiocarbonyl] -4- (2, 3_Difluorenylphenyl) Lui Hei Phenyl N-[(4,5-dimethyl-2-methoxyphenyl) thioformate and 1- (2,3-dimethylbenzene (Meth) piperazine, which was reacted in the same manner as in Example 197 above, to obtain the above compound. Yield: 89%

溶點· 15 1〜15 2 °C 'H NMR(500MHz?CDC13)(5: 2.21(3H, s), 2. 24(3H, s), 2.29(6H,s), 3.03(4H,t), 3. 83(3H, s), 4.10(4H,t), 6.69(1H,s), 6.97(2H,m), 7.11(lH,t) t施例200) l-[(4,5-二甲基-2-甲氧基苯基)胺基硫代 幾基]-4-(3,5-二氟化苯基)哌嗪 將苯基N-[(4,5-二甲基-2-甲氧基苯基)硫代甲酸酯 與1-(3,5-二氟化苯基)略嗔,採行如同上述實施例197 相同的方法進行反應,而可獲得上述化合物。 收成率:92%Melting point 15 1 ~ 15 2 ° C 'H NMR (500MHz? CDC13) (5: 2.21 (3H, s), 2. 24 (3H, s), 2.29 (6H, s), 3.03 (4H, t) , 3. 83 (3H, s), 4.10 (4H, t), 6.69 (1H, s), 6.97 (2H, m), 7.11 (lH, t) t Example 200) l-[(4,5- Dimethyl-2-methoxyphenyl) aminothio-chipinyl] -4- (3,5-difluorophenyl) piperazine Phenyl N-[(4,5-dimethyl- The 2-methoxyphenyl) thioformate and 1- (3,5-difluorinated phenyl) were slightly reacted in the same manner as in Example 197 above to obtain the above compound. Yield: 92%

熔點:167〜168°C Ή NMR(5〇〇MHz,CDC13) 5 : 2. 20(3H, s), 2. 24(3H, s), 2.27(3ll,s),2.32(3H,s),3.39(4H,t,J = 5.0Hz),3.83 ---------^裝-- (請先閱讀背面之注意事項再填寫本頁)Melting point: 167 ~ 168 ° C Ή NMR (500MHz, CDC13) 5: 2. 20 (3H, s), 2. 24 (3H, s), 2.27 (3ll, s), 2.32 (3H, s) , 3.39 (4H, t, J = 5.0Hz), 3.83 --------- ^ install-(Please read the precautions on the back before filling this page)

、1T it -125- 575564 A7 B7 五、發明説明(121) (3H,s), 4.14(4H,t), 6.70(1H,s), 6.80(2H,m), 7.36 (lH,s), 7.44(lH,s) 實施例201) 1_[(4,5-二甲基-2-甲氧基苯基)胺基硫代 罗炭基]-4-(3,5-二氯化苯基)σ辰嗔 將苯基N-[(4,5-二甲基_2_甲氧基苯基)硫代甲酸酯 與1-(3,5-一氟化苯基)派嘻,採行如同上述實施例197 相同的方法進行反應,而可獲得上述化合物。 收成率·· 85%, 1T it -125- 575564 A7 B7 V. Description of the invention (121) (3H, s), 4.14 (4H, t), 6.70 (1H, s), 6.80 (2H, m), 7.36 (lH, s), 7.44 (lH, s) Example 201) 1 _ [(4,5-Dimethyl-2-methoxyphenyl) aminothiocarbanyl] -4- (3,5-dichlorophenyl ) Σ 辰 嗔 Phenyl N-[(4,5-dimethyl_2_methoxyphenyl) thioformate and 1- (3,5-monofluorinated phenyl) The reaction was performed in the same manner as in the above-mentioned Example 197 to obtain the above-mentioned compound. Yield · 85%

熔點·· 188〜189°C XH NMR(500MHz?CDC13)(J: 2.21(3H,s) 2. 24(3H, s), 3. 40(4H, t), 3. 83(3H, s), 4. 25(4H, t), 6. 70(1H, s), 7. 13(3H,m), 7.37(2H,m)Melting point: 188 ~ 189 ° C XH NMR (500MHz? CDC13) (J: 2.21 (3H, s) 2. 24 (3H, s), 3. 40 (4H, t), 3. 83 (3H, s) , 4. 25 (4H, t), 6. 70 (1H, s), 7. 13 (3H, m), 7.37 (2H, m)

Mass(EI) m/z:423.0956 計算值: 423.0938) 實施例202) l-[(4,5-二甲基-2-曱氧基苯基)胺基硫代 Μ基]-4-(2 -氟化苯基)旅嘻 經濟部中央標準局員工消費合作社印製 丨 •批衣-- (請先閱讀背面之注意事項再填寫本頁) d 將苯基Ν-[(4,5-二甲基-2-甲氧基苯基)硫代甲酸酯 與1(2-氟化苯基)哌嗪,採行如同上述實施例197相 同的方法進行反應,而可獲得上述化合物。 收成率:85%Mass (EI) m / z: 423.0956 Calculated: 423.0938) Example 202) l-[(4,5-dimethyl-2-methoxyoxyphenyl) aminothioM] -4- (2 -Fluorinated phenyl) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 丨 • Approval-- (Please read the precautions on the back before filling this page) The methyl-2-methoxyphenyl) thioformate and 1 (2-fluorinated phenyl) piperazine were reacted in the same manner as in Example 197 above to obtain the above compound. Yield: 85%

熔點:139〜140°C NMR(5〇〇MHz5CDC13) 5 :2. 21(3H, s), 2. 24(3H, s), 3.40(4H,t), 3.83(3H,s), 4. 25(4H, t), 6.70(lH,s), 7. 13(3H,m), 7. 37(2H,m) -126- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(122) _ 貫施例203) 1-[(4,5-二甲基_2-甲氧基苯基)胺基硫代 羰基]-4-(2-氯化苯基)哌嗪 將苯基N-[(4,5-二曱基_2_甲氧基苯基)硫代甲酸酯 與1-(2-氯化苯基)哌嗪,採行如同上述實施例197相 同的方法進行反應,而可獲得上述化合物。 收成率:85%Melting point: 139 ~ 140 ° C NMR (500MHz5CDC13) 5: 2.21 (3H, s), 2. 24 (3H, s), 3.40 (4H, t), 3.83 (3H, s), 4. 25 (4H, t), 6.70 (lH, s), 7. 13 (3H, m), 7. 37 (2H, m) -126- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 (Mm) 575564 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the Invention (122) _ Implementation Example 203) 1-[(4,5-dimethyl_2-methoxyphenyl) amine Thiocarbonyl] -4- (2-chlorophenyl) piperazine connects phenyl N-[(4,5-diamidino-2-methoxyphenyl) thioformate with 1- ( 2-Chlorophenyl) piperazine was reacted in the same manner as in Example 197 above to obtain the above compound. Yield: 85%

熔點:115〜116DC Η 醒R(5〇〇MHz,CDC13)(5: 2.21(3H,s),2.24(3H,s), 3.18(4H,t), 3.83(3H,s), 4. 09 (4H, t), 6.69(lH,s), 7. 05(2H, m), 7. 33(1H, s), 7. 41(2H, m) 實施例204) 1_[(4,5-二甲基-2-甲氧基苯基)胺基硫代 爹炭基]-4-(2-甲氧基苯基)哌嗪 將苯基Ν-[(4,5_二曱基-2-甲氧基苯基)硫代甲酸酯 與1 -(2-甲氧基苯基)哌嗪,採行如同上述實施例丨97 相同的方法進行反應,而可獲得上述化合物。 收成率:90% 熔點:油狀 !H NMR(500MHz5CDC13) 5 : 2. 2 0 (3H , s), 2. 23(3H, s), 3. 14(4H, t, J = 5. 0Hz), 3. 82(3H, s), 3.88(3H, s), 4. 06(4H, t,J = 5.0Hz), 6.94(3H,m), 7.30(lH,s), 7.40(lH,s) 實施例205) l-[(4,5-二甲基-2-曱氧基苯基)胺基硫代 羰基]-4-(2-曱基硫代苯基)哌嗪 將苯基N-[(4,5-二甲基-2-甲氧基苯基)硫代甲酸酯 與!-(2_曱基硫代苯基)旅嗔,採行如同上述實施例197 -127- -·批衣-- (請先閲讀背面之注意事項再填寫本頁) 訂 it 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(123) 相同的方法進行反應,而可獲得上述化合物。 收成率:93%Melting point: 115 ~ 116DC Η R (500MHz, CDC13) (5: 2.21 (3H, s), 2.24 (3H, s), 3.18 (4H, t), 3.83 (3H, s), 4. 09 (4H, t), 6.69 (lH, s), 7.05 (2H, m), 7.33 (1H, s), 7. 41 (2H, m) Example 204) 1 _ [(4,5- Dimethyl-2-methoxyphenyl) aminothioalkyl] -4- (2-methoxyphenyl) piperazine The phenyl group N-[(4,5_diamidino-2 -Methoxyphenyl) thioformate and 1- (2-methoxyphenyl) piperazine can be reacted in the same manner as in the above Example 97 to obtain the above compound. Yield: 90% Melting point: oily! H NMR (500MHz5CDC13) 5: 2. 2 0 (3H, s), 2. 23 (3H, s), 3. 14 (4H, t, J = 5. 0Hz) , 3. 82 (3H, s), 3.88 (3H, s), 4. 06 (4H, t, J = 5.0Hz), 6.94 (3H, m), 7.30 (lH, s), 7.40 (lH, s Example 205) l-[(4,5-Dimethyl-2-fluorenyloxyphenyl) aminothiocarbonyl] -4- (2-fluorenylthiophenyl) piperazine -[(4,5-dimethyl-2-methoxyphenyl) thioformate with! -(2_fluorenylthiophenyl), which is used in the same way as in the above Example 197 -127--Approval-(Please read the precautions on the back before filling this page) Order it This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) 575564 Printed by A7 B7, Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (123) The same method can be used to obtain the above compounds. Yield: 93%

熔點:136〜137°C NMR(5〇〇MHz5CDC13) 5 :2. 20(3H, s), 2. 26(3H, s), 2.45(3H,s), 3.33(4H,t), 4. 39(4H, t), 6.74(lH,s), 7. 16(3H, m), 7.47(2H,m) 實施例206) l-[(4,5-二甲基-2-曱氧基苯基)胺基硫代 罗炭基]-4-(3 -經苯基)旅嗪 將苯基N-[(4,5-二甲基-2-甲氧基苯基)硫代甲酸酯 與1-(3-羥苯基)哌嗉,採行如同上述實施例197相同 的方法進行反應,而可獲得上述化合物。 收成率:77% 溶點:Decomposed (200°C) !Η NMR(500MHz,CDC13) 5 : 2.17 (3H,s), 2.23(3H, s), 3.31(4H,t), 3.82(3H,s), 4.03(3H,t), 6.37(2H,m), 6.47(lH,d), 7.13(lH,t), 7.45(lH,s) 實施例207) 1·[(4,5-二甲基-2-曱氧基苯基)胺基硫代Melting point: 136 ~ 137 ° C NMR (500MHz5CDC13) 5: 2.20 (3H, s), 2. 26 (3H, s), 2.45 (3H, s), 3.33 (4H, t), 4. 39 (4H, t), 6.74 (lH, s), 7.16 (3H, m), 7.47 (2H, m) Example 206) l-[(4,5-dimethyl-2-fluorenyloxy Phenyl) aminothiocarbamoyl] -4- (3-Phenyl) trazinePhenyl N-[(4,5-dimethyl-2-methoxyphenyl) thiocarboxylic acid The ester was reacted with 1- (3-hydroxyphenyl) piperidine in the same manner as in Example 197 above to obtain the above compound. Yield: 77% Melting point: Decomposed (200 ° C)! Η NMR (500MHz, CDC13) 5: 2.17 (3H, s), 2.23 (3H, s), 3.31 (4H, t), 3.82 (3H, s ), 4.03 (3H, t), 6.37 (2H, m), 6.47 (lH, d), 7.13 (lH, t), 7.45 (lH, s) Example 207) 1. ((4,5-dimethyl -2-methyloxyphenyl) aminothio

Ik基]-4-(2 -氧化苯基苯基)π辰嘻 將苯基Ν-[(4,5-二曱基-2-甲氧基苯基)硫代甲酸酯 與1-(2-氧化苯基苯基)哌嗉,採行如同上述實施例197 相同的方法進行反應,而可獲得上述化合物。 收成率:86% 熔點:油狀 -128- ί紙張尺度適用中關家標準(CNS) M規格(:跑297公- 丨 裝 訂 (請先閱讀背面之注意事項再填寫本頁) 575564 經濟部中央標準局員工消費合作社印製 A 7 —_____B7 ____ 五、發明説明(124) !H NMR(500MHz, CDC13) 5 : 2.17(3H, s), 2.24(3H,s), 3.19(4H,t), 3.89(3H,s), 3. 85(4H, t), 6.66(lH,s), 6.91(2H,m), 6.98(lH,m), 7.05(3H,m), 7.13(lH,m), 7.23(lH,m), 7.31(2H,m), 7.36(1H,s) 實施例208)卜[(4,5-二曱基-2-曱氧基苯基)胺基硫代 幾基]-4-(2-異丙苯基苯)派嗓 將苯基N-[(4,5-二甲基-2-曱氧基苯基)硫代甲酸酯 與1_(2_異丙苯基苯)呢嗔,採行如同上述實施例197 相同的方法進行反應,而可獲得上述化合物。 收成率:75% 熔點:157〜158°C NMR(500MHz,CDC13)5:2.20(3H, s), 2.21(3H, s), 2.24 (3H,s), 3.19(4H,t), 3.82(3H,s), 4. 05(4H, t), 5.07 (lH,s), 5.16(lH,s), 6.69(lH,s), 7. 11 (33H, m), 7.33 (1H, s), 7. 45(1H, s) 實施例209) l-[(4,5-二甲基-2-甲氧基苯基)胺基硫代 羰基]-4-(2-甲氧基曱基苯基)哌嗪 將苯基N-[(4,5-二甲基-2-甲氧基苯基)硫代甲酸酯 與1-(2-甲氧基甲基苯基)哌嗪,採行如同上述實施 例19 7相同的方法進行反應,而可獲得上述化合物。 收成率·· 87% 熔點:油狀 NMR(500MHz,CDC13)5 : 2. 20(3H, s), 2. 23(3H, s), 2.29(3H,s), 3.13(4H,t), 3.8 3 (3H, s), 3.85(3H,s), -129- 本紙張尺度適用巾酬家標準(CNS ) A4規格(210X297公釐)— '—" -- (請先閲讀背面之注意事 4 項再填- 裝— :寫本頁)Ik-based] -4- (2-oxophenylphenyl) π Chenhe converts phenyl N-[(4,5-diamidino-2-methoxyphenyl) thioformate to 1- ( The 2-oxyphenylphenyl) piperidine was reacted in the same manner as in Example 197 above to obtain the above compound. Yield: 86% Melting point: Oily -128- ί The paper size applies the Zhongguanjia Standard (CNS) M specification (: Runs 297 kilometers-丨 binding (please read the precautions on the back before filling this page) 575564 Central Ministry of Economic Affairs Printed by the Consumer Bureau of Standards Bureau A 7 —_____ B7 ____ 5. Description of the Invention (124)! H NMR (500MHz, CDC13) 5: 2.17 (3H, s), 2.24 (3H, s), 3.19 (4H, t), 3.89 (3H, s), 3. 85 (4H, t), 6.66 (lH, s), 6.91 (2H, m), 6.98 (lH, m), 7.05 (3H, m), 7.13 (lH, m) , 7.23 (lH, m), 7.31 (2H, m), 7.36 (1H, s) Example 208) [(4,5-Difluorenyl-2-methoxyphenyl) aminothiochi ] -4- (2-Isopropylphenylbenzene) sends phenyl N-[(4,5-dimethyl-2-methoxyphenyl) thioformate to 1_ (2_isopropyl The above compound can be obtained by carrying out the reaction in the same manner as in Example 197 described above. Yield: 75% Melting point: 157 ~ 158 ° C NMR (500MHz, CDC13) 5: 2.20 (3H, s), 2.21 (3H, s), 2.24 (3H, s), 3.19 (4H, t), 3.82 ( 3H, s), 4. 05 (4H, t), 5.07 (lH, s), 5.16 (lH, s), 6.69 (lH, s), 7. 11 (33H, m), 7.33 (1H, s) 7.45 (1H, s) Example 209) l-[(4,5-dimethyl-2-methoxyphenyl) aminothiocarbonyl] -4- (2-methoxyfluorenyl Phenyl) piperazine Phenyl N-[(4,5-dimethyl-2-methoxyphenyl) thioformate and 1- (2-methoxymethylphenyl) piperazine, The reaction was carried out in the same manner as in Example 197 above to obtain the above compound. Yield: 87% Melting point: Oily NMR (500MHz, CDC13) 5: 2. 20 (3H, s), 2. 23 (3H, s), 2.29 (3H, s), 3.13 (4H, t), 3.8 3 (3H, s), 3.85 (3H, s), -129- This paper size is applicable to towel standard (CNS) A4 specification (210X297 mm) — '— "-(Please read the note on the back first 4 items to refill-Pack —: Write this page)

、1T 575564 A7 --____ B7 經濟部中央標準局員工消費合作社印製 五、發明説明(125) 4.05(4H,t), 6.69(lH,s), 6.83(2H,m), 7.30(lH,s), 7·40(1H,s) 實施例210) l-[(4,5-二甲基甲氧基苯基)胺基硫代 幾基]-4-(1-萘基)旅嘻 將苯基N_[(4,5-二甲基_2_甲氧基苯基)硫代曱酸酯 與(1-萘基)哌嗪,採行如同上述實施例197相同的方 法進行反應,而可獲得上述化合物。 收成率:87% 熔點:139〜140°C IfJMIKSOOMI^CDClW: 2.23(3H,s),2.24(3H,s), 3.2K4H, t), 3.84(4H,s), 4. 09(4H, t), 6. 70(1H, s), 7.10(lH,d), 7.48(5H,m), 7.85(lH,m), 8.22(lH,d) 實施例211) l-[(5-乙醯基-2-甲氧基-4-甲基苯基)胺 基硫代羰基]-4-(3,5-二甲氧基苯基)哌嗪 將苯基N-(5-乙醯基-2_甲氧基-4-甲基苯基)甲酸酯 與1-(3,5_甲氧基苯基)派嗪,採行如同上述實施例17〇 相同的方法進行反應,而可獲得上述化合物。 收成率·· 91% 熔點:103〜105°C 'H NMR(500MHz,CDC13)(5:2.54(3H,s), 2.59(3H,s), 3.27 (4H,t), 3.70(4H, t), 3.79(6H,s), 3. 94(3H, s), 7.05 (lH,s), 8.72(lH,s) 實施例212) 卜[(5-乙醯基_2_曱氧基-2-曱基苯基)胺 基硫代羰基]-4-(3,5-二甲基苯基)哌嗪 -130- (請先閲讀背面之注意事項再填寫本頁) 4 項再填· 裝· 、\-口 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564、 1T 575564 A7 --____ B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economy s), 7.40 (1H, s) Example 210) l-[(4,5-Dimethylmethoxyphenyl) aminothio-kisyl] -4- (1-naphthyl) The reaction of phenyl N _ [(4,5-dimethyl_2_methoxyphenyl) thiophosphonate with (1-naphthyl) piperazine was carried out in the same manner as in Example 197 above. The above compounds can be obtained. Yield: 87% Melting point: 139 ~ 140 ° C IfJMIKSOOMI ^ CDClW: 2.23 (3H, s), 2.24 (3H, s), 3.2K4H, t), 3.84 (4H, s), 4. 09 (4H, t ), 6. 70 (1H, s), 7.10 (lH, d), 7.48 (5H, m), 7.85 (lH, m), 8.22 (lH, d) Example 211) l-[(5-acetamidine Methyl-2-methoxy-4-methylphenyl) aminothiocarbonyl] -4- (3,5-dimethoxyphenyl) piperazine Phenyl N- (5-ethylfluorenyl- 2-methoxy-4-methylphenyl) formate and 1- (3,5-methoxyphenyl) pyrazine can be reacted in the same manner as in Example 17 above to obtain The above compounds. Yield: 91% Melting point: 103 ~ 105 ° C 'H NMR (500MHz, CDC13) (5: 2.54 (3H, s), 2.59 (3H, s), 3.27 (4H, t), 3.70 (4H, t ), 3.79 (6H, s), 3.94 (3H, s), 7.05 (lH, s), 8.72 (lH, s) Example 212) [(5-Ethyl-2- 2-fluorenylphenyl) aminothiocarbonyl] -4- (3,5-dimethylphenyl) piperazine-130- (Please read the notes on the back before filling this page) 4 items The size of this paper is applicable to the Chinese National Standard (CNS) A4 (210X297 mm) 575564

、發明説明(126) (請先閱讀背面之注意事項再填寫本頁) 將苯基N-(5-乙醯基-2-甲氧基-2-甲基苯基)甲酸酯 與^^,^甲基苯基)哌嗪,採行如同上述實施例17〇相 同的方法進行反應,而可獲得上述化合物。 收成率:88%、 Explanation of the invention (126) (Please read the precautions on the back before filling in this page) Phenyl N- (5-ethylfluorenyl-2-methoxy-2-methylphenyl) formate and ^ Methylphenyl) piperazine can be reacted in the same manner as in Example 170 above to obtain the above compound. Yield: 88%

熔點:140〜142°C H NMR(500MHz, CDC13) (5 : 2. 30(3H, s), 2.54(3H,s), 2.59 (3H,s),3.26(4H,t),3.70(4H,t), 3.97(3H,s), 6.61 (3H,m),6.70(lH,s),7.06(lH,s),8.72(lH,s) 貫施例212) l-[(5_乙醯基-2-甲氧基-2-甲基苯基)胺 基硫代羰基]-4-(3,5-二氯化苯基)哌嗪 將苯基N-(5-乙醯基-2-曱氧基-2-甲基苯基)曱酸酯 與1_(3,5_二氯化苯基)派嗔,採行如同上述實施例17〇 相同的方法進行反應,而可獲得上述化合物。 收成率:78%Melting point: 140 ~ 142 ° CH NMR (500MHz, CDC13) (5: 2. 30 (3H, s), 2.54 (3H, s), 2.59 (3H, s), 3.26 (4H, t), 3.70 (4H, t), 3.97 (3H, s), 6.61 (3H, m), 6.70 (lH, s), 7.06 (lH, s), 8.72 (lH, s) (Example 212) l-[(5_ 乙醯Methyl-2-methoxy-2-methylphenyl) aminothiocarbonyl] -4- (3,5-dichlorophenyl) piperazine Phenyl N- (5-ethylfluorenyl-2 -Methoxy-2-methylphenyl) phosphonate and 1- (3,5-dichlorophenyl) pyridine were reacted in the same manner as in Example 170 above to obtain the above compound. . Yield: 78%

熔點:170〜172°C NMR(500MHz,CDC13)5: 2. 54(3H, s), 2. 59(3H, s), 3.32 (4H,t), 3.74(4H,t), 3.94(3H,s), 6.69(lH,s), 6.86 (3H,m), 7.04(lH,s), 8.69(lH,s) 經濟部中央標準局員工消費合作社印製 實施例214) 1-{[5·(1_羥乙基)_2-曱氧基-4-曱基苯基] 胺基羰基}_4-(3,5-二甲氧基苯基)哌嗪 將1-[(5-乙醯基-2-曱氧基_4_甲基苯基)胺基羰基]-4·(3,5-二甲氧基苯基)派嗪(〇.2g,〇.47毫莫耳),溶解於 無水乙醇(lml)中,並添加硼氫化鈉(17_3mg)後,於室 溫下攪拌2小時。減壓濃縮去除乙醇後,再以管柱層 131 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29?公釐) 經濟部中央標準局員工消費合作社印製 575564 A7 ^______ 五、發明説明(127) 析法(乙基醋酸自曰骯·已基= 1:2)進行分離精製後,便可 獲得上述化合物。 收成率:96%Melting point: 170 ~ 172 ° C NMR (500MHz, CDC13) 5: 2. 54 (3H, s), 2. 59 (3H, s), 3.32 (4H, t), 3.74 (4H, t), 3.94 (3H , s), 6.69 (lH, s), 6.86 (3H, m), 7.04 (lH, s), 8.69 (lH, s) Example 214 printed by the Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs, Example 214) 1-{(5 · (1-Hydroxyethyl) _2-methoxy-4-fluorenylphenyl] aminocarbonyl} _4- (3,5-dimethoxyphenyl) piperazine 2--2-methoxy-4-methylphenyl) aminocarbonyl] -4 · (3,5-dimethoxyphenyl) pyrazine (0.2 g, 0.47 mmol), dissolved After adding sodium borohydride (17-3 mg) to anhydrous ethanol (1 ml), the mixture was stirred at room temperature for 2 hours. After the ethanol was removed by concentration under reduced pressure, the column layer was 131-This paper size is applicable to the Chinese National Standard (CNS) A4 (210X29? Mm). Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 ^ ______ 5. Description of the invention (127) The above compound can be obtained after separation and purification (ethyl acetate since hexane · hexyl = 1: 2). Yield: 96%

熔點:152〜154°C 1H NMR(500MHz,CDC13)5: 1.4l(3H,d)? 2. 32(3H, s), 3.27 (4H,t), 3.71(4H,t), 3.79(6H,S), 3.87(3H,s), 5.04 (lH,q),6.10( 3H,m),6.63(1 H,s),8.22 (lH,s) ? 實施例215) 羥乙基)-2_甲氧基-4-甲基苯基] 胺基羰基}-4-(3,5-二曱基笨基)呢嗔 將1-[(5-乙醯基-2-甲氧基_4_甲基苯基)胺基羰基杆 4-(3,5-二曱基苯基),採行如同上述實施例214相同的 方法進行反應,而可獲得上述化合物。 收成率:96%Melting point: 152 ~ 154 ° C 1H NMR (500MHz, CDC13) 5: 1.4l (3H, d)? 2. 32 (3H, s), 3.27 (4H, t), 3.71 (4H, t), 3.79 (6H , S), 3.87 (3H, s), 5.04 (lH, q), 6.10 (3H, m), 6.63 (1H, s), 8.22 (lH, s)? Example 215) Hydroxyethyl) -2 _Methoxy-4-methylphenyl] aminocarbonyl} -4- (3,5-difluorenylbenzyl)? 1-[(5-ethylfluorenyl-2-methoxy-4 The methyl compound) 4- (3,5-difluorenylphenyl) can be reacted in the same manner as in Example 214 above to obtain the above compound. Yield: 96%

熔點:140〜142°C NMR(500MHz,CDC13)5: l,48(3H,d), 2.33(3H,s), 3.26 (4H, t), 3. 68(4H, t), 3. 87(3H, s), 5. 06(1H, q), 6. 61 (3H,m), 6.64(lH,s), 7.01(1H,S), 8.22(lH,s) 實施例216) M(2_曱氧基-4-甲基_5_苯乙烯基)胺基 魏基]-4-(3,5-二甲氧基苯基)哌嗪 將1-{[5-(1-羥乙基)-2-甲氧基曱基苯基]胺基羰 基卜4-(3,5-一甲氧基苯基)派嗔(〇.2g,〇.47毫莫耳),溶 解於氯仿(15ml)中,並添加吡啶姆對甲苯磺酸酯 (〇.12g,〇.47毫莫耳)後,再以管柱層析法(乙基醋酸酯 -132- 本紙張尺度 (CNS) A4 規格(-—---- |丨_;——.---f I— C請先閱讀背面之注意事項真填寫本fo 訂 έ 575564 經濟部中央標準局員工消費合作社印製 A7 _____________ B7 五、發明説明(128) 一一 骨;L·:已基= 1:2)進行分離精製後,便可獲得上述化合物。 收成率:84% 熔點:163〜165°CNMR(500MHz,CDC13)5: 2.31(3H,s), 3. 23(4H, t), 3. 58(4H, t), 3. 77(6H, s), 3. 87(3H, s), 5.20(1H,d), 5.62(lH,d), 6.59(3H,m), 6.63(1H,s), 6.88(lH,t), 6.99(1H,s), 8.32(1H,s) 實施例217) K(2-甲氧基_4-曱基_5_苯乙烯基)胺基 羰基]-4-(3,5-二甲基苯基)哌嘻 將1-{[5-(1-羥乙基)-2-甲氧基_4_曱基苯基]胺基羰 基}-4-(3,5-二曱基苯基)哌嗪,採行如同上述實施例216 相同的方法進行反應,而可獲得上述化合物。 收成率:82% 熔點:201〜203°C 'H NMR(500MHz,CDC13)(? : 2. 29(6H, s), 2. 34(3H, s), 3.24(4H,t),3.68(4H,t), 3.87(3H,s), 5.22(lH,d), 5.66(lH,d),6.59(3H,m),6.63(lll,s),6.86(lH,t), 7.〇2(1H,s), 8.32(1H,s) 實施例218) l-[(5-乙醯基-2_甲氧基-4-甲基苯基)胺 基幾基]-4-(3,5-二曱氧基苯基)哌嗪 將苯基N-(5-乙醯基_2_甲氧基-4-甲基苯基)硫代甲 酸醋與1-(3,5_二甲氧基苯基)哌嗪,採行如同上述實施 例197相同的方法進行反應,而可獲得上述化合物。 收成率:82% -133- 本紙張尺度適用巾關家標準(CNS) A4^^Gx297公董) ' " (請先閱讀背面之注意事項再填寫本頁) I# 項再填> 裝· 訂 it 經濟部中央標準局員工消費合作社印製 575564 A7 B7 _ " -- -- ----- ------ . —— 五、發明説明(129)Melting point: 140 ~ 142 ° C NMR (500MHz, CDC13) 5: 1,48 (3H, d), 2.33 (3H, s), 3.26 (4H, t), 3. 68 (4H, t), 3. 87 (3H, s), 5.06 (1H, q), 6.61 (3H, m), 6.64 (lH, s), 7.01 (1H, S), 8.22 (lH, s) Example 216) M ( 2-Methoxy-4-methyl-5styryl) aminoweiyl] -4- (3,5-dimethoxyphenyl) piperazine will be 1-{[5- (1-hydroxy Ethyl) -2-methoxyfluorenylphenyl] aminocarbonyl 4- (3,5-monomethoxyphenyl) pyrazine (0.2 g, 0.47 mmol), dissolved in chloroform (15ml), and then added pyrimide p-toluenesulfonate (0.12g, 0.47mmol), and then column chromatography (ethyl acetate-132- this paper size (CNS) A4 Specifications (-—---- | 丨 _; ——.--- f I— C Please read the notes on the back to fill in this form fo Order 575564 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 _____________ B7 5 Explanation of the invention (128) One bone; L ·: Hexyl = 1: 2) After separation and purification, the above compounds can be obtained. Yield: 84% Melting point: 163 ~ 165 ° CNMR (500MHz, CDC13) 5: 2.31 (3H, s), 3. 23 (4H, t), 3. 58 (4H, t), 3. 77 (6H, s), 3. 87 (3H, s), 5.20 (1H, d), 5.62 (lH, d), 6.59 (3H, m), 6.63 (1H, s), 6.88 (lH, t), 6.99 (1H, s), 8.32 (1H, s) Example 217) K (2-A Oxy_4-fluorenyl-5_styryl) aminocarbonyl] -4- (3,5-dimethylphenyl) piperidine 1-{[5- (1-hydroxyethyl) -2 -Methoxy_4_fluorenylphenyl] aminocarbonyl} -4- (3,5-difluorenylphenyl) piperazine can be reacted in the same manner as in Example 216 above to obtain the above-mentioned Compounds. Yield: 82% Melting point: 201 ~ 203 ° C 'H NMR (500MHz, CDC13) (?: 2. 29 (6H, s), 2. 34 (3H, s), 3.24 (4H, t), 3.68 ( 4H, t), 3.87 (3H, s), 5.22 (lH, d), 5.66 (lH, d), 6.59 (3H, m), 6.63 (ll, s), 6.86 (lH, t), 7. 2 (1H, s), 8.32 (1H, s) Example 218) l-[(5-ethylfluorenyl-2_methoxy-4-methylphenyl) aminoquinyl] -4- (3 Phenyl N- (5-ethylfluorenyl-2-methoxy-4-methylphenyl) thioformate with 1- (3,5-di The methoxyphenyl) piperazine was reacted in the same manner as in Example 197 above to obtain the above compound. Yield: 82% -133- This paper size applies to towel family standards (CNS) A4 ^^ Gx297 public director) '" (Please read the precautions on the back before filling out this page) I # then fill in > · Order it printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 B7 _ "------- ------. —— V. Description of the invention (129)

熔點:163〜165°C !H NMR(500MHz, CDC13) 5 : 2.16(3H,s), 2. 56(3H, s), 3.35C4H, t), 3.9K6H, s), 4. 03(3H, s), 4.13(4H, t), 6· 06(3H,m),6· 73(1H,s),8. 62(1H,s) 實施例219) l-[(5_乙醯基-2-甲氧基-4-甲基苯基)胺 基硫代幾基]-4-(3,5-二甲基苯基)派嗔 將苯基N-(5-乙醯基-2-甲氧基_4_甲基苯基)硫代甲 酸酯與1-(3,5-二甲基苯基)哌嗪,採行如同上述實施例 197相同的方法進行反應,而可獲得上述化合物。 收成率:79%Melting point: 163 ~ 165 ° C! H NMR (500MHz, CDC13) 5: 2.16 (3H, s), 2. 56 (3H, s), 3.35C4H, t), 3.9K6H, s), 4. 03 (3H , s), 4.13 (4H, t), 0.606 (3H, m), 6.73 (1H, s), 8.62 (1H, s) Example 219) l-[(5_ethy -2-Methoxy-4-methylphenyl) aminothioquinoyl] -4- (3,5-dimethylphenyl) -Methoxy_4-methylphenyl) thioformate and 1- (3,5-dimethylphenyl) piperazine can be reacted in the same manner as in Example 197 above to obtain The above compounds. Yield: 79%

熔點:180〜182°C NMR(500MHz, CDCI3) 5 : 2. 29(6H, s), 2. 57(6H, s), 3.32(4H,4t,),3.92(3H,s),4.12(4H,t),6.56(3H,m), 6.72(lH,s),7.39(lH,s) 貫%例220) -乙酸基-2 -甲氧基甲基苯基)胺 基硫代幾基]-4-(3,5_二氯化苯基)旅嗪 將苯基N-(5-乙醯基-2-甲氧基_4_曱基苯基)硫代甲 酸酯與二氯化苯基)哌嗉,採行如同上述實施例 197相同的方法進行反應,而可獲得上述化合物。 收成率:79%Melting point: 180 ~ 182 ° C NMR (500MHz, CDCI3) 5: 2. 29 (6H, s), 2. 57 (6H, s), 3.32 (4H, 4t,), 3.92 (3H, s), 4.12 ( 4H, t), 6.56 (3H, m), 6.72 (lH, s), 7.39 (lH, s) (% of Example 220) -Acetyl-2-methoxymethylphenyl) aminothiochi ] -4- (3,5_dichlorophenyl) travelazine Phenyl N- (5-ethylamido-2-methoxy-4_fluorenylphenyl) thioformate with dichloro The phenyl) piperidine was reacted in the same manner as in Example 197 above to obtain the above compound. Yield: 79%

熔點:201〜203°C NMR(500MHz,CDC13)5: 2. 20(3H, s), 2. 57(3H? s) 3.46(4H5t), 3.92C3H, s), 4. 25(4H, t), 6.64(1H s) 6.88(3H,m), 7.72(lH,s), 8.57(1H,S) ’ ’ -134- 本紙張尺度適财縣(CNS) M規格(21GX297公羞)— -—- I ^批衣-- (請先閲讀背面之注意事項再填寫本頁)Melting point: 201 ~ 203 ° C NMR (500MHz, CDC13) 5: 2. 20 (3H, s), 2. 57 (3H? S) 3.46 (4H5t), 3.92C3H, s), 4. 25 (4H, t ), 6.64 (1H s) 6.88 (3H, m), 7.72 (lH, s), 8.57 (1H, S) '' -134- The paper size of Shicai County (CNS) M specifications (21GX297 public shame) —- —- I ^ 批 衣-(Please read the notes on the back before filling in this page)

、1T i# 經濟部中央標準局員工消費合作社印製 575564 A7 B7 五、發明説明(130) 實施例221) 1-{[5-(1-羥乙基)-2-甲氧基-4-甲基苯基] 胺基硫代羰基卜4-(3,5-二甲氧基苯基)哌嗪 將1_[(5-乙醯基-2-甲氧基_4_甲基苯基)胺基硫代羰 基]-4-(3,5-二甲氧基苯基),採行如同上述實施例214 相同的方法進行反應,而可獲得上述化合物。 收成率:94%1T i # Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 B7 V. Description of the invention (130) Example 221) 1-{[5- (1-hydroxyethyl) -2-methoxy-4- Methylphenyl] aminothiocarbonyl 4- (3,5-dimethoxyphenyl) piperazine 1 _ [(5-ethylamido-2-methoxy_4_methylphenyl) Aminothiocarbonyl] -4- (3,5-dimethoxyphenyl) was reacted in the same manner as in Example 214 above to obtain the above compound. Yield: 94%

熔點:146〜148°C 'H NMR(500MHz,CDC13)5 : 1.44(3H,d), 2. 32(3H, s), 3.35(4H,t), 3.78(6H,s), 3.84(3H,s), 4.11(4H,t), 5. 06(1H,q),6· 13(3H,m),6. 66(1H,s),7· 41(1H,s), 7. 77(1H, s) 實施例222) l-{[5-(l-羥乙基)-2-曱氧基-4-甲基苯基] 胺基硫代羰基}-4-(3,5-二甲基苯基)哌嗪 將1-[(5-乙醯基-2-甲氧基-4-甲基苯基)胺基硫代羰 基]-4-(3,5-二甲基苯基),採行如同上述實施例214相 同的方法進行反應,而可獲得上述化合物。 收成率:93%Melting point: 146 ~ 148 ° C 'H NMR (500MHz, CDC13) 5: 1.44 (3H, d), 2. 32 (3H, s), 3.35 (4H, t), 3.78 (6H, s), 3.84 (3H , S), 4.11 (4H, t), 5.06 (1H, q), 6.13 (3H, m), 6.66 (1H, s), 7.41 (1H, s), 7. 77 (1H, s) Example 222) l-{[5- (l-hydroxyethyl) -2-methoxy-4-methylphenyl] aminothiocarbonyl} -4- (3,5- Dimethylphenyl) piperazine 1-[(5-ethylfluorenyl-2-methoxy-4-methylphenyl) aminothiocarbonyl] -4- (3,5-dimethylbenzene Group), the same method as in Example 214 was used for the reaction to obtain the above compound. Yield: 93%

熔點:150〜152°C !H NMR(500MHz,CDC13)5 : 1.44(3H,d), 2. 29(6H, s), 2.32(3H,s), 3.30C4H, t), 3.84(3H,s), 4. 07(4H, t), 5. 〇6(lH,q),6. 61(3H,m),6· 66(1H,s),7· 38(1H,s), 7· 79(1H,s) 貫施例223) l-{[5-(1-經乙基)-2-曱氧基-4-曱基苯基] 胺基硫代羰基}-4-(3,5-二氣化苯基)哌嗉 -135- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X297公釐) ^^裝 . 訂. (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 575564 A7 ----------- B7 五、發明説明(131) 將丨-[(5-乙醯基-2-曱氧基甲基苯基)胺基硫代羰 基]-4-(3,5-二氯化苯基),採行如同上述實施例214相 同的方法進行反應,而可獲得上述化合物。 收成率·· 77%Melting point: 150 ~ 152 ° C! H NMR (500MHz, CDC13) 5: 1.44 (3H, d), 2. 29 (6H, s), 2.32 (3H, s), 3.30C4H, t), 3.84 (3H, s), 4.07 (4H, t), 5.〇6 (lH, q), 6.61 (3H, m), 6.66 (1H, s), 7.38 (1H, s), 7 · 79 (1H, s) Example 223) l-{[5- (1-Ethyl) -2-methoxyoxy-4-fluorenylphenyl] aminothiocarbonyl} -4- (3 , 5-Digasified phenyl) piperazine-135- This paper size applies to Chinese National Standard (CNS) A4 (210 X297 mm) ^^ Pack. Order. (Please read the precautions on the back before filling this page ) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 ----------- B7 V. Description of the invention (131) The phenyl) aminothiocarbonyl] -4- (3,5-dichlorinated phenyl) was reacted in the same manner as in Example 214 above to obtain the above compound. Yield · 77%

熔點:166〜168°C NMR(500MHz,CDC13)(5: 1.45(3H,d), 2. 33(3H, s), 3-35(4H,t), 3.84(3H,s), 4. 03(4H, t), 5.07(lH,q), 6.68(3H,m), 6.83(lH,s), 7.37(lH,s), 7.82(lH,s) 實施例224)乙基2-({[4-(3,5-二甲氧基苯基)哌嗉] 幾基}-2-甲氧基-4,5-二甲基苯胺)醋酸酯 將1-[(4,5-二甲基-2·甲氧基苯基)胺基幾基]_4_(3,5_ 二甲氧基苯基)哌嗔(0.2g,0.5毫莫耳),溶解於二甲基甲 醯胺(15ml)中,並添加氫化納(I8.5mg,0.5毫莫耳)後, 於至溫下擴;掉3小時。減壓濃縮去除溶劑,再以管柱 層析法(乙基醋酸酯:己烷= 1:2)進行分離精製後,便可 獲得上述化合物。 收成率·· 79% 熔點:油狀 ^ NMR(500MHz,CDC13)5 : 1.36(3H,t), 2. 15(3H, s), 2.23(3H,s), 2.9K4H, t), 3. 22(4H, t), 3.82(6h/s), 4.12(3H,s),4.18(2H,s),5.98(3H,m), 6.69(1H,S)’ 7. 03(1H, s) ’ 貫施例225)乙基2-({[4-(3,5-«—甲基笨基)口底嗜]罗炭 基}-2-曱氧基-4,5-二甲基苯胺)醋酸酯 136 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) .~ 裝 訂 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 575564 A7 ----- B7 五、發明説明(132) 將1-[(4,5-二甲基-2-甲氧基苯基)胺基羰基]_4_(3,5_ —甲基苯基)略嗔,採行如同上述實施例224相同的方 法進行反應,而可獲得上述化合物。 收成率:78% 熔點:油狀 !H NMR(500MHz,CDC13)5: 1.26(3H,t), 1.56(6H,s), 2. 24(3H,s),3. 32(4H,t),3.52(411,t),3.82(3H,S) 4.15(2H,q),4.18(2H,s),6.70(3H,m),6.94(1H,S)’ 7. 46(1H, s) ’ ’ 實施例226) 2-({[4-(3,5-二曱氧基苯基)哌嗪]羰基}_ 2-甲氧基-4,5-二曱基苯胺)醋酸酯 將乙基2-({[4-(3,5-二甲氧基苯基)哌嗪]羰基}_2_ 甲氧基_4,5-二甲基苯胺)醋酸酯(200mg,0 41毫莫耳), 溶解於二氧烷:蒸餾水=4:l(15ml)中,並添加鋰化气 水化物(50.7mg,1.23毫莫耳),於室溫下攪拌3小時, 然後添加1N鹽酸予以酸性化後,採用乙基醋酸醋進 行萃取並乾燥過濾。然後利用減壓濃縮將溶劑予以去 除後,以管柱層析(乙基醋酸酯:己烷=丨:2),進行八 離精製後便可獲得上述化合物。 刀 收成率:80%Melting point: 166 ~ 168 ° C NMR (500MHz, CDC13) (5: 1.45 (3H, d), 2. 33 (3H, s), 3-35 (4H, t), 3.84 (3H, s), 4. 03 (4H, t), 5.07 (lH, q), 6.68 (3H, m), 6.83 (lH, s), 7.37 (lH, s), 7.82 (lH, s) Example 224) Ethyl 2- ( {[4- (3,5-Dimethoxyphenyl) piperidinium] quinyl} -2-methoxy-4,5-dimethylaniline) acetate will be 1-[(4,5-di Methyl-2 · methoxyphenyl) aminopropyl] -4_ (3,5_dimethoxyphenyl) piperidine (0.2g, 0.5mmol), dissolved in dimethylformamide (15ml ), And after adding sodium hydride (I8.5mg, 0.5mmol), it was expanded at room temperature for 3 hours. The solvent was removed under reduced pressure, and the compound was separated and purified by column chromatography (ethyl acetate: hexane = 1: 2). Yield: 79% Melting point: oily ^ NMR (500MHz, CDC13) 5: 1.36 (3H, t), 2. 15 (3H, s), 2.23 (3H, s), 2.9K4H, t), 3. 22 (4H, t), 3.82 (6h / s), 4.12 (3H, s), 4.18 (2H, s), 5.98 (3H, m), 6.69 (1H, S) '7. 03 (1H, s) '' Example 225) Ethyl 2-({[4- (3,5-«— methylbenzyl)] [Carbonyl] -2-carboxy-4,5-dimethylaniline ) Acetate 136-This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm). Binding (please read the precautions on the back before filling this page) Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 ----- B7 V. Description of the invention (132) The 1-[(4,5-dimethyl-2-methoxyphenyl) aminocarbonyl group] _4_ (3,5_ —methylphenyl) is slightly Alas, the same method as in Example 224 was used for the reaction to obtain the above compound. Yield: 78% Melting point: oily! H NMR (500MHz, CDC13) 5: 1.26 (3H, t), 1.56 (6H, s), 2. 24 (3H, s), 3. 32 (4H, t) , 3.52 (411, t), 3.82 (3H, S) 4.15 (2H, q), 4.18 (2H, s), 6.70 (3H, m), 6.94 (1H, S) '7. 46 (1H, s) 'Example 226) 2-({[4- (3,5-Dioxophenyl) piperazine] carbonyl} _ 2-methoxy-4,5-difluorenylaniline) acetate 2-({[4- (3,5-Dimethoxyphenyl) piperazine] carbonyl} _2_methoxy_4,5-dimethylaniline) acetate (200mg, 0 41 mmol) , Dissolved in dioxane: distilled water = 4: 1 (15ml), and added lithiated gas hydrate (50.7mg, 1.23mmol), stirred at room temperature for 3 hours, and then added 1N hydrochloric acid to acidify Extraction with ethyl acetate and drying filtration. Then, the solvent was removed by concentration under reduced pressure, and column chromatography (ethyl acetate: hexane = 丨: 2) was used for purification by eight-step separation to obtain the above compound. Knife Yield: 80%

熔點:188〜189°C 4 丽R(500MHz,CDC13)6: 2.14(3H,s),2.23(3H,S) 2.93(4H,t),3.35(4H,t),3.75(6H,s),3.87(31 s) 4.18(2H,s),5.96(3H,m),6.71(lH,s),7.71(ih,’s)’ -137- 本紙張尺度適用中國國家標準(CNS)八4規格(210X297公釐) I—-----—9^------訂------ (請先閱讀背面之注意事項、再填寫本頁』 575564 A7 B7 經濟部中央榡準局員工消費合作社印製 五、發明説明(133 ) 貫施例227) 2-({[4-(3,5-二甲基苯基)哌嗪]羰基卜2_ 甲氧基-4,5-二甲基苯胺)醋酸酯 將乙基2-({ [4-(3,5-二甲基苯基)旅嘻]鑛基卜甲氧 基-4,5-二甲基苯胺)醋酸酯,採行如同上述實施例226 相同的方法進行反應,而可獲得上述化合物。 收成率:78% 熔點·· 170〜171°C JH NMR(500MHz,CDC13)(5: 2.13(3H,s), 2. 24(9H, s), 2.91(4H,t),3.35(4H,t),3.83(3H,s),4.18(2H,s), 6.45(3H,m),6.70(2H,s),6.80(1H,s) 實施例228) l-[(2-羥基-4,5-二甲基苯基)胺基羰基]_ 4-(3,5-二甲基苯胺)哌嗪 a) 4,5-二甲基-2-硝基苯 將3,4-二甲基苯(12.1§,〇.1莫耳),添加三氟醋酸 (250ml),並以水槽徐緩添加亞氮酸鈉(124g,〇18莫 耳)’於室溫下攪拌14小時。利用減壓濃縮將三氟醋 酸予以去除後,再添加水(15〇mi),利用乙醚進行萃取 後,再以管柱層析法進行分離精製後,便可獲得上述 化合物。 收成率:80% iH NMR(500MHz,CDC13)(5: 2.17(6H,s),6.74(lH,s), 7.15(5H,m),7.31(lH,s) b ) 4,5 -—曱基-2 -經胺苯 將4,5-二甲基-2-硝基苯基(ll_7g,〇.〇7莫耳),添加 -138- (請先閱讀背面之注意事 J# •項再填- 裝-- :寫本頁)Melting point: 188 ~ 189 ° C 4 Li R (500MHz, CDC13) 6: 2.14 (3H, s), 2.23 (3H, S) 2.93 (4H, t), 3.35 (4H, t), 3.75 (6H, s) , 3.87 (31 s) 4.18 (2H, s), 5.96 (3H, m), 6.71 (lH, s), 7.71 (ih, 's)' -137- This paper standard applies to China National Standard (CNS) 8-4 Specifications (210X297 mm) I —-----— 9 ^ ------ Order ------ (Please read the notes on the back before filling this page "575564 A7 B7 Central Ministry of Economic Affairs 榡Printed by the Consumer Bureau of the Prospective Bureau. 5. Description of the Invention (133) Implementation Example 227) 2-({[4- (3,5-dimethylphenyl) piperazine] carbonyl group 2_methoxy-4,5 -Dimethylaniline) acetate Ethyl 2-({[4- (3,5-dimethylphenyl) british] mine-based methoxy-4,5-dimethylaniline) acetate The reaction was carried out in the same manner as in Example 226 above to obtain the above compound. Yield: 78% Melting point 170 ~ 171 ° C JH NMR (500MHz, CDC13) (5: 2.13 (3H, s), 2. 24 (9H, s), 2.91 (4H, t), 3.35 (4H, t), 3.83 (3H, s), 4.18 (2H, s), 6.45 (3H, m), 6.70 (2H, s), 6.80 (1H, s) Example 228) l-[(2-hydroxy-4 , 5-dimethylphenyl) aminocarbonyl] _ 4- (3,5-dimethylaniline) piperazine a) 4,5-dimethyl-2-nitrobenzene 3,4-dimethyl Benzene (12.1§, 0.1 mole), trifluoroacetic acid (250 ml) was added, and sodium nitrite (124 g, 0.018 mole) was slowly added in a water tank 'and stirred at room temperature for 14 hours. The trifluoroacetic acid was removed by concentration under reduced pressure, and then water (150 mi) was added, followed by extraction with ether, followed by separation and purification by column chromatography to obtain the above compound. Yield: 80% iH NMR (500MHz, CDC13) (5: 2.17 (6H, s), 6.74 (lH, s), 7.15 (5H, m), 7.31 (lH, s) b) 4,5 -— , -2-4,5-dimethyl-2-nitrophenyl (ll_7g, 0.07 mole) via amine benzene, add -138- (Please read the notes on the back J # first, then fill in -Install-: Write this page)

、1T, 1T

Jt 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 575564 A7 ___________ B7 __ 五、發明説明(134) 四氫%喃(100ml)與乙醇(40ml),並以徐緩添加鈀/活 性碳(0.57g),進行5小時的氫化反應。待利用相同方 法進行反應結束後,以管柱層析法進行分離精製後, 便可獲得上述化合物。 收成率:77% 4 NMR(500MHz,CDCl3M:2.11(6H,s),6.56(2H,s) c) 苯基N-(4,5-二甲基_2-經苯基)甲酸酯 於4,5-二曱基-2-甲氧基苯胺(6.8〇§,〇力5莫耳)中, 添加二氯曱烷(100ml),一邊攪拌同時徐緩添加苯基氯 化甲酸酯(8.0g,0.05莫耳),待攪拌2小時後,再添加 水(150ml),並利用二氯曱烧予以進行萃取,並以管柱 層析法進行分離精製後,便可獲得上述化合物。 收成率:92% NMR(500MHz5CDC13)5:2. 17(6H, s), 6. 74(1H, s), 7.15(5H,m), 7.31(1H,S) d) 苯基N-[2-(t-丁基二乙基甲矽烷氧基)-4,5-二曱基 苯基]曱酸酯 於苯基N-(4,5-二甲基-2-羥苯基)曱酸酯(7.72g,0.03 莫耳)與味唾(2.2g,33毫莫耳)中,添加二氣甲烷(100 ml) ’ 一邊攪拌同時徐緩添加t— 丁基二甲基氯化甲矽烷 (5.〇g,33毫莫耳),待攪拌2小時後,再添加水(15〇ml), 並利用二氯甲烧予以進行萃取,施行乾燥並減壓濃縮, 且以官柱層析法進行分離精製後,便可獲得上述化合 物〇 -139- i紙張尺度適用中國國CNS) A4規格了 I--------------、訂------0 (請先閱讀背面之注意事項再填寫本頁) 575564 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(135) ~ " 收成率:83% 'H NMR(500MHz5CDC13)(5 : 0. 27(6H, s), 0. 98(9H, s), 2· 17(6H,s),7. 12(5H,m),7. 30(2H,s) e) 1-[(2_羥基_4,5-二曱基苯基)胺基羰基]_4_(3,5_二甲 氧基苯)哌嗪 將苯基N-[2-(t-丁基二甲基曱矽烷氧基)_4,5_二曱 基苯基]甲酸酯(0.17g,0.5毫莫耳)與^(3,^二甲氧基苯) 哌嗪(0.13g,0.6毫莫耳)中,溶解於四氳α比喃(1〇〇ml)後, 添加DBU(0.09g,0.6毫莫耳),攪拌2小時。將反應物 予以濃縮後,以管柱層析法進行分離精製後,便可獲 得上述化合物。 收成率:87% H NMR(500MHz?CDC13)(5: 2.14(3H,s), 2.18(3H,s), 3.26(4H,t), 3.67(4H,t), 3. 79(6H, s), 6.07(3H,m), 6.40(3H,m), 6.67(lH,s), 6.82(1H,s), 8.87(lH,s) 貫靶例229) ^[(2-羥基-4,5-二曱基苯基)胺基羰基]- 4-(3,5-二甲基苯)哌嗪 將苯基N-[2-羥基-4,5-二甲基苯基)甲酸酯與^ (3,5""一甲基苯)哌嘻,採行如同上述實施例228相同的 方法進行反應,而可獲得上述化合物。 收成率·· 84%Jt This paper size applies to China National Standard (CNS) A4 (210X297 mm) Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 575564 A7 ___________ B7 __ 5. Description of the invention (134) Tetrahydrofuran (100ml) and ethanol ( 40 ml), and palladium / activated carbon (0.57 g) was slowly added, and a hydrogenation reaction was performed for 5 hours. After completion of the reaction by the same method, separation and purification by column chromatography can obtain the above compounds. Yield: 77% 4 NMR (500MHz, CDCl3M: 2.11 (6H, s), 6.56 (2H, s) c) Phenyl N- (4,5-dimethyl_2-phenylphenyl) formate in Dichloromethane (100 ml) was added to 4,5-difluorenyl-2-methoxyaniline (6.80§, 5 mol), and phenylchloroformate (8.0) was slowly added while stirring. g, 0.05 mol), after stirring for 2 hours, water (150 ml) was added, and extracted with dichloromethane, and separated and purified by column chromatography to obtain the above compound. Yield: 92% NMR (500MHz5CDC13) 5: 2. 17 (6H, s), 6. 74 (1H, s), 7.15 (5H, m), 7.31 (1H, S) d) Phenyl N- [2 -(t-butyldiethylsilyloxy) -4,5-difluorenylphenyl] phosphonate in phenyl N- (4,5-dimethyl-2-hydroxyphenyl) phosphonic acid Diethyl methane (100 ml) was added to the ester (7.72 g, 0.03 mol) and flavor saliva (2.2 g, 33 mmol). Slowly add t-butyldimethylsilyl chloride (5 〇g, 33 millimoles), after stirring for 2 hours, water (150 ml) was added, and extracted with dichloromethane, dried and concentrated under reduced pressure, and performed by official column chromatography After separation and purification, the above compounds can be obtained. ○ -139- i Paper size is applicable to China's CNS) A4 specifications I --------------, order ------ 0 (please Read the notes on the back before filling this page) 575564 Printed A7 B7 by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (135) ~ " Yield: 83% 'H NMR (500MHz5CDC13) (5: 0. 27 (6H, s), 0.98 (9H, s), 2.17 (6H, s), 7.12 (5H, m), 7. 30 (2H, s) e) 1-[(2_ Hydroxy_4,5-difluorenylphenyl) amine Carbonyl] _4_ (3,5_dimethoxyphenyl) piperazine Phenyl N- [2- (t-butyldimethylphosphosilyloxy) _4,5_difluorenylphenyl] formate (0.17g, 0.5 mmol) and ^ (3, ^ dimethoxybenzene) piperazine (0.13 g, 0.6 mmol), dissolved in tetrahydropyrane (1000 ml), and added DBU (0.09 g, 0.6 mmol) and stirred for 2 hours. After concentrating the reaction product and separating and purifying it by column chromatography, the above compound can be obtained. Yield: 87% H NMR (500MHz? CDC13) (5: 2.14 (3H, s), 2.18 (3H, s), 3.26 (4H, t), 3.67 (4H, t), 3. 79 (6H, s ), 6.07 (3H, m), 6.40 (3H, m), 6.67 (lH, s), 6.82 (1H, s), 8.87 (lH, s) Through Target Example 229) ^ [(2-hydroxy-4, 5-Difluorenylphenyl) aminocarbonyl]-4- (3,5-dimethylphenyl) piperazine Phenyl N- [2-hydroxy-4,5-dimethylphenyl) formate With ^ (3,5 " -methylbenzene) piperidine, the same method as described in Example 228 was used for the reaction to obtain the above compound. Yield · 84%

熔點:160〜162°C -140- 本紙張尺度適财® 標準(CNS ) A4規格( 裝 訂 (請先閱讀背面之注意事項再填寫本頁) 575564 A7 ..... -- Ό ------- D / 五、發明説明(136) 經濟部中央標準局員工消費合作社印製 H ™(500MHz)CDCl3)5: 2.13(3Η)5), 2. 17(3Η, s), 2.31(6H,s), 3.26(4H,t), 3. 75(4H, t), 6.73(3H,m), 6.81(1H,s), 8.86(1H,s) 貫施例230) 1_[(2-羥基·4,5-二甲基苯基)胺基羰基]- 4-(3,6-二I化苯基)派嗪 將苯基N_[2-羥基_4,5_二曱基苯基)曱酸酯與卜 (3,6-一氟化苯)哌嗪,採行如同上述實施例228相同的 方法進行反應,而可獲得上述化合物。 收成率:80% 熔點:152〜154°C H NMR(500MHz, CDC13) ά : 2.17(3H,S), 2.20(3H,s), 3.30(4H,t), 3.70(4H,t), 6.40(3H,m), 6.70(lH,s), 6.82(1H,s), 6.98(1H,s) 實施例231) 1_[(2-羥基-4,5-二甲基苯基)胺基羰基]_ 4-(3,5-二氯化苯基)哌嗪 將苯基N-[2-羥基-4,5-二曱基苯基)曱酸酯與“ (3,5-二氯化苯)哌嗪,採行如同上述實施例228相同的 方法進行反應,而可獲得上述化合物。 收成率:77% 溶點:油狀 !H NMR(5〇〇MHz,CDC13)5: 2.15(3H,s), 2. 20(3H, s), 3.32(4H,t), 3.69(4 H,t), 6.29(3H,m), 6.69(1H,S), 6-81(1H,s), 8.65(1H,s) -141 - 本紙張尺度適用中國國家標準(CNS ) a4規格(210X297公釐) I------—^^装-- C请先聞讀背面之注意事項存填寫本買) 訂 4 575564 A7 B7 五、發明説明(137) 以下係針對上述所製得本發明化合物的抗癌藥理 活性進行試驗。本發明化合物的抗癌活性,乃遵從活 體外法,採用5種人類腫瘤細胞株與2種白血病腫瘤 細胞株,分別進行測試,其結果如下表中所示。所謂 活體外方法,乃依照下列方式進行。 實驗例1) ★針對人類腫瘤細胞株的活體外抗癌效果 1. 腫瘤細胞株:A549(人類 non-small lung cell) SKOV-3 (人類卵巢) HCT-15 (人類直腸) XF-498 (人類 CNS) SKMEL-2 (人類黑色素細胞) 2. 貫驗方法 a.採用包含屬於人類腫瘤細胞株的A549(人類non-small lung cell)、SKOV-3 (人類卵巢)、HCT-15 (人類直腸)、XF_498(人類 CNS)、SKMEL-2(人 類黑色素細胞)等10% FBS的RPMI 1640培養 基,於37°C下,以C02、培養器進行培養,繁 殖係1週内施行1〜2次。細胞由附著面脫離之際, 則採用溶解於0.5%胰蛋白酶及3mM CDTA PBS㈠的溶液。 b_於96孔平板(Nunc)的各孔中,添加5 X 103〜2X 104 細胞,於37°C下,以5% C02、培養器進行24 小時的培養。 -142- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填_ :寫本頁) 經濟部中央標準局員工消費合作社印製 575564 Α7 Β7 五、發明説明(138) c. 將各種試藥溶解於少量的DMSO中,並調整至對 試驗為適當的濃度,利用實驗用培養基進行稀 釋,使最終DMSO濃度在0.5%以下。 d. 將上述b.項中施4亍2 4小時培養的各孔的培養基, 予以吸收並去除後,再將c.項中所製得的藥物, 分別各添加2 // 1後,再進行48小時的培養。於 藥物的添加之際,收集Tz(Time zero)板。 e. Tz板及各培養基結束的板,以SRB分析法,遵 照TCA,固定細胞,以0.4%溶液,進行染色溶 析,以520nm測量OD值。 3.結果計算 a. 添加藥物並開始進行培養的時間時進行收集,並 求取SBR蛋白質量的值,以此為Time zero(Tz)。 b. 未添加藥物,僅有細胞的孔之OD值,稱為控制 值(C)〇 c. 添加藥物處理的孔之OD .值,稱為藥物處理測試 值(T)。 d. 由Tz. C與T,以生長刺激、淨生長抑制及淨殺 死等,可判斷藥物效果。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) e. 當Τ^Τζ時,細胞反應計算式為lOOX(T-Tz)/ (C-Tz),而當 T< Tz 時,則為 100X(T-Tz)/Tz。 其結果如下表中所示。 ★參考文獻 -143 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 575564Melting point: 160 ~ 162 ° C -140- This paper is suitable for Standards ® Standard (CNS) A4 specification (binding (please read the precautions on the back before filling this page) 575564 A7 .....----- ---- D / V. Description of the invention (136) Printed by H ™ (500MHz) CDCl3) 5: 2.13 (3Η) 5), 2. 17 (3Η, s), 2.31 ( 6H, s), 3.26 (4H, t), 3.75 (4H, t), 6.73 (3H, m), 6.81 (1H, s), 8.86 (1H, s) (Example 230) 1 _ ((2 -Hydroxy · 4,5-dimethylphenyl) aminocarbonyl]-(4-, 3,6-di-I-phenyl) pyrazine Phenyl N_ [2-hydroxy_4,5_difluorenylbenzene The above-mentioned compound can be obtained by the same method as in Example 228 above for the reaction of the phosphonium ester with di (3,6-difluorobenzene) piperazine. Yield: 80% Melting point: 152 ~ 154 ° CH NMR (500MHz, CDC13) ά: 2.17 (3H, S), 2.20 (3H, s), 3.30 (4H, t), 3.70 (4H, t), 6.40 ( 3H, m), 6.70 (lH, s), 6.82 (1H, s), 6.98 (1H, s) Example 231) 1 _ [(2-hydroxy-4,5-dimethylphenyl) aminocarbonyl] _ 4- (3,5-dichlorophenyl) piperazine combines phenyl N- [2-hydroxy-4,5-difluorenylphenyl) phosphonate with "(3,5-dichlorobenzene ) Piperazine, which was reacted in the same manner as in Example 228 above to obtain the above compound. Yield: 77% Melting point: oily! H NMR (500 MHz, CDC13) 5: 2.15 (3H, s), 2. 20 (3H, s), 3.32 (4H, t), 3.69 (4 H, t), 6.29 (3H, m), 6.69 (1H, S), 6-81 (1H, s), 8.65 (1H, s) -141-This paper size is applicable to Chinese National Standard (CNS) a4 specification (210X297mm) I -------^^ installed-C Please read and read the notes on the back first (Buy this) Order 4 575564 A7 B7 V. Description of the invention (137) The following is a test of the anti-cancer pharmacological activity of the compound of the present invention prepared as described above. The anti-cancer activity of the compound of the present invention is in accordance with the in vitro method using 5 kinds Human tumor cell lines and two leukemia tumor cell lines The results are shown in the following table. The so-called in vitro method is performed in the following manner. Experimental Example 1) ★ In vitro anticancer effect on human tumor cell lines 1. Tumor cell line: A549 (human non -small lung cell) SKOV-3 (Human ovary) HCT-15 (Human rectum) XF-498 (Human CNS) SKMEL-2 (Human melanocytes) 2. Test method a. Use A549 containing human tumor cell line (Human non-small lung cell), SKOV-3 (human ovary), HCT-15 (human rectum), XF_498 (human CNS), SKMEL-2 (human melanocytes) and other 10% FBS in RPMI 1640 medium, at 37 Cultivate with C02 and an incubator at ° C. The breeding system is performed once or twice a week. When cells are detached from the attachment surface, a solution dissolved in 0.5% trypsin and 3 mM CDTA PBS㈠ is used. B_ 于 96 5 X 103 ~ 2X 104 cells were added to each well of a well plate (Nunc), and cultured at 37 ° C for 24 hours in a 5% CO 2 incubator. -142- This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) (Please read the notes on the back before filling _: write this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 575564 Α7 Β7 Five Explanation of the invention (138) c. Dissolve various reagents in a small amount of DMSO, adjust to the appropriate concentration for the test, and dilute with the experimental medium to make the final DMSO concentration below 0.5%. d. After absorbing and removing the culture medium in each well of 4 亍 2 for 4 hours in item b. above, add the medicines prepared in item c. 2 and 1 respectively, and then proceed. 48 hours of culture. At the time of drug addition, Tz (Time zero) plates were collected. e. Tz plates and plates at the end of each culture medium were fixed by SRB analysis in accordance with TCA, cells were stained with 0.4% solution, and OD values were measured at 520 nm. 3. Result calculation a. Collect the time when the drug is added and start culturing, and obtain the value of the SBR protein mass as Time Zero (Tz). b. The OD value of the wells with only no cells is called the control value (C). c. The OD value of the wells with drug treatment is called the drug treatment test value (T). d. From Tz. C and T, the effect of the drug can be judged by growth stimulation, net growth inhibition, and net killing. Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the notes on the back before filling this page) e. When T ^ Τζ, the cell response formula is lOOX (T-Tz) / (C-Tz), When T < Tz, it is 100X (T-Tz) / Tz. The results are shown in the following table. ★ References -143-This paper size applies to China National Standard (CNS) Α4 size (210X 297 mm) 575564

and M * R.β〇yd.;and M * R. β〇yd .;

A7 B7 五、發明説明(139) 1) P.Skehan,R.Strong/ ^cudiero, A.Monks, J · B · ficaiahan,H Vistica, J.Warren, H.Bokesch, S.Renney, and M.R.Boyd ; Froc.AK,A7 B7 V. Description of the invention (139) 1) P. Skehan, R. Strong / ^ cudiero, A. Monks, J. B. ficaiahan, H. Vistica, J. Warren, H. Bokesch, S. Renney, and MRBoyd ; Froc.AK,

Assoc. Cancer Res., 30, 612 (1989). 2) L.V.Rubinstein, R,H. Shoemaker , K.D^Faull, R.M.Siroon, S.Tosini,P.Skehan, D.Scudiero, A.Ko! J.Natl. Cancer Inst., 82, 1113 (1990) .少 3) P.Skehan, R.Strong, D. Scud iero, A . Monks , J\B.Mcmahan, D.T.Vistica, J.Warreπ , H.Bokesch, S.Kenney and S.R. Boyd .: J.Natl· Cancer Inst., 8! .07 (1990) 4.結果 相較於屬於對照藥物的順氯氨鉑,本發明化合物遺 有極優越的抗癌效果,充分展現於人類固態癌上。由 所有的化合物中,在人類的固態癌上,均可觀察出較 亞德利亞黴素具有同等以上的抗癌效果。 ---------------IT------Φ (請先閲讀背面之注意事項再填寫本頁} 經濟部中央標準局員工消費合作社印製Assoc. Cancer Res., 30, 612 (1989). 2) LV Rubinstein, R, H. Shoemaker, KD ^ Faull, RMSiroon, S. Tosini, P. Skehan, D. Scudiero, A. Ko! J. Natl Cancer Inst., 82, 1113 (1990). 3) P. Skehan, R. Strong, D. Scud iero, A. Monks, J \ B. Mcmahan, DTVistica, J. Warreπ, H. Bokesch, S. .Kenney and SR Boyd.: J.Natl. Cancer Inst., 8! Shown on human solid cancer. From all the compounds, in human solid cancer, it is observed that it has an anticancer effect more than equal to that of adriamycin. --------------- IT ------ Φ (Please read the notes on the back before filling out this page} Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

575564 五、發明説明(140)575564 V. Description of the invention (140)

A B 經濟部令夹標隼局員工消費合作社印製 EDr>o 二 / 识/Μ 實施例編號 A 549 SK-OV-3 SK-MEL-2 XF-498 HCT 15 4 0.007 0.022 0.007 0.94 0.093 5 0.71 0.96 0.60 >10.0 0.96 9 0.15 0.07 0.21 ,0.11 0.11 11 0.91 0.56. 0.62 0.73 0.71 ]4 0.022 0Ό2 - 0.001 0.16 0Ό07 15 0.002- 0.05 0.052 0.035 0.038 16 0.008 0.04 0.038 0.005 0.061 17 0.018 0.01 0.021 0.077 0.008 22 0.0009 0.006 0.027、 0.0053 0.01 23 0.09 0.04 0.09 0.092 0.05 24 0.03 0.006 0.01 0.234 0.01 27 0.02 0.11 0.01 0.046 0.165 is 0.06 0.07 0.001 0.41 0.05 46 0.21 0.12 0.08 0.14 0.16 47 0.92 0.62 0.47 0.64 0.81 53 0.47 0.47 0.64 0.67 0.71 56 0.017 0.0027 0.01 0.013 0.045 57 0.27 0.15 0.18 0.22 0.25 63 0.04 0.1 0.11 0.03 0.07 64 0.42 0.56 0.52 0.23 0.37 73 0.01 0.0054 1 0.02 0.013 0.012 74 0.016 0.0138 0.02 0.026 0.021 75 0.19 0.09 0Ό9 0.13 0.12 順白 0.8184 0.7134 0.7147 0771 3.0381 亞衞 0.0168 0.0176 0.0108 0.0250 1.6689 (請先閱讀背面之注意事項再填寫本頁) -145- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 575564 A7 B7 五、發明説明(14ι) 實方膝丨偏號 A 549 y SK-uV-3 SK - MEL-2 XF 438 HCT 15 81 0.0032 0.0007 0.0107 0.0097 0.0054 82 0.0676 0.0249 0.0754 0.0479 0.0346 8Γ〕 0.048 0.117 0.039 0.104 0.10 88 0.014 0.043 0.02 0.009 0.011 99 0.43 0.41- 0.40 0.52 0.36 100 4.54 3.02 1 3.47 0.66 4.21 103 0.52 0.46 0.49 0.36 0.33 109 0.47 0.91 0.86 0.53 0.49 110 0.52 1.06 0.97 0.81 0.69 112 0.5G 6.43 0.22 · 2.07 0.61 128 0.40 0.37 0.42 0.44 0.51 順寥篇白 0.8184 0.7134 0.7147 0.771 3.0381 亞癖哑讎 0.0168 0.0176 0.0108 0.0250 1.6689 1 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印策 146- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 575564 A7 B7 五、發明説明(142 經濟部中央標準局員工消費合作社印製 實施備醺 - ^Ά549 SK-OV-3 SK-MEL-2 1 XF-498 HCT15 132 0.03 0.01 0.03 0.04 0.04 133 0.57 0.94 0.53 0.61 0.57 134 0.0009 0.0091 0.0086 0.002 0.0065 135 0.056 0.092 0.102 0.06 0.06G 140 0.33 0.47· 0.56 0.54 0.49 142 0.015 0.011 ; 0.021 0.026 0Ό17 143 0.0004 0.0095 0.0121 0.0009 0.0108 147 0.031 0.092 0.024 0.466 0.18 148 0.01 0.07 0.03 0.05 0.05 151 0.004 0.008 0.007 · 0.007 0.037 152 0.18 0.37 0.2 0.26 0.44 156 0.06 0.10 0.09 0.06 0.07 157 0.000002 0.000002 0.000043 0.000245 0.000211 159 0.05 0.10 0.07 0.21 0.17 MMMiQ 0.8184 0.7134 0.7147 0.0771 3.0381 亞衞哑讎 0.0168 0.0176 0.0108 0.0250 1.6689 147 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 575564 A7 B7 五、發明説明(143) 實施備扁號 SK-OV-3 SK-MEL - 2 XF 498 HCT 15 171 0.000645 0.00372 0.003233 0.000572 0.001809 172 0Ό047 0.0097 0.0233 0.0086 0.0180 174 0.54 0.56 0.27 0.49 0.33 177 0.52 0.39 0.17 0.12 0.09 179 1.04 0.98 · 0.72 0.74 0.63 lcS3 0.42 2.27 ,1.17 1.41 2.09 184 0.28 0.34 0.17 0.12 0.20 190 0.004 0.008 0.002 0.443 0.017 191 0.09 0.28 0.06 0.47 0.40 198 0.021 0Ό68 0.008 · 0.072 0.56 200 0.50 0.53 0.26 1.01 0.44 201 0.014 0.053 0.049. 0.026 0.071 202 0.57 1.26 0.48 ^ 2.09 0.64 206 0.47 0.54 0.52 0.70 0.38 順讎白 0.8184 0.7134 07147 0.7771 3.0381 亞衞丨》« 0.0168 0.0176 0.0108 0.0250 1.6689 (請先閱讀背面之注意事項再填寫本頁) 1· *項再填· 裝- 訂 it 經濟部中央標準局員工消費合作社印製 -148 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 575564 A7 B7_ _______ 五、發明説明(144) " 實驗例2) ★針對動物白血病細胞的活體外抗癌效果 1 ·實驗材料 腫瘤細胞株:L1210 (老鼠白血病細胞) P3 88 (老鼠的林巴結贅生細胞) 2·實驗方法(染料排斥分析) 1) 將以包含l〇%FBS的RPMI 1640培養基進行培 養的L1210及P388細胞,調整至1 X i〇5cell/ml 之濃度。 2) 分別添加以對數級數稀釋的各濃度藥物,於於 37°C下,以5% C02、培養器進行48小時後, 測量存活細胞數。該存活細胞數係利用錐蟲藍 實施染料排斥分析,而進行檢測。 3) 由所測量而得細胞數目,與控制值相比較,計 异出代表50%細胞生長抑制的化合物濃度 (IC50)。結果如下表中所示。 ★㈣x獻 φ 1) P.Skehan R. str ong^^^Scud i er o A.Honks, J „ B. Mcmahan , D.T.Vistica, J.warren, H.Bokesch, S.Kenney and M.R.Boyd.; Proc. Am· Assoc. Cancer Res·, 30, 612 (1989). 2) L.V.Rubinsteiii, R . H . Shoemaker , K. D . Pau ] J , R # H . Sirion , S.Tosini, P.Skehan r D.Scudierot A.roonks, J'Natl· Cancer Inst., 82, 1113 (1990) 3) P.Skehan,R. Strong, D.Scudiero,J.B.McMahan, D.T.Vistica, J. Warren , H.Bokesch t S.Reηney, and M,R Λ Boyd ; -149- ” 本紙張尺度適用中國國家標準(CNS ) A4規格(2l〇x297公釐) ---------装------訂------ (請先閲讀背面之注意事項再填寫本頁) 575564 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(145 ) #' 1107 (1990) J.N a t]. Cancer [n s t.3.結果本發明化合物,針對LI210,P3 88老鼠腫瘤細胞進 行抗癌效果的檢測結果中顯示,較對照藥物絲裂黴素 C具有同等以上的抗癌效果。 -150- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填、 :寫本頁) 575564 A7AB Ministry of Economic Affairs ordered the printing of EDr by the Consumers' Cooperatives of the Jiaojiao Bureau. O Second / Knowledge / M Example No. A 549 SK-OV-3 SK-MEL-2 XF-498 HCT 15 4 0.007 0.022 0.007 0.94 0.093 5 0.71 0.96 0.60 > 10.0 0.96 9 0.15 0.07 0.21, 0.11 0.11 11 0.91 0.56. 0.62 0.73 0.71] 4 0.022 0Ό2-0.001 0.16 0Ό07 15 0.002- 0.05 0.052 0.035 0.038 16 0.008 0.04 0.038 0.005 0.061 17 0.018 0.01 0.021 0.077 0.008 22 0.0009 0.006 0.027 , 0.0053 0.01 23 0.09 0.04 0.09 0.092 0.05 24 0.03 0.006 0.01 0.234 0.01 27 0.02 0.11 0.01 0.046 0.165 is 0.06 0.07 0.001 0.41 0.05 46 0.21 0.12 0.08 0.14 0.16 47 0.92 0.62 0.47 0.64 0.81 53 0.47 0.47 0.64 0.67 0.71 56 0.017 0.0027 0.01 0.013 0.045 57 0.27 0.15 0.18 0.22 0.25 63 0.04 0.1 0.11 0.03 0.07 64 0.42 0.56 0.52 0.23 0.37 73 0.01 0.0054 1 0.02 0.013 0.012 74 0.016 0.0138 0.02 0.026 0.021 75 0.19 0.09 0Ό9 0.13 0.12 Shunbai 0.8184 0.7134 0.7147 0771 3.0381 Asian Guard 0.0168 0.0176 0.0108 0.0250 1.6689 (Please read the notes on the back before filling this page) -145- Paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 575564 A7 B7 V. Description of the invention (14ι) Solid square knee 丨 A 549 y SK-uV-3 SK-MEL-2 XF 438 HCT 15 81 0.0032 0.0007 0.0107 0.0097 0.0054 82 0.0676 0.0249 0.0754 0.0479 0.0346 8Γ] 0.048 0.117 0.039 0.104 0.10 88 0.014 0.043 0.02 0.009 0.011 99 0.43 0.41- 0.40 0.52 0.36 100 4.54 3.02 1 3.47 0.66 4.21 103 0.52 0.46 0.49 0.36 0.33 109 0.47 0.91 0.86 0.53 0.49 110 0.52 1.06 0.97 0.81 0.69 112 0.5G 6.43 0.222.07 0.61 128 0.40 0.37 0.42 0.44 0.51 Short article 0.8184 0.7134 0.7147 0.771 3.0381 Asian addiction dummy 0.0168 0.0176 0.0108 0.0250 1.6689 1 (In this page) The policy of employee consumer cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 146- This paper size applies to the Chinese National Standard (CNS) A4 specification (210X 297 mm) 575564 A7 B7 V. Description of the invention Printing implementation-^ Ά549 SK-OV-3 SK-MEL-2 1 XF-498 HCT15 132 0.03 0.01 0.03 0.04 0.04 133 0.57 0.94 0.53 0.61 0.57 134 0.0009 0.0091 0.0086 0.002 0.0065 135 0.056 0.092 0.102 0.06 0.06G 140 0.33 0.470.56 0.54 0.59 0.49 142 0.015 0.011; 0.021 0.026 0Ό17 143 0.0004 0.0095 0.0121 0.0009 0.0108 147 0.031 0.092 0.024 0.066 0.48 0.18 148 0.01 0.07 0.03 0.05 0.05 151 0.004 0.008 0.007 0.007 0.037 152 0.18 0.37 0.2 0.26 0.44 156 0.06 0.10 0.09 0.06 0.07 157 0.000002 0.000002 0.000043 0.000245 0.000245 0.000211 159 0.05 0.10 0.07 0.21 0.17 MMMiQ 0.8184 0.7134 0.7147 0.0771 3.0771 Asia Pacific Mute 0.0168 0.0176 0.0108 0.0250 1.6689 147 (Please first Read the notes on the reverse side and fill in this page) This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X 297 mm) 575564 A7 B7 V. Description of the invention (143) Implementation number SK-OV-3 SK-MEL -2 XF 498 HCT 15 171 0.000645 0.00372 0.003233 0.000572 0.001809 172 0Ό047 0.0097 0.0233 0.0086 0.0180 174 0.54 0.56 0.27 0.49 0.33 177 0.52 0.39 0.17 0.12 0.09 179 1.04 0.98 · 0.72 0.74 0.63 lcS3 0.42 2.27, 1.17 1.41 2.09 184 0.28 0.34 0.14 0.20 190 0.004 0.008 0.002 0.443 0.017 191 0.09 0.28 0.06 0.47 0.40 198 0.021 0Ό68 0.0080.072 0.56 200 0.50 0.53 0.26 1.01 0.44 201 0.014 0.053 0.049. 0.026 0.071 202 0.57 1.26 0.48 ^ 2.09 0.64 206 0.47 0.54 0.52 0.70 0.38 cis white 0.8184 0.7134 07147 0.7771 3.0381 Asian Guard 丨 "« 0.0168 0.0176 0.0108 0.0250 1.6689 (Please read the precautions on the back before filling out this page) 1 · * Fill in and fill out-Order it Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 575564 A7 B7_ _______ 5. Description of the Invention (144) " Experimental Example 2) ★ For animal leukemia cells Anti-cancer effect in vitro 1 · Experimental materials Tumor cell line: L1210 (mouse leukemia cells) P3 88 (lymph node neoplastic cells in mice) 2 · Experimental method (dye exclusion analysis) 1) L1210 and P388 cells cultured in RPMI 1640 medium were adjusted to a concentration of 1 × 10 5 cells / ml. 2) Add each concentration of drug diluted in logarithmic series, and measure the number of viable cells after incubation at 5% C02 for 48 hours at 37 ° C. This number of viable cells was tested by dye exclusion analysis using trypan blue. 3) The number of cells obtained from the measurement is compared with the control value, and the compound concentration (IC50) representing 50% cell growth inhibition is calculated. The results are shown in the following table. ㈣x 献 φ 1) P. Skehan R. str ong ^^^ Scud i er o A. Honks, J „B. Mcmahan, DTVistica, J.warren, H. Bokesch, S. Kenney and MRBoyd .; Proc Am. Assoc. Cancer Res., 30, 612 (1989). 2) LVRubinsteiii, R. H. Shoemaker, K. D. Pau] J, R # H. Sirion, S. Tosini, P. Skehan r D .Scudierot A.roonks, J'Natl. Cancer Inst., 82, 1113 (1990) 3) P. Skehan, R. Strong, D. Scudiero, JBMcMahan, DTVistica, J. Warren, H. Bokesch t S. Reηney, and M, R Λ Boyd; -149- ”This paper size is applicable to China National Standard (CNS) A4 (2l0x297 mm) --------- Installation ------ Order- ----- (Please read the precautions on the back before filling this page) 575564 A7 B7 Printed by the Consumers 'Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of Invention (145) #' 1107 (1990) JN at]. Cancer [ ns t.3. Results The test results of the compounds of the present invention on antitumor effects of LI210, P3 88 mouse tumor cells show that they have an anticancer effect that is equal to or more than that of the control drug mitomycin C. -150- This paper size applies to Chinese National Standard (CNS) A4 (210X 297mm) (Please read the precautions on the back before filling in,: Write this page) 575564 A7

7 B 五、發明説明(146 經濟部中央標準局員工消費合作社印製 實施瓣扁號 〆 L1210 P388 8 0.9 0.4 12 0.2 - 13 0.5 — 14 0.3 - - 15 0.3 0.4 16 0.5 0.3 17 1.2 0.8 ’ 24 0.5 0.5 49 1,5 - 56 0.2 0.2 57 1.8 1.2 60 1.1 - (53 0.5 0.3 64 1.9 1.4 69 - 0.5 71 - 0.07 72 - 0.9 73 0.2 0.04 74 0.5 0.4 7(3 - 0.4 77 - 0.5 c L6 1.1 -151 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) I------- —«t衣------IT------0, 瑋* (請先閱讀背面之注意事項再填寫本頁) 575564 A7 B7 五、發明説明(147)7 B V. Description of the invention 0.5 49 1,5-56 0.2 0.2 57 1.8 1.2 60 1.1-(53 0.5 0.3 64 1.9 1.4 69-0.5 71-0.07 72-0.9 73 0.2 0.04 74 0.5 0.4 7 (3-0.4 77-0.5 c L6 1.1 -151 -This paper size is applicable to China National Standard (CNS) A4 (210X297mm) I ------- — «t-shirt ------ IT ------ 0, Wei * (please first Read the notes on the back and fill out this page) 575564 A7 B7 V. Invention Description (147)

經濟部中央標準局員工消費合作社印製 U 實方綱編號 u _ L1210 P388 132 0.4 0.4 134 0.5 0.2 140 1.8 1.6 143 0.5 0.4 144 • 1.2 0.5 148 1.6 1 - 149 1.0 0.6 151 — 1.2 152 0,3 0.3 154 - 0.1 157 1.7 1.0 158 0.5 0.2 c 1.6 , 1.1 實施備扁號 L1210 P388 170 0.4 0.4 173 0.5 0.2 178 1.8 1.6 181 0.5 0.4 182 .1.2 0.5 186 1.6 - 187 1.0 0.6 190 0.3 0.3 195 1.7 1.0 196 0.5 0.2 $/¾¾¾¾ 1.6 1.1 ----------衣-- (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs of the U. 154-0.1 157 1.7 1.0 158 0.5 0.2 c 1.6, 1.1 Implementation Preparation L1210 P388 170 0.4 0.4 173 0.5 0.2 178 1.8 1.6 181 0.5 0.4 182 .1.2 0.5 186 1.6-187 1.0 0.6 190 0.3 0.3 195 1.7 1.0 196 0.5 0.2 $ / ¾¾¾¾¾ 1.6 1.1 ---------- Clothing-(Please read the precautions on the back before filling in this page)

、1T -152- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 575564 A7 --—一 _ Β7 五、發明説明(148) -- 實驗例3) ★針對老鼠P388細胞的活體内抗癌效果 I實驗材料 採用BDFI老鼠 2·實驗方法 υ以8隻6週齡BDFI老鼠為一組,利用〇8入/2老 鼠,將繁殖中的P388細胞分別於各隻老鼠中, 月旻腔移植1 X 1 〇6cell/〇 lml。 2) 試驗藥物,係懸浮於〇.5%Tween8〇中,染料^ 9 則每9小時分別將各濃度注射於腹腔中。 ’ ’ 3) 每日觀察老鼠,測量存活率,並由各實驗組的中 間存活時間,計算相對於對照組的投藥組之平均 存活日增加比率(T/C%),而判定抗癌效果。結果 如下表中所示。 ★參考文獻 A. Goldin et al: Europ. J. Cancer, 17,129(1981) 3.結果 通過利用P388老鼠腫瘤細胞的活體内實驗,編號 8’ 15’ 16,20,56,73,74等發明物質的有效性 (T/C>125%) 〇 -153- 本紙張尺度適用中國國家標準(CNS ) A4規格(2ΐ〇χ:297公羞了 (請先閱讀背面之注意事項再填寫本頁)、 1T -152- This paper size is applicable to Chinese National Standard (CNS) Α4 specification (210X 297mm) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 575564 A7 --- --- _B7 V. Description of the invention (148)- Experimental example 3) ★ In vivo anticancer effect on mouse P388 cells I Experimental material BDFI mice 2 · Experimental method υ 8 6-week-old BDFI mice were used as a group. P388 cells were transplanted in each mouse, and 1 × 106 cells / ml were transplanted into the lumen cavity. 2) The test drug was suspended in 0.5% Tween80, and the dye was injected into the abdominal cavity every 9 hours. 3) The mice were observed daily, the survival rate was measured, and the average survival day increase ratio (T / C%) relative to the administration group of the control group was calculated from the intermediate survival time of each experimental group to determine the anticancer effect. The results are shown in the following table. ★ References A. Goldin et al: Europ. J. Cancer, 17, 129 (1981) 3. Results In vivo experiments using P388 mouse tumor cells, No. 8 '15' 16, 20, 56, 73, 74 and other inventive substances Validity (T / C > 125%) 〇-153- This paper size applies the Chinese National Standard (CNS) A4 specifications (2ΐ〇χ: 297) (Please read the precautions on the back before filling this page)

575564 A7 B7 五、發明説明(149) 經濟部中央標準局員工消費合作社印製 袭 實施讽編號 - Dose(mg/kg) ^ T/C(%) mmmm 8 200 140.9 隔1,5,9日 100 104.5 15 25 150 每曰隔9日' 10 110 1() 50 165 每日隔9曰 25 110 100 150 22 50 140 每曰隔9日 25 110 200 227.3 5(5 100 140.9 隔1,5,9曰 50 118.2 50 165.0 5(3 25 ’145.0 每日隔9日 10 140.0 50 180.0 73 25 150.0 每曰 隔9日 10 140.0 . 50 250.0 74 25 150.0 每曰 隔9日 10 140.0 (請先閱讀背面之注意事項再填寫本頁) -154- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 575564 A7 B7 五、發明説明(150) __ 實施搬扁號 Dose(mg/kg) ^ T/C(%) mmmm 1 200 218.2 -—~- — -1 81 100 145.5 隔1,5,9日, 50 127.3 50 210.0 81 25 140.0 毎日隔9日 10 140.0 82 100 127.3 隔1,5,9曰’ 50 . 100.0 100 150.0 50 110.0 每日 隔9日 25 110.0 (請先閱讀背面之注意事項再填寫本頁) 實方娜_ Dose(mg/kg) T/C(%) 100 150.0 i 135 50 110.0 每日 隔9日 25 100.0 200 125.0 144 100 110.0 每日 隔9日 50 110.0 155- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 實方讎編號 Dose(mg/kg) T/C(%) 搬弊嫌’ 100 140.0 171 50 100.0 -隔 1,4,8 日, 25 100.0 200 190.9 172 100 127.3 隔I,4,8曰 50 * 118.2 575564 五、發明説明(151) 貫驗例4) ★急性毒性實驗 1·實驗方法: 將所購得6週齡的| ^ a# 於實驗進行前,在二雄性30土2,, 下,使其自由攝取;;::=、濕度6°±5%條件 ^ ^ 取乾秌飼枓及水分。將該等實驗用 士 又為、、且,为別將藥物投與腹腔内,並 己、κ 14日期間的外觀狀態及死生與否,將已死亡 的動物予以進行解剖,並以肉眼觀察病情狀態。依 …、理查文爾德-偉康森法(Richfiled_Wilc〇x〇n method)求取LD5。值。結果如下表中所示。 、本發明化合物,在急性毒性中,均較順氯氨鉑 或亞德利亞黴素具有優越的安全性,就投藥量限 制、毒性等,均可確認已然超越習知技術化合物, 足夠克服習知技術缺點。 經濟部中央標準局員工消費合作社印製 -156 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇x297公釐) 575564 A7 B7 五、發明説明(152)575564 A7 B7 V. Description of the invention (149) Printed implementation code of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs-Dose (mg / kg) ^ T / C (%) mmmm 8 200 140.9 100 every 1,5,9 days 104.5 15 25 150 every 9 days' 10 110 1 () 50 165 every 9 days 25 110 100 150 22 50 140 every 9 days 25 110 200 227.3 5 (5 100 140.9 every 1, 5, 9 50 118.2 50 165.0 5 (3 25 '145.0 every other day 10 140.0 50 180.0 73 25 150.0 every other day 10 140.0. 50 250.0 74 25 150.0 every other day 10 140.0 (Please read the notes on the back first (Fill in this page again) -154- This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210X297 mm) 575564 A7 B7 V. Description of the invention (150) __ Implementation of flat number Dose (mg / kg) ^ T / C (%) mmmm 1 200 218.2 -—— ~-— -1 81 100 145.5 every 1,5,9 days, 50 127.3 50 210.0 81 25 140.0 every other day 10 140.0 82 100 127.3 every 1,5,9 days . 100.0 100 150.0 50 110.0 Every other day 9 25 110.0 (Please read the precautions on the back before filling this page) Shifangna_ Do se (mg / kg) T / C (%) 100 150.0 i 135 50 110.0 Every other day every day 25 100.0 200 125.0 144 100 110.0 Every other day every day 50 110.0 155- This paper size applies Chinese National Standard (CNS) A4 Specifications (210X297 mm) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs, the Dose Code (Dose (mg / kg) T / C (%)) "100 140.0 171 50 100.0-every 1, 4, 8 days, 25 100.0 200 190.9 172 100 127.3 I, 4, 8 50 * 118.2 575564 V. Description of the invention (151) Continuing test example 4) ★ Acute toxicity test 1 · Experiment method: Purchase the 6-week-old | ^ a # Before the experiment, the two males were allowed to ingest freely under the conditions of 30, 2, and 3; :: =, humidity 6 ° ± 5% conditions ^ ^ The dried mash and water were taken. These experimenters were used again, and, in order not to administer drugs into the abdominal cavity, and the appearance status and death of κ during the 14th day, the dead animals were dissected and the condition was observed with the naked eye status. LD5 is calculated according to the Richfiled-Wilcon method. value. The results are shown in the following table. In the acute toxicity, the compounds of the present invention are superior to cisplatin or adriamycin in acute toxicity. With regard to dosage limits, toxicity, etc., it can be confirmed that the compounds have exceeded the conventional technology, which is sufficient to overcome the habit. Know the technical disadvantages. Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs -156 This paper size applies to the Chinese National Standard (CNS) A4 (21 × 297 mm) 575564 A7 B7 V. Description of the invention (152)

表4 實施例編號 LD5〇(nig/kg)(i„p) ,· ................ 8 707 12 165 13 284.8 15 190 1G 282.8 22 >2,000 28 >2,000 56 4 410 57 455 73 250 74 361.4 順讎白 9.7 (請先閲讀背面之注意事項再填寫本頁)Table 4 Example No. LD50 (nig / kg) (i'p), ... 8 707 12 165 13 284.8 15 190 1G 282.8 22 > 2,000 28 > 2,000 56 4 410 57 455 73 250 74 361.4 Shun white 9.7 (Please read the precautions on the back before filling this page)

、1T d 經濟部中央標準局員工消費合作社印製 •157- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 575564 A7 B7 五、發明説明(153 畫 實施例編號 LD5〇(ingykg)(i.p) 81 Ι,βΟΟ ' 82 700 順白 9.7 實施例編號 , LD5〇(mg/kg) 132 573.1 134 723.7 144 . 348.9 146 309.6 148 >2,000 149 ' 417.6 , 順讎白 9.7 經 濟 部 t 央 標 準 員 工 消 f 合 作 社 印 製 實施例編號 LD5〇(nig/kg) 170 573 172 723 182 348 184 309 186 >2,000 187 • 417.6 順白 9.7 158 (請先閲讀背面之注意事項再填寫本頁)1T d Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs • 157- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 575564 A7 B7 V. Description of the invention (153 painted embodiment number LD5. (ingykg) (ip) 81 Ι, βΟΟ '82 700 Cis white 9.7 Example number, LD50 (mg / kg) 132 573.1 134 723.7 144. 348.9 146 309.6 148 > 2,000 149' 417.6, Cis white 9.7 Ministry of Economic Affairs t Central Standards Staff Consumers Cooperative Society Printing Example Number LD50 (nig / kg) 170 573 172 723 182 348 184 309 186 > 2,000 187 • 417.6 Shunbai 9.7 158 (Please read the precautions on the back before filling this page )

本紙張尺度適用中國國家標準(CNS ) A4規格(2丨〇'乂297公釐)This paper size applies to China National Standard (CNS) A4 specification (2 丨 〇 '乂 297mm)

Claims (1)

575564 * U 4 Α8 Β8575564 * U 4 Α8 Β8 J τ明荼申请專利範圍修正本 申請專利範圍 第861 12235號專利申諳亲由 92年7月4曰 ! 一種新㈣衍生物及其藥學上容許的酸加成鹽,係指如 下一般結構式(1)所示者,J τ Ming Tu's application for amendments to the scope of patent application No. 861 12235 of this application Patent application dated July 4, 1992! A new hydrazone derivative and its pharmaceutically acceptable acid addition salt refer to the following general structural formula (1) As shown, (請先閱讀背面之注意事填寫本頁) 裝 經濟部智慧財產局員工消費合作社印製 〜C6烷基、取代或非取代之C2〜C6不飽和烷基、苯基、 取代或非取代的(^〜(:4烷氧基、乙醯基、或&amp;及r2 同時形成碳化氫3〜4不飽和或飽和環;而r3、r4、r5、 R6及I分別代表氫原子、鹵原子、羥基、Ci〜C4低級 烧基、(^〜匕低級硫代烷基、取代或非取代的Ci〜c4 低級烧氧基、C〗〜C4低級硫代烷氧基、(^〜0:4環烷氧 基、取代或非取代的苯基、或r3與r4互相結合而形成 苯并基或萘并基; X係指氧原子、硫原子; Y係指-NRs·基(此處r8係為η或Ci〜C4烧基),且Y 係結合於結構式(1)化合物中,γ所結合之芳香族環的 3-位置或4-位置處; Z係指氫原子、羥原子、c 1〜C4低級烷氧基、c i〜 C 4低級烧基胺基、σ底嗔基、吼淀基、σ塞吩基; 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 29?ΠΤ - 575564 A8 B8 C8 D8 、申清專利範圍 =係指一⑽或氮原子(但A為氣原子時,RlA 不為&lt;^〜(:6烷基)。 2·—種新哌嗪衍生物或其 未千上容許的酸加成鹽的製造方 二,係指製造—般結構式⑴所示化合物的製造方法 t ’係將下列—般結構式⑷所示化合物,於-般的有 機溶劑存在下,與彳卜… &gt;基供給試藥進行反應而製得 的一般結構式(b)所示化人舲 一 化口物,並使該一般結構式(b)戶斤 示化合物與一般結構式_ 斤不化合物,進行反應而 得一般結構式(1)所示化合物的方法, R2 製 (請先閱讀背面之注音?事項相填、寫本貢)(Please read the cautions on the back and fill in this page first) Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs ~ C6 alkyl, substituted or unsubstituted C2 ~ C6 unsaturated alkyl, phenyl, substituted or unsubstituted ( ^ ~ (: 4 alkoxy, ethanoyl, or &amp; and r2 simultaneously form a hydrocarbon 3 ~ 4 unsaturated or saturated ring; and r3, r4, r5, R6, and I represent a hydrogen atom, a halogen atom, and a hydroxyl group, respectively , Ci ~ C4 lower alkynyl, (^ ~ lower thioalkyl, substituted or unsubstituted Ci ~ c4 lower alkoxy, C〗 ~ C4 lower thioalkoxy, (^ ~ 0: 4 cycloalkane Oxygen, substituted or unsubstituted phenyl, or r3 and r4 combine with each other to form benzo or naphthyl; X means oxygen atom and sulfur atom; Y means -NRs · group (here r8 is η Or Ci ~ C4 alkyl), and Y is bound to the 3-position or 4-position of the aromatic ring to which γ is bonded in the compound of structural formula (1); Z refers to a hydrogen atom, a hydroxyl atom, and c 1 ~ C4 lower alkoxy group, ci ~ C 4 lower alkylamino group, σ base group, hydrazine group, σ sephenyl group; This paper size applies to China National Standard (CNS) A4 specification (210 X 29 ? ΠΤ-575564 A8 B8 C8 D8, the scope of patent application = refers to a nitrogen atom or a nitrogen atom (but when A is a gas atom, R1A is not <^ ~ (: 6 alkyl). 2 · a kind of new piperazine The second method for producing a derivative or an unacceptable acid addition salt thereof is a method for producing a compound represented by the general structural formula ⑴. In the presence of an organic solvent, it is reacted with a base-supplying reagent to produce a general compound represented by the general structural formula (b) and the compound shown in the general structural formula (b) Method for reacting with general structural formula _ compound to obtain compound represented by general structural formula (1), by R2 (please read the note on the back? Fill in the matter and write the tribute) (b) 訂:(b) Order: 式中,Ri,R2,R3,R4,R5,R6,R7,a,x,y,z 係指如同前所定 義,而Liei則係指與氫原子相同脫離基。 , 經濟部智慧財產局員工消費合作社印製 -2. 本紙張尺度適用中國國家標準(CNS)A4規格(2]0 X 297公沒)In the formula, Ri, R2, R3, R4, R5, R6, R7, a, x, y, z are as defined above, and Liei means the same leaving group as the hydrogen atom. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs -2. This paper size applies to China National Standard (CNS) A4 (2) 0 X 297
TW86112235A 1996-06-29 1997-08-26 Piperazine derivatives and process for the preparation thereof TW575564B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR19960025827 1996-06-29
KR19960025825 1996-06-29
KR19960025826 1996-06-29
KR19960040596 1996-09-18
KR1019970022984A KR100204320B1 (en) 1996-06-29 1997-06-03 Novel piperazine derivatives and their preparation method

Publications (1)

Publication Number Publication Date
TW575564B true TW575564B (en) 2004-02-11

Family

ID=32738939

Family Applications (1)

Application Number Title Priority Date Filing Date
TW86112235A TW575564B (en) 1996-06-29 1997-08-26 Piperazine derivatives and process for the preparation thereof

Country Status (1)

Country Link
TW (1) TW575564B (en)

Similar Documents

Publication Publication Date Title
CN107001347B (en) Oxa- loop coil analog derivative, preparation method and its application in medicine
TWI268924B (en) Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processTW es for preparing them
CA2230960C (en) Piperazine derivatives and process for the preparation thereof
CN1989113B (en) Quinazoline derivatives
KR100396738B1 (en) Piperazine derivatives and process for the preparation thereof
EP0749425A1 (en) New piperazine derivatives and methods for the preparation thereof and compositions containing the same
CN111051300B (en) Novel heteroaryl amide derivatives as selective inhibitors of histone deacetylase 1 and/or 2 (HDAC 1-2)
CN102405213B (en) Cyclopropyl amide derivatives targeting the histamine h3 receptor
JP2008513451A (en) 4-Arylspirocycloalkyl-2-aminopyrimidinecarboxamide KCNQ potassium channel modulator
WO2005000778A1 (en) Hsp90 FAMILY PROTEIN INHIBITORS
JP2012250983A (en) Kappa opioid receptor ligand
KR20120043058A (en) Nitrogenous-ring acylguanidine derivative
CN107459476A (en) Anti- aminated compounds of indole ring third and preparation method thereof, pharmaceutical composition and purposes
TW575564B (en) Piperazine derivatives and process for the preparation thereof
CN107922419A (en) Imidazo [1,2 B] [1,2,4] pyrrolotriazine derivatives as antiparasitic agent
TWI236469B (en) Diamine compound with condensed-ring groups
TW421646B (en) Benzopyran derivatives having K&lt;+&gt;-channel opening activity
WO2023011416A1 (en) Multi-target inhibitor targeting hdac and nad synthesis and use of multi-target inhibitor
TW499427B (en) A alpha-methylene-3-di[(substituted)phenyl]methyl-gamma-butyrolactone, halogenated derivatives thereof, and anti-cancer compositions containing the same
CN107973788A (en) BBI608 derivatives and its preparation and purposes
KR20230170684A (en) Pyrimidine Derivatives Useful as LRRK2 Kinase Inhibitors
JPS6069089A (en) Dihydropyridine-5-phosphonate derivative and production thereof
RU2590163C2 (en) Derivatives of 6-methyl-4-phenyl-5-(phenyl or cycloalkyl)-carbamoyl-1,2,3,4-tetrahydropyrimidin-2-one as antituberculous agents
CN104744451A (en) 1-(3-amino propyl) substituted cyclic amine compound as well as preparation method, pharmaceutical composition and use thereof
TW406074B (en) Heterocyclyloxybenzoylguanidines

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees